{
  "meta": {
    "title": "Inicet_Mock_Test-5",
    "url": "https://brainandscalpel.vercel.app/inicet-mock-test-5-3795b672.html",
    "scrapedAt": "2025-11-29T17:24:17.470Z"
  },
  "questions": [
    {
      "id": 96355,
      "choices": [
        {
          "id": 383564,
          "text": "<p><span style=\"font-size:14.0pt;\">Severe Obstruction</span></p>"
        },
        {
          "id": 383565,
          "text": "<p><span style=\"font-size:14.0pt;\">Severe Restriction</span></p>"
        },
        {
          "id": 383566,
          "text": "<p><span style=\"font-size:14.0pt;\">Mixed Obstruction–Restriction</span></p>"
        },
        {
          "id": 383567,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudorestriction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old woman presents with dyspnea and orthopnea. She is a lifelong non-smoker. Her pulmonary function testing (PFT) results are as follows:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_z1tGVYm.png\" width=\"635\" height=\"274\"></strong></span></p>",
      "unique_key": "Q7485842",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Mixed Obstruction–Restriction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 1. Identify Obstruction:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>FEV₁/FVC = 61% (&lt;70%) → Obstructive defect</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>FEV₁ = 30% predicted → Severe obstruction</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 2. Identify Restriction:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>TLC = 52% predicted → True restriction</strong></span></li><li><span style=\"font-size:14.0pt;\">Restrictive defect is confirmed when <strong>TLC &lt; 80% predicted</strong>, not merely a reduced FVC.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 3. Integration:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Both <strong>obstructive</strong> and <strong>restrictive</strong> features are present → <strong>Mixed pattern</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 4. Rule out Pseudorestriction:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In pseudorestriction (as in severe air trapping), <strong>TLC is normal or high</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Here, TLC is reduced, confirming <strong>true restriction</strong> rather than pseudo.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Severe Obstruction:&nbsp;</strong>FEV₁/FVC ↓ supports obstruction, but TLC is also ↓ → not pure obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Severe Restriction:&nbsp;</strong>Restrictive defect present, but FEV₁/FVC ratio is ↓ → not pure restriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pseudorestriction:&nbsp;</strong>Seen in air trapping (↓FVC, <strong>normal/increased TLC</strong>). Here TLC is ↓ (52%) → true, not pseudo, restriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>mixed obstructive–restrictive pattern</strong> on PFT is diagnosed when both:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>FEV₁/FVC &lt; 70%</strong> (obstruction) and</span></li><li><span style=\"font-size:14.0pt;\"><strong>TLC &lt; 80% predicted</strong> (restriction).</span></li></ul>",
      "correct_choice_id": 383566,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96355/Medicine_INICET_GT_30_Oct_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96355/Medicine_INICET_GT_30_Oct_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96300,
      "choices": [
        {
          "id": 383348,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate antitoxin administration after sensitivity testing</span></p>"
        },
        {
          "id": 383349,
          "text": "<p><span style=\"font-size:14.0pt;\">Start IV antibiotics and observe</span></p>"
        },
        {
          "id": 383350,
          "text": "<p><span style=\"font-size:14.0pt;\">Remove membrane and give local antiseptics&nbsp;</span></p>"
        },
        {
          "id": 383351,
          "text": "<p><span style=\"font-size:14.0pt;\">Wait for culture confirmation before starting treatment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">6-year-old unimmunized child presents with low-grade fever, sore throat, and difficulty swallowing for 3 days. Examination reveals the findings shown in the image, a characteristic bull neck appearance, and a muffled voice. The child appears toxic and has moderate respiratory distress. What is the most appropriate first step in management?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20161546.jpg\" width=\"400\" height=\"540\"></strong></span></p>",
      "unique_key": "Q5253405",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Immediate antitoxin administration after sensitivity testing</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This child presents with classic signs of diphtheria, including the pathognomonic greyish-white membrane that bleeds on attempted removal, bull neck appearance (due to significant cervical lymphadenopathy), and muffled voice (suggesting laryngeal involvement).</span></li><li><span style=\"font-size:14.0pt;\">Diphtheria toxin causes local tissue destruction and can lead to myocarditis, neuritis, and respiratory failure when systemically absorbed.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Antitoxin neutralizes circulating toxin, preventing further damage, and should be administered immediately after a sensitivity test to check for hypersensitivity to horse serum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The dose depends on the site and extent of disease, with 80,000-120,000 units indicated for severe pharyngeal/laryngeal disease as in this case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start IV antibiotics and observe:</strong> While antibiotics (penicillin or erythromycin) are essential to eradicate the organism and prevent further toxin production, they will not neutralize already circulating toxin. Antibiotics should be given after antitoxin administration but aren't sufficient alone for a child with signs of severe disease and toxin effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Remove membrane and give local antiseptics</strong>: Attempting to remove the membrane is contraindicated as it may cause bleeding, increases pain, and can promote toxin absorption. The membrane also provides important diagnostic evidence and should be sampled for culture rather than removed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Wait for culture confirmation before starting treatment:</strong> Delaying treatment until culture confirmation (which may take 48-72 hours) significantly increases mortality. Treatment should be initiated based on clinical diagnosis in an unimmunized child with characteristic features, as the case fatality rate increases with each day of delayed treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Diphtheria is a medical emergency requiring immediate intervention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The management priority is antitoxin administration after sensitivity testing to neutralize circulating toxin, followed by appropriate antibiotics and supportive care.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The dosage of antitoxin depends on disease severity, with higher doses (80,000-120,000 units) indicated for severe or extensive disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20162048.jpg\" width=\"928\" height=\"349\"></span></p>",
      "correct_choice_id": 383348,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96300/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96300/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96404,
      "choices": [
        {
          "id": 383760,
          "text": "<p><span style=\"font-size:14.0pt;\">Autoclaving at 134°C for 60 minutes</span></p>"
        },
        {
          "id": 383761,
          "text": "<p><span style=\"font-size:14.0pt;\">Soaking in 1N NaOH for 1 hour</span></p>"
        },
        {
          "id": 383762,
          "text": "<p><span style=\"font-size:14.0pt;\">Immersion in 0.5% sodium hypochlorite for 2 hours</span></p>"
        },
        {
          "id": 383763,
          "text": "<p><span style=\"font-size:14.0pt;\">Gamma radiation at 25 kGy dose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old neurosurgeon expresses concern about prion contamination after operating on a patient later diagnosed with Creutzfeldt-Jakob disease. The surgical team prepares to sterilize the neurosurgical instruments used during the case. Which of the following decontamination strategies is insufficient for inactivating prion proteins?</span></p>",
      "unique_key": "Q6580773",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Gamma radiation at 25 kGy dose</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prions, unlike typical infectious agents, are <strong>extremely resistant</strong> to standard physical and chemical sterilization techniques.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their <strong>pathogenic isoform (PrP&lt;sup&gt;Sc&lt;/sup&gt;)</strong> aggregates and resists breakdown because of its stable <strong>beta-sheet conformation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">According to CDC and WHO recommendations, effective inactivation of prions includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Autoclaving at 134°C for 1–1.5 hours</strong> under vacuum</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immersion in 1N sodium hydroxide for 1 hour</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Immersion in 0.5% sodium hypochlorite for at least 1–2 hours</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">In contrast, <strong>gamma irradiation at 25 kGy</strong>, which is effective for sterilizing many bacteria and viruses, <strong>does not reliably inactivate prions</strong>, even at high doses.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Autoclaving at 134°C for 60 minutes:</strong> Effective method. High-pressure steam at this temperature denatures PrP&lt;sup&gt;Sc&lt;/sup&gt; structures when done properly under vacuum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Soaking in 1N NaOH for 1 hour:</strong> Effective method. Strong alkaline conditions degrade the prion protein and denature its pathogenic form.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Immersion in 0.5% Sodium hypochlorite for 2 hours:</strong> Effective method. This is a WHO-endorsed chemical sterilant for prion-contaminated tools.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prion proteins are <strong>highly resistant</strong> to conventional sterilization. <strong>Gamma radiation, UV light, and alcohols are ineffective.</strong>&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Only extreme protocols like <strong>autoclaving at 134°C</strong>, <strong>NaOH</strong>, or <strong>sodium hypochlorite</strong> for prolonged periods can reliably inactivate prions on medical equipment.</span></li></ul>",
      "correct_choice_id": 383763,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96404/Microbiology_INICET_GT_30_Oct_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96404/Microbiology_INICET_GT_30_Oct_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96407,
      "choices": [
        {
          "id": 383772,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4, 5</span></p>"
        },
        {
          "id": 383773,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4, 5</span></p>"
        },
        {
          "id": 383774,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
        },
        {
          "id": 383775,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Peripheral IV cannulation in newborn requires:&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">24G needle</span></li><li><span style=\"font-size:14.0pt;\">16G needle</span></li><li><span style=\"font-size:14.0pt;\">5 mL syringe</span></li><li><span style=\"font-size:14.0pt;\">Adhesive tape</span></li><li><span style=\"font-size:14.0pt;\">Normal saline</span><br><br>&nbsp;</li></ol>",
      "unique_key": "Q9342452",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 3, 4, 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Newborns require small-bore cannula (<strong>24G</strong>) with 5ml syringe, adhesive tape, and normal saline for patency check.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Option:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>2. 16G needle:</strong> 16G needle is used in trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Use <strong>24–26G</strong> needles for neonates to avoid vascular trauma.</span></p>",
      "correct_choice_id": 383772,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96407/Anesthesia_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96407/Anesthesia_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96388,
      "choices": [
        {
          "id": 383696,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 383697,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 383698,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 383699,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements correctly identify key differentiators in larval behaviour among intestinal nematodes?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Hookworm and Strongyloides stercoralis share skin penetration and pulmonary migration, but only Strongyloides can complete its life cycle within the host via autoinfection.</span></li><li><span style=\"font-size:14.0pt;\">Trichuris trichiura and Enterobius vermicularis lack a larval lung migration phase and reside primarily in the small intestine.</span></li><li><span style=\"font-size:14.0pt;\">Ascaris lumbricoides uniquely has both fertilized and unfertilized eggs, and its larvae undergo hepatic-tracheal migration.</span></li><li><span style=\"font-size:14.0pt;\">Strongyloides stercoralis is the only nematode which is diagnosed by finding larvae, not eggs, in stool.</span></li></ol>",
      "unique_key": "Q7665779",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Hookworm and Strongyloides stercoralis share skin penetration and pulmonary migration, but only Strongyloides can complete its life cycle within the host via autoinfection:&nbsp;</strong>Correct. Hookworm and Strongyloides enter via skin and migrate via lungs. However, Strongyloides is the <strong>only helminth</strong> in this group capable of <strong>internal autoinfection</strong>, often leading to <strong>hyperinfection</strong> in immunocompromised patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Ascaris lumbricoides uniquely has both fertilized and unfertilized eggs, and its larvae undergo hepatic-tracheal migration:&nbsp;</strong>Correct.&nbsp; Ascaris produces both egg types. After ingestion, <strong>larvae migrate to the lungs</strong>, causing <strong>Löffler’s syndrome</strong>, then are coughed up and swallowed, returning to the small intestine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Strongyloides stercoralis is the only nematode which is diagnosed by finding larvae, not eggs, in stool:&nbsp;</strong>Correct. Unlike other intestinal nematodes, Strongyloides is diagnosed by <strong>rhabditiform larvae</strong> in stool. Eggs are rarely seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Trichuris trichiura and Enterobius vermicularis lack a larval lung migration phase and reside primarily in the small intestine:&nbsp;</strong>Incorrect. Both Trichuris and Enterobius <strong>do not undergo lung migration</strong>, <strong>but they reside in the large intestine</strong>, not the small intestine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Strongyloides stercoralis</strong> is the only intestinal nematode that can cause autoinfection and is diagnosed by <strong>larvae in stool</strong>, not eggs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Trichuris and Enterobius lack a lung phase and reside in the <strong>large intestine</strong>, not the small intestine.</span></li></ul>",
      "correct_choice_id": 383696,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96388/Microbiology_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96388/Microbiology_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96408,
      "choices": [
        {
          "id": 383776,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 383777,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 5</span></p>"
        },
        {
          "id": 383778,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 5</span></p>"
        },
        {
          "id": 383779,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which statement(s) is/are accurate concerning local anesthetics?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Prilocaine is longer acting than Bupivacaine.</span></li><li><span style=\"font-size:14.0pt;\">Tetracaine is more potent than Lignocaine.</span></li><li><span style=\"font-size:14.0pt;\">Dibucaine is the longest acting local anesthetic.</span></li><li><span style=\"font-size:14.0pt;\">Bupivacaine can produce cardiotoxicity.</span></li><li><span style=\"font-size:14.0pt;\">Cocaine can produce hypotension.</span></li></ol>",
      "unique_key": "Q5014986",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Tetracaine is more Potent than Lignocaine:&nbsp;</strong>Tetracaine is considered a <strong>high-potency local anesthetic</strong> and is <strong>generally more potent</strong> than <strong>lignocaine (lidocaine)</strong>, which is an <strong>intermediate-potency local anesthetic</strong>.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Dibucaine is the Longest-Acting Local Anesthetic:&nbsp;</strong>Dibucaine is known for its <strong>very long duration of action</strong> among <strong>local anesthetics</strong>, making it one of the <strong>longest-acting agents</strong> in this class.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Bupivacaine can produce Cardiotoxicity:&nbsp;</strong>Bupivacaine, particularly when used in <strong>high doses</strong> or <strong>inadvertently administered</strong> <strong>systemically</strong>, can <strong>produce cardiotoxicity</strong>, including <strong>potential</strong> for <strong>cardiac arrhythmias</strong> and <strong>toxicity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Prilocaine is Longer Acting than Bupivacaine:&nbsp;</strong>Bupivacaine is known for its <strong>long duration of action</strong>, while prilocaine has a <strong>shorter duration of action</strong> compared to bupivacaine. Therefore, this statement is <strong>false</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Cocaine can produce Hypotension:&nbsp;</strong>Cocaine, as a vasoconstrictor, can <strong>lead to hypertension</strong> rather than <strong>hypotension</strong> due to its <strong>effects on the cardiovascular system</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Based on potency &amp; duration local anaesthetics are classified into:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hALdtUh.png\" width=\"677\" height=\"365\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cocaine</strong> causes <strong>vasoconstriction</strong> leading to <strong>hypertension</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bupivacaine</strong> is the <strong>most cardiotoxic local anesthetic</strong>.</span></li></ul>",
      "correct_choice_id": 383776,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96408/Anesthesia_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96408/Anesthesia_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96110,
      "choices": [
        {
          "id": 382604,
          "text": "<p><span style=\"font-size:14.0pt;\">1–a, 2–c, 3–b, 4–d</span></p>"
        },
        {
          "id": 382605,
          "text": "<p><span style=\"font-size:14.0pt;\">1–a, 2–b, 3–d, 4–c</span></p>"
        },
        {
          "id": 382606,
          "text": "<p><span style=\"font-size:14.0pt;\">1–a, 2–b, 3–c, 4–d</span></p>"
        },
        {
          "id": 382607,
          "text": "<p><span style=\"font-size:14.0pt;\">1–d, 2–a, 3–b, 4–c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the type of muscle contraction with its defining characteristic choose the correct match:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9DBdWjK.png\" width=\"1094\" height=\"226\"></span></p>",
      "unique_key": "Q6138273",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1–a, 2–b, 3–c, 4–d</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1–a. Isometric →</strong> <strong>Constant muscle length, variable tension:</strong> Tension ↑ but <strong>length constant</strong> (e.g., holding a weight steady).</span></li><li><span style=\"font-size:14.0pt;\"><strong>2–b. Isotonic (concentric) →</strong> <strong>Constant tension, shortening of muscle:</strong> Tension constant, <strong>muscle shortens</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3–c. Eccentric →</strong> <strong>Muscle lengthens while contracting:</strong> Muscle <strong>lengthens while contracting</strong> (controlled lowering of weight).</span></li><li><span style=\"font-size:14.0pt;\"><strong>4–d. Isokinetic →</strong> <strong>Constant velocity of contraction:</strong> Muscle contracts at <strong>constant velocity</strong> (requires specialized equipment).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14.0pt;\">Different muscle contractions vary by whether <strong>length, tension, or velocity</strong> remains constant during contraction.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"color:black;font-size:14.0pt;\"><strong>Isometric:</strong> Length constant, tension changes</span></li><li><span style=\"color:black;font-size:14.0pt;\"><strong>Isotonic (Concentric):</strong> Tension constant, muscle shortens</span></li><li><span style=\"color:black;font-size:14.0pt;\"><strong>Eccentric:</strong> Muscle lengthens while contracting</span></li><li><span style=\"color:black;font-size:14.0pt;\"><strong>Isokinetic:</strong> Constant velocity contraction</span></li></ul>",
      "correct_choice_id": 382606,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96110/Physiology_INICET_GT_30_Oct_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96110/Physiology_INICET_GT_30_Oct_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96112,
      "choices": [
        {
          "id": 382612,
          "text": "<p><span style=\"font-size:14.0pt;\">DNA Polymerase I (E. coli)</span></p>"
        },
        {
          "id": 382613,
          "text": "<p><span style=\"font-size:14.0pt;\">Klenow fragment</span></p>"
        },
        {
          "id": 382614,
          "text": "<p><span style=\"font-size:14.0pt;\">Restriction Endonuclease</span></p>"
        },
        {
          "id": 382615,
          "text": "<p><span style=\"font-size:14.0pt;\">RNA polymerase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A molecular biologist is developing a diagnostic PCR-based assay to detect mutations in a gene associated with colorectal cancer. During optimization, she uses a modified DNA polymerase that can synthesize DNA and proofread errors but cannot remove nucleotides ahead of the growing DNA strand. Which of the following enzymes is she most likely using in this experiment?&nbsp;</span></p>",
      "unique_key": "Q1855695",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Klenow fragment</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>modified DNA polymerase</strong> used in a <strong>PCR-based assay</strong> that can <strong>synthesize DNA and proofread errors (3′→5′ exonuclease activity)</strong> but <strong>cannot remove nucleotides ahead of the growing strand (no 5′→3′ exonuclease activity)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This exactly describes the <strong>Klenow fragment</strong>, which is a <strong>large fragment of </strong><i><strong>E. coli</strong></i><strong> DNA polymerase I</strong> produced when the enzyme is cleaved by the protease <strong>subtilisin</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This cleavage removes the <strong>5′→3′ exonuclease domain</strong>, leaving behind two functional domains:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>5′→3′ polymerase activity</strong> – allows DNA synthesis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3′→5′ exonuclease activity</strong> – enables proofreading and correction of misincorporated bases.</span></li></ol></li><li><span style=\"font-size:14.0pt;\">Because it lacks the 5′→3′ exonuclease function, the Klenow fragment cannot remove nucleotides ahead of the growing DNA strand (no “nick translation” activity).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This makes it ideal for <strong>DNA labeling, sequencing, and site-directed mutagenesis</strong>, where controlled synthesis and proofreading are required without strand degradation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. DNA Polymerase I (E. coli):&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Native <i>E. coli</i> DNA polymerase I possesses <strong>three enzymatic activities</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">5′→3′ polymerase activity (DNA synthesis)</span></li><li><span style=\"font-size:14.0pt;\">3′→5′ exonuclease activity (proofreading)</span></li><li><span style=\"font-size:14.0pt;\">5′→3′ exonuclease activity (nick translation)</span><br><span style=\"font-size:14.0pt;\">Since the question specifies that the enzyme <strong>cannot remove nucleotides ahead of the strand</strong>, this enzyme is excluded because it retains the <strong>5′→3′ exonuclease</strong> function.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Restriction Endonuclease:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Restriction endonucleases are enzymes that <strong>cut DNA at specific palindromic recognition sequences</strong>. They do not participate in DNA synthesis or proofreading, so they are unrelated to polymerase function or PCR-based applications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. RNA Polymerase:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>RNA polymerase synthesizes <strong>RNA</strong> from a <strong>DNA template</strong>, not DNA. It does not have <strong>proofreading activity</strong> comparable to DNA polymerases and lacks both <strong>5′→3′ and 3′→5′ exonuclease</strong> activities. Hence, it does not match the enzyme described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Klenow fragment</strong> is a modified form of <i>E. coli</i> <strong>DNA polymerase I</strong> that <strong>retains 5′→3′ polymerase and 3′→5′ exonuclease (proofreading) activities</strong> but <strong>lacks 5′→3′ exonuclease activity</strong>, making it suitable for <strong>DNA synthesis without strand degradation</strong>.</span></p>",
      "correct_choice_id": 382613,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96112/Biochemistry_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96112/Biochemistry_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96134,
      "choices": [
        {
          "id": 382696,
          "text": "<p><span style=\"font-size:14.0pt;\">If the test is positive, the patient definitely has the disease</span></p>"
        },
        {
          "id": 382697,
          "text": "<p><span style=\"font-size:14.0pt;\">If the test is negative, the patient is very unlikely to have the disease</span></p>"
        },
        {
          "id": 382698,
          "text": "<p><span style=\"font-size:14.0pt;\">If the disease is common in the population and the test is positive, the patient must have the disease</span></p>"
        },
        {
          "id": 382699,
          "text": "<p><span style=\"font-size:14.0pt;\">If the disease is rare in the population and the test is positive, the patient is likely to have the disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old asymptomatic man participates in a community screening program for a condition which is serious but treatable early stage. The screening test used by the program is known to have very high sensitivity. Which of the following inferences is most appropriate when interpreting an individual’s test result?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7146993",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)</strong> <strong>If the disease is common in the population and the test is positive, the patient must have the disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sensitivity</strong> = probability that the test is positive <strong>given disease</strong> (true-positive rate). A <strong>highly sensitive</strong> screening test has <strong>few false negatives</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Whether a <strong>positive</strong> result indicates true disease depends on the <strong>positive predictive value (PPV)</strong>, which rises as <strong>prevalence</strong> increases (Bayes’ theorem).</span></li><li><span style=\"font-size:14.0pt;\">Therefore, when the <strong>disease is prevalent</strong> and the test is <strong>positive</strong>, the person is <strong>more likely</strong> to truly have the disease—<strong>but a screening positive must always be followed by a confirmatory diagnostic test</strong> (standard screening principle; Ref. Park 27/e p155).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. If the test is positive, the patient definitely has the disease:</strong> Overstated. A positive result’s certainty depends mainly on <strong>specificity</strong> and <strong>prevalence</strong>; screening tests can yield <strong>false positives</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. If the test is negative, the patient is very unlikely to have the disease:&nbsp;</strong>Too absolute. High sensitivity makes a <strong>negative</strong> result <strong>reassuring</strong> (few false negatives), but it is not 100%.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. If the disease is rare in the population and the test is positive, the patient is likely to have the disease:</strong> Backwards. When prevalence is <strong>low</strong>, <strong>PPV is low</strong>; many positives are <strong>false positives</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For a <strong>highly sensitive screening test</strong>, a <strong>negative</strong> result helps <strong>rule out</strong> disease (“SnNout”).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For a <strong>positive</strong> result, the chance it is a <strong>true positive</strong> (PPV) is <strong>higher when prevalence is higher</strong>; <strong>all positive screens require confirmatory diagnostic testing</strong>.</span></li></ul>",
      "correct_choice_id": 382698,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96134/NEET_PG_30_Oct_2025_GT_PSM_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96134/NEET_PG_30_Oct_2025_GT_PSM_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96135,
      "choices": [
        {
          "id": 382700,
          "text": "<p><span style=\"font-size:14.0pt;\">Transmission occurs mainly by direct skin penetration of the foot; oral transmission can also occur</span></p>"
        },
        {
          "id": 382701,
          "text": "<p><span style=\"font-size:14.0pt;\">Heavy infection is associated with iron-deficiency anemia and hypoalbuminemia</span></p>"
        },
        {
          "id": 382702,
          "text": "<p><span style=\"font-size:14.0pt;\">Hookworm infection is known as miners’ anemia and Egyptian chlorosis</span></p>"
        },
        {
          "id": 382703,
          "text": "<p><span style=\"font-size:14.0pt;\">Hookworm problem is assessed by Chandler’s Index assesses per gram of stool of individual case</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about hookworm disease is incorrect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3884697",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hookworm problem is assessed by Chandler’s Index assesses per gram of stool of individual case</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Chandler’s Index</strong> is used to assess the <strong>community burden</strong> of hookworm infection, not the parasite load of an individual case. It is calculated as:</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chandler’s Index = % positivity × average eggs per gram of stool in a community sample</strong></span></li><li><span style=\"font-size:14.0pt;\">This provides a measure of <strong>community-level endemicity</strong> rather than an <strong>individual’s stool count</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Transmission occurs mainly by direct skin penetration of the foot; oral transmission can also occur:</strong> Correct. Hookworm larvae in contaminated soil penetrate skin (commonly the feet) to cause infection. Oral transmission is rare but possible with Ancylostoma duodenale.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Heavy infection is associated with iron-deficiency anemia and hypoalbuminemia:&nbsp;</strong>Correct. Hookworms feed on intestinal blood; chronic heavy infections cause iron-deficiency anemia, hypoalbuminemia, growth retardation, and edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hookworm infection is known as miners’ anemia and Egyptian chlorosis:&nbsp;</strong>Correct. Historically, hookworm was prevalent among miners and Egyptians, leading to the colloquial terms “miners’ anemia” and “Egyptian chlorosis.”</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Chandler’s Index</strong> measures the <strong>community-level prevalence and intensity</strong> of hookworm infection—not individual stool counts. Hookworm infection primarily spreads via <strong>skin penetration</strong> and is a major cause of <strong>iron-deficiency anemia</strong> in endemic regions.</span></p>",
      "correct_choice_id": 382703,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96135/NEET_PG_30_Oct_2025_GT_PSM_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96135/NEET_PG_30_Oct_2025_GT_PSM_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96372,
      "choices": [
        {
          "id": 383632,
          "text": "<p><span style=\"font-size:14.0pt;\">The pathology is often seen in middle age</span></p>"
        },
        {
          "id": 383633,
          "text": "<p><span style=\"font-size:14.0pt;\">Females are affected five times more</span></p>"
        },
        {
          "id": 383634,
          "text": "<p><span style=\"font-size:14.0pt;\">Its rate of growth is very fast</span></p>"
        },
        {
          "id": 383635,
          "text": "<p><span style=\"font-size:14.0pt;\">The pathology may compress the jugular vein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents with a sudden episode of bleeding from the right ear. An ENT specialist packs the ear and, upon removal of the pack, finds an aural polyp. She reports pulsatile tinnitus in the same ear for the past 2 years and a change in voice for the last 2 months. On laryngeal examination, the right vocal cord is found paralyzed in the abducted position, but there is no cervical lymphadenopathy. Which of the following statements about the underlying pathology is false?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4334539",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Its rate of growth is very fast</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture is <strong>classic for a glomus jugulotympanicum (paraganglioma)</strong> — a benign, slow-growing, highly vascular tumor arising from <strong>paraganglionic cells</strong> associated with the <strong>jugular bulb and middle ear</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Clinical Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pulsatile tinnitus</strong> — due to vascular nature of the tumor (“tumor blush” on otoscopy).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Aural polyp / red mass behind tympanic membrane</strong> — may bleed on touch.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Otorhagia</strong> — due to erosion of surrounding bone and vessels.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lower cranial nerve palsies (IX, X, XI)</strong> — as tumor expands at the jugular foramen, leading to <strong>vocal cord paralysis</strong> (recurrent laryngeal nerve involvement).</span></li><li><span style=\"font-size:14.0pt;\">May extend to involve <strong>facial nerve</strong> or cause <strong>jugular bulb compression</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Origin:</strong> From <strong>chief cells of paraganglia</strong> in the <strong>adventitia of the jugular bulb (glomus jugulare)</strong> or <strong>middle ear (glomus tympanicum)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nature:</strong> <strong>Benign and slow-growing</strong>, but locally aggressive; may erode bone and invade nearby structures.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Epidemiology:</strong> Predominantly in <strong>middle-aged women</strong> (female:male ratio ≈ 5:1).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Growth rate:</strong> <strong>Very slow</strong>; may progress over several years before causing symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The pathology is often seen in middle age:&nbsp;</strong>True. Commonly affects adults between 30–60 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Females are affected five times more:&nbsp;</strong>True. Strong female preponderance (~5:1).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The pathology may compress the jugular vein:&nbsp;</strong>True. Jugular bulb is often eroded or compressed (seen radiologically).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Glomus jugulotympanicum</strong> is a <strong>benign, slow-growing vascular paraganglioma</strong> of the middle ear and jugular bulb, typically affecting <strong>middle-aged females</strong> and presenting with <strong>pulsatile tinnitus</strong>, <strong>aural bleeding</strong>, and <strong>lower cranial nerve palsies</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Its growth is <strong>slow</strong>, not rapid — distinguishing it from malignant lesions.</span></li></ul>",
      "correct_choice_id": 383634,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96372/ENT_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96372/ENT_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96305,
      "choices": [
        {
          "id": 383368,
          "text": "<p><span style=\"font-size:14.0pt;\">Left abducens nerve</span></p>"
        },
        {
          "id": 383369,
          "text": "<p><span style=\"font-size:14.0pt;\">Left medial longitudinal fasciculus</span></p>"
        },
        {
          "id": 383370,
          "text": "<p><span style=\"font-size:14.0pt;\">Right oculomotor nerve</span></p>"
        },
        {
          "id": 383371,
          "text": "<p><span style=\"font-size:14.0pt;\">Left vestibular nucleus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 43-year-old woman with multiple sclerosis presents with complaints of diplopia. On examination, she cannot adduct her left eye when looking to the right, but the right eye abducts with nystagmus towards end gaze. Her pupils are equal and reactive. Which of the following neural pathways is most likely affected?</span></p>",
      "unique_key": "Q1851809",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Left medial longitudinal fasciculus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has classic features of <strong>internuclear ophthalmoplegia (INO)</strong> — a hallmark of <strong>multiple sclerosis</strong> in young adults.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">INO results from a <strong>lesion in the medial longitudinal fasciculus (MLF)</strong>, a fiber tract that connects the <strong>abducens nucleus</strong> of one side to the <strong>contralateral oculomotor nucleus</strong>, coordinating <strong>horizontal conjugate gaze</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>In this case:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When looking <strong>right</strong>, the <strong>right abducens nerve</strong> functions normally, causing <strong>abduction</strong> of the right eye.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>left eye</strong>, however, fails to adduct because the <strong>left MLF</strong> is damaged and does not transmit the signal from the <strong>right abducens nucleus</strong> to the <strong>left oculomotor nucleus</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nystagmus</strong> in the abducting eye (right) is often seen due to overcorrection as the system tries to maintain conjugate gaze.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Left abducens nerve</strong>: Would result in <strong>impaired abduction</strong> of the <strong>left eye</strong>, not adduction. In this case, <strong>adduction</strong> is impaired.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Right oculomotor nerve</strong>: A lesion here would affect <strong>right eye adduction</strong>, not the left. Also, there would likely be <strong>ptosis</strong> and <strong>pupil dilation</strong>, which are not present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Left vestibular nucleus</strong>: Involved in the <strong>vestibulo-ocular reflex</strong>, not <strong>voluntary conjugate gaze</strong>. Lesions here would affect reflexive eye movements but not produce the pattern described in this vignette.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Internuclear ophthalmoplegia (INO)</strong> is caused by a lesion of the <strong>medial longitudinal fasciculus (MLF)</strong>, resulting in <strong>impaired adduction</strong> of the <strong>ipsilateral eye</strong> and <strong>nystagmus</strong> of the <strong>contralateral abducting eye</strong> during conjugate gaze.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is commonly seen in <strong>multiple sclerosis</strong>.</span></li></ul>",
      "correct_choice_id": 383369,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96305/Ophthalmology_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96305/Ophthalmology_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96360,
      "choices": [
        {
          "id": 383584,
          "text": "<p><span style=\"font-size:14.0pt;\">Leucovorin</span></p>"
        },
        {
          "id": 383585,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucarpidase</span></p>"
        },
        {
          "id": 383586,
          "text": "<p><span style=\"font-size:14.0pt;\">Sodium bicarbonate</span></p>"
        },
        {
          "id": 383587,
          "text": "<p><span style=\"font-size:14.0pt;\">Allopurinol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A leukemia patient on high-dose methotrexate develops nephrotoxicity with dangerously elevated plasma drug levels. Which of the following agents is specifically indicated to rapidly degrade circulating methotrexate?</span></p>",
      "unique_key": "Q6349391",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Glucarpidase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Glucarpidase</strong> is a recombinant enzyme (carboxypeptidase G2) that <strong>rapidly hydrolyzes methotrexate</strong> into its inactive metabolites: <strong>DAMPA</strong> (4-deoxy-4-amino-N10-methylpteroic acid) and <strong>glutamate</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is especially indicated in patients receiving <strong>high-dose methotrexate</strong> who develop <strong>renal dysfunction</strong>, leading to impaired methotrexate clearance. Because methotrexate is primarily renally excreted, any reduction in glomerular filtration significantly increases plasma drug levels, worsening toxicity (e.g., mucositis, myelosuppression, neurotoxicity).</span></li><li><span style=\"font-size:14.0pt;\">Glucarpidase acts <strong>independently of renal clearance</strong> and provides <strong>rapid plasma methotrexate reduction</strong>, even when standard therapies (leucovorin, hydration, urine alkalinization) fail.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Leucovorin:&nbsp;</strong>Leucovorin (folinic acid) is a <strong>rescue therapy</strong> that supplies <strong>reduced folates</strong> to normal cells, bypassing the inhibition of dihydrofolate reductase (DHFR) by methotrexate. However, it <strong>does not lower methotrexate levels</strong>, and its protective effect is <strong>time-limited and insufficient</strong> in cases of renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sodium bicarbonate:&nbsp;</strong>Used to <strong>alkalinize the urine</strong>, sodium bicarbonate helps prevent <strong>methotrexate crystallization</strong> in renal tubules. It is <strong>preventive</strong>, not curative. In established renal failure with elevated methotrexate levels, it is insufficient to reverse toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Allopurinol:&nbsp;</strong>This is a <strong>xanthine oxidase inhibitor</strong> used to prevent <strong>tumor lysis syndrome</strong> by reducing uric acid formation. It has <strong>no effect on methotrexate levels</strong> and plays <strong>no role</strong> in methotrexate-induced nephrotoxicity or its treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In patients with <strong>high-dose methotrexate toxicity</strong> and <strong>renal dysfunction</strong>, <strong>glucarpidase</strong> is the treatment of choice to rapidly degrade methotrexate and reduce plasma levels.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Leucovorin protects normal cells but does not eliminate the drug.</span></li><li><span style=\"font-size:14.0pt;\">Supportive measures (hydration, alkalinization) are useful but inadequate once clearance is compromised.</span></li><li><span style=\"font-size:14.0pt;\">Always consider glucarpidase when methotrexate toxicity persists despite standard rescue measures.</span></li></ul>",
      "correct_choice_id": 383585,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96360/Pharmacology_INICET_GT_30_Oct_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96360/Pharmacology_INICET_GT_30_Oct_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96397,
      "choices": [
        {
          "id": 383732,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 383733,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 383734,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 383735,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man from a rural area presents with fever, rash, and a necrotic eschar. His initial serology includes a positive Weil-Felix test showing high titers against Proteus OXK. Regarding the diagnostic features of rickettsial diseases, which of the following statements is/are accurate?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Scrub typhus is associated with positive OXK agglutination, while epidemic typhus shows high OX19 titers.</span></li><li><span style=\"font-size:14.0pt;\">Weil-Felix test is typically positive in Q fever and ehrlichiosis due to shared lipopolysaccharide antigens.</span></li><li><span style=\"font-size:14.0pt;\">Direct immunofluorescence from skin biopsy offers high sensitivity during early rash phase.</span></li><li><span style=\"font-size:14.0pt;\">Indirect immunofluorescence assay (IFA) is the gold standard for confirming most rickettsial infections.</span></li></ol>",
      "unique_key": "Q4352479",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 1 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Scrub typhus is associated with positive OXK agglutination, while epidemic typhus shows high OX19 titers:</strong> True.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Scrub typhus</strong> = positive <strong>OXK</strong> titer</span></li><li><span style=\"font-size:14.0pt;\"><strong>Epidemic typhus (R. prowazekii)</strong> = positive <strong>OX19</strong></span></li><li><span style=\"font-size:14.0pt;\">These are hallmark differentiating serologic markers in <strong>Weil-Felix test</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>4.</strong> <strong>Indirect immunofluorescence assay (IFA) is the gold standard for confirming most rickettsial infections:</strong> True.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>IFA (Indirect immunofluorescence assay)</strong> is the <strong>most sensitive and specific test</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A titer of <strong>≥1:64</strong> is diagnostic. Used to confirm the diagnosis after Weil-Felix screening.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>2. Weil-Felix test is typically positive in Q fever and ehrlichiosis due to shared lipopolysaccharide antigens:</strong> False.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Q fever (Coxiella burnetii)</strong> and <strong>ehrlichiosis</strong> do <strong>not</strong> show Weil-Felix positivity.</span></li><li><span style=\"font-size:14.0pt;\">These organisms <strong>lack cross-reactive Proteus antigens</strong>, making Weil-Felix <strong>unreliable</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>3.</strong> <strong>Direct immunofluorescence from skin biopsy offers high sensitivity during early rash phase:</strong> False.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Direct immunofluorescence</strong> from rash biopsies can be used, but it is <strong>not very sensitive</strong>, especially in early disease.</span></li><li><span style=\"font-size:14.0pt;\">Its utility is <strong>less than</strong> PCR or IFA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Weil-Felix Test</strong> helps <strong>preliminarily differentiate</strong> rickettsial infections based on cross-reactivity with <strong>OX19, OX2, and OXK</strong> antigens, but must be confirmed with <strong>IFA</strong>, the gold standard for antibody detection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Q fever and ehrlichiosis</strong> are not detected by Weil-Felix.</span></li></ul>",
      "correct_choice_id": 383733,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96397/Microbiology_INICET_GT_30_Oct_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96397/Microbiology_INICET_GT_30_Oct_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96392,
      "choices": [
        {
          "id": 383712,
          "text": "<p><span style=\"font-size:14.0pt;\">Type I only</span></p>"
        },
        {
          "id": 383713,
          "text": "<p><span style=\"font-size:14.0pt;\">Type II and Type III</span></p>"
        },
        {
          "id": 383714,
          "text": "<p><span style=\"font-size:14.0pt;\">Type III and Type IV</span></p>"
        },
        {
          "id": 383715,
          "text": "<p><span style=\"font-size:14.0pt;\">Type II, Type III, and Type I</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher is developing a drug that blocks complement activation. For which type(s) of hypersensitivity would this agent likely reduce tissue injury?&nbsp;</span></p>",
      "unique_key": "Q5217609",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Type II and Type III</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Both Type II (antibody-mediated cytotoxic) and Type III (immune complex-mediated) hypersensitivity reactions prominently involve complement activation as part of their effector mechanisms.</span></li><li><span style=\"font-size:14.0pt;\">Type II reactions involve antibodies (mostly IgG/IgM) binding to antigens on host cells, <strong>leading to:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Complement-mediated lysis</span></li><li><span style=\"font-size:14.0pt;\">Opsonization and phagocytosis</span></li><li><span style=\"font-size:14.0pt;\">Antibody-dependent cellular cytotoxicity (ADCC)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Type III reactions involve circulating immune complexes (Ag–Ab) that deposit in tissues (e.g., glomeruli, vessels), triggering complement activation → inflammation and recruitment of neutrophils → tissue damage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>By inhibiting complement, this drug would blunt both:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Cytolytic effects in Type II</span></li><li><span style=\"font-size:14.0pt;\">Inflammatory cascade in Type III</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Type I only:&nbsp;</strong>Incorrect. Type I hypersensitivity (e.g., anaphylaxis, asthma) is IgE-mediated, involving mast cell degranulation and histamine release. Complement is not involved, so this drug would have no effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Type III and Type IV:&nbsp;</strong>Incorrect. While Type III is complement-mediated, Type IV hypersensitivity is T-cell mediated, involving delayed-type responses like macrophage activation and cytokine release (e.g., in contact dermatitis, TB). Complement does not play a role.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Type II, Type III, and Type I:&nbsp;</strong>Incorrect. Although Type II and III are complement-mediated, Type I is not, so inclusion of Type I here is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Complement activation plays a pivotal role in the pathogenesis of Type II and III hypersensitivity reactions through immune-mediated cytotoxicity and inflammation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In contrast, Type I (IgE-mast cell) and Type IV (T-cell mediated) hypersensitivities operate via complement-independent pathways.</span></li><li><span style=\"font-size:14.0pt;\">Therapeutic strategies targeting complement would therefore selectively benefit disorders in which complement contributes directly to tissue damage.</span></li></ul>",
      "correct_choice_id": 383713,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96392/Microbiology_INICET_GT_30_Oct_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96392/Microbiology_INICET_GT_30_Oct_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96313,
      "choices": [
        {
          "id": 383400,
          "text": "<p><span style=\"font-size:14.0pt;\">T4a</span></p>"
        },
        {
          "id": 383401,
          "text": "<p><span style=\"font-size:14.0pt;\">T3</span></p>"
        },
        {
          "id": 383402,
          "text": "<p><span style=\"font-size:14.0pt;\">T4b</span></p>"
        },
        {
          "id": 383403,
          "text": "<p><span style=\"font-size:14.0pt;\">M1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">According to 8th AJCC classification of colorectal cancers, tumor deposits in the visceral peritoneum and serosal breach are staged as?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3674926",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) T4a</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20174518.jpg\" width=\"738\" height=\"738\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:14.0pt;\">According to the <strong>8th AJCC (American Joint Committee on Cancer) TNM Classification</strong> for colorectal carcinoma, <strong>T4a</strong> lesions are those in which the <strong>tumor penetrates the visceral peritoneum</strong>, leading to <strong>serosal breach</strong> or direct exposure of the tumor on the peritoneal surface.</span></p>",
      "correct_choice_id": 383400,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96313/NEET_PG_30_Oct_2025_GT_Surgery_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96313/NEET_PG_30_Oct_2025_GT_Surgery_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96105,
      "choices": [
        {
          "id": 382584,
          "text": "<p><span style=\"font-size:14.0pt;\">1-2-3-4</span></p>"
        },
        {
          "id": 382585,
          "text": "<p><span style=\"font-size:14.0pt;\">1-2-4-3</span></p>"
        },
        {
          "id": 382586,
          "text": "<p><span style=\"font-size:14.0pt;\">3-1-2-4</span></p>"
        },
        {
          "id": 382587,
          "text": "<p><span style=\"font-size:14.0pt;\">1-3-2-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Arrange the sequence of events occurring after the P wave in an ECG:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">a wave in JVP</span></li><li><span style=\"font-size:14.0pt;\">First heart sound</span></li><li><span style=\"font-size:14.0pt;\">Rapid filling of ventricles</span></li><li><span style=\"font-size:14.0pt;\">T wave in ECG</span></li></ol>",
      "unique_key": "Q9145490",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-2-4-3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>P wave</strong> on an ECG represents <strong>atrial depolarization</strong>, which leads to <strong>atrial contraction</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">After the P wave, the following sequence of events occurs in a specific order:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. a wave in JVP</strong>: The <strong>a wave</strong> in the jugular venous pressure (JVP) is caused by <strong>atrial contraction</strong>, which immediately follows the P wave on the ECG. This event represents the mechanical contraction of the atria after depolarization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. First heart sound (S1)</strong>: The <strong>first heart sound (S1)</strong> is heard when the <strong>atrioventricular valves (tricuspid and mitral valves)</strong> close at the beginning of <strong>ventricular contraction</strong> (systole). This follows the a wave and is a key indicator of the start of the <strong>isovolumetric contraction</strong> phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. T wave in ECG</strong>: The <strong>T wave</strong> represents <strong>ventricular repolarization</strong>, which leads to <strong>ventricular relaxation</strong>. This is an electrical event that occurs before the mechanical relaxation of the ventricles. Repolarization precedes the mechanical relaxation process, allowing the ventricles to begin filling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Rapid filling of ventricles</strong>: After repolarization (T wave), the ventricles undergo <strong>rapid filling</strong> during the early phase of diastole as the atrioventricular valves reopen. This mechanical event occurs after the electrical repolarization (T wave).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xAkyojc.png\" width=\"628\" height=\"547\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Sequence breakdown:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>P wave</strong> triggers atrial contraction, which is reflected as the <strong>a wave</strong> in the JVP.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>first heart sound (S1)</strong> occurs as the AV valves close due to increased ventricular pressure.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>T wave</strong> marks ventricular repolarization, signaling the beginning of relaxation.</span></li><li><span style=\"font-size:14.0pt;\">Finally, the <strong>rapid filling of ventricles</strong> happens after relaxation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The correct sequence following the <strong>P wave</strong> involves:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Atrial contraction (a wave in JVP)</strong>,</span></p><p><span style=\"font-size:14.0pt;\"><strong>2. First heart sound (AV valve closure)</strong>,</span></p><p><span style=\"font-size:14.0pt;\"><strong>4. T wave (ventricular repolarization)</strong>,</span></p><p><span style=\"font-size:14.0pt;\"><strong>3. Rapid ventricular filling</strong>.</span></p>",
      "correct_choice_id": 382585,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96105/Physiology_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96105/Physiology_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96277,
      "choices": [
        {
          "id": 383256,
          "text": "<p><span style=\"font-size:14.0pt;\">GnRH analogs for 6 months</span></p>"
        },
        {
          "id": 383257,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic cystectomy</span></p>"
        },
        {
          "id": 383258,
          "text": "<p><span style=\"font-size:14.0pt;\">Continuous oral contraceptive pills</span></p>"
        },
        {
          "id": 383259,
          "text": "<p><span style=\"font-size:14.0pt;\">Total hysterectomy with oophorectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman presents with chronic pelvic pain, dysmenorrhea, and deep dyspareunia. Pelvic ultrasound shows a 4 cm cystic lesion in the left ovary with homogeneous \"ground-glass\" echogenicity, consistent with an ovarian endometrioma. She expresses a strong desire to conceive in the near future. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3908307",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Laparoscopic cystectomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An <strong>endometrioma</strong> (also called a “chocolate cyst”) is a localized form of <strong>endometriosis</strong>, commonly found on the ovaries. It contains old, altered blood from ectopic endometrial glands and stroma.</span></li><li><span style=\"font-size:14.0pt;\">In women who <strong>desire fertility</strong>, the most appropriate management is <strong>laparoscopic cystectomy</strong>, which involves <strong>surgical excision of the endometriotic cyst wall</strong> while preserving healthy ovarian tissue.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Rationale:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Medical therapy</strong> (OCPs or GnRH analogs) suppresses ovulation and <strong>prevents pregnancy</strong>, making it inappropriate for women seeking fertility.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Laparoscopic cystectomy</strong> relieves pain, restores normal ovarian anatomy, and <strong>improves fertility outcomes</strong> by removing ectopic endometrial tissue that interferes with ovulation and fertilization.</span></li><li><span style=\"font-size:14.0pt;\">Surgical excision also reduces recurrence risk and provides tissue for histopathologic confirmation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key advantages of laparoscopic cystectomy:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Alleviates <strong>dysmenorrhea and dyspareunia</strong></span></li><li><span style=\"font-size:14.0pt;\">Enhances <strong>spontaneous conception rates</strong></span></li><li><span style=\"font-size:14.0pt;\">Decreases <strong>recurrence of endometrioma</strong> compared to drainage alone</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. GnRH analogs for 6 months:&nbsp;</strong>These suppress ovarian estrogen production, inducing a hypoestrogenic (pseudomenopausal) state that temporarily alleviates pain. However, ovulation suppression <strong>prevents conception</strong> and <strong>recurrence occurs</strong> once therapy stops. Thus, it is not suitable for women desiring fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Continuous oral contraceptive pills:&nbsp;</strong>OCPs reduce menstrual flow and endometrial proliferation, which helps control symptoms and prevent recurrence. However, they <strong>inhibit ovulation</strong> and therefore are used in <strong>women not desiring pregnancy</strong>, not in those seeking fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Total hysterectomy with oophorectomy:&nbsp;</strong>This is reserved for <strong>women with severe disease who have completed childbearing</strong> or for those unresponsive to conservative management. It <strong>eliminates fertility permanently</strong>, making it inappropriate for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a woman with <strong>ovarian endometrioma who desires fertility</strong>, the <strong>next best step</strong> is <strong>laparoscopic cystectomy</strong>, which removes the cyst wall, relieves pain, and <strong>improves fertility outcomes</strong> while preserving ovarian function.</span></p>",
      "correct_choice_id": 383257,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96277/Ini-Cet_Gt_30_Oct_2025_Obg_Q_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96277/Ini-Cet_Gt_30_Oct_2025_Obg_Q_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96399,
      "choices": [
        {
          "id": 383740,
          "text": "<p><span style=\"font-size:14.0pt;\">Granulomatous inflammation with multinucleated giant cells</span></p>"
        },
        {
          "id": 383741,
          "text": "<p><span style=\"font-size:14.0pt;\">Follicular hyperplasia with scalloping of colloid</span></p>"
        },
        {
          "id": 383742,
          "text": "<p><span style=\"font-size:14.0pt;\">Follicular atrophy with extensive Hurthle cell metaplasia</span></p>"
        },
        {
          "id": 383743,
          "text": "<p><span style=\"font-size:14.0pt;\">Amyloid deposition in thyroid stroma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman presents with weight loss, heat intolerance, palpitations, and tremors. On examination, she has a diffuse, non-tender goiter and a fine tremor of her hands. Laboratory findings reveal elevated free T₄ and suppressed TSH. Thyroid biopsy of this patient is shown below.&nbsp;Which of the following best describes the underlying pathologic finding?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180318.jpg\" width=\"486\" height=\"440\"></span></p>",
      "unique_key": "Q9068135",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Follicular hyperplasia with scalloping of colloid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The classic features of <strong>Graves disease</strong>, an autoimmune <strong>hyperthyroid state</strong> caused by <strong>TSH receptor–stimulating IgG antibodies</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Histologic hallmarks of Graves disease:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Follicular epithelial hyperplasia</strong> (tall, crowded epithelial cells forming papillary infoldings).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Scalloped colloid</strong>, reflecting active reabsorption of thyroglobulin.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Absence of lymphoid destruction</strong> (unlike Hashimoto thyroiditis).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These features explain the <strong>diffuse goiter</strong> and <strong>hypermetabolic symptoms</strong> seen in this patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Granulomatous inflammation with multinucleated giant cells</strong>: Seen in <strong>subacute (de Quervain) thyroiditis</strong>, often following viral infection, presenting with a <strong>painful, tender thyroid</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Follicular atrophy with extensive Hurthle cell metaplasia:&nbsp;</strong>Characteristic of <strong>Hashimoto thyroiditis</strong>, which presents with <strong>hypothyroidism</strong> and <strong>anti-TPO antibodies</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amyloid deposition in thyroid stroma</strong>: Seen in <strong>medullary thyroid carcinoma</strong>, derived from <strong>parafollicular (C) cells</strong>, producing <strong>calcitonin</strong> that deposits as amyloid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Graves disease</strong> shows <strong>follicular hyperplasia with scalloping of colloid</strong> due to <strong>TSH receptor–stimulating antibodies</strong>, resulting in <strong>diffuse thyroid hyperactivity</strong> and <strong>thyrotoxicosis</strong>.</span></p>",
      "correct_choice_id": 383741,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96399/Pathology_INICET_GT_30_Oct_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96399/Pathology_INICET_GT_30_Oct_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96117,
      "choices": [
        {
          "id": 382632,
          "text": "<p><span style=\"font-size:14.0pt;\">Homogentisate oxidase</span></p>"
        },
        {
          "id": 382633,
          "text": "<p><span style=\"font-size:14.0pt;\">Fumarylacetoacetate hydrolase</span></p>"
        },
        {
          "id": 382634,
          "text": "<p><span style=\"font-size:14.0pt;\">Tyrosine transaminase</span></p>"
        },
        {
          "id": 382635,
          "text": "<p><span style=\"font-size:14.0pt;\">Maleyl-acetate isomerase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-month-old infant presents with vomiting, failure to thrive, and a cabbage-like odor to the urine. Laboratory evaluation reveals severe liver dysfunction, renal tubular damage, and elevated succinylacetone levels in the blood. Which of the following enzyme deficiencies is the most likely cause of this condition?&nbsp;</span></p>",
      "unique_key": "Q8565251",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Fumarylacetoacetate hydrolase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tyrosinemia type I</strong> (also called <strong>hepatorenal tyrosinemia</strong>) is an <strong>autosomal recessive</strong> disorder caused by a deficiency of <strong>fumarylacetoacetate hydrolase (FAH)</strong>, the <strong>final enzyme</strong> in the <strong>tyrosine degradation pathway</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Normally, tyrosine is degraded to <strong>fumarate and acetoacetate</strong> via several steps.</span></li><li><span style=\"font-size:14.0pt;\">When <strong>FAH</strong> is deficient, its substrate <strong>fumarylacetoacetate</strong> and its toxic by-product <strong>succinylacetone</strong> accumulate.</span></li><li><span style=\"font-size:14.0pt;\">These metabolites cause <strong>progressive hepatic failure</strong>, <strong>renal Fanconi-like syndrome</strong>, and <strong>neurologic crises</strong> due to inhibition of heme synthesis enzymes (ALA dehydratase).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Failure to thrive, vomiting, jaundice, and <strong>hepatomegaly</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Renal tubular dysfunction</strong> → aminoaciduria, rickets</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cabbage-like odor</strong> of urine (due to sulfur-containing compounds)</span></li><li><span style=\"font-size:14.0pt;\">Elevated <strong>tyrosine</strong>, <strong>methionine</strong>, and <strong>succinylacetone</strong> levels in plasma</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Early treatment with <strong>nitisinone (NTBC)</strong>, which inhibits an upstream enzyme (<strong>4-hydroxyphenylpyruvate dioxygenase</strong>), prevents accumulation of toxic intermediates.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Homogentisate oxidase:&nbsp;</strong>Deficiency causes <strong>alkaptonuria</strong>, characterized by <strong>dark urine</strong>, <strong>ochronosis</strong>, and <strong>degenerative arthritis</strong>, not liver failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tyrosine transaminase:&nbsp;</strong>Deficiency leads to <strong>Tyrosinemia type II (Richner–Hanhart syndrome)</strong> with <strong>keratitis, skin lesions, and intellectual disability</strong>, but <strong>no hepatic or renal involvement</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Maleyl-acetate isomerase:&nbsp;</strong>Deficiency is <strong>not associated with classic tyrosinemia type I</strong>; this enzyme acts <strong>upstream of FAH</strong>, and its block does not lead to succinylacetone accumulation or hepatic necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Tyrosinemia type I</strong> results from <strong>fumarylacetoacetate hydrolase deficiency</strong>, causing accumulation of <strong>fumarylacetoacetate and succinylacetone</strong>, leading to <strong>severe hepatic and renal dysfunction</strong>.</span></p>",
      "correct_choice_id": 382633,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96117/Biochemistry_INICET_GT_30_Oct_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96117/Biochemistry_INICET_GT_30_Oct_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96295,
      "choices": [
        {
          "id": 383328,
          "text": "<p><span style=\"font-size:14.0pt;\">28-32 weeks&nbsp;</span></p>"
        },
        {
          "id": 383329,
          "text": "<p><span style=\"font-size:14.0pt;\">32-34 weeks&nbsp;</span></p>"
        },
        {
          "id": 383330,
          "text": "<p><span style=\"font-size:14.0pt;\">&gt;34 weeks&nbsp;</span></p>"
        },
        {
          "id": 383331,
          "text": "<p><span style=\"font-size:14.0pt;\">36-38 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">At which gestational age is this feeding method typically initiated in stable preterm infants?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-29%20102222.jpg\" width=\"544\" height=\"289\"></p>",
      "unique_key": "Q1501001",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 32-34 weeks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The progression of feeding methods in preterm infants follows a developmental sequence based on the maturation of feeding skills.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">At 32-34 weeks gestational age, infants typically develop adequate coordination to handle paladai spoon feeding.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This specialized feeding method serves as an important transitional step between nasogastric tube feeding and direct breastfeeding.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The paladai is particularly valuable because it allows controlled delivery of milk while requiring less energy expenditure from the infant compared to full breastfeeding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Table Decision tool: initiation and advancement of preterm infant feeding&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-29%20102419.jpg\" width=\"837\" height=\"660\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The progression of feeding methods in preterm infants follows a developmental sequence: IV fluids (&lt;28 weeks), nasogastric/orogastric feeding (28-32 weeks), paladai feeding (32-34 weeks), and direct breastfeeding (&gt;34 weeks).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The paladai spoon offers several advantages, including controlled flow, reduced energy expenditure, safer feeding compared to bottles, and a helpful transition to breastfeeding</span></li></ul>",
      "correct_choice_id": 383329,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96295/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96295/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96130,
      "choices": [
        {
          "id": 382680,
          "text": "<p><span style=\"font-size:14.0pt;\">Total ₹4000: ₹3,000 to the acceptor, ₹400 to ASHA/health worker, ₹600 to “others” (facility/provider)</span></p>"
        },
        {
          "id": 382681,
          "text": "<p><span style=\"font-size:14.0pt;\">Total ₹4500: ₹2,000 to the acceptor, ₹300 to ASHA/health worker, ₹2200 to “others”</span></p>"
        },
        {
          "id": 382682,
          "text": "<p><span style=\"font-size:14.0pt;\">Total ₹5000: ₹3000 to the acceptor, ₹400 to ASHA/health worker, ₹1600 to “others”</span></p>"
        },
        {
          "id": 382683,
          "text": "<p><span style=\"font-size:14.0pt;\">Total ₹4000: ₹1400 to the acceptor, ₹400 to ASHA/health worker, ₹2200 to “others”</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old multiparous woman delivers vaginally in a Mission Parivar Vikas (MPV) district and opts for post-partum tubectomy (PPS) before discharge. The facility wants to process incentives under the RCH Sterilization Incentive Package. Which of the following correctly states the total incentive and its breakup for PPS in MPV districts?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5477141",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Total ₹4000: ₹3,000 to the acceptor, ₹400 to ASHA/health worker, ₹600 to “others” (facility/provider)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Under the <strong>Sterilization Incentive Package (RCH Program)</strong>, <strong>Mission Parivar Vikas (MPV) districts</strong> receive enhanced incentives to accelerate fertility regulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For <strong>post-partum sterilization (PPS)</strong>, the table shows:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Acceptor:</strong> ₹3,000</span></li><li><span style=\"font-size:14.0pt;\"><strong>ASHA/health worker:</strong> ₹400</span></li><li><span style=\"font-size:14.0pt;\"><strong>Others (facility/provider/operating team as per program norms):</strong> ₹600</span></li><li><span style=\"font-size:14.0pt;\"><strong>Total:</strong> <strong>₹4,000</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This higher payout reflects programmatic prioritization of immediate postpartum contraception in high-focus MPV districts.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mfRCV5R.png\" width=\"1241\" height=\"643\"></strong></span></p>",
      "correct_choice_id": 382680,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96130/NEET_PG_30_Oct_2025_GT_PSM_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96130/NEET_PG_30_Oct_2025_GT_PSM_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96348,
      "choices": [
        {
          "id": 383536,
          "text": "<p><span style=\"font-size:14.0pt;\">Carbimazole</span></p>"
        },
        {
          "id": 383537,
          "text": "<p><span style=\"font-size:14.0pt;\">Radioactive iodine</span></p>"
        },
        {
          "id": 383538,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 383539,
          "text": "<p><span style=\"font-size:14.0pt;\">Liothyronine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old woman is brought to the emergency department by her family because of&nbsp;severe palpitations, sweating, and shortness of breath&nbsp;for the past few hours. She has a&nbsp;3-month history of heat intolerance, irritability, tremulousness, and weight loss despite an increased appetite. Physical examination is shown in below mentioned image. She appears agitated and restless. On examination, her&nbsp;pulse is 160/min, regular, and&nbsp;BP is 150/60 mmHg. ECG shows&nbsp;sinus tachycardia. Which among the following is the most immediate life-saving drug for this patient?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20175836.jpg\" width=\"414\" height=\"403\"></strong></span></p>",
      "unique_key": "Q8105791",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Propranolol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient is presenting with clinical features of <strong>thyroid storm</strong>, a life-threatening exacerbation of hyperthyroidism.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The signs of exophthalmos and a diffuse goiter suggest Graves' disease as the underlying cause.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In a thyroid storm, <strong>propranolol</strong> is the drug of choice for immediate symptomatic control as it reduces tachycardia, palpitations, and tremors by blocking β-adrenergic receptors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Additionally, propranolol partially inhibits peripheral conversion of T4 to T3, further decreasing circulating levels of the more active thyroid hormone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Carbimazole:</strong> This antithyroid drug inhibits thyroid hormone synthesis. However, it takes days to weeks to show its effect and is not useful for immediate symptomatic relief during a thyroid storm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Radioactive iodine:</strong> This therapy is used for definitive treatment of hyperthyroidism but is contraindicated in thyroid storm as it can worsen symptoms in the acute phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Liothyronine:</strong> This is a synthetic T3 hormone and is used in the treatment of hypothyroidism. It would exacerbate hyperthyroid symptoms and is inappropriate in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Propranolol is the most immediate life-saving drug in thyroid storm as it rapidly controls adrenergic symptoms and inhibits peripheral conversion of T4 to T3.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Other therapies, including carbimazole or propylthiouracil, and supportive measures are initiated alongside propranolol to stabilize the patient.</span></li></ul>",
      "correct_choice_id": 383538,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96348/Pharmacology_INICET_GT_30_Oct_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96348/Pharmacology_INICET_GT_30_Oct_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96266,
      "choices": [
        {
          "id": 383212,
          "text": "<p><span style=\"font-size:14.0pt;\">Reapply the same patch and continue the current cycle</span></p>"
        },
        {
          "id": 383213,
          "text": "<p><span style=\"font-size:14.0pt;\">Apply a new patch and continue the same cycle without backup contraception</span></p>"
        },
        {
          "id": 383214,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop the current cycle, apply a new patch immediately, and use backup contraception for 7 days</span></p>"
        },
        {
          "id": 383215,
          "text": "<p><span style=\"font-size:14.0pt;\">Wait until the next menstrual period to start a new patch</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman using a transdermal contraceptive patch reports that her patch became partially detached, and she realized it had been off for more than 24 hours. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q2168913",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Stop the current cycle, apply a new patch immediately, and use backup contraception for 7 days</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">If a <strong>contraceptive patch</strong> (such as <strong>ethinyl estradiol/norelgestromin</strong>) becomes <strong>partially or completely detached for more than 24 hours</strong>, contraceptive hormone levels may fall below effective levels, <strong>increasing the risk of ovulation and unintended pregnancy</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Management steps:</strong></span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Stop the current cycle.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Apply a new patch immediately</strong> — this starts a <strong>new 4-week cycle</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Use backup contraception</strong> (e.g., condoms) for <strong>the first 7 days</strong> of the new cycle to ensure contraceptive protection while hormone levels stabilize.</span></li></ol></li><li><span style=\"font-size:14.0pt;\">If the patch had been detached for <strong>less than 24 hours</strong>, it could be reapplied (or replaced with a new one) and the cycle continued without backup contraception.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Reapply the same patch and continue the current cycle:&nbsp;</strong>Incorrect if detachment &gt;24 hours — hormone levels may have dropped too low for reliable contraception.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Apply a new patch and continue the same cycle without backup contraception:&nbsp;</strong>Unsafe, as ovulation may occur if the patch was off &gt;24 hours; backup contraception is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Wait until the next menstrual period to start a new patch:&nbsp;</strong>Unnecessary delay — ovulation could occur during this time, increasing pregnancy risk. Immediate reapplication and new cycle initiation are recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">If a <strong>contraceptive patch is detached for more than 24 hours</strong>, <strong>start a new cycle immediately with a new patch</strong> and <strong>use backup contraception for 7 days</strong> to maintain pregnancy prevention.</span></p>",
      "correct_choice_id": 383214,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96266/Ini-Cet_Gt_30_Oct_2025_Obg_Q_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96266/Ini-Cet_Gt_30_Oct_2025_Obg_Q_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96294,
      "choices": [
        {
          "id": 383324,
          "text": "<p><span style=\"font-size:14.0pt;\">Using palm on the lower third of sternum</span></p>"
        },
        {
          "id": 383325,
          "text": "<p><span style=\"font-size:14.0pt;\">Using two fingers on the middle third of sternum</span></p>"
        },
        {
          "id": 383326,
          "text": "<p><span style=\"font-size:14.0pt;\">Using the two thumbs on the lower third of sternum</span></p>"
        },
        {
          "id": 383327,
          "text": "<p><span style=\"font-size:14.0pt;\">Using three fingers on the lower third of sternum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A term newborn suddenly develops apnea and bradycardia in the delivery room. The team initiates resuscitation, and chest compressions are required. Which technique is considered the most effective for delivering compressions in neonates?</span></p>",
      "unique_key": "Q4704754",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Using the two thumbs on the lower third of sternum</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>two-thumb encircling technique</strong> is the preferred method for chest compressions in neonates.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both thumbs are placed on the lower third of the sternum while the fingers encircle and support the infant’s back.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This method generates higher coronary perfusion pressure and is less tiring for the rescuer, making it the most effective approach.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20155301.jpg\" width=\"582\" height=\"413\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Using palm on the lower third of sternum:&nbsp;</strong>This is incorrect because the palm technique is used in <strong>adult CPR</strong>, not in neonates. Applying a palm on a newborn’s sternum would exert excessive force and risk rib or sternal injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Using two fingers on the middle third of sternum:&nbsp;</strong>The <strong>two-finger technique</strong> can be used when a single rescuer is providing compressions, but it is less effective than the two-thumb technique. Also, compressions must be placed on the <strong>lower third</strong>, not the middle third, to avoid injury to the upper sternum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Using three fingers on the lower third of sternum:&nbsp;</strong>Using three fingers is not a standard technique in neonatal resuscitation. It increases the chance of excessive pressure and instability compared to the recommended two-finger or two-thumb method.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">In neonatal resuscitation, chest compressions should be performed on the <strong>lower third of the sternum</strong>, with the <strong>two-thumb encircling technique</strong> being the most effective and recommended method.</span></p>",
      "correct_choice_id": 383326,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96294/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96294/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96298,
      "choices": [
        {
          "id": 383340,
          "text": "<p><span style=\"font-size:14.0pt;\">Twin A has a Silverman Anderson score of 2 and requires observation, while Twin B has a score of 9 and requires intubation&nbsp;</span></p>"
        },
        {
          "id": 383341,
          "text": "<p><span style=\"font-size:14.0pt;\">Twin A has a Silverman Anderson score of 3 and requires observation, while Twin B has a score of 5 and requires CPAP&nbsp;</span></p>"
        },
        {
          "id": 383342,
          "text": "<p><span style=\"font-size:14.0pt;\">Twin A has a Silverman Anderson score of 1 and requires oxygen by nasal cannula, while Twin B has a score of 8 and requires intubation</span></p>"
        },
        {
          "id": 383343,
          "text": "<p><span style=\"font-size:14.0pt;\">Twin A has a Silverman Anderson score of 2 and requires observation, while Twin B has a score of 6 and requires CPAP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">You are called to evaluate two preterm twins, both born at 28 weeks gestation. Twin A shows the following: synchronous chest and abdominal movement during respiration, barely visible lower chest retractions, no xiphoid retraction, slight nasal flaring, and no expiratory grunt. Twin B exhibits see-saw breathing, marked lower chest retractions, just visible xiphoid retraction, marked nasal flaring, and expiratory grunt audible without a stethoscope. Which of the following statements is correct regarding these twins?</span></p>",
      "unique_key": "Q1234598",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Twin A has a Silverman Anderson score of 2 and requires observation, while Twin B has a score of 9 and requires intubation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step-by-Step Calculation of Silverman-Anderson Scores:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Twin A:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chest-Abdomen Synchrony: Synchronous → 0</span></li><li><span style=\"font-size:14.0pt;\">Lower Chest Retraction: Barely visible → 1</span></li><li><span style=\"font-size:14.0pt;\">Xiphoid Retraction: None → 0</span></li><li><span style=\"font-size:14.0pt;\">Nasal Flaring: Slight → 1</span></li><li><span style=\"font-size:14.0pt;\">Expiratory Grunt: None → 0</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Total Score for Twin A = 0 + 1 + 0 + 1 + 0 = 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management:</strong> Score ≤ 2 indicates mild respiratory distress<strong> → Observation</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Twin B:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chest-Abdomen Synchrony: See-saw breathing → 2</span></li><li><span style=\"font-size:14.0pt;\">Lower Chest Retraction: Marked → 2</span></li><li><span style=\"font-size:14.0pt;\">Xiphoid Retraction: Just visible → 1</span></li><li><span style=\"font-size:14.0pt;\">Nasal Flaring: Marked → 2</span></li><li><span style=\"font-size:14.0pt;\">Expiratory Grunt: Audible without a stethoscope → 2</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Total Score for Twin B = 2 + 2 + 1 + 2 + 2 = 9</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management:</strong> Score ≥ 7 indicates severe respiratory distres<strong>s → Requires Intubation.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This answer <strong>accurately reflects the calculated scores and appropriate interventions</strong> based on <strong>neonatal respiratory distress severity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20160956.jpg\" width=\"1035\" height=\"753\"></strong></span></p>",
      "correct_choice_id": 383340,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96298/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96298/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96312,
      "choices": [
        {
          "id": 383396,
          "text": "<p><span style=\"font-size:14.0pt;\">Bulbar urethra, micturating cystogram</span></p>"
        },
        {
          "id": 383397,
          "text": "<p><span style=\"font-size:14.0pt;\">Bulbar urethra, ascending urethrogram</span></p>"
        },
        {
          "id": 383398,
          "text": "<p><span style=\"font-size:14.0pt;\">Prostatic urethra, suprapubic cystostomy</span></p>"
        },
        {
          "id": 383399,
          "text": "<p><span style=\"font-size:14.0pt;\">Prostatic urethra, ascending cysto-urethrogram</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A man is brought to the emergency after a fall-stride injury. He feels the urge to micturate but is unable to pass urine and there is blood at the tip of the meatus with extensive swelling of the perineal region and penis and scrotum. What is the location of the injury and the next step?</span></p>",
      "unique_key": "Q7277702",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Bulbar urethra, ascending urethrogram</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The bulbar urethra is the most commonly injured part of the urethra in cases of fall astride injury (perineal trauma).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Rupture of the bulbar urethra results in extravasation of urine and blood into the superficial perineal space, leading to swelling of the perineum, scrotum, and penis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of blood at the meatus and the inability to void are key diagnostic clues.</span></li><li><span style=\"font-size:14.0pt;\">The next step is ascending urethrography to confirm the diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Bulbar urethra, micturating cystogram:&nbsp;</strong>A micturating cystourethrogram (MCU) is performed only after ensuring urethral continuity, typically during follow-up after catheterization or repair. It is not used here, because of urethral injury, contrast injection through the bladder may worsen extravasation or obscure the site of injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Options C and D. Prostatic urethra, suprapubic cystostomy and Prostatic urethra, ascending cysto-urethrogram:&nbsp;</strong>Injuries to the prostatic urethra are typically associated with pelvic fractures. They may cause high-riding prostate and per rectal findings, which are not observed in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Blunt trauma to the perineum with blood at the urethral meatus, inability to void, and swelling of the perineum, scrotum, and penis is highly suggestive of a <strong>bulbar urethral injury</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Prompt diagnosis and management, including urethrography for confirmation, are essential to prevent complications.</span></li></ul>",
      "correct_choice_id": 383397,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96312/NEET_PG_30_Oct_2025_GT_Surgery_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96312/NEET_PG_30_Oct_2025_GT_Surgery_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96119,
      "choices": [
        {
          "id": 382640,
          "text": "<p><span style=\"font-size:14.0pt;\">The enzyme deficient is phenylalanine hydroxylase</span></p>"
        },
        {
          "id": 382641,
          "text": "<p><span style=\"font-size:14.0pt;\">Tyrosine becomes an essential amino acid</span></p>"
        },
        {
          "id": 382642,
          "text": "<p><span style=\"font-size:14.0pt;\">The condition can lead to mental retardation if untreated</span></p>"
        },
        {
          "id": 382643,
          "text": "<p><span style=\"font-size:14.0pt;\">Dietary phenylalanine should be stopped</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An infant presented to the OPD with a history of vomiting and poor feeding. A musty (mousy) odor is noted in the baby’s sweat and urine. Guthrie test was found to be positive. All of the following statements regarding this disease are true except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1707775",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Dietary phenylalanine should be stopped</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The infant’s presentation — <strong>vomiting, poor feeding, musty odor of sweat/urine</strong>, and a <strong>positive Guthrie test</strong> — is classic for <strong>Phenylketonuria (PKU)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Dietary phenylalanine should be stopped – FALSE</strong></span><br><span style=\"font-size:14.0pt;\">Phenylalanine is an <strong>essential amino acid</strong> — it <strong>cannot be completely eliminated</strong>, only <strong>restricted</strong> to safe levels.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>low-phenylalanine diet</strong> with adequate protein and <strong>tyrosine supplementation</strong> is required.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The enzyme deficient is phenylalanine hydroxylase:&nbsp;</strong>True. PKU is caused by deficiency of <strong>phenylalanine hydroxylase</strong>, which normally converts <strong>phenylalanine → tyrosine</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Tyrosine becomes an essential amino acid:&nbsp;</strong>True.<strong>&nbsp;</strong>Because tyrosine synthesis is impaired, it must be supplied through diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The condition can lead to mental retardation if untreated:&nbsp;</strong>True. Accumulated phenylalanine is <strong>neurotoxic</strong>, causing <strong>intellectual disability, seizures, and developmental delay</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>Phenylketonuria (PKU)</strong>, <strong>phenylalanine hydroxylase deficiency</strong> leads to phenylalanine accumulation; <strong>dietary phenylalanine should be restricted, not stopped</strong>, and <strong>tyrosine becomes essential</strong>.</span></p>",
      "correct_choice_id": 382643,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96119/Biochemistry_INICET_GT_30_Oct_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96119/Biochemistry_INICET_GT_30_Oct_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96283,
      "choices": [
        {
          "id": 383280,
          "text": "<p><span style=\"font-size:14.0pt;\">Serous cystadenoma</span></p>"
        },
        {
          "id": 383281,
          "text": "<p><span style=\"font-size:14.0pt;\">Corpus luteum cyst</span></p>"
        },
        {
          "id": 383282,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometriotic cyst&nbsp;</span></p>"
        },
        {
          "id": 383283,
          "text": "<p><span style=\"font-size:14.0pt;\">Theca lutein cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old woman with a history of <strong>i</strong>nfertility undergoes diagnostic laparoscopy. Intraoperatively, the ovary is found and shown below. The surrounding peritoneum shows areas of fibrosis and adhesions. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20152605.jpg\" width=\"594\" height=\"382\"></strong></span></p>",
      "unique_key": "Q5300627",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Endometriotic cyst&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shown is consistent with <strong>Endometrioma.</strong>&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">An <strong>endometriotic cyst</strong> or <strong>ovarian endometrioma</strong> is a type of <strong>ovarian cyst associated with endometriosis</strong>, characterized by the accumulation of <strong>old, altered blood</strong> within the cyst cavity, giving it a <strong>“chocolate-colored” appearance</strong> on rupture.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathogenesis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Endometriosis occurs due to <strong>ectopic implantation of endometrial tissue</strong> on the ovary and other pelvic structures.</span></li><li><span style=\"font-size:14.0pt;\">With each menstrual cycle, the ectopic tissue bleeds, leading to the collection of degraded hemoglobin and hemosiderin-laden macrophages—forming the <strong>“chocolate cyst.”</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Typical features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Symptoms:</strong> Dysmenorrhea, dyspareunia, chronic pelvic pain, infertility</span></li><li><span style=\"font-size:14.0pt;\"><strong>Laparoscopic findings:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">“Powder-burn” lesions (bluish-black deposits on peritoneum)</span></li><li><span style=\"font-size:14.0pt;\">Dense adhesions between pelvic organs</span></li><li><span style=\"font-size:14.0pt;\">Ovarian cysts with dark, thick, tar-like fluid</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Relevance in this case:</strong> The described cyst that ruptured releasing thick, chocolate-like material is classic for <strong>endometriosis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Serous cystadenoma:&nbsp;</strong>A benign epithelial ovarian tumor filled with <strong>clear, straw-colored fluid</strong>. It does not contain old blood or cause adhesions typical of endometriosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Corpus luteum cyst:&nbsp;</strong>Formed from a <strong>persisting corpus luteum</strong>, often containing <strong>yellow or blood-tinged fluid</strong>. These cysts usually resolve spontaneously and are not associated with infertility or chronic pelvic adhesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Theca lutein cyst:&nbsp;</strong>Typically, <strong>bilateral</strong> and associated with <strong>high β-hCG states</strong> (e.g., molar pregnancy, multiple gestation). They contain <strong>clear or straw-colored fluid</strong>, not chocolate-colored material.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>“chocolate cyst”</strong> seen during laparoscopy—containing <strong>thick, tarry, altered blood</strong>—is characteristic of an <strong>ovarian endometrioma</strong>, a manifestation of <strong>endometriosis</strong>, which is a leading cause of <strong>infertility and chronic pelvic pain</strong> in women of reproductive age.</span></p>",
      "correct_choice_id": 383282,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96283/Ini-Cet_Gt_30_Oct_2025_Obg_Q_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96283/Ini-Cet_Gt_30_Oct_2025_Obg_Q_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96379,
      "choices": [
        {
          "id": 383660,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4 and 5 are correct</span></p>"
        },
        {
          "id": 383661,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3 and 5 are correct</span></p>"
        },
        {
          "id": 383662,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4 and 5 are correct</span></p>"
        },
        {
          "id": 383663,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4 and 5 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding the pathological features of Keloid formation, which of the following statements are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Keloids are characterized by excessive deposition of collagen that extends beyond the boundaries of the original wound.</span></li><li><span style=\"font-size:14.0pt;\">They commonly regress spontaneously over time.</span></li><li><span style=\"font-size:14.0pt;\">Keloids are more frequent among individuals of African descent and may have a genetic predisposition.</span></li><li><span style=\"font-size:14.0pt;\">The collagen arrangement within keloids is haphazardly organized.</span></li><li><span style=\"font-size:14.0pt;\">Keloids are most frequently found in skin overlying the sternum and upper back.</span></li></ol>",
      "unique_key": "Q6315869",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 3, 4 and 5 are correct</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Keloids</strong> are an abnormal wound healing response characterized by <strong>excessive collagen deposition (mainly type III collagen)</strong> that <strong>extends beyond the boundaries of the original wound</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike hypertrophic scars, keloids do not regress and often recur after excision.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key pathological features:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180029.jpg\" width=\"920\" height=\"364\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Keloids are characterized by excessive deposition of collagen that extends beyond the boundaries of the original wound:&nbsp;</strong>Extension beyond wound boundaries — distinguishes keloids from hypertrophic scars.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Keloids are more frequent among individuals of African descent and may have a genetic predisposition:&nbsp; </strong>Genetic predisposition — higher incidence in individuals of <strong>African, Hispanic, and Asian descent</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. The collagen arrangement within keloids is haphazardly organized:&nbsp;</strong>Haphazard collagen arrangement — collagen bundles are thick, irregular, and disorganized.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Keloids are most frequently found in skin overlying the sternum and upper back:&nbsp;</strong>Common sites— presternal region, shoulders, upper back, and earlobes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>No spontaneous regression</strong> — often persist and may enlarge over time.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. They commonly regress spontaneously over time:&nbsp;</strong>Incorrect. Keloids <strong>do not regress spontaneously</strong>; they may continue to enlarge even after healing, unlike <strong>hypertrophic scars</strong>, which may regress.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Keloids</strong> are characterized by <strong>overgrowth of disorganized collagen that extends beyond the wound margin</strong>, show <strong>no spontaneous regression</strong>, and have a <strong>predilection for Africans</strong> and areas like the <strong>sternum and shoulders</strong>.</span></p>",
      "correct_choice_id": 383660,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96379/Pathology_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96379/Pathology_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96396,
      "choices": [
        {
          "id": 383728,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated eosinophils in the CSF with cloudy appearance</span></p>"
        },
        {
          "id": 383729,
          "text": "<p><span style=\"font-size:14.0pt;\">Motile trophozoites on wet mount preparation of fresh CSF</span></p>"
        },
        {
          "id": 383730,
          "text": "<p><span style=\"font-size:14.0pt;\">Growth on Sabouraud agar with fuzzy colonies</span></p>"
        },
        {
          "id": 383731,
          "text": "<p><span style=\"font-size:14.0pt;\">PCR detection of cyst wall gene markers in serum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-year-old boy is brought to the emergency department with high-grade fever, severe headache, nausea, and altered mental status. His symptoms began two days after swimming in a local freshwater lake. Which of the following findings would most reliably support a diagnosis of primary amoebic meningoencephalitis (PAM) caused by Naegleria fowleri?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6217588",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Motile trophozoites on wet mount preparation of fresh CSF</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Motile trophozoites</strong> seen on <strong>immediate wet mount microscopy</strong> of <strong>freshly collected CSF</strong> is the most reliable early diagnostic clue for Naegleria fowleri infection.</span></li><li><span style=\"font-size:14.0pt;\">These trophozoites exhibit <strong>lobopodial, directional movement</strong> and can be visualized under phase-contrast microscopy.</span></li><li><span style=\"font-size:14.0pt;\">Delayed examination reduces the chance of detecting motility, making rapid processing crucial.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Elevated eosinophils in the CSF with cloudy appearance:&nbsp;</strong>Eosinophilic pleocytosis is more typical of <strong>helminthic CNS infections</strong> (e.g., <strong>Angiostrongylus</strong>), not amoebic meningoencephalitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Growth on Sabouraud agar with fuzzy colonies:</strong> Sabouraud dextrose agar is selective for <strong>fungal organisms</strong>, not Naegleria. N. fowleri requires <strong>non-nutrient agar with E. coli overlay</strong> for culture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. PCR detection of cyst wall gene markers in serum:</strong> N. fowleri cysts are <strong>not present in human tissue or CSF</strong>. PCR targeting trophozoite genes in <strong>CSF</strong> is useful, but <strong>not in serum</strong> and <strong>not the most immediate or practical</strong> test for early diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In suspected <strong>Naegleria fowleri</strong> infections, especially after recent freshwater exposure and fulminant meningoencephalitis, the <strong>most rapid and reliable test</strong> is <strong>wet mount of fresh CSF</strong> showing <strong>motile trophozoites</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early detection is critical, as the disease progresses rapidly and has a high mortality rate without timely treatment.</span></li></ul>",
      "correct_choice_id": 383729,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96396/Microbiology_INICET_GT_30_Oct_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96396/Microbiology_INICET_GT_30_Oct_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96282,
      "choices": [
        {
          "id": 383276,
          "text": "<p><span style=\"font-size:14.0pt;\">Ovarian cystectomy</span></p>"
        },
        {
          "id": 383277,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaginal hysterectomy</span></p>"
        },
        {
          "id": 383278,
          "text": "<p><span style=\"font-size:14.0pt;\">Tubal ligation</span></p>"
        },
        {
          "id": 383279,
          "text": "<p><span style=\"font-size:14.0pt;\">Abdominal hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During which of the following procedures is this instrument most commonly used?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20151432.jpg\" width=\"408\" height=\"449\"></strong></span></p>",
      "unique_key": "Q9966134",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Tubal ligation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>The instrument shown in the image is Babcock’s forceps</strong>. It is a <strong>non-toothed, fenestrated, atraumatic grasping instrument</strong> used to hold and manipulate <strong>delicate tubular structures</strong> such as the <strong>fallopian tubes, ureters, intestines, and appendix</strong> without causing injury.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>tubal ligation</strong>, it is specifically used to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Gently grasp and elevate the fallopian tube</strong> from the mesosalpinx.</span></li><li><span style=\"font-size:14.0pt;\">Allow for ligation or cauterization of the tube for sterilization.</span><br><span style=\"font-size:14.0pt;\">The smooth, rounded edges and fenestrated jaws ensure minimal tissue trauma during handling.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Design features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Fenestrated tip to prevent crushing</span></li><li><span style=\"font-size:14.0pt;\">Curved jaws for gentle grip</span></li><li><span style=\"font-size:14.0pt;\">Used primarily in procedures involving soft tissues or hollow tubes</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, in gynecologic practice, <strong>Babcock’s forceps</strong> is most frequently used during <strong>tubal ligation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ovarian cystectomy:&nbsp;</strong>Involves dissection and excision of an ovarian cyst; <strong>Allis forceps</strong> or <strong>toothed tissue forceps</strong> are used instead for firm grip, as the ovary is a solid organ.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vaginal hysterectomy:&nbsp;</strong>Requires instruments such as <strong>Heaney clamps</strong>, <strong>Kocher’s clamps</strong>, and <strong>Allis forceps</strong> for firm tissue handling, not Babcock’s forceps.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abdominal hysterectomy:&nbsp;</strong>Also utilizes <strong>Kocher’s</strong>, <strong>Allis</strong>, and <strong>Heaney clamps</strong> for gripping ligaments and uterine vessels — not suitable for delicate tubular structures like Babcock’s.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Babcock’s forceps</strong> is an <strong>atraumatic grasping instrument</strong> primarily used to hold <strong>soft, tubular structures</strong> such as the <strong>fallopian tubes during tubal ligation</strong>, ensuring tissue handling without crushing or injury.</span></p>",
      "correct_choice_id": 383278,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96282/Ini-Cet_Gt_30_Oct_2025_Obg_Q_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96282/Ini-Cet_Gt_30_Oct_2025_Obg_Q_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96405,
      "choices": [
        {
          "id": 383764,
          "text": "<p><span style=\"font-size:14.0pt;\">Culture on Sabouraud’s Dextrose Agar</span></p>"
        },
        {
          "id": 383765,
          "text": "<p><span style=\"font-size:14.0pt;\">Latex agglutination for cryptococcal capsular antigen</span></p>"
        },
        {
          "id": 383766,
          "text": "<p><span style=\"font-size:14.0pt;\">Gram stain of CSF</span></p>"
        },
        {
          "id": 383767,
          "text": "<p><span style=\"font-size:14.0pt;\">Nigrosin negative stain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old renal transplant recipient presents with headache, low-grade fever, and photophobia. Physical exam reveals neck stiffness. A lumbar puncture is performed. CSF analysis shows elevated opening pressure, lymphocytic pleocytosis, and the presence of round budding yeast cells. India ink staining is negative. Which of the following is the most sensitive test to confirm the diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1062263",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Latex agglutination for cryptococcal capsular antigen</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Latex agglutination test detects <strong>capsular polysaccharide antigen</strong> of Cryptococcus neoformans (and C. gattii) in <strong>CSF or serum</strong> and has a <strong>&gt;95% sensitivity</strong>, making it the <strong>most sensitive and rapid</strong> test, especially when <strong>India ink is negative</strong> (which occurs in ~30–40% of cases with low fungal burden).</span></li><li><span style=\"font-size:14.0pt;\">This test can even be used <strong>before culture results</strong> are available.</span></li><li><span style=\"font-size:14.0pt;\">It works even when fungal cells are sparse or immune suppression reduces inflammatory response.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Culture on Sabouraud’s Dextrose Agar:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While definitive, it takes <strong>several days</strong> and is <strong>less sensitive</strong> than antigen detection in early disease.</span></li><li><span style=\"font-size:14.0pt;\">Colony appearance is creamy, mucoid; but not useful for rapid diagnosis in critical cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gram stain of CSF:&nbsp;</strong>Shows <strong>Gram-positive budding yeast cells</strong>, but is <strong>low sensitivity</strong> and less reliable than antigen detection or India ink.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Nigrosin negative stain:&nbsp;</strong>Like India ink, detects <strong>capsular halo</strong>, but has similar limitations in <strong>low fungal burden</strong>, hence <strong>lower sensitivity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In suspected <strong>cryptococcal meningitis</strong>, especially in <strong>immunocompromised</strong> patients (e.g., HIV, transplant), the <strong>most sensitive diagnostic test</strong> is <strong>latex agglutination</strong> for <strong>capsular antigen</strong> detection in CSF or serum.</span></li><li><span style=\"font-size:14.0pt;\">India ink has limited sensitivity, and culture takes time.</span></li></ul>",
      "correct_choice_id": 383765,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96405/Microbiology_INICET_GT_30_Oct_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96405/Microbiology_INICET_GT_30_Oct_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96374,
      "choices": [
        {
          "id": 383640,
          "text": "<p><span style=\"font-size:14.0pt;\">Doppler ultrasound</span></p>"
        },
        {
          "id": 383641,
          "text": "<p><span style=\"font-size:14.0pt;\">Elastography</span></p>"
        },
        {
          "id": 383642,
          "text": "<p><span style=\"font-size:14.0pt;\">Contrast-enhanced ultrasound</span></p>"
        },
        {
          "id": 383643,
          "text": "<p><span style=\"font-size:14.0pt;\">CT scan with contrast</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The ultrasound image shown demonstrates a specialized liver imaging technique that assesses tissue stiffness by measuring shear wave velocity. Which of the following techniques is being depicted?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_z85YIs3.png\" width=\"577\" height=\"374\"></span></p>",
      "unique_key": "Q9767171",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Elastography</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The provided image shows a liver ultrasound with a colored ROI (region of interest) where quantitative values of tissue stiffness are displayed in kilopascals (kPa).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This corresponds to shear wave elastography, a non-invasive imaging technique that measures tissue elasticity (fibrosis) by calculating the propagation speed of shear waves through the liver parenchyma.</span></li><li><span style=\"font-size:14.0pt;\">Normal liver tissue is more elastic (low stiffness), whereas fibrosis and cirrhosis cause increased stiffness (higher kPa values).</span></li><li><span style=\"font-size:14.0pt;\">Elastography is increasingly used in hepatology as a non-invasive alternative to liver biopsy for staging fibrosis in chronic hepatitis B, hepatitis C, NAFLD, and alcoholic liver disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Doppler ultrasound:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Doppler evaluates blood flow and velocity within vessels or organs using frequency shifts.</span></li><li><span style=\"font-size:14.0pt;\">It does not measure stiffness or provide kPa values.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Contrast-enhanced ultrasound:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Uses microbubble contrast agents to evaluate vascular perfusion in real time.</span></li><li><span style=\"font-size:14.0pt;\">Helpful for detecting tumors and differentiating benign vs malignant lesions, but not for fibrosis staging.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CT scan with contrast:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Provides cross-sectional anatomical imaging with iodine contrast.</span></li><li><span style=\"font-size:14.0pt;\">Useful for tumor detection and vascular anatomy, but it does not quantify liver stiffness or elasticity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ultrasound elastography is a non-invasive tool that measures liver stiffness using shear wave velocity, reported in kilopascals (kPa).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is widely used in assessing and staging hepatic fibrosis, reducing the need for invasive liver biopsy.</span></li></ul>",
      "correct_choice_id": 383641,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96374/RADIOLOGY_INICET_GT_5_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96374/RADIOLOGY_INICET_GT_5_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96338,
      "choices": [
        {
          "id": 383496,
          "text": "<p><span style=\"font-size:14.0pt;\">Esophageal varices and hepatic fibrosis</span></p>"
        },
        {
          "id": 383497,
          "text": "<p><span style=\"font-size:14.0pt;\">Glycemic control</span></p>"
        },
        {
          "id": 383498,
          "text": "<p><span style=\"font-size:14.0pt;\">Cardiac function</span></p>"
        },
        {
          "id": 383499,
          "text": "<p><span style=\"font-size:14.0pt;\">Arthropathy and hypogonadism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old man is being evaluated for liver transplantation due to decompensated cirrhosis. He is found to be C282Y homozygous, and liver biopsy confirms hereditary hemochromatosis. He has several complications: cardiac dysfunction, arthropathy, diabetes, and hypogonadism related to iron overload. Which of the following disease manifestations would not be expected to improve with phlebotomy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6986945",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Arthropathy and hypogonadism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZkXCkmK.png\" width=\"683\" height=\"454\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>hereditary hemochromatosis</strong>, iron removal by <strong>phlebotomy</strong> can reverse hepatic, cardiac, and endocrine dysfunction <strong>if instituted early</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, <strong>arthropathy and hypogonadism</strong> are typically <strong>irreversible</strong> complications that do <strong>not improve with iron depletion</strong>.</span></li></ul>",
      "correct_choice_id": 383499,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96338/Medicine_INICET_GT_30_Oct_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96338/Medicine_INICET_GT_30_Oct_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96100,
      "choices": [
        {
          "id": 382564,
          "text": "<p><span style=\"font-size:14.0pt;\">Clotted blood from femoral vein</span></p>"
        },
        {
          "id": 382565,
          "text": "<p><span style=\"font-size:14.0pt;\">Muscle tissue from thigh</span></p>"
        },
        {
          "id": 382566,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary epithelial scrapings</span></p>"
        },
        {
          "id": 382567,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulp from molar tooth</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A severely decomposed body is recovered from a dense forest two weeks after being reported missing. Most of the soft tissues have degraded, and the body is in an advanced state of decomposition. The forensic team is tasked with establishing the identity of the individual using DNA analysis. Which of the following samples is the most appropriate for obtaining DNA in this scenario?</span></p>",
      "unique_key": "Q9323899",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Pulp from molar tooth</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In cases of <strong>advanced decomposition</strong>, soft tissues like blood, lung epithelium, and even muscle degrade rapidly due to enzymatic autolysis and bacterial putrefaction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hard tissues</strong>—such as <strong>teeth and bones</strong>—are <strong>resistant to enzymatic breakdown</strong>, making them the <strong>most reliable source for DNA extraction</strong> in such cases.</span></li><li><span style=\"font-size:14.0pt;\">Among teeth, the <strong>pulp cavity of molars</strong> is particularly well-preserved and protected, offering a <strong>concentrated and high-quality source of nuclear DNA</strong> even in bodies that are weeks to months old.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Clotted blood from femoral vein:&nbsp;</strong>Clotted blood is a <strong>poor source</strong> of DNA in postmortem cases, especially after decomposition sets in. Also, EDTA blood is preferred over clotted blood for preserving DNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Muscle tissue from thigh:&nbsp;</strong>Muscle tissue may retain some DNA in <strong>early decomposition</strong>, but in <strong>advanced decay</strong>, it is significantly degraded and no longer reliable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pulmonary epithelial scrapings:&nbsp;</strong>Lung tissue and mucosal scrapings are <strong>extremely susceptible to autolysis and microbial invasion</strong>, making them <strong>unreliable</strong> in severely decomposed bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In forensic identification of <strong>decomposed bodies</strong>, <strong>teeth (especially molars)</strong> and <strong>dense bones (like femur)</strong> are the <strong>preferred sources of DNA</strong>, due to their resistance to degradation and ability to preserve nuclear material.</span></p>",
      "correct_choice_id": 382567,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96100/FMT_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96100/FMT_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96088,
      "choices": [
        {
          "id": 382516,
          "text": "<p><span style=\"font-size:14.0pt;\">1st &amp; 2nd lumbricals – bipennate; 3rd &amp; 4th lumbricals – unipennate</span></p>"
        },
        {
          "id": 382517,
          "text": "<p><span style=\"font-size:14.0pt;\">1st &amp; 2nd lumbricals – unipennate; 3rd &amp; 4th lumbricals – bipennate</span></p>"
        },
        {
          "id": 382518,
          "text": "<p><span style=\"font-size:14.0pt;\">1st &amp; 3rd lumbricals – bipennate; 2nd &amp; 4th lumbricals – unipennate</span></p>"
        },
        {
          "id": 382519,
          "text": "<p><span style=\"font-size:14.0pt;\">2nd &amp; 3rd lumbricals – bipennate; 1st &amp; 4th lumbricals – unipennate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the hand, which lumbrical muscles are unipennate and which are bipennate in their fiber arrangement?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4536027",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1st &amp; 2nd lumbricals – unipennate; 3rd &amp; 4th lumbricals – bipennate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>lumbrical muscles of the hand</strong> arise from the tendons of the <strong>flexor digitorum profundus (FDP)</strong> and insert into the <strong>extensor expansion</strong> on the dorsal aspect of the corresponding fingers.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Arrangement:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>1st &amp; 2nd lumbricals:</strong> Unipennate (arise from the lateral two FDP tendons of index and middle fingers).</span></li><li><span style=\"font-size:14.0pt;\"><strong>3rd &amp; 4th lumbricals:</strong> Bipennate (arise from adjacent FDP tendons).</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Function:&nbsp;</strong>They <strong>flex the metacarpophalangeal (MCP) joints</strong> and <strong>extend the interphalangeal (IP) joints</strong>, producing the characteristic “writing” or “pen-holding” movement.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Innervation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">1st and 2nd → <strong>Median nerve</strong></span></li><li><span style=\"font-size:14.0pt;\">3rd and 4th → <strong>Deep branch of ulnar nerve</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Hence, weakness in the first two lumbricals (as in <strong>median nerve palsy</strong>) leads to difficulty performing fine finger flexion—matching the scenario described.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NFWfYYn.png\" width=\"765\" height=\"543\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>lumbrical muscles</strong> exhibit distinct fiber patterns:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1st &amp; 2nd – Unipennate</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>3rd &amp; 4th – Bipennate</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">They flex MCP joints and extend IP joints, with dual innervation from the <strong>median and ulnar nerves</strong>.</span></p>",
      "correct_choice_id": 382517,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96088/Anatomy_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96088/Anatomy_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96391,
      "choices": [
        {
          "id": 383708,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute glomerulonephritis</span></p>"
        },
        {
          "id": 383709,
          "text": "<p><span style=\"font-size:14.0pt;\">Paroxysmal nocturnal hemoglobinuria (PNH)</span></p>"
        },
        {
          "id": 383710,
          "text": "<p><span style=\"font-size:14.0pt;\">Alkaptonuria</span></p>"
        },
        {
          "id": 383711,
          "text": "<p><span style=\"font-size:14.0pt;\">Porphyria cutanea tarda</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man presents with episodes of dark-colored urine and symptoms of fatigue and pallor. Laboratory tests reveal hemolytic anemia and pancytopenia. Flow cytometry of the patient is shown below.&nbsp;Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180223.jpg\" width=\"708\" height=\"404\"></span></p>",
      "unique_key": "Q8064854",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Paroxysmal nocturnal hemoglobinuria (PNH)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Flow cytometry</strong> is the diagnostic test of choice for <strong>Paroxysmal Nocturnal Hemoglobinuria (PNH)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It identifies <strong>loss of glycosylphosphatidylinositol (GPI)-anchored surface proteins</strong>, such as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">CD55 (decay-accelerating factor)</span></li><li><span style=\"font-size:14.0pt;\">CD59 (membrane inhibitor of reactive lysis)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These proteins normally protect red blood cells from <strong>complement-mediated lysis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>PIGA gene mutation</strong> in hematopoietic stem cells leads to a deficiency of these GPI-linked proteins, resulting in complement activation and <strong>intravascular hemolysis</strong>, especially at night (due to mild respiratory acidosis during sleep).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key findings:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Morning hemoglobinuria</strong> (dark urine)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pancytopenia</strong> (bone marrow involvement)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Thrombosis</strong> (hepatic, portal, or cerebral veins) — major cause of mortality</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Flow cytometry interpretation (image):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Panel A (Normal individual):</strong> All cells express CD55 and CD59 (black cluster).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Panel B (PNH patient):</strong> A subset of cells (red cluster) is <strong>deficient in CD55/CD59</strong>, confirming PNH.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute glomerulonephritis:&nbsp;</strong>Characterized by <strong>hematuria</strong> (intact RBCs in urine), <strong>RBC casts</strong>, and <strong>proteinuria</strong>, not free hemoglobin from intravascular lysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Alkaptonuria:&nbsp;</strong>A metabolic disorder due to <strong>homogentisic acid oxidase deficiency</strong> leading to <strong>homogentisic aciduria</strong>, causing <strong>black urine on standing</strong>, but not related to complement-mediated hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Porphyria cutanea tarda:&nbsp;</strong>A <strong>hepatic porphyria</strong> due to <strong>uroporphyrinogen decarboxylase deficiency</strong>, leading to <strong>uroporphyrin accumulation</strong> and <strong>red-brown urine</strong> that fluoresces under UV light, not due to RBC destruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Paroxysmal Nocturnal Hemoglobinuria (PNH)</strong> is caused by a <strong>PIGA gene mutation</strong> resulting in <strong>loss of GPI-anchored complement regulatory proteins (CD55 and CD59)</strong>, leading to <strong>complement-mediated intravascular hemolysis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Flow cytometry</strong> showing absence of <strong>CD55/CD59</strong> is diagnostic.</span></li></ul>",
      "correct_choice_id": 383709,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96391/Pathology_INICET_GT_30_Oct_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96391/Pathology_INICET_GT_30_Oct_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96395,
      "choices": [
        {
          "id": 383724,
          "text": "<p><span style=\"font-size:14.0pt;\">Platelet concentrate</span></p>"
        },
        {
          "id": 383725,
          "text": "<p><span style=\"font-size:14.0pt;\">Cryoprecipitate</span></p>"
        },
        {
          "id": 383726,
          "text": "<p><span style=\"font-size:14.0pt;\">Packed red blood cells</span></p>"
        },
        {
          "id": 383727,
          "text": "<p><span style=\"font-size:14.0pt;\">Albumin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man with a history of massive blood loss due to trauma is receiving multiple transfusions. After several units of packed red blood cells, his coagulation profile shows prolonged PT and aPTT, and fibrinogen levels are markedly decreased. Fresh frozen plasma is unavailable. Which of the following is the best blood product to correct his coagulation abnormalities?</span></p>",
      "unique_key": "Q3381271",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cryoprecipitate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cryoprecipitate</strong> is a <strong>plasma-derived blood product</strong> obtained by thawing <strong>fresh frozen plasma (FFP)</strong> at low temperatures (1–6°C) and collecting the <strong>cold-insoluble fraction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>rich in high–molecular-weight coagulation proteins</strong>, specifically:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Fibrinogen</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\">Factor VIII</span></li><li><span style=\"font-size:14.0pt;\">Factor XIII</span></li><li><span style=\"font-size:14.0pt;\">von Willebrand factor (vWF)</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical uses of cryoprecipitate:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hypofibrinogenemia</strong> (e.g., DIC, massive transfusion)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Congenital fibrinogen deficiency</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Factor XIII deficiency</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>von Willebrand disease</strong> or <strong>Hemophilia A</strong> (if specific factor concentrates are unavailable)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> Cryoprecipitate replaces <strong>fibrinogen</strong> and <strong>clot-stabilizing factors</strong>, restoring coagulation cascade integrity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Platelet concentrate:&nbsp;</strong>Used in <strong>thrombocytopenia</strong> or <strong>platelet dysfunction</strong>, not in coagulation factor deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Packed red blood cells (PRBCs):&nbsp;</strong>Used to correct <strong>anemia</strong> and improve <strong>oxygen delivery</strong>, not coagulopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Albumin:&nbsp;</strong>Used for <strong>volume expansion</strong> and <strong>hypoalbuminemia</strong>, but lacks clotting factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cryoprecipitate</strong> is the blood product of choice for patients with <strong>low fibrinogen levels</strong> or deficiencies of <strong>Factor VIII, XIII, or von Willebrand factor</strong> during <strong>massive transfusion, DIC, or inherited disorders</strong>.</span></p>",
      "correct_choice_id": 383725,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96395/Pathology_INICET_GT_30_Oct_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96395/Pathology_INICET_GT_30_Oct_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96293,
      "choices": [
        {
          "id": 383320,
          "text": "<p><span style=\"font-size:14.0pt;\">4</span></p>"
        },
        {
          "id": 383321,
          "text": "<p><span style=\"font-size:14.0pt;\">6</span></p>"
        },
        {
          "id": 383322,
          "text": "<p><span style=\"font-size:14.0pt;\">8</span></p>"
        },
        {
          "id": 383323,
          "text": "<p><span style=\"font-size:14.0pt;\">10</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A newborn at 1 minute has HR 110 bpm, irregular breathing, some flexion, grimace, and pink body with blue extremities. What is the APGAR score?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8115510",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HR (2) + Respiration (1) + Tone (1) + Reflex (1) + Color (1) = <strong>6</strong>, indicating moderate birth asphyxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">APGAR helps assess <strong>transition and need for resuscitation</strong>, not long-term outcome.</span></li><li><span style=\"font-size:14.0pt;\"><strong>&gt;7 normal</strong>, <strong>4–7 moderate</strong>, <strong>0–3 severe birth asphyxia</strong>.</span></li></ul>",
      "correct_choice_id": 383321,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96293/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96293/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96310,
      "choices": [
        {
          "id": 383388,
          "text": "<p><span style=\"font-size:14.0pt;\">Onlay</span></p>"
        },
        {
          "id": 383389,
          "text": "<p><span style=\"font-size:14.0pt;\">Inlay</span></p>"
        },
        {
          "id": 383390,
          "text": "<p><span style=\"font-size:14.0pt;\">Sublay</span></p>"
        },
        {
          "id": 383391,
          "text": "<p><span style=\"font-size:14.0pt;\">Intraperitoneal (IPOM)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the site of mesh repair done in the image.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20174409.jpg\" width=\"704\" height=\"519\"></strong></span></p>",
      "unique_key": "Q7714076",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Onlay</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Onlay&nbsp;</strong>mesh is placed <strong>above the muscle layer</strong> on the anterior surface of the fascia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This technique is commonly used in open inguinal hernia repair as shown in the image.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inlay:</strong> The mesh is positioned <strong>between tissue planes</strong>, often within the hernia defect itself. This approach does not provide strong reinforcement and is rarely used in open inguinal hernia repair.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sublay:</strong> The mesh is placed <strong>under the muscle layer</strong> and above the peritoneum or posterior fascia. This technique, often termed <strong>\"posterior mesh placement\"</strong>, is commonly used in laparoscopic inguinal hernia repair, providing robust support and tension-free reinforcement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intraperitoneal (IPOM):</strong> The mesh is placed <strong>inside the peritoneal cavity</strong> in direct contact with the intestines. This is primarily utilized in laparoscopic ventral hernia repairs rather than open inguinal hernia repair due to risks of adhesions and complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Onlay mesh repair is done in open while sublay mesh placement is the preferred technique in lap inguinal hernia repair, ensuring strong reinforcement and minimal recurrence.</span></p>",
      "correct_choice_id": 383388,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96310/NEET_PG_30_Oct_2025_GT_Surgery_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96310/NEET_PG_30_Oct_2025_GT_Surgery_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96315,
      "choices": [
        {
          "id": 383408,
          "text": "<p><span style=\"font-size:14.0pt;\">Ask to speak a sentence → GCS → IV line → Endotracheal intubation&nbsp;</span></p>"
        },
        {
          "id": 383409,
          "text": "<p><span style=\"font-size:14.0pt;\">IV line → Endotracheal intubation → GCS → Ask to speak a sentence&nbsp;</span></p>"
        },
        {
          "id": 383410,
          "text": "<p><span style=\"font-size:14.0pt;\">Ask to speak a sentence → IV line → Endotracheal intubation → GCS&nbsp;</span></p>"
        },
        {
          "id": 383411,
          "text": "<p><span style=\"font-size:14.0pt;\">Ask to speak a sentence → Endotracheal intubation → IV line → GCS&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following represents the correct sequence of ATLS primary survey steps?</span></p>",
      "unique_key": "Q9013644",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ask to speak a sentence → Endotracheal intubation → IV line → GCS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>The ATLS primary survey follows ABCDE:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Airway with cervical spine protection → Ask to speak a sentence to assess airway patency.</span></li><li><span style=\"font-size:14.0pt;\">Breathing → Endotracheal intubation if needed.</span></li><li><span style=\"font-size:14.0pt;\">Circulation → IV line for fluid resuscitation.</span></li><li><span style=\"font-size:14.0pt;\">Disability → GCS for neurological status.</span></li><li><span style=\"font-size:14.0pt;\">Exposure → Full body check.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>The ATLS primary survey follows the sequence:</strong> Airway, Breathing, Circulation, and Disability (ABCD), ensuring rapid identification and correction of life-threatening conditions in trauma patients.</span></p>",
      "correct_choice_id": 383411,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96315/NEET_PG_30_Oct_2025_GT_Surgery_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96315/NEET_PG_30_Oct_2025_GT_Surgery_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96336,
      "choices": [
        {
          "id": 383488,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal CSF excludes the diagnosis</span></p>"
        },
        {
          "id": 383489,
          "text": "<p><span style=\"font-size:14.0pt;\">Antiganglioside antibodies are not diagnostic</span></p>"
        },
        {
          "id": 383490,
          "text": "<p><span style=\"font-size:14.0pt;\">In case of relapse, re-treatment with the same agent is recommended</span></p>"
        },
        {
          "id": 383491,
          "text": "<p><span style=\"font-size:14.0pt;\">Axonal variants have poorer outcomes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man presents with progressive weakness of both lower limbs for 4 days, followed by difficulty in lifting his arms. He had a brief episode of diarrhea 2 weeks ago. On examination, he has areflexia, symmetric flaccid weakness, and bilateral facial weakness, but no sensory level or bladder involvement. Nerve conduction study shows demyelination, and CSF analysis shows mildly elevated protein with few cells. Which of the following statements regarding the disease is incorrect?</span></p>",
      "unique_key": "Q1868191",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Normal CSF excludes the diagnosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Guillain-Barré Syndrome (GBS)</strong> is an <strong>acute immune-mediated polyneuropathy</strong> often triggered by infections such as Campylobacter jejuni, CMV, or EBV.</span></li><li><span style=\"font-size:14.0pt;\">It is characterized by <strong>rapidly progressive, symmetrical limb weakness</strong>, <strong>areflexia</strong>, and <strong>variable cranial nerve involvement</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key Diagnostic Features:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Yv4gGax.png\" width=\"674\" height=\"304\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Treatment Principles:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>IVIG (0.4 g/kg/day × 5 days)</strong> or <strong>plasmapheresis</strong> — equally effective.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Corticosteroids</strong> are <strong>not beneficial</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>If relapse occurs</strong>, the <strong>same modality (IVIG or PLEX)</strong> may be repeated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Prognosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Axonal variants (AMAN, AMSAN)</strong> → <strong>slower or incomplete recovery</strong>, hence poorer outcome compared to demyelinating (AIDP) type.</span></li><li><span style=\"font-size:14.0pt;\"><strong>CSF may remain normal</strong> in the <strong>first week</strong> of illness; protein elevation appears later. Thus, a normal CSF <strong>does not rule out</strong> GBS.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Antiganglioside antibodies are not diagnostic:</strong> True — these support diagnosis but are <strong>not required</strong> for confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. In case of relapse, re-treatment with same agent is recommended:</strong> True — relapse can be treated again with <strong>IVIG or PLEX</strong>, whichever was effective initially.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Axonal variants have poorer outcomes:</strong> True — due to axonal loss and slower regeneration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>normal CSF early in the disease does not exclude GBS</strong>. Diagnosis is <strong>clinical</strong>, supported by electrodiagnostic studies.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IVIG or plasmapheresis</strong> are mainstays of therapy; both can be repeated if relapse occurs. <strong>Axonal forms</strong> carry a <strong>worse prognosis</strong> than demyelinating types.</span></li></ul>",
      "correct_choice_id": 383488,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96336/Medicine_Inicet_Gt_30_Oct_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96336/Medicine_Inicet_Gt_30_Oct_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96327,
      "choices": [
        {
          "id": 383452,
          "text": "<p><span style=\"font-size:14.0pt;\">After a transient ischaemic attack (TIA), surgery can proceed without delay if otherwise indicated.</span></p>"
        },
        {
          "id": 383453,
          "text": "<p><span style=\"font-size:14.0pt;\">After an ischaemic stroke, surgery should not be delayed if there is heart failure, uncontrolled infection, or persistent high embolic risk, and no intracranial bleed on imaging.</span></p>"
        },
        {
          "id": 383454,
          "text": "<p><span style=\"font-size:14.0pt;\">After an intracranial haemorrhage, surgery should ideally be delayed for more than 1 month.</span></p>"
        },
        {
          "id": 383455,
          "text": "<p><span style=\"font-size:14.0pt;\">In a patient with intracranial haemorrhage and unstable haemodynamics, surgery must be absolutely contraindicated regardless of the cardiac condition.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old man with infective endocarditis develops neurological symptoms suggestive of a stroke. Brain MRI confirms an ischaemic infarct. According to current recommendations, which of the following statements regarding timing of cardiac surgery is not correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9176501",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) In a patient with intracranial haemorrhage and unstable haemodynamics, surgery must be absolutely contraindicated regardless of the cardiac condition.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>timing of cardiac surgery</strong> after neurological complications of infective endocarditis must balance <strong>neurological recovery</strong> against <strong>life-threatening cardiac deterioration</strong> or <strong>uncontrolled sepsis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>After TIA:</strong></span><br><span style=\"font-size:14.0pt;\">Surgery can proceed <strong>without delay</strong> if indicated (Class I, Level B).</span></li><li><span style=\"font-size:14.0pt;\"><strong>After ischaemic stroke:</strong></span><br><span style=\"font-size:14.0pt;\">Surgery should <strong>not be delayed</strong> in cases with <strong>heart failure, uncontrolled infection, abscess</strong>, or <strong>persistent high embolic risk</strong>, as long as the patient is <strong>not comatose</strong> and <strong>intracranial haemorrhage is excluded</strong> on imaging (Class I, Level B).</span></li><li><span style=\"font-size:14.0pt;\"><strong>After intracranial haemorrhage (ICH):</strong></span><br><span style=\"font-size:14.0pt;\">Surgery is preferably <strong>delayed &gt;1 month</strong> with <strong>repeat imaging</strong> to ensure stability before proceeding (Class IIa, Level C).</span></li><li><span style=\"font-size:14.0pt;\"><strong>ICH with unstable condition (heart failure, abscess, uncontrolled infection):</strong> <strong>Urgent or emergency surgery may still be considered</strong>, balancing the chance of <strong>meaningful neurological recovery</strong> against cardiac risk (Class IIa, Level C). Hence, it is <strong>not absolutely contraindicated</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. After a transient ischaemic attack (TIA), surgery can proceed without delay if otherwise indicated:&nbsp;</strong>Correct. Immediate surgery can be performed if otherwise indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. After an ischaemic stroke, surgery should not be delayed if there is heart failure, uncontrolled infection, or persistent high embolic risk, and no intracranial bleed on imaging:&nbsp;</strong>Correct. Can proceed after confirming absence of haemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. After an intracranial haemorrhage, surgery should ideally be delayed for more than 1 month with repeat imaging before proceeding:&nbsp;</strong>Correct. Advisable in stable patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cardiac surgery timing after neurological events in infective endocarditis:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4Ky3GRp.png\" width=\"678\" height=\"292\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Surgery after neurological complications in infective endocarditis is <strong>not absolutely contraindicated</strong>, even in the setting of ICH, if the cardiac condition is <strong>unstable or life-threatening</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Decisions should be <strong>multidisciplinary</strong> and individualized.</span></li></ul>",
      "correct_choice_id": 383455,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96327/Medicine_Inicet_Gt_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96327/Medicine_Inicet_Gt_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96104,
      "choices": [
        {
          "id": 382580,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 382581,
          "text": "<p><span style=\"font-size:14.0pt;\">3 only</span></p>"
        },
        {
          "id": 382582,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 382583,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is true about cardiac muscle contraction?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Extracellular Ca²⁺ is important for contraction</span></li><li><span style=\"font-size:14.0pt;\">Ca²⁺ is released from mitochondria</span></li><li><span style=\"font-size:14.0pt;\">Ca²⁺ is released from the sarcoplasmic reticulum</span></li><li><span style=\"font-size:14.0pt;\">Ligand-gated Ca²⁺ channels on sarcolemma have no role in EC coupling</span></li></ol>",
      "unique_key": "Q2232745",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Extracellular Ca²⁺ is important for contraction</strong>: This is true. In cardiac muscle, extracellular calcium is essential for the contraction process. About 20% of the calcium required for contraction comes from the extracellular fluid. This extracellular Ca²⁺ triggers the release of additional calcium from the sarcoplasmic reticulum through calcium-induced calcium release (CICR).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Ca²⁺ is released from the sarcoplasmic reticulum</strong>: This is true. The sarcoplasmic reticulum is the primary source of calcium release inside the cardiac muscle cell, which is essential for contraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Ca²⁺ is released from mitochondria</strong>: This is false. In cardiac muscle, calcium is not released from the mitochondria during contraction. Instead, calcium is stored and released from the sarcoplasmic reticulum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Ligand-gated Ca²⁺ channels on sarcolemma have no role in EC coupling</strong>: This is false. Voltage-gated (not ligand-gated) Ca²⁺ channels on the sarcolemma (also known as L-type calcium channels) play an essential role in excitation-contraction (EC) coupling. They allow the entry of extracellular calcium, which triggers the release of more calcium from the sarcoplasmic reticulum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In cardiac muscle contraction, both <strong>extracellular calcium</strong> and calcium released from the <strong>sarcoplasmic reticulum</strong> are crucial for the process, and voltage-gated calcium channels on the sarcolemma play an important role in excitation-contraction coupling.</span></p>",
      "correct_choice_id": 382582,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96104/Physiology_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96104/Physiology_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96347,
      "choices": [
        {
          "id": 383532,
          "text": "<p><span style=\"font-size:14.0pt;\">His glaucoma may worsen with cholinomimetic use</span></p>"
        },
        {
          "id": 383533,
          "text": "<p><span style=\"font-size:14.0pt;\">Cholinergic stimulation may exacerbate conduction abnormalities</span></p>"
        },
        {
          "id": 383534,
          "text": "<p><span style=\"font-size:14.0pt;\">His bladder symptoms suggest obstructive uropathy, not detrusor weakness</span></p>"
        },
        {
          "id": 383535,
          "text": "<p><span style=\"font-size:14.0pt;\">Cholinomimetics are ineffective in post-surgical urinary retention</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old man is recovering postoperatively from a hernia repair. On the second postoperative day, he has not passed urine and complains of suprapubic discomfort. Physical examination reveals a distended bladder. The intern suggests initiating a parasympathomimetic agent to stimulate detrusor contraction. His chart reveals the following:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">History of myasthenia gravis (well controlled on pyridostigmine)</span></li><li><span style=\"font-size:14.0pt;\">History of open-angle glaucoma</span></li><li><span style=\"font-size:14.0pt;\">Baseline ECG showing intermittent PR prolongation with occasional dropped beats, attributed to age-related conduction system disease</span></li><li><span style=\"font-size:14.0pt;\">No history of infection or nephrolithiasis</span></li></ul><p><span style=\"font-size:14.0pt;\">Which of the following best explains why this patient may not be a suitable candidate for the proposed pharmacologic intervention?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6638401",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cholinergic stimulation may exacerbate conduction abnormalities</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cholinomimetic agents (e.g., bethanechol) are commonly used for <strong>atonic bladder</strong> due to their ability to stimulate <strong>M3 receptors</strong>, enhancing detrusor muscle contraction.</span></li><li><span style=\"font-size:14.0pt;\">However, these drugs also stimulate <strong>M2 receptors in the heart</strong>, which <strong>slow AV nodal conduction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In a patient with <strong>pre-existing conduction abnormalities</strong> (e.g., <strong>intermittent PR prolongation and dropped beats</strong>), <strong>parasympathomimetics can worsen bradyarrhythmias or lead to complete heart block</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This makes their use <strong>contraindicated in partial heart block</strong>, even if the patient has other indications like urinary retention or glaucoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. His glaucoma may worsen with cholinomimetic use:&nbsp;</strong>Incorrect. On the contrary, cholinomimetics like <strong>pilocarpine</strong> or <strong>carbachol</strong> are used to <strong>treat</strong> glaucoma by improving aqueous outflow.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. His bladder symptoms suggest obstructive uropathy, not detrusor weakness:&nbsp;</strong>Incorrect. While obstructive uropathy is a consideration, the patient’s bladder is distended and he is post-op, making <strong>detrusor underactivity</strong> a more likely etiology. Cholinomimetics are appropriate unless contraindicated by another condition (e.g., heart block).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cholinomimetics are ineffective in post-surgical urinary retention:</strong> Incorrect. They are actually <strong>commonly used</strong> in this setting, especially <strong>bethanechol</strong>. Their ineffectiveness is not the issue here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cholinomimetic drugs</strong> are contraindicated in patients with <strong>AV conduction defects</strong>, such as <strong>partial heart block</strong>, due to their <strong>bradycardic and AV node-slowing effects</strong> via M2 receptor stimulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Always review the cardiac conduction status before initiating these agents.</span></li></ul>",
      "correct_choice_id": 383533,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96347/Pharmacology_INICET_GT_30_Oct_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96347/Pharmacology_INICET_GT_30_Oct_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96131,
      "choices": [
        {
          "id": 382684,
          "text": "<p><span style=\"font-size:14.0pt;\">Sentinel surveillance overestimates incidence because it samples only pregnant women</span></p>"
        },
        {
          "id": 382685,
          "text": "<p><span style=\"font-size:14.0pt;\">Sentinel surveillance primarily tracks trends and can reveal under-reporting; passive notifications may miss cases</span></p>"
        },
        {
          "id": 382686,
          "text": "<p><span style=\"font-size:14.0pt;\">Passive surveillance is superior for trend detection because it covers the whole population</span></p>"
        },
        {
          "id": 382687,
          "text": "<p><span style=\"font-size:14.0pt;\">The sentinel rise must be spurious because the passive system is comprehensive</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A state’s sentinel ANC network reports a rise in HIV positivity over 3 years, but routine case notifications from facilities show a flat trend. Which best reconciles the discrepancy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8723047",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Sentinel surveillance primarily tracks trends and can reveal under-reporting; passive notifications may miss cases</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sentinel surveillance</strong> deliberately samples <strong>selected, stable sites</strong> (e.g., ANC/STI clinics) at <strong>regular intervals</strong> using a <strong>consistent protocol</strong>, making it well-suited to detect <strong>directional change (trends)</strong> in the wider population.</span></li><li><span style=\"font-size:14.0pt;\">Because the methodology is standardized (same clinics, fixed sample size, same assays), changes in sentinel HIV positivity often reflect <strong>real shifts</strong> and/or <strong>gaps in routine case ascertainment</strong>.</span></li><li><span style=\"font-size:14.0pt;\">By contrast, <strong>passive surveillance</strong> depends on facilities to <strong>report all diagnosed cases</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is highly vulnerable to <strong>incomplete reporting, variable testing intensity, stock-outs, staffing changes, stigma-driven non-attendance,</strong> and <strong>delays</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A <strong>flat passive curve</strong> alongside a <strong>rising sentinel trend</strong> therefore commonly indicates <strong>under-reporting or reduced testing</strong> in the passive system rather than the absence of a true increase.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sentinel overestimates incidence because it samples pregnant only women:</strong> Incorrect. Sentinel ANC data are <strong>not used to estimate incidence</strong>; they are used to <strong>monitor trends</strong>. Although pregnant women are a specific subpopulation, the <strong>consistent sampling frame</strong> makes sentinel data sensitive to <strong>temporal changes</strong>. It does not inherently “overestimate.”</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Passive surveillance is superior for trend detection because it covers the whole population:</strong> Incorrect. Passive data may cover more facilities but are <strong>less stable</strong> for trend analysis because <strong>completeness and testing practices fluctuate</strong>. Trend sensitivity is exactly where <strong>sentinel</strong> excels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The sentinel rise must be spurious because the passive system is comprehensive:</strong> Incorrect. Dismissing standardized sentinel signals because passive data are flat <strong>ignores the known limitations of passive systems</strong> and the <strong>design purpose</strong> of sentinel networks (to detect trends and identify “missing cases”).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sentinel surveillance</strong> (e.g., ANC clinics) uses <strong>consistent, selected sites</strong> to provide <strong>stable trend data</strong> and can <strong>unmask under-reporting</strong> in <strong>passive</strong> systems.</span></li><li><span style=\"font-size:14.0pt;\">A rising sentinel trend with flat passive notifications should prompt investigation of <strong>gaps in testing/reporting</strong> rather than dismissal of the sentinel signal.</span></li></ul>",
      "correct_choice_id": 382685,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96131/NEET_PG_30_Oct_2025_GT_PSM_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96131/NEET_PG_30_Oct_2025_GT_PSM_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96394,
      "choices": [
        {
          "id": 383720,
          "text": "<p><span style=\"font-size:14.0pt;\">Aflatoxin</span></p>"
        },
        {
          "id": 383721,
          "text": "<p><span style=\"font-size:14.0pt;\">Ergot alkaloids</span></p>"
        },
        {
          "id": 383722,
          "text": "<p><span style=\"font-size:14.0pt;\">Ochratoxin A</span></p>"
        },
        {
          "id": 383723,
          "text": "<p><span style=\"font-size:14.0pt;\">Muscarine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An environmental surveillance team isolated the colony shown in the image from improperly stored cereal grains. Upon further analysis, fungal DNA sequencing confirmed the genus Penicillium. Which mycotoxin, known for its nephrotoxic potential and foodborne association, is most likely to be produced by this fungal isolate under conducive conditions?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ssMSmBx.png\" width=\"303\" height=\"436\"></strong></span></p>",
      "unique_key": "Q6763869",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ochratoxin A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ochratoxin A</strong> is a <strong>nephrotoxic mycotoxin</strong> produced by <strong>Penicillium verrucosum</strong> (as well as Aspergillus ochraceus).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It contaminates stored food products such as cereals, bread, and coffee under humid conditions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It has been implicated in <strong>Balkan endemic nephropathy</strong>, and chronic exposure may also pose a <strong>carcinogenic risk</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since the image shows characteristic Penicillium colony morphology, <strong>Ochratoxin A is the most relevant associated toxin</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aflatoxin:&nbsp;</strong>Aflatoxins are produced by <strong>Aspergillus flavus</strong> and <strong>A. parasiticus</strong>, not Penicillium. They are <strong>hepatotoxic</strong> and associated with <strong>hepatocellular carcinoma</strong>, especially through <strong>contaminated nuts and grains</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ergot alkaloids:&nbsp;</strong>These are produced by <strong>Claviceps purpurea</strong>, not Penicillium. They contaminate <strong>rye</strong> and cause <strong>vasospastic symptoms</strong> (ergotism or “St. Anthony’s fire”).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Muscarine:&nbsp;</strong>Muscarine is found in <strong>toxic mushrooms</strong> (like Inocybe and Clitocybe species), not molds like Penicillium. It causes <strong>cholinergic toxicity</strong>, not food spoilage-related mycotoxicosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Penicillium species, although common environmental molds, are significant due to their production of <strong>ochratoxin A</strong>, a <strong>nephrotoxin</strong> found in improperly stored grains and bread.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Accurate identification and mycotoxin correlation are essential for diagnosing <strong>toxin-related endemic diseases</strong> and implementing food safety controls.</span></li></ul>",
      "correct_choice_id": 383722,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96394/Microbiology_INICET_GT_30_Oct_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96394/Microbiology_INICET_GT_30_Oct_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96222,
      "choices": [
        {
          "id": 383040,
          "text": "<p><span style=\"font-size:14.0pt;\">Median = Mean = Mode</span></p>"
        },
        {
          "id": 383041,
          "text": "<p><span style=\"font-size:14.0pt;\">Mode = 4 × Median – 2 × Mean</span></p>"
        },
        {
          "id": 383042,
          "text": "<p><span style=\"font-size:14.0pt;\">Mode = 3 × Median – 2 × Mean</span></p>"
        },
        {
          "id": 383043,
          "text": "<p><span style=\"font-size:14.0pt;\">Median is the least affected by extreme values</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A statistician is analyzing a dataset that shows a characteristic distribution pattern, as illustrated in the histogram below. Which of the following statements is true regarding measures of central tendency in this type of distribution?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MAVRRB1.png\" width=\"636\" height=\"371\"></strong></span></p>",
      "unique_key": "Q3735882",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Mode = 3 × Median – 2 × Mean</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>bimodal or moderately skewed distributions</strong>, direct determination of the mode is often challenging.</span></li><li><span style=\"font-size:14.0pt;\">To address this, the <strong>empirical relation</strong> is used:</span><br><span style=\"font-size:14.0pt;\"><strong>Mode = 3 × Median – 2 × Mean</strong></span></li><li><span style=\"font-size:14.0pt;\">This allows statisticians to estimate the mode when raw data are unavailable but mean and median are known.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Median = Mean = Mode:</strong> This occurs only in a <strong>perfectly normal (Gaussian) distribution</strong>, not in bimodal or skewed data.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mode = 4 × Median – 2 × Mean:</strong> Incorrect; this formula does not exist in measures of central tendency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Median is the least affected by extreme values:</strong> While true in <strong>skewed distributions with outliers</strong>, the histogram here is bimodal, not skewed, so the question specifically targets the empirical mode formula.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Central Tendency in Various Distributions<strong>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vAljFSa.png\" width=\"1246\" height=\"258\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>In a bimodal series, Mode = 3 Median – 2 Mean</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>In distribution with extreme values (Outliers):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Most affected measure of central tendency: <strong>Mean</strong></span></li><li><span style=\"font-size:14.0pt;\">Least affected measure of central tendency: <strong>Mode</strong></span></li><li><span style=\"font-size:14.0pt;\">Most preferable measure of central tendency: <strong>Median</strong></span></li></ul></li></ul>",
      "correct_choice_id": 383042,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96222/NEET_PG_30_Oct_2025_GT_PSM_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96222/NEET_PG_30_Oct_2025_GT_PSM_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96302,
      "choices": [
        {
          "id": 383356,
          "text": "<p><span style=\"font-size:14.0pt;\">Retinoblastoma</span></p>"
        },
        {
          "id": 383357,
          "text": "<p><span style=\"font-size:14.0pt;\">Choroidal hemangioma</span></p>"
        },
        {
          "id": 383358,
          "text": "<p><span style=\"font-size:14.0pt;\">Choroidal melanoma</span></p>"
        },
        {
          "id": 383359,
          "text": "<p><span style=\"font-size:14.0pt;\">Central serous chorioretinopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old male presents with progressive loss of vision in his right eye. Fundus fluorescein angiography is performed, and the image is shown below. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20162447.jpg\" width=\"456\" height=\"419\"></span></p>",
      "unique_key": "Q1570678",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Choroidal melanoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>double circulation pattern</strong> seen on <strong>fundus fluorescein angiography (FFA)</strong> is a <strong>hallmark feature</strong> of <strong>choroidal melanoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This refers to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Retinal vessels</strong> traversing over the tumor.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intrinsic tumor vasculature</strong>, both seen as two distinct vascular networks.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This finding represents <strong>vascular supply from both the retinal and choroidal circulation</strong>, which is characteristic of malignant choroidal tumors.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Indocyanine green (ICG) angiography</strong> provides even better visualization due to its deeper choroidal penetration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Retinoblastoma:</strong> Usually presents in children and shows <strong>calcification</strong> with chalky-white appearance; not associated with double circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Choroidal hemangioma:</strong> May show early hyperfluorescence on FFA but does <strong>not show double circulation</strong> pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Central serous chorioretinopathy (CSCR):</strong> Typically shows <strong>ink blot or smoke stack leak</strong>, not an elevated vascular tumor with double circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Double circulation</strong> on FFA (retinal + intrinsic tumor vessels) is a classic angiographic sign of <strong>choroidal melanoma</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This finding helps differentiate it from other intraocular tumors and lesions.</span></li></ul>",
      "correct_choice_id": 383358,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96302/Ophthalmology_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96302/Ophthalmology_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96352,
      "choices": [
        {
          "id": 383552,
          "text": "<p><span style=\"font-size:14.0pt;\">Verapamil + Ivabradine</span></p>"
        },
        {
          "id": 383553,
          "text": "<p><span style=\"font-size:14.0pt;\">Ranolazine + Nicorandil</span></p>"
        },
        {
          "id": 383554,
          "text": "<p><span style=\"font-size:14.0pt;\">Metoprolol + Trimetazidine</span></p>"
        },
        {
          "id": 383555,
          "text": "<p><span style=\"font-size:14.0pt;\">Atenolol + Ranolazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with chronic stable angina is prescribed multiple agents for symptom control. Which of the following combinations poses the highest risk of life-threatening bradyarrhythmia due to additive effects on sinoatrial (SA) nodal activity?</span></p>",
      "unique_key": "Q4614931",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Verapamil + Ivabradine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Verapamil</strong> is a non-dihydropyridine calcium channel blocker that <strong>slows AV nodal conduction and SA node firing</strong>, reducing heart rate and contractility.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ivabradine</strong> selectively inhibits the <strong>funny current (If)</strong> in the SA node, reducing the pacemaker activity without affecting contractility or BP.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Combined use leads to excessive suppression of nodal activity</strong>, risking <strong>severe bradycardia, sinus arrest, or high-grade AV block</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This combination is <strong>contraindicated or used with extreme caution</strong> under close ECG monitoring.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ranolazine + Nicorandil:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ranolazine</strong> inhibits late Na⁺ current, improving myocardial relaxation and reducing oxygen demand.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nicorandil</strong> is a nitrate and K⁺ channel opener; it primarily affects vascular tone.</span></li><li><span style=\"font-size:14.0pt;\">Both do <strong>not directly affect SA or AV node conduction</strong>, so the risk of bradyarrhythmia is minimal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Metoprolol + Trimetazidine:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Metoprolol</strong> can slow the heart rate via β₁-blockade.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Trimetazidine</strong> modulates myocardial metabolism and <strong>does not affect nodal conduction or HR</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This combination is generally <strong>safe</strong> from a rhythm perspective.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Atenolol + Ranolazine:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Both drugs may reduce myocardial workload, but <strong>Ranolazine's effect on HR is minimal</strong>, and <strong>atenolol</strong>, though a β₁-blocker, when used alone rarely causes life-threatening bradycardia.</span></li><li><span style=\"font-size:14.0pt;\">Not a synergistic nodal suppressant combination.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Avoid combining two drugs that both slow the SA node — especially ivabradine + verapamil/diltiazem or β-blockers — due to cumulative bradycardic risk.</span></p>",
      "correct_choice_id": 383552,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96352/Pharmacology_INICET_GT_30_Oct_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96352/Pharmacology_INICET_GT_30_Oct_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96403,
      "choices": [
        {
          "id": 383756,
          "text": "<p><span style=\"font-size:14.0pt;\">HBsAg, anti-HBc IgM, anti-HDV IgM</span></p>"
        },
        {
          "id": 383757,
          "text": "<p><span style=\"font-size:14.0pt;\">HBsAg, anti-HBc IgG, HDV RNA, anti-HDV IgG</span></p>"
        },
        {
          "id": 383758,
          "text": "<p><span style=\"font-size:14.0pt;\">HBsAg, anti-HBs, HDV RNA</span></p>"
        },
        {
          "id": 383759,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-HBc IgM, anti-HDV IgM, anti-HBs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old male with a history of chronic hepatitis B presents with signs of worsening liver function. The clinician suspects a secondary viral infection contributing to hepatic deterioration. Which of the following lab findings would most accurately support a diagnosis of chronic hepatitis D superinfection?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1616101",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) HBsAg, anti-HBc IgG, HDV RNA, anti-HDV IgG</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hepatitis D virus (HDV) is a <strong>defective RNA virus</strong> that <strong>requires the presence of Hepatitis B virus (HBV)</strong>, specifically the <strong>HBsAg envelope</strong>, for replication and transmission.</span></li><li><span style=\"font-size:14.0pt;\">There are <strong>two patterns</strong> of HDV infection:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Co-infection</strong>: HBV and HDV acquired simultaneously (in an otherwise healthy person).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Superinfection</strong>: HDV infection in a patient who is already <strong>chronically infected with HBV</strong>.</span></li></ol></li><li><span style=\"font-size:14.0pt;\">The patient is <strong>already a chronic HBV carrier</strong> and now shows signs of hepatic worsening, suggesting <strong>HDV superinfection</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>chronic superinfection</strong>, lab results would include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>HBsAg</strong>: Persistently positive due to chronic HBV</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-HBc IgG</strong>: Indicates prior/chronic infection (not IgM, which reflects acute infection)</span></li><li><span style=\"font-size:14.0pt;\"><strong>HDV RNA</strong>: Indicates <strong>ongoing active replication</strong> of HDV</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-HDV IgG</strong>: Present in <strong>chronic phase</strong> (IgM more common in acute)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>Option B</strong> reflects the <strong>correct serological pattern</strong> for <strong>chronic HDV superinfection</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. HBsAg, anti-HBc IgM, anti-HDV IgM:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Indicates <strong>acute co-infection</strong>, not superinfection.</span></li><li><span style=\"font-size:14.0pt;\">Anti-HBc IgM points to recent HBV infection, which contradicts the “chronic HBV carrier” status in the stem.</span></li><li><span style=\"font-size:14.0pt;\">Anti-HDV IgM is associated with <strong>acute HDV</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incorrect:&nbsp;</strong>Pattern matches co-infection, not superinfection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. HBsAg, anti-HBs, HDV RNA:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Anti-HBs</strong> indicates resolution or immunity; it <strong>should not co-exist</strong> with HBsAg.</span></li><li><span style=\"font-size:14.0pt;\">If a person has anti-HBs, they have cleared HBV or been vaccinated and thus <strong>cannot harbor HDV</strong>, as HDV needs HBsAg.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incorrect:&nbsp;</strong>Serologically contradictory – anti-HBs and HBsAg are mutually exclusive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Anti-HBc IgM, anti-HDV IgM, anti-HBs:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Anti-HBc IgM = acute HBV</span></li><li><span style=\"font-size:14.0pt;\">Anti-HBs = resolved HBV or post-vaccination</span></li><li><span style=\"font-size:14.0pt;\">Again, anti-HBs should not be present with ongoing infection.</span></li><li><span style=\"font-size:14.0pt;\">Anti-HDV IgM = acute HDV, not chronic.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incorrect:&nbsp;</strong>Inconsistent with chronic HBV + chronic HDV picture.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Chronic HDV superinfection</strong> occurs in <strong>HBV carriers</strong> and leads to a <strong>more severe disease course</strong> with higher risks of <strong>fulminant hepatitis, cirrhosis, and hepatocellular carcinoma</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Serologic markers of chronic HDV superinfection include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>HBsAg</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-HBc IgG</strong> (not IgM)</span></li><li><span style=\"font-size:14.0pt;\"><strong>HDV RNA</strong> (evidence of viral replication)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-HDV IgG</strong></span></li></ul></li></ul>",
      "correct_choice_id": 383757,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96403/Microbiology_INICET_GT_30_Oct_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96403/Microbiology_INICET_GT_30_Oct_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96353,
      "choices": [
        {
          "id": 383556,
          "text": "<p><span style=\"font-size:14.0pt;\">Beer potomania</span></p>"
        },
        {
          "id": 383557,
          "text": "<p><span style=\"font-size:14.0pt;\">Heart failure</span></p>"
        },
        {
          "id": 383558,
          "text": "<p><span style=\"font-size:14.0pt;\">Low solute diet</span></p>"
        },
        {
          "id": 383559,
          "text": "<p><span style=\"font-size:14.0pt;\">SIAD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man is admitted with dyspnea and hyponatremia. Laboratory findings are shown as follows. Which of the following is the most likely cause of this patient’s hyponatremia?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VFvtNux.png\" width=\"328\" height=\"245\"></span></p>",
      "unique_key": "Q2817100",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Heart failure</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s hyponatremia is most consistent with <strong>hypervolemic hyponatremia due to heart failure</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In heart failure, there is increased total body water and sodium, but <strong>decreased effective circulating volume</strong> leads to <strong>nonosmotic release of ADH</strong>.</span></li><li><span style=\"font-size:14.0pt;\">As a result:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Serum sodium</strong> is low (dilutional hyponatremia).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Urine osmolality</strong> is elevated (ADH-mediated water reabsorption).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Urine sodium</strong> is low (&lt;20 mEq/L) due to activation of the renin–angiotensin–aldosterone system (RAAS) causing sodium retention.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Beer potomania:</strong> Characterized by very low urine osmolality (&lt;100 mOsm/kg) due to reduced solute intake; not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Low solute diet:</strong> Causes hyponatremia with low urine osmolality from decreased solute load; inconsistent with this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. SIAD:</strong> Shows euvolemic hyponatremia with urine sodium &gt;40 mEq/L and urine osmolality &gt;100 mOsm/kg; inconsistent with this patient’s low urine sodium and clinical presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>heart failure</strong>, hyponatremia results from <strong>water retention secondary to nonosmotic ADH release</strong> and <strong>renal sodium conservation</strong> due to low effective arterial volume.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This leads to <strong>low serum sodium</strong>, <strong>high urine osmolality</strong>, and <strong>low urine sodium</strong>.</span></li></ul>",
      "correct_choice_id": 383557,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96353/Medicine_INICET_GT_30_Oct_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96353/Medicine_INICET_GT_30_Oct_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96085,
      "choices": [
        {
          "id": 382504,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteomyelitis&nbsp;</span></p>"
        },
        {
          "id": 382505,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute Gouty Arthritis&nbsp;</span></p>"
        },
        {
          "id": 382506,
          "text": "<p><span style=\"font-size:14.0pt;\">Cellulitis&nbsp;</span></p>"
        },
        {
          "id": 382507,
          "text": "<p><span style=\"font-size:14.0pt;\">Charcot Neuroarthropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old male with a 20-year history of poorly controlled Type 2 Diabetes Mellitus and established peripheral neuropathy presents with a hot, swollen, and red right foot that he noticed after twisting his ankle a week ago. He has discomfort, no pain. On examination, the foot is warm to the touch and grossly swollen. He has significantly diminished sensation in a stocking distribution. An X-ray of the foot is performed. Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DOZZCwV.png\" width=\"310\" height=\"465\"></span></p>",
      "unique_key": "Q1478268",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Charcot Neuroarthropathy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This diagnosis is defined by the combination of severe sensory neuropathy (poorly controlled diabetes, absent protective sensation) and progressive, destructive joint changes.</span></li><li><span style=\"font-size:14.0pt;\">The patient is a long-standing diabetic with established neuropathy who presents with a hot, swollen, and red foot but little to no pain.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The lack of pain despite severe visible inflammation is a key sign of a neuropathic joint.</span></li><li><span style=\"font-size:14.0pt;\">The description of fragmentation, debris, dislocation, and new bone formation (Eichenholtz Stages) involving the midfoot (tarsal/tarsometatarsal joints) is the definitive radiographic evidence of joint disintegration secondary to unchecked mechanical stress in an insensate foot.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Osteomyelitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Osteomyelitis (bone infection) is common in diabetic feet.</span></li><li><span style=\"font-size:14.0pt;\">But is typically associated with a chronic ulcer and, on X-ray, shows focal bone erosion and lysis or periosteal reaction, not the widespread disorganization and fragmentation across multiple joint lines seen in this case.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clinically, it often presents with fever or deep, throbbing pain, which is inconsistent with the patient's low pain report.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acute Gouty Arthritis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Gout causes an exquisitely painful, sudden flare (often in the MTP1​ joint) and is diagnosed by aspirating monosodium urate crystals.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While the joint would be hot and red, it would be excruciatingly painful (a significant contrast to this patient's \"discomfort\"), and the X-ray would not show the massive, destructive fragmentation and dislocation of the midfoot joints.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cellulitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cellulitis is a soft-tissue bacterial infection causing redness, warmth, and swelling.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does not cause the underlying bone and joint destruction seen on the X-ray.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While Charcot foot often presents with associated cellulitis, the deep bone changes mandate the primary diagnosis of Charcot neuroarthropathy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The classic presentation of acute Charcot foot—specifically the combination of a high-risk patient (diabetic neuropathy) with an acutely swollen, warm, but painless or mildly painful joint, and the hallmark radiographic findings of severe joint destruction and disorganization.</span></p>",
      "correct_choice_id": 382507,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96085/Orthopedic_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96085/Orthopedic_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96349,
      "choices": [
        {
          "id": 383540,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated blood ketones with normal glucose levels</span></p>"
        },
        {
          "id": 383541,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated liver transaminases</span></p>"
        },
        {
          "id": 383542,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased serum insulin levels</span></p>"
        },
        {
          "id": 383543,
          "text": "<p><span style=\"font-size:14.0pt;\">Elevated serum amylase and lipase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old woman with&nbsp;type 2 diabetes mellitus&nbsp;presents for a follow-up visit 3 weeks after being started on&nbsp;dapagliflozin&nbsp;for better glycemic control. She reports&nbsp;increased frequency of urination&nbsp;and a&nbsp;recent urinary tract infection. On evaluation, her&nbsp;serum bicarbonate level is mildly reduced&nbsp;(18 mEq/L). She&nbsp;denies nausea, vomiting, abdominal pain, or breathlessness. Her&nbsp;blood glucose level is 130 mg/dL, and she appears well hydrated. The physician suspects a&nbsp;rare but serious adverse effect&nbsp;associated with her new medication. Which of the following laboratory findings would most likely confirm this adverse effect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3199882",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Elevated blood ketones with normal glucose levels</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient was recently started on <strong>dapagliflozin</strong>, a <strong>sodium-glucose cotransporter 2 (SGLT2) inhibitor</strong> used in type 2 diabetes to promote glucosuria and lower plasma glucose levels.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A <strong>rare but serious complication</strong> of SGLT2 inhibitors is <strong>euglycemic diabetic ketoacidosis (euDKA)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>In euDKA:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Urinary glucose loss</strong> leads to relatively <strong>normal or mildly elevated blood glucose</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Insulin levels fall</strong> due to lower plasma glucose.</span></li><li><span style=\"font-size:14.0pt;\">Simultaneously, <strong>glucagon rises</strong>, promoting <strong>lipolysis</strong> and <strong>ketone body formation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This leads to <strong>high anion gap metabolic acidosis</strong> (evidenced by low bicarbonate).</span></li><li><span style=\"font-size:14.0pt;\">Classic symptoms of DKA (nausea, vomiting, fruity breath, Kussmaul breathing) may be <strong>mild or absent</strong>, especially early in the disease course.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>key lab finding</strong> that confirms this condition is the presence of <strong>elevated blood ketones with normal or only mildly elevated glucose</strong> — consistent with <strong>euDKA</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Elevated liver transaminases:&nbsp;</strong>These are associated with <strong>hepatotoxic drugs</strong> such as <strong>pioglitazone</strong> or <strong>statins</strong>, not dapagliflozin. This would not explain the metabolic acidosis or urinary symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreased serum insulin levels:&nbsp;</strong>While a physiologic consequence of SGLT2 inhibitor use, low insulin is <strong>not diagnostic</strong> by itself and is <strong>not a specific marker</strong> for euDKA. The diagnosis depends on evidence of ketosis and acidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Elevated serum amylase and lipase:&nbsp;</strong>These findings suggest <strong>pancreatitis</strong>, which is more commonly associated with <strong>GLP-1 receptor agonists</strong> like <strong>exenatide</strong> or <strong>liraglutide</strong>, not SGLT2 inhibitors. Pancreatitis does not typically cause euglycemic ketoacidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">SGLT2 inhibitors (e.g., dapagliflozin) can cause euglycemic diabetic ketoacidosis, characterized by elevated ketones and metabolic acidosis despite normal or mildly elevated glucose levels.</span></p>",
      "correct_choice_id": 383540,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96349/Pharmacology_INICET_GT_30_Oct_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96349/Pharmacology_INICET_GT_30_Oct_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96125,
      "choices": [
        {
          "id": 382660,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1 and 3 are correct</span></p>"
        },
        {
          "id": 382661,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 2 and 4 are correct</span></p>"
        },
        {
          "id": 382662,
          "text": "<p><span style=\"font-size:14.0pt;\">Statements 1, 2, and 4 are correct</span></p>"
        },
        {
          "id": 382663,
          "text": "<p><span style=\"font-size:14.0pt;\">All are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Consider the following statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Specific phobia is characterized by marked fear or anxiety about a specific object or situation, which is actively avoided or endured with intense distress.</span></li><li><span style=\"font-size:14.0pt;\">Behavioural therapy is the treatment of choice.</span></li><li><span style=\"font-size:14.0pt;\">To diagnose specific phobia, symptoms must persist for at least 1 month.</span></li><li><span style=\"font-size:14.0pt;\">Blood-injection-injury type of specific phobia may be associated with vasovagal syncope and a biphasic heart rate response.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6662339",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Statements 1, 2, and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Specific phobia is characterized by marked fear or anxiety about a specific object or situation, which is actively avoided or endured with intense distress:&nbsp;</strong>Correct. Specific phobia involves <strong>marked fear/anxiety</strong> about a <strong>specific object or situation</strong> (e.g., flying, animals, injections), which is <strong>avoided or endured with distress</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Behavioural therapy is the treatment of choice:&nbsp;</strong>Correct.<strong>&nbsp;</strong>Behavioural therapy is the treatment of choice for patients with specific phobia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Blood-injection-injury type of specific phobia may be associated with vasovagal syncope and a biphasic heart rate response:&nbsp;</strong>Correct. In <strong>blood-injection-injury type phobia</strong>, there's often a <strong>unique vasovagal (biphasic)</strong> response: an initial <strong>increase in heart rate and BP</strong> followed by a <strong>sudden drop</strong>, sometimes leading to <strong>syncope</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>To diagnose specific phobia, symptoms must persist for at least 1 month</strong>: Incorrect. The required <strong>duration for diagnosis is ≥6 months</strong>, not 1 month (as per DSM-5 criteria).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Specific phobia is a persistent (&gt;6 months), excessive fear of a clearly defined object or situation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Insight is usually preserved</strong>, and <strong>blood-injection-injury phobia</strong> is unique in its <strong>physiological response</strong> (vasovagal syncope).</span></li></ul>",
      "correct_choice_id": 382662,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96125/Psychiatry_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96125/Psychiatry_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96318,
      "choices": [
        {
          "id": 383416,
          "text": "<p><span style=\"font-size:14.0pt;\">Most commonly seen in the lower leg, particularly in the gaiter area</span></p>"
        },
        {
          "id": 383417,
          "text": "<p><span style=\"font-size:14.0pt;\">Caused by ambulatory venous hypertension</span></p>"
        },
        {
          "id": 383418,
          "text": "<p><span style=\"font-size:14.0pt;\">Has punched-out edges</span></p>"
        },
        {
          "id": 383419,
          "text": "<p><span style=\"font-size:14.0pt;\">An active venous ulcer is classified as CEAP C6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man with a history of chronic varicose veins presents with a non-healing ulcer over the medial aspect of his lower leg. On examination, the ulcer is shallow, irregular, and has a granulating floor. Which of the following statements about venous ulcers is not true?</span></p>",
      "unique_key": "Q9830753",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Has punched-out edges</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Venous ulcers characteristically have <strong>gently sloping edges</strong>, not punched-out edges. They often contain granulation tissue and exudate, and they heal poorly due to persistent venous hypertension.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Punched-out edges are instead a feature of <strong>arterial ulcers</strong> or <strong>trophic ulcers</strong> (e.g., neuropathic ulcers).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Most commonly seen in the lower leg, particularly in the gaiter area:&nbsp;</strong>True. Venous ulcers occur most often in the <strong>gaiter area</strong> (medial lower leg between the calf and ankle), where venous pressure is greatest.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Caused by ambulatory venous hypertension:&nbsp;</strong>True. The underlying pathophysiology is <strong>ambulatory venous hypertension</strong>, resulting from incompetent venous valves and impaired calf muscle pump.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. An active venous ulcer is classified as CEAP C6:&nbsp;</strong>True. According to the <strong>CEAP classification</strong> (Clinical-Etiological-Anatomical-Pathophysiological), active venous ulcers are <strong>C6</strong>, while healed venous ulcers are <strong>C5</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Venous ulcers are typically found in the gaiter region, caused by ambulatory venous hypertension, with sloping edges and CEAP classification C6 when active — punched-out edges suggest arterial ulcers, not venous.</span></p>",
      "correct_choice_id": 383418,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96318/NEET_PG_30_Oct_2025_GT_Surgery_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96318/NEET_PG_30_Oct_2025_GT_Surgery_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96330,
      "choices": [
        {
          "id": 383464,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 383465,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydroxychloroquine</span></p>"
        },
        {
          "id": 383466,
          "text": "<p><span style=\"font-size:14.0pt;\">Leflunomide</span></p>"
        },
        {
          "id": 383467,
          "text": "<p><span style=\"font-size:14.0pt;\">Sulfasalazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old woman with grossly deforming arthritis has been on methotrexate for the past 2 years. She is reluctant to start anti–TNF-α therapy due to concerns about immunosuppression. Recently, she developed scaly rashes behind her pinna&nbsp;as shown below. Which drug should be particularly avoided?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Y5nXtr5.png\" width=\"407\" height=\"229\"></strong></span></p>",
      "unique_key": "Q2054366",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hydroxychloroquine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient likely has <strong>psoriatic arthritis (PsA)</strong> - indicated by <strong>deforming arthritis</strong> and <strong>new psoriatic plaques behind the ear</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In such cases, <strong>hydroxychloroquine</strong> should be <strong>avoided</strong> as it can <strong>precipitate, worsen, or reactivate psoriasis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The dermatologic adverse effect of hydroxychloroquine is not fully understood.</span></li><li><span style=\"font-size:14.0pt;\">It may alter keratinocyte proliferation or immune signaling, leading to <strong>new or aggravated psoriatic lesions</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Both <strong>chloroquine</strong> and <strong>hydroxychloroquine</strong> are known triggers, even when used for non-dermatologic indications such as SLE or RA.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Hence, in <strong>psoriatic arthritis or known psoriasis</strong>, hydroxychloroquine should be <strong>avoided</strong>, particularly when cutaneous disease is active.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Methotrexate:&nbsp;</strong>Beneficial in psoriatic arthritis, improving both joint and skin manifestations</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Leflunomide:&nbsp;</strong>Can be safely used in PsA; may even help cutaneous psoriasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sulfasalazine:&nbsp;</strong>Useful for mild <strong>peripheral joint involvement</strong>, though less effective for axial or skin disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hydroxychloroquine</strong> should be <strong>avoided in patients with psoriasis or psoriatic arthritis</strong>, as it can <strong>induce or exacerbate psoriatic skin lesions</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preferred agents for PsA:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>TNF-α inhibitors</strong> (e.g., etanercept, adalimumab)</span></li><li><span style=\"font-size:14.0pt;\"><strong>IL-17 inhibitors</strong> (e.g., secukinumab)</span></li><li><span style=\"font-size:14.0pt;\"><strong>IL-12/23 inhibitors</strong> (e.g., ustekinumab)</span></li><li><span style=\"font-size:14.0pt;\"><strong>DMARDs</strong> such as <strong>methotrexate or leflunomide</strong> for peripheral arthritis.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Avoid <strong>hydroxychloroquine</strong> in psoriasis — it may <strong>trigger or worsen psoriatic flares</strong> even in previously stable disease.</span></li></ul>",
      "correct_choice_id": 383465,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96330/Medicine_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96330/Medicine_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96101,
      "choices": [
        {
          "id": 382568,
          "text": "<p><span style=\"font-size:14.0pt;\">Collect 50 ml urine only; blood is not needed</span></p>"
        },
        {
          "id": 382569,
          "text": "<p><span style=\"font-size:14.0pt;\">Collect 10 ml blood in heparin tube and freeze immediately</span></p>"
        },
        {
          "id": 382570,
          "text": "<p><span style=\"font-size:14.0pt;\">Collect 100 ml urine and 5 ml blood. Add NaF to both blood and urine, and potassium oxalate to only blood</span></p>"
        },
        {
          "id": 382571,
          "text": "<p><span style=\"font-size:14.0pt;\">Delay collection to 96 hours for peak metabolite concentration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A rape survivor presents 3 days after the incident. She suspects she was drugged with GHB (gamma-hydroxybutyrate) at a party. Which of the following specimen collection protocols would maximize the chance of detecting the drug?</span></p>",
      "unique_key": "Q1482626",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Collect 100 ml urine and 5 ml blood. Add NaF to both blood and urine, and potassium oxalate to only blood</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Detection of GHB in forensic settings is difficult because the drug is rapidly metabolized and eliminated from the body.</span></li><li><span style=\"font-size:14.0pt;\"><strong>To maximize detection:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Urine samples</strong> are preferred as they allow longer detection times (up to 12–24 hours, sometimes longer). Collecting at least <strong>100 mL urine</strong> improves sensitivity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Blood samples</strong> (5 mL) are also collected because they may detect the drug earlier, though the detection window is shorter.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Preservatives</strong> such as sodium fluoride (NaF) are added to both blood and urine to inhibit bacterial growth and enzymatic degradation of GHB.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Potassium oxalate</strong> is added to blood specifically to prevent clotting.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Prompt collection is essential, as delaying sample acquisition significantly reduces the chance of detecting the drug due to its short half-life.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Collect 50 ml urine only; blood is not needed:</strong> Incomplete. While urine is useful but 100 ml, <strong>blood sample is essential within 24 hours</strong> for forensic validity and correlation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Collect 10 ml blood in heparin tube and freeze immediately:&nbsp;</strong>Heparin interferes with PCR and <strong>should not be used</strong> for GHB analysis. Also, freezing isn't optimal unless processing is significantly delayed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Delay collection to 96 hours for peak metabolite concentration:&nbsp;</strong>Incorrect. <strong>Delaying reduces detection</strong> chances as GHB has a <strong>very short half-life</strong>. Early collection is crucial.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>GHB detection</strong> requires <strong>timely sample collection</strong> using <strong>appropriate preservatives</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Blood (5 ml) within 24 hours</strong> (in NaF and potassium oxalate tubes)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Urine (100 ml) within 96 hours&nbsp;</strong>to optimize forensic toxicology testing.</span></li></ul></li></ul>",
      "correct_choice_id": 382570,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96101/FMT_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96101/FMT_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96093,
      "choices": [
        {
          "id": 382536,
          "text": "<p><span style=\"font-size:14.0pt;\">General Visceral Efferent (GVE)</span></p>"
        },
        {
          "id": 382537,
          "text": "<p><span style=\"font-size:14.0pt;\">General Somatic Afferent (GSA)</span></p>"
        },
        {
          "id": 382538,
          "text": "<p><span style=\"font-size:14.0pt;\">General Somatic Efferent (GSE)</span></p>"
        },
        {
          "id": 382539,
          "text": "<p><span style=\"font-size:14.0pt;\">General Visceral Afferent (GVA)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During evaluation of a patient with dysphonia and loss of gag reflex, injury to the cranial nerve X (vagus nerve) is suspected. Which of the following functional components is not represented in this cranial nerve?</span></p>",
      "unique_key": "Q4864010",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) General Somatic Efferent (GSE)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>vagus nerve (cranial nerve X)</strong> carries multiple functional components responsible for motor, sensory, and parasympathetic functions:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>GSA (General Somatic Afferent):</strong> Provides sensory innervation to the <strong>external auditory canal</strong>, <strong>external ear</strong>, and part of the <strong>dura mater</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>GVA (General Visceral Afferent):</strong> Carries sensory fibers from the <strong>thoracic and abdominal viscera</strong>, including <strong>aortic baroreceptors and chemoreceptors</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>GVE (General Visceral Efferent):</strong> Provides <strong>parasympathetic fibers</strong> to the <strong>heart</strong>, <strong>lungs</strong>, and <strong>gastrointestinal tract</strong> up to the midgut.</span></li><li><span style=\"font-size:14.0pt;\"><strong>SVE (Special Visceral Efferent):</strong> Supplies muscles derived from the <strong>4th and 6th pharyngeal arches</strong>, including <strong>pharyngeal and laryngeal muscles</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>GSE (General Somatic Efferent)</strong> component is <strong>absent</strong> in the vagus nerve.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">GSE fibers supply <strong>somite-derived skeletal muscles</strong> such as those controlled by cranial nerves III, IV, VI, and XII — not branchial arch-derived muscles.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qEfKQ2F.png\" width=\"1034\" height=\"600\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. General Visceral Efferent (GVE):&nbsp;</strong>Incorrect. These fibers mediate <strong>parasympathetic control</strong> of thoracic and abdominal organs via the dorsal motor nucleus of the vagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. General Somatic Afferent (GSA):&nbsp;</strong>Incorrect. Present in the vagus nerve, providing <strong>somatic sensation</strong> from the <strong>external ear</strong> and <strong>dura mater</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. General Visceral Afferent (GVA):&nbsp;</strong>Incorrect. These fibers carry <strong>visceral sensory input</strong> from the <strong>thoracic and abdominal viscera</strong> to the nucleus tractus solitarius.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>vagus nerve (cranial nerve X)</strong> contains <strong>GSA, GVA, GVE, and SVE</strong> fibers but <strong>lacks GSE fibers</strong>, which are confined to <strong>cranial nerves III, IV, VI, and XII</strong> that innervate somite-derived skeletal muscles.</span></p>",
      "correct_choice_id": 382538,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96093/Anatomy_INICET_GT_30_Oct_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96093/Anatomy_INICET_GT_30_Oct_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96367,
      "choices": [
        {
          "id": 383612,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 383613,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 383614,
          "text": "<p><span style=\"font-size:14.0pt;\">All except 4</span></p>"
        },
        {
          "id": 383615,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements correctly distinguishes fast-acting erythrocytic schizonticides from primary tissue schizonticides?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Fast-acting erythrocytic schizonticides are effective for acute attacks but not for causal prophylaxis.</span></li><li><span style=\"font-size:14.0pt;\">Primary tissue schizonticides act on pre-erythrocytic stages and prevent infection after sporozoite entry.</span></li><li><span style=\"font-size:14.0pt;\">Both classes eradicate dormant hypnozoites of P. vivax.</span></li><li><span style=\"font-size:14.0pt;\">Only primary tissue schizonticides are safe in pregnancy.</span></li></ol>",
      "unique_key": "Q6220846",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1 and 2 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Fast-acting erythrocytic schizonticides are effective for acute attacks but not for causal prophylaxis:&nbsp;</strong>Fast‑acting erythrocytic schizonticides (chloroquine, quinine, artemisinins, mefloquine) kill blood-stage schizonts, quickly controlling symptoms during acute attacks. However, they do <strong>not</strong> act on hepatic pre-erythrocytic stages, so they cannot provide causal prophylaxis or eradicate dormant hypnozoites.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Primary tissue schizonticides act on pre-erythrocytic stages and prevent infection after sporozoite entry:&nbsp;</strong>Primary tissue schizonticides (proguanil, pyrimethamine) act on the pre-erythrocytic (hepatic) stage, preventing the development of blood-stage infection after sporozoite entry — hence used for causal prophylaxis.</span><br><span style=\"font-size:14.0pt;\">This is why only <strong>statements 1 and 2</strong> are correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Both classes eradicate dormant hypnozoites of P. vivax:&nbsp;</strong>Incorrect. Only primaquine eradicates dormant hypnozoites of P. vivax/P. ovale (radical cure). Neither fast-acting erythrocytic schizonticides nor primary tissue schizonticides do this.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Only primary tissue schizonticides are safe in pregnancy:&nbsp;</strong>Incorrect. <strong>Chloroquine</strong> (a fast-acting erythrocytic schizonticide) is actually safe in pregnancy. <strong>Primaquine</strong> (a hepatic agent) is contraindicated in pregnancy due to hemolysis risk in G6PD-deficient fetuses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fast-acting erythrocytic schizonticides</strong>: Treat acute attacks, no effect on hepatic stages (cannot prevent relapse).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Primary tissue schizonticides</strong>: Act on pre-erythrocytic hepatic stages (causal prophylaxis), but do not eradicate hypnozoites.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Only primaquine</strong> eradicates dormant hypnozoites (radical cure).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chloroquine</strong> is safe in pregnancy; primaquine is not.</span></li></ul>",
      "correct_choice_id": 383612,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96367/Pharmacology_INICET_GT_30_Oct_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96367/Pharmacology_INICET_GT_30_Oct_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96309,
      "choices": [
        {
          "id": 383384,
          "text": "<p><span style=\"font-size:14.0pt;\">To dilate a stricture</span></p>"
        },
        {
          "id": 383385,
          "text": "<p><span style=\"font-size:14.0pt;\">To excise the sentinel pile</span></p>"
        },
        {
          "id": 383386,
          "text": "<p><span style=\"font-size:14.0pt;\">To create an end-to-end anastomosis in the bowel</span></p>"
        },
        {
          "id": 383387,
          "text": "<p><span style=\"font-size:14.0pt;\">To measure the internal pressure of the rectum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man undergoes an anorectal surgery. During the reconstruction phase of the surgery, the surgical team uses the device shown in the image. Which of the following best describes the function of this device?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20174351.jpg\" width=\"636\" height=\"270\"></span></p>",
      "unique_key": "Q5583398",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) To create an end-to-end anastomosis in the bowel</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The instrument in the image is a <strong>circular stapler</strong>, commonly used in <strong>colorectal and gastrointestinal surgeries</strong>, especially during <strong>low anterior resection</strong> or <strong>esophagogastric anastomosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is introduced into the lumen of one bowel end, and the opposite end is attached to the stapler’s anvil.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Function</strong>: It <strong>fires a circular double row of staples</strong>, then cuts between them, thus creating a secure <strong>end-to-end anastomosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This technique ensures hemostasis and reduces the risk of leakage at the anastomotic site.</span></li><li><span style=\"font-size:14.0pt;\">Frequently used in <strong>colorectal resections</strong>, particularly <strong>low pelvic anastomoses</strong> where manual suturing is technically difficult.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To dilate strictures: &nbsp;</strong>Dilation is typically performed using <strong>balloon dilators</strong> or <strong>bougies</strong>, not a stapler.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. To excise sentinel pile:&nbsp;</strong>Sentinel pile is seen in chronic fissures, which are excised with knife/scissors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To measure the internal pressure of the rectum:&nbsp;</strong>This is done via <strong>anorectal manometry</strong>, not with a surgical stapler.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A circular stapler is a surgical instrument used to create an end-to-end anastomosis between hollow organs, especially in gastrointestinal surgeries such as low anterior resection.</span></p>",
      "correct_choice_id": 383386,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96309/NEET_PG_30_Oct_2025_GT_Surgery_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96309/NEET_PG_30_Oct_2025_GT_Surgery_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96221,
      "choices": [
        {
          "id": 383036,
          "text": "<p><span style=\"font-size:14.0pt;\">Accessibility</span></p>"
        },
        {
          "id": 383037,
          "text": "<p><span style=\"font-size:14.0pt;\">Relevance</span></p>"
        },
        {
          "id": 383038,
          "text": "<p><span style=\"font-size:14.0pt;\">Adequacy</span></p>"
        },
        {
          "id": 383039,
          "text": "<p><span style=\"font-size:14.0pt;\">Impact&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A state implements a clean water and sanitation program to reduce diarrheal disease. After five years, diarrhea incidence declines by 40%, but simultaneously, economic development, better nutrition, and new rotavirus vaccine rollouts also occurred. In your evaluation, attributing the 40% drop solely to the water program would primarily violate which evaluation criterion?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3195963",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Impact&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Impact evaluation</strong> measures the <strong>overall health and developmental effects</strong> of a program.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Crucially, it must determine the <strong>net effect attributable</strong> to the program, separating it from other contextual influences (e.g., socioeconomic changes, additional health interventions).</span></li><li><span style=\"font-size:14.0pt;\">In this case, diarrhea incidence likely fell due to <strong>multiple factors</strong>, not sanitation alone.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Concluding that the water program was the sole cause <strong>overstates its impact</strong> and ignores confounding influences, which invalidates the attribution of impact.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Accessibility:</strong> Refers to whether the target population could use the service. The program may have been accessible, but that’s not the problem here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Relevance:</strong> Indicates whether the service addressed a real need (diarrhea reduction). Clearly relevant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Adequacy:</strong> Concerns whether implementation matched planned targets. The issue is not about reaching planned coverage but about <strong>causal attribution of health outcomes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Impact evaluation must attribute only the portion of outcome change truly caused by the program, accounting for other concurrent interventions and contextual factors.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Over-attributing outcome improvements to a single intervention violates the principle of valid impact assessment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note -</strong> <strong>Evaluation of Health Services:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Relevance: Appropriateness (need) of a health service</span></li><li><span style=\"font-size:14.0pt;\">Adequacy: Sufficient attention to pre-determined course of action</span></li><li><span style=\"font-size:14.0pt;\">Accessibility: Proportion of population expected to use the service</span></li><li><span style=\"font-size:14.0pt;\">Acceptability: Socially and culturally acceptable</span></li><li><span style=\"font-size:14.0pt;\">Effectiveness: Extent of prevention/alleviation of underlying problem</span></li><li><span style=\"font-size:14.0pt;\">Efficiency: How well resources are utilized</span></li><li><span style=\"font-size:14.0pt;\">Impact: Overall effect of programme/service on health and development</span></li></ul>",
      "correct_choice_id": 383039,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96221/NEET_PG_30_Oct_2025_GT_PSM_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96221/NEET_PG_30_Oct_2025_GT_PSM_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96140,
      "choices": [
        {
          "id": 382720,
          "text": "<p><span style=\"font-size:14.0pt;\">100</span></p>"
        },
        {
          "id": 382721,
          "text": "<p><span style=\"font-size:14.0pt;\">150</span></p>"
        },
        {
          "id": 382722,
          "text": "<p><span style=\"font-size:14.0pt;\">200</span></p>"
        },
        {
          "id": 382723,
          "text": "<p><span style=\"font-size:14.0pt;\">300</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health officer is planning a school eye screening program in a rural block. The total number of students from grades V to VIII is estimated to be 30,000. According to the national SES guidelines, how many trained teachers should be recruited to complete the initial screening?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5679522",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 200</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to the <strong>School Eye Screening (SES) program</strong> under the National Programme for Control of Blindness (NPCB):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Target group:</strong> Middle school children (Grades V to VIII = 10–14 years)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Teacher-to-student screening ratio:</strong> 1 teacher per <strong>150 students</strong></span></li><li><span style=\"font-size:14.0pt;\">So for <strong>30,000 students</strong>:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BLm2UXQ.png\" width=\"550\" height=\"89\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hence, <strong>200 trained teachers</strong> should be recruited to perform the initial screening.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To implement large-scale screening in schools, <strong>task-shifting</strong> is done by training schoolteachers to screen for visual impairment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This increases efficiency and ensures early detection of refractive errors in children.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cut-off for referral</strong> in SES: &lt;6/9 vision in either eye</span></li><li><span style=\"font-size:14.0pt;\"><strong>Each teacher</strong> can screen <strong>150 students</strong> after a <strong>1-day training at PHC</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Teacher kit includes</strong>: Vision charts, rope/tape for 20-ft distance, referral cards</span></li><li><span style=\"font-size:14.0pt;\"><strong>Referral system</strong>: Students with visual impairment are sent to the nearest PHC with ophthalmic assistant</span></li></ul>",
      "correct_choice_id": 382722,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96140/NEET_PG_30_Oct_2025_GT_PSM_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96140/NEET_PG_30_Oct_2025_GT_PSM_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96285,
      "choices": [
        {
          "id": 383288,
          "text": "<p><span style=\"font-size:14.0pt;\">6 weeks abstinence and delay conception by 6 months</span></p>"
        },
        {
          "id": 383289,
          "text": "<p><span style=\"font-size:14.0pt;\">6 months abstinence and delay conception by 6 years</span></p>"
        },
        {
          "id": 383290,
          "text": "<p><span style=\"font-size:14.0pt;\">3 weeks abstinence and delay conception by 2 years</span></p>"
        },
        {
          "id": 383291,
          "text": "<p><span style=\"font-size:14.0pt;\">3 months abstinence and delay conception by 1 year</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient has recently undergone surgical repair of a vesicovaginal fistula (VVF) and is being discharged. For optimal healing and prevention of recurrence, how long should she be advised to abstain from sexual intercourse and delay conception?</span></p>",
      "unique_key": "Q8618142",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 3 months abstinence and delay conception by 1 year</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Vesicovaginal fistula (VVF)</strong> is an abnormal communication between the <strong>urinary bladder and the vagina</strong>, leading to <strong>continuous leakage of urine per vaginam</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Surgical repair (via abdominal or vaginal route) aims to close the defect and restore urinary continence.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Postoperative management and counseling</strong> are crucial to ensure proper healing and prevent recurrence:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Sexual intercourse:&nbsp;</strong>The patient should abstain from sexual activity for <strong>at least 3 months</strong> post-surgery to allow complete epithelial healing and prevent mechanical disruption of the repair.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Conception:&nbsp;</strong>Pregnancy and vaginal delivery place stress on the repaired site; hence, conception should be <strong>deferred for at least 1 year</strong> to allow full tissue recovery.</span><br><span style=\"font-size:14.0pt;\">When pregnancy does occur, <strong>delivery should be by cesarean section</strong> to prevent recurrence of the fistula.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Summary of recommendations:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Abstinence:</strong> 3 months</span></li><li><span style=\"font-size:14.0pt;\"><strong>Delay conception:</strong> 1 year</span></li><li><span style=\"font-size:14.0pt;\"><strong>Future delivery:</strong> Cesarean section preferred</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">After <strong>vesicovaginal fistula repair</strong>, patients should <strong>abstain from sexual intercourse for 3 months</strong> and <strong>delay conception for 1 year</strong> to ensure complete healing of the fistula site and prevent recurrence.</span></p>",
      "correct_choice_id": 383291,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96285/Ini-Cet_Gt_30_Oct_2025_Obg_Q_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96285/Ini-Cet_Gt_30_Oct_2025_Obg_Q_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96136,
      "choices": [
        {
          "id": 382704,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 382705,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 382706,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 382707,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding non-pharmacologic therapy is/are true?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">DASH typically lowers SBP 8–14 mmHg, often exceeding the effect of sodium restriction alone.</span></li><li><span style=\"font-size:14.0pt;\">Regular aerobic activity (≥30 min most days) lowers SBP 4–9 mmHg.</span></li><li><span style=\"font-size:14.0pt;\">Alcohol moderation to &lt;2 drinks/day has negligible BP effect (≈0–1 mmHg).</span></li><li><span style=\"font-size:14.0pt;\">Weight loss of 10 kg lowers SBP 5–20 mmHg.</span></li></ol>",
      "unique_key": "Q6375213",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>DASH typically lowers SBP 8–14 mmHg, often exceeding the effect of sodium restriction alone:</strong> The DASH eating pattern (fruits/vegetables, low-fat dairy, reduced saturated/total fat) reduces SBP by <strong>~8–14 mmHg</strong>, typically more than sodium restriction alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Regular aerobic activity (≥30 min most days) lowers SBP 4–9 mmHg:&nbsp;</strong>Regular aerobic exercise (≥30 min on most days) lowers SBP by <strong>~4–9 mmHg</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Weight loss of 10 kg lowers SBP 5–20 mmHg:</strong> About <strong>5–20 mmHg</strong> SBP reduction per <strong>10-kg</strong> loss (dose-responsive).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Alcohol moderation to &lt;2 drinks/day has negligible BP effect (≈0–1 mmHg):</strong> False. Limiting alcohol to <strong>&lt;2 drinks/day</strong> reduces SBP by <strong>~2–4 mmHg</strong>, not “negligible (0–1 mmHg).”</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Lifestyle Modifications to Manage Hypertension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-28%20144752.jpg\" width=\"1035\" height=\"714\"></strong></span></p>",
      "correct_choice_id": 382706,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96136/NEET_PG_30_Oct_2025_GT_PSM_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96136/NEET_PG_30_Oct_2025_GT_PSM_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96111,
      "choices": [
        {
          "id": 382608,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 3 only</span></p>"
        },
        {
          "id": 382609,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 382610,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 4 only</span></p>"
        },
        {
          "id": 382611,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with long-standing hypertension is started on an ACE inhibitor. Regarding the juxtaglomerular apparatus (JGA) and its physiological control, consider the following statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Decreased sodium chloride delivery to the macula densa stimulates renin release.</span></li><li><span style=\"font-size:14.0pt;\">β₁-adrenergic receptor activation on juxtaglomerular cells enhances renin secretion.</span></li><li><span style=\"font-size:14.0pt;\">Afferent arteriole constriction directly inhibits renin secretion.</span></li><li><span style=\"font-size:14.0pt;\">Angiotensin II exerts positive feedback on renin release from JG cells.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following combination is correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8497021",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1 and 2 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Decreased sodium chloride delivery to the macula densa stimulates renin release:&nbsp;</strong>Correct.<strong>&nbsp;</strong>The <strong>macula densa</strong> senses <strong>NaCl concentration</strong> in the distal tubule. ↓ NaCl (as in low GFR or hypovolemia) → macula densa releases <strong>prostaglandins (PGE₂)</strong> → stimulates <strong>renin release</strong> from JG cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. β₁-adrenergic receptor activation on juxtaglomerular cells enhances renin secretion:&nbsp;</strong>Correct. <strong>β₁-adrenergic stimulation</strong> (via sympathetic activity) increases <strong>cAMP</strong> in JG cells → promotes <strong>renin secretion</strong>. This is why <strong>β-blockers</strong> (like propranolol) reduce renin release.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect</strong> <strong>Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Afferent arteriole constriction directly inhibits renin secretion:&nbsp;</strong>Incorrect. <strong>Afferent arteriole constriction</strong> actually <strong>stimulates</strong> renin release indirectly by lowering renal perfusion pressure sensed by baroreceptors in JG cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Angiotensin II exerts positive feedback on renin release from JG cells:&nbsp;</strong>Incorrect. <strong>Angiotensin II</strong> exerts <strong>negative feedback</strong> on JG cells, inhibiting renin release. Therefore, <strong>ACE inhibitors</strong> or <strong>ARBs</strong> remove this inhibition → cause <strong>increased plasma renin activity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Renin secretion by <strong>juxtaglomerular cells</strong> is stimulated by:</span></li></ul><ol><li><span style=\"font-size:14.0pt;\"><strong>↓ renal perfusion pressure</strong> (intrarenal baroreceptor mechanism),</span></li><li><span style=\"font-size:14.0pt;\"><strong>↓ NaCl at macula densa</strong>, and</span></li><li><span style=\"font-size:14.0pt;\"><strong>↑ sympathetic β₁ activity</strong>.</span></li></ol><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Angiotensin II provides negative feedback</strong> to maintain renin homeostasis.</span></li></ul>",
      "correct_choice_id": 382609,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96111/Physiology_INICET_GT_30_Oct_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96111/Physiology_INICET_GT_30_Oct_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96346,
      "choices": [
        {
          "id": 383528,
          "text": "<p><span style=\"font-size:14.0pt;\">Ergotamine</span></p>"
        },
        {
          "id": 383529,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 383530,
          "text": "<p><span style=\"font-size:14.0pt;\">Topiramate</span></p>"
        },
        {
          "id": 383531,
          "text": "<p><span style=\"font-size:14.0pt;\">Olcegepant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old man presents to the emergency department with complaints of severe pain and discoloration in his lower extremities, as shown in the image. His medical history reveals that he was recently prescribed medication for an acute migraine attack. Physical examination reveals cold, dusky toes and diminished pulses in his lower extremities. Which of the following drugs is most likely responsible for his condition?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20175816.jpg\" width=\"617\" height=\"454\"></strong></span></p>",
      "unique_key": "Q7407422",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ergotamine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ergotamine is an <strong>ergot alkaloid</strong> used for the <strong>acute treatment of migraine attacks</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It acts as a <strong>partial agonist at serotonin (5-HT₁B/₁D) receptors</strong>, leading to <strong>cranial vasoconstriction</strong> and relief of migraine pain.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, it also has potent <strong>α-adrenergic and 5-HT₂ agonist activity</strong>, which can cause <strong>vasoconstriction in peripheral and coronary vessels</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In susceptible individuals or when taken in high doses, ergotamine can cause <strong>severe peripheral vasospasm</strong>, leading to <strong>limb ischemia, gangrene, and a condition known as ergotism (also referred to as St. Anthony’s fire)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The patient’s symptoms of <strong>cold, dusky toes with diminished pulses</strong> following use of an acute migraine medication are classic for this adverse effect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Propranolol:&nbsp;</strong>Propranolol is a <strong>non-selective beta-blocker</strong> used in the <strong>prophylactic treatment of migraines</strong>, not for acute attacks. It does <strong>not cause vasospastic ischemia</strong>. Common side effects include <strong>bradycardia</strong>, fatigue, and hypotension, but not gangrene or peripheral ischemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Topiramate:&nbsp;</strong>An <strong>anticonvulsant</strong> used for <strong>migraine prophylaxis</strong>, topiramate works by modulating GABA and glutamate neurotransmission. It does <strong>not cause vasoconstriction</strong> and is not associated with peripheral ischemia. Side effects include cognitive slowing, weight loss, and paresthesias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Olcegepant:&nbsp; </strong>A <strong>CGRP receptor antagonist</strong>, olcegepant is a newer class of <strong>anti-migraine drug</strong> used for acute migraine therapy. It promotes <strong>vasodilation</strong>, the opposite of vasospasm, and is <strong>not associated with ischemic complications</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ergotamine, used for acute migraine attacks, can cause severe peripheral vasoconstriction due to its α-adrenergic and serotonergic activity, leading to ischemia and gangrene (ergotism).</span></p>",
      "correct_choice_id": 383528,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96346/Pharmacology_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96346/Pharmacology_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96406,
      "choices": [
        {
          "id": 383768,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxacillin disk diffusion test</span></p>"
        },
        {
          "id": 383769,
          "text": "<p><span style=\"font-size:14.0pt;\">Gram stain and colony morphology</span></p>"
        },
        {
          "id": 383770,
          "text": "<p><span style=\"font-size:14.0pt;\">PCR detection of mecA gene</span></p>"
        },
        {
          "id": 383771,
          "text": "<p><span style=\"font-size:14.0pt;\">Latex agglutination test for PBP-2a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male is admitted with a severe skin and soft tissue infection unresponsive to first-line β-lactam antibiotics. Culture from the wound grows gram-positive cocci in clusters. The attending physician suspects MRSA and requests further testing for rapid confirmation. Which of the following laboratory methods offers the fastest and most specific identification of MRSA in this scenario?</span></p>",
      "unique_key": "Q9978234",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) PCR detection of mecA gene</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PCR detection of the mecA gene is the <strong>most rapid and specific diagnostic method</strong> for confirming MRSA (Methicillin-Resistant Staphylococcus aureus).</span></li><li><span style=\"font-size:14.0pt;\">The mecA gene encodes <strong>PBP-2a</strong>, a penicillin-binding protein that confers resistance to β-lactam antibiotics by reducing their binding affinity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PCR not only detects this gene <strong>directly</strong> from the sample but also provides <strong>rapid results</strong>, which is crucial for early intervention and antibiotic stewardship.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Oxacillin disk diffusion test:&nbsp;</strong>Although commonly used, this <strong>phenotypic test</strong> takes longer (24–48 hours) and requires specific incubation conditions (2–4% NaCl, 30°C). It also lacks the <strong>molecular specificity</strong> of PCR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Gram stain and colony morphology:&nbsp;</strong>This method confirms Staphylococcus aureus but <strong>cannot distinguish</strong> MRSA from methicillin-sensitive S. aureus (MSSA). It's useful for <strong>preliminary identification</strong>, not resistance detection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Latex agglutination test for PBP-2a:&nbsp;</strong>This test is fairly specific and detects the protein product of mecA, but it's <strong>less rapid</strong> and can be affected by variable expression levels of PBP-2a. PCR is still more sensitive and direct.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PCR detection of the mecA gene is the gold standard for rapid and specific confirmation of MRSA.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It detects the genetic basis of resistance and allows prompt initiation of appropriate antibiotics like vancomycin or linezolid.</span></li></ul>",
      "correct_choice_id": 383770,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96406/Microbiology_INICET_GT_30_Oct_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96406/Microbiology_INICET_GT_30_Oct_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96220,
      "choices": [
        {
          "id": 383032,
          "text": "<p><span style=\"font-size:14.0pt;\">Corneal ulcer prevalence &gt; 0.05% indicates a public health problem</span></p>"
        },
        {
          "id": 383033,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum retinol &lt;10 mcg/dl in &gt;5% children is diagnostic of community-level deficiency</span></p>"
        },
        {
          "id": 383034,
          "text": "<p><span style=\"font-size:14.0pt;\">Keratomalacia prevalence &gt;0.01% does not warrant intervention</span></p>"
        },
        {
          "id": 383035,
          "text": "<p><span style=\"font-size:14.0pt;\">Bitot’s spot prevalence &gt;0.5% is considered significant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health team conducts a nutritional survey among preschool children (ages 6 months to 6 years) in a rural community to assess for vitamin A deficiency. The following indicators are evaluated:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bitot's spots prevalence: 0.7%</span></li><li><span style=\"font-size:14.0pt;\">Corneal ulcer prevalence: 0.06%</span></li><li><span style=\"font-size:14.0pt;\">Serum retinol &lt;10 mcg/dl in 4.5%</span></li><li><span style=\"font-size:14.0pt;\">Corneal xerosis/keratomalacia prevalence: 0.02%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Based on WHO-recommended thresholds for xerophthalmia surveillance, which of the following statements is incorrect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6811045",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Keratomalacia prevalence &gt;0.01% does not warrant intervention</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Keratomalacia (as well as corneal xerosis or ulceration) prevalence <strong>&gt;0.01%</strong> <strong>does</strong> warrant <strong>urgent public health intervention</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It indicates a <strong>clinical emergency</strong> and is <strong>never ignored</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Corneal ulcer prevalence &gt; 0.05% indicates a public health problem:&nbsp;</strong>Corneal ulcer prevalence &gt; <strong>0.05%</strong> exceeds the WHO threshold, indicating a public health problem.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Serum retinol &lt;10 mcg/dl in &gt;5% children is diagnostic of community-level deficiency:&nbsp;</strong>Serum retinol &lt;10 mcg/dl in <strong>&gt;5%</strong> of children signifies a biochemical indicator of vitamin A deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bitot’s spot prevalence &gt;0.5% is considered significant: </strong>Bitot’s spot prevalence &gt; <strong>0.5%</strong> is considered <strong>epidemiologically significant</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prevalence criteria for determining the Xerophthalmia problem in a community:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZIwPId4.png\" width=\"1078\" height=\"297\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Prevalence is measured in population at risk</strong>, i.e., <strong>pre-school children 6 months – 6 years</strong>.</span></li></ul>",
      "correct_choice_id": 383034,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96220/NEET_PG_30_Oct_2025_GT_PSM_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96220/NEET_PG_30_Oct_2025_GT_PSM_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96363,
      "choices": [
        {
          "id": 383596,
          "text": "<p><span style=\"font-size:14.0pt;\">Acne rosacea</span></p>"
        },
        {
          "id": 383597,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexural psoriasis</span></p>"
        },
        {
          "id": 383598,
          "text": "<p><span style=\"font-size:14.0pt;\">Levodopa-associated dermatitis</span></p>"
        },
        {
          "id": 383599,
          "text": "<p><span style=\"font-size:14.0pt;\">Seborrhoeic dermatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old man with Parkinson’s disease presents with a recurrent itchy, erythematous rash affecting his neck, retroauricular areas, and nasolabial folds. The rash also occurred last winter and improved during the warmer months. On examination, there is erythema with greasy, yellowish scales in the affected areas. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q9004598",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Seborrhoeic dermatitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seborrhoeic dermatitis is a chronic, relapsing inflammatory skin condition affecting <strong>sebaceous gland-rich areas</strong> such as the scalp, face (especially nasolabial folds), retroauricular areas, and upper trunk.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is characterized by <strong>erythema with greasy, yellowish scales</strong> and can be itchy.</span></li><li><span style=\"font-size:14.0pt;\">It is more common in individuals with <strong>Parkinson’s disease</strong> due to altered sebum production and immune changes.</span></li><li><span style=\"font-size:14.0pt;\">Symptoms often worsen in <strong>cold, dry winter months</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Caused in part by an inflammatory reaction to <i>Malassezia</i> yeast.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acne rosacea: </strong>Incorrect<strong>.&nbsp;</strong>Rosacea presents with central facial erythema, telangiectasia, papules, and pustules. It does not typically involve greasy scales and is not specifically linked to Parkinson’s disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Flexural psoriasis: </strong>Incorrect<strong>.&nbsp;</strong>Flexural psoriasis involves smooth, red plaques in skin folds (axilla, groin, inframammary), without the greasy scaling typical of seborrhoeic dermatitis, and usually spares the nasolabial folds.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Levodopa-associated dermatitis: </strong>Incorrect<strong>.&nbsp;</strong>Levodopa may cause drug rashes, but these are not recurrent in the same sebaceous-rich locations and do not have the characteristic scaling of seborrhoeic dermatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Seborrhoeic dermatitis</strong> is a chronic inflammatory condition affecting sebaceous gland-rich areas, often associated with Parkinson’s disease, and presents with erythema and greasy scales in the nasolabial folds, scalp, and retroauricular areas, with flares in winter months.</span></p>",
      "correct_choice_id": 383599,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96363/Dermatology_INICET_GT_30_Oct_Question__4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96363/Dermatology_INICET_GT_30_Oct_Question__4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96359,
      "choices": [
        {
          "id": 383580,
          "text": "<p><span style=\"font-size:14.0pt;\">It is effective against MRSA, VRE, and anaerobes.</span></p>"
        },
        {
          "id": 383581,
          "text": "<p><span style=\"font-size:14.0pt;\">It is ineffective against Pseudomonas.</span></p>"
        },
        {
          "id": 383582,
          "text": "<p><span style=\"font-size:14.0pt;\">It acts by inhibiting the 30S ribosomal subunit like other tetracyclines.</span></p>"
        },
        {
          "id": 383583,
          "text": "<p><span style=\"font-size:14.0pt;\">It requires dose adjustment in renal failure due to primary renal excretion.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Considering the pharmacology and clinical use of tigecycline, all of the following statements are true, except?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6178366",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) It requires dose adjustment in renal failure due to primary renal excretion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tigecycline is primarily excreted via the biliary/fecal route</strong> and does <strong>not require dose adjustment in renal impairment.</strong>&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This makes it a favorable option in patients with reduced kidney function.</span></li><li><span style=\"font-size:14.0pt;\">The statement claiming it requires adjustment due to <strong>renal excretion</strong> is <strong>incorrect</strong>, making it the right answer in an \"EXCEPT\" style question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is effective against MRSA, VRE, and anaerobes:&nbsp;</strong>True. Tigecycline has a broad antimicrobial spectrum and is effective against multidrug-resistant organisms like MRSA (Methicillin-resistant Staphylococcus aureus), VRE (Vancomycin-resistant Enterococcus), and anaerobes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It is ineffective against Pseudomonas:&nbsp;</strong>True. Despite its broad coverage, tigecycline is notably ineffective against Pseudomonas species. This is an important clinical limitation and often tested.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It acts by inhibiting the 30S ribosomal subunit like other tetracyclines:&nbsp;</strong>True. Like tetracyclines, tigecycline binds to the 30S ribosomal subunit, inhibiting protein synthesis. However, it is structurally modified to evade resistance via efflux pumps and ribosomal protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tigecycline is a <strong>glycylcycline antibiotic</strong> with enhanced resistance to efflux-mediated resistance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>biliary-excreted</strong>, making it safe in renal impairment, and is useful against resistant Gram-positive and anaerobic organisms.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, its <strong>ineffectiveness against Proteus and Pseudomonas</strong> and <strong>lack of renal dose adjustment</strong> are high-yield distinctions in clinical decision-making.</span></li></ul>",
      "correct_choice_id": 383583,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96359/Pharmacology_INICET_GT_30_Oct_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96359/Pharmacology_INICET_GT_30_Oct_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96103,
      "choices": [
        {
          "id": 382576,
          "text": "<p><span style=\"font-size:14.0pt;\">10 millivolts hyperpolarization</span></p>"
        },
        {
          "id": 382577,
          "text": "<p><span style=\"font-size:14.0pt;\">122 millivolts depolarization</span></p>"
        },
        {
          "id": 382578,
          "text": "<p><span style=\"font-size:14.0pt;\">61 millivolts depolarization</span></p>"
        },
        {
          "id": 382579,
          "text": "<p><span style=\"font-size:14.0pt;\">61 millivolts hyperpolarization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The ICF concentration of K⁺ is 140 mEq/L and ECF concentration is 14 mEq/L, and the cell is permeable only to K⁺. What would be the expected change if the extracellular K⁺ concentration is reduced from 14 to 1.4 millimolar?&nbsp;</span></p>",
      "unique_key": "Q5036204",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 61 millivolts hyperpolarization</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This question involves the calculation of the resting membrane potential (RMP) using the <strong>Nernst equation</strong>, which describes the equilibrium potential for an ion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For potassium (K⁺), the Nernst equation can be simplified as:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4aP9J1M.png\" width=\"436\" height=\"109\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Given:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Initial extracellular concentration [K⁺ outside] = 14 mEq/L</span></li><li><span style=\"font-size:14.0pt;\">Intracellular concentration [K⁺ inside] = 140 mEq/L</span></li><li><span style=\"font-size:14.0pt;\">After the change, [K⁺ outside] = 1.4 mEq/L</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 1: Calculate initial RMP:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Before the change:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GKKYb9D.png\" width=\"628\" height=\"238\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is the initial resting membrane potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 2: Calculate the new RMP after reducing [K⁺ outside]:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">After reducing extracellular potassium to 1.4 mEq/L:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_k5Avllo.png\" width=\"627\" height=\"256\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is the new resting membrane potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 3: Determine the change in RMP:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The initial RMP was <strong>−61 mV</strong>, and the new RMP is <strong>−122 mV</strong>. The change is:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">−122&nbsp;mV−(−61&nbsp;mV) = −61&nbsp;mV</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, the membrane potential has <strong>hyperpolarized</strong> by 61 millivolts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When extracellular K⁺ concentration is reduced, the cell undergoes <strong>61 millivolts hyperpolarization</strong>, as the loss of K⁺ leads to the inside of the cell becoming more negative.</span></p>",
      "correct_choice_id": 382579,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96103/Physiology_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96103/Physiology_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96299,
      "choices": [
        {
          "id": 383344,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 1a</span></p>"
        },
        {
          "id": 383345,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 1b</span></p>"
        },
        {
          "id": 383346,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 2a</span></p>"
        },
        {
          "id": 383347,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 2b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A preterm neonate (born at 30 weeks gestation) presents on day 10 of life with abdominal distension, feeding intolerance, and bloody stools. On examination, the infant appears lethargic, has a tense abdomen, and shows visible bowel loops. A plain abdominal X-ray is performed and showed pneumatosis intestinalis. In which stage of Necrotising enterocolitis, this condition is seen?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20161127.jpg\" width=\"525\" height=\"588\"></span></p>",
      "unique_key": "Q1303200",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)</strong>&nbsp;<strong>Stage 2a</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Stage.jpg\" width=\"1494\" height=\"1873\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Modified Bell's staging is the standard classification system for Necrotizing Enterocolitis, helping guide management based on clinical, radiological, and laboratory findings.</span></p>",
      "correct_choice_id": 383346,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96299/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96299/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96378,
      "choices": [
        {
          "id": 383656,
          "text": "<p><span style=\"font-size:14.0pt;\">Langerhans cell histiocytosis</span></p>"
        },
        {
          "id": 383657,
          "text": "<p><span style=\"font-size:14.0pt;\">Rosai–Dorfman disease&nbsp;</span></p>"
        },
        {
          "id": 383658,
          "text": "<p><span style=\"font-size:14.0pt;\">Hodgkin lymphoma</span></p>"
        },
        {
          "id": 383659,
          "text": "<p><span style=\"font-size:14.0pt;\">Kikuchi disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A lymph node biopsy from a young adult presenting with massive, painless cervical lymphadenopathy shows the histopathological image provided. Immunohistochemistry reveals CD207 negative, S-100 positive, and CD1a negative staining. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180011.jpg\" width=\"505\" height=\"376\"></span></p>",
      "unique_key": "Q7811522",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Rosai–Dorfman disease&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rosai–Dorfman disease (RDD)</strong>, also known as <strong>Sinus histiocytosis with massive lymphadenopathy</strong>, is a <strong>benign histiocytic proliferative disorder</strong> characterized by the accumulation of <strong>large S100-positive histiocytes</strong> within lymph node sinuses.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Histologic Feature:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows <strong>emperipolesis</strong> — the hallmark of RDD — where <strong>intact lymphocytes, plasma cells, or RBCs</strong> are present <strong>within the cytoplasm of large histiocytes</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Unlike phagocytosis, the engulfed cells remain <strong>viable and intact</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Histiocytes are large with <strong>abundant pale cytoplasm</strong> and vesicular nuclei.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Massive, painless bilateral cervical lymphadenopathy</strong> (most common).</span></li><li><span style=\"font-size:14.0pt;\">May have <strong>fever, leukocytosis, and elevated ESR</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Can involve <strong>extranodal sites</strong> (skin, respiratory tract, CNS, bone).</span></li><li><span style=\"font-size:14.0pt;\">Self-limiting in most cases, though corticosteroids or surgery may be required for severe organ involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Immunohistochemistry:&nbsp; </strong>S100 positive, CD68 positive, CD1a negative (helps distinguish from Langerhans cell histiocytosis).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Langerhans cell histiocytosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cells have <strong>Birbeck granules (tennis-racket-shaped)</strong> on EM.</span></li><li><span style=\"font-size:14.0pt;\"><strong>CD1a positive</strong>, <strong>S100 positive</strong>, but <strong>emperipolesis absent</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Presents with lytic bone lesions, skin rash, or diabetes insipidus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hodgkin lymphoma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Characterized by <strong>Reed–Sternberg cells</strong> (“owl-eye” nuclei).</span></li><li><span style=\"font-size:14.0pt;\">Shows background inflammatory infiltrate, not emperipolesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Kikuchi disease (Necrotizing histiocytic lymphadenitis):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Occurs in young women; features <strong>necrosis and karyorrhectic debris</strong>.</span></li><li><span style=\"font-size:14.0pt;\">No emperipolesis, and histiocytes lack S100 expression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Rosai–Dorfman disease</strong> is characterized by <strong>massive, painless cervical lymphadenopathy</strong> and the presence of <strong>emperipolesis</strong> — intact lymphocytes within the cytoplasm of <strong>S100-positive histiocytes</strong>.</span></p>",
      "correct_choice_id": 383657,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96378/Pathology_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96378/Pathology_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96284,
      "choices": [
        {
          "id": 383284,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 383285,
          "text": "<p><span style=\"font-size:14.0pt;\">Brachytherapy</span></p>"
        },
        {
          "id": 383286,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemoradiation</span></p>"
        },
        {
          "id": 383287,
          "text": "<p><span style=\"font-size:14.0pt;\">External beam radiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman presents with foul-smelling, blood-stained vaginal discharge mixed with mucus. On pelvic examination, there is a necrotic growth on the cervix with extension<strong>&nbsp;</strong>into the lateral parametrium. What is the most appropriate management for this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4421769",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Chemoradiation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s presentation—<strong>postmenopausal age</strong>, <strong>foul-smelling bloody discharge</strong>, and <strong>necrotic cervical growth with parametrium involvement</strong>—is classic for <strong>locally advanced carcinoma cervix (Stage IIB)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">According to the <strong>FIGO (International Federation of Gynecology and Obstetrics) staging system</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Stage IIB</strong>: Tumor extends beyond the cervix with <strong>parametrial involvement</strong> but <strong>not up to the pelvic wall</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stages IIB to IVA</strong> are considered <strong>locally advanced cervical cancers</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management of Stage IIB cervical cancer:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>treatment of choice</strong> is <strong>concurrent chemoradiation</strong>, which includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>External beam radiotherapy (EBRT)</strong> to the pelvis</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intracavitary brachytherapy</strong>, and</span></li><li><span style=\"font-size:14.0pt;\"><strong>Weekly cisplatin-based chemotherapy</strong> as a radiosensitizer</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This combined approach improves <strong>local control</strong>, <strong>survival</strong>, and <strong>reduces recurrence</strong> compared to radiation alone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Rationale:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Surgery (radical hysterectomy) is indicated only for <strong>early stages (IA to IB1)</strong>, where parametrial invasion is absent.</span></li><li><span style=\"font-size:14.0pt;\">Once the <strong>parametrium is involved</strong>, complete surgical resection is not feasible, and chemoradiation becomes the definitive treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chemotherapy:&nbsp;</strong>Systemic chemotherapy alone has a <strong>limited role</strong> in locally advanced cervical cancer. It may be used <strong>palliatively</strong> for recurrent or metastatic disease, not as initial therapy for Stage IIB disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Brachytherapy:&nbsp;</strong>Used as part of radiation therapy but <strong>not alone</strong> in cases with parametrial involvement. It is performed <strong>after EBRT</strong> to deliver a high dose to the tumor while sparing surrounding tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. External beam radiotherapy:&nbsp;</strong>Used in conjunction with <strong>chemotherapy</strong> and <strong>brachytherapy</strong>, but <strong>alone</strong> it provides inferior outcomes. Combining with chemotherapy (chemoradiation) increases radiosensitivity and survival rates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>Stage IIB carcinoma of the cervix</strong> (tumor involving the <strong>parametrium but not the pelvic wall</strong>), the <strong>treatment of choice</strong> is <strong>concurrent chemoradiation</strong>, which includes <strong>external beam radiotherapy with weekly cisplatin chemotherapy</strong> followed by <strong>intracavitary brachytherapy</strong>.</span></p>",
      "correct_choice_id": 383286,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96284/Ini-Cet_Gt_30_Oct_2025_Obg_Q_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96284/Ini-Cet_Gt_30_Oct_2025_Obg_Q_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96383,
      "choices": [
        {
          "id": 383676,
          "text": "<p><span style=\"font-size:14.0pt;\">E-test (Epsilometer test)</span></p>"
        },
        {
          "id": 383677,
          "text": "<p><span style=\"font-size:14.0pt;\">Broth dilution method</span></p>"
        },
        {
          "id": 383678,
          "text": "<p><span style=\"font-size:14.0pt;\">Agar dilution method</span></p>"
        },
        {
          "id": 383679,
          "text": "<p><span style=\"font-size:14.0pt;\">Kirby-Bauer disk diffusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following antimicrobial susceptibility methods provide quantitative MIC values, except:</span></p>",
      "unique_key": "Q7091041",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Kirby-Bauer disk diffusion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Kirby-Bauer disk diffusion method</strong> is a <strong>qualitative test</strong>, not a quantitative one.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves placing antibiotic-impregnated disks on Mueller-Hinton agar where a lawn culture of the test organism has been inoculated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">After incubation, the diameter of the zone of inhibition is measured and interpreted using <strong>CLSI guidelines</strong> to classify the organism as <strong>susceptible, intermediate, or resistant</strong> — but <strong>no MIC value is provided</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, the <strong>broth and agar dilution methods</strong> use serial dilutions of antibiotics to determine the <strong>lowest concentration that inhibits visible growth</strong>, thereby directly measuring the MIC.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Similarly, the <strong>E-test</strong> combines both diffusion and dilution principles and produces a visible MIC value along the strip.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PoEaXGi.png\" width=\"943\" height=\"498\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. E-test (Epsilometer test):&nbsp;</strong>This method yields a <strong>quantitative MIC</strong> by reading the point where the elliptical zone of inhibition intersects the calibrated strip.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Broth dilution method:</strong> Serial dilutions of the antibiotic in broth are inoculated with the test organism; the <strong>MIC is the lowest concentration without visible growth</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Agar dilution method:</strong> Similar to broth dilution, but the antibiotic is incorporated into agar; the <strong>lowest concentration preventing growth is recorded as the MIC</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Only dilution-based methods (broth, agar, and E-test) provide direct quantitative MIC values.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The Kirby-Bauer disk diffusion test provides qualitative results and does not yield an exact MIC.</span></li></ul>",
      "correct_choice_id": 383679,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96383/Microbiology_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96383/Microbiology_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96324,
      "choices": [
        {
          "id": 383440,
          "text": "<p><span style=\"font-size:14.0pt;\">Small sized tumor but N1 axillary metastasis</span></p>"
        },
        {
          "id": 383441,
          "text": "<p><span style=\"font-size:14.0pt;\">History of previous breast or chest wall radiation</span></p>"
        },
        {
          "id": 383442,
          "text": "<p><span style=\"font-size:14.0pt;\">Severe orthopnea&nbsp;</span></p>"
        },
        {
          "id": 383443,
          "text": "<p><span style=\"font-size:14.0pt;\">Diffuse microcalcifications on a mammogram</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the options below is an acceptable condition for breast conservative surgery?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6294182",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>A) Small sized tumor but N1 axillary metastasis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Small sized tumor with limited axillary nodal metastasis (N1)</strong> is acceptable for BCS. The presence of nodal disease is <strong>not a contraindication</strong> to breast-conserving surgery, as axillary dissection (or sentinel node biopsy) plus adjuvant therapy can adequately manage nodal involvement.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key requirement for BCS is that the <strong>primary tumor should be small enough relative to breast size</strong> to allow clear surgical margins with a good cosmetic outcome, and postoperative radiotherapy must be feasible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. History of previous breast or chest wall radiation:&nbsp;</strong>This is a contraindication to BCS because radiation is mandatory after BCS, and re-irradiation is unsafe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Severe orthopnea:&nbsp;</strong>This makes postoperative radiotherapy difficult to tolerate (lying flat for radiation sessions is essential), making it a contraindication to BCS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Diffuse microcalcifications on a mammogram:&nbsp;</strong>This indicates <strong>widespread ductal carcinoma in situ (DCIS)</strong> or multifocal disease, which is a contraindication to BCS as adequate margins cannot be achieved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Breast conservative surgery (BCS)</strong> is acceptable in <strong>small localized tumors</strong> (even with N1 nodal disease), provided clear margins can be achieved and radiotherapy is feasible.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Contraindications include <strong>prior chest irradiation, diffuse microcalcifications, multicentric disease, pregnancy (relative), and inability to undergo radiotherapy</strong>.</span></li></ul>",
      "correct_choice_id": 383440,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96324/NEET_PG_30_Oct_2025_GT_Surgery_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96324/NEET_PG_30_Oct_2025_GT_Surgery_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96106,
      "choices": [
        {
          "id": 382588,
          "text": "<p><span style=\"font-size:14.0pt;\">10 L</span></p>"
        },
        {
          "id": 382589,
          "text": "<p><span style=\"font-size:14.0pt;\">15 L</span></p>"
        },
        {
          "id": 382590,
          "text": "<p><span style=\"font-size:14.0pt;\">20 L</span></p>"
        },
        {
          "id": 382591,
          "text": "<p><span style=\"font-size:14.0pt;\">28 L</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a volunteer, 10 grams of mannitol was injected into the venous blood. At equilibrium, the urinary excretion of mannitol was found to be 10% and the plasma concentration of mannitol was measured at 60 mg/dl. Calculate the extracellular fluid (ECF) volume based on this information.<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7509477",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 15 L</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">We are using the formula to calculate the volume of distribution of mannitol, which is:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EtMEt98.png\" width=\"273\" height=\"99\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Where:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">a = amount of mannitol injected (in grams)</span></li><li><span style=\"font-size:14.0pt;\">e = amount of mannitol excreted (10% of injected amount)</span></li><li><span style=\"font-size:14.0pt;\">c = concentration of mannitol in plasma (converted to grams per ml)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step-by-step calculation:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Amount injected (a):</strong></span><br><span style=\"font-size:14.0pt;\">The total amount of mannitol injected is given as <strong>10 grams</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Amount excreted (e):</strong></span><br><span style=\"font-size:14.0pt;\">10% of the injected mannitol is excreted:</span><br><span style=\"font-size:14.0pt;\">e=10%&nbsp;of&nbsp;10&nbsp;grams=1&nbsp;gram</span></li><li><span style=\"font-size:14.0pt;\"><strong>Plasma concentration (c):</strong></span><br><span style=\"font-size:14.0pt;\">The plasma concentration of mannitol is given as 60 mg/dl. To convert to grams per ml:</span><br><span style=\"font-size:14.0pt;\">60&nbsp;mg/dl=0.6&nbsp;grams/L=0.006&nbsp;grams/ml</span></li><li><span style=\"font-size:14.0pt;\"><strong>Substitute into the formula:</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_df3Ugvz.png\" width=\"821\" height=\"148\"></strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, the extracellular fluid volume is <strong>15 liters</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The formula for calculating the extracellular fluid (ECF) volume is based on the amount of substance injected, excreted, and the concentration remaining in the plasma. Here, the ECF volume is <strong>15 liters</strong>.</span></p>",
      "correct_choice_id": 382589,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96106/Physiology_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96106/Physiology_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96356,
      "choices": [
        {
          "id": 383568,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of bronchiectasis on CT chest</span></p>"
        },
        {
          "id": 383569,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of asthma&nbsp;</span></p>"
        },
        {
          "id": 383570,
          "text": "<p><span style=\"font-size:14.0pt;\">Peripheral eosinophilia &gt; 500/µL</span></p>"
        },
        {
          "id": 383571,
          "text": "<p><span style=\"font-size:14.0pt;\">Positive skin test to Aspergillus fumigatus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman with a history of asthma since childhood presents with worsening cough, wheeze, and expectoration of brownish mucus plugs. CT chest shows central bronchiectasis with mucus impaction. Her total serum IgE is 2200 IU/mL and peripheral eosinophil count is 1300/µL. Skin prick test to Aspergillus fumigatus is positive. Which of the following is essential for the diagnosis of the suspected condition?</span></p>",
      "unique_key": "Q9672045",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Positive skin test to Aspergillus fumigatus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Allergic Bronchopulmonary Aspergillosis (ABPA)</strong> is an <strong>immunologic pulmonary disorder</strong> caused by hypersensitivity to Aspergillus fumigatus in patients with asthma or cystic fibrosis.</span></li><li><span style=\"font-size:14.0pt;\">According to the <strong>2021 ISHAM revised diagnostic criteria</strong>, <strong>the essential (mandatory) components</strong> for diagnosing ABPA are:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qvbcnBi.png\" width=\"717\" height=\"314\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hence, <strong>sensitization to A. fumigatus</strong> (by skin test or specific IgE) is the <strong>essential hallmark</strong> for diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Presence of bronchiectasis on CT chest:&nbsp;</strong>Supports diagnosis but is <strong>not essential</strong> — radiologic finding may be absent in early ABPA (called serologic ABPA).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Presence of asthma:&nbsp;</strong>It is a predisposing condition and not a mandatory criterion.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Peripheral eosinophilia &gt; 500/µL:&nbsp;</strong>Helpful supportive feature but <strong>not essential</strong>; can be absent if the patient is on corticosteroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>essential diagnostic feature</strong> of ABPA is <strong>Aspergillus sensitization</strong> -&nbsp; demonstrated by a <strong>positive skin test or specific IgE to A. fumigatus</strong>, along with <strong>elevated total IgE (≥500 IU/mL)</strong> and compatible clinical-radiologic findings.</span></p>",
      "correct_choice_id": 383571,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96356/Medicine_INICET_GT_30_Oct_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96356/Medicine_INICET_GT_30_Oct_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96278,
      "choices": [
        {
          "id": 383260,
          "text": "<p><span style=\"font-size:14.0pt;\">Fine-needle aspiration cytology (FNAC) to rule out malignancy</span></p>"
        },
        {
          "id": 383261,
          "text": "<p><span style=\"font-size:14.0pt;\">Wide local excision</span></p>"
        },
        {
          "id": 383262,
          "text": "<p><span style=\"font-size:14.0pt;\">Incision and drainage</span></p>"
        },
        {
          "id": 383263,
          "text": "<p><span style=\"font-size:14.0pt;\">Trial of nonsteroidal anti-inflammatory drugs (NSAIDs)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old woman presents with a painful swelling near her previous cesarean section scar. She reports that the lump increases in size and becomes more painful during menstruation. On examination, there is a firm, tender nodule at the edge of the surgical scar. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q2991903",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Wide local excision</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with <strong>cyclic pain and swelling at a cesarean section scar</strong>, which is characteristic of <strong>scar endometriosis (abdominal wall endometriosis)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It occurs when <strong>endometrial tissue is implanted into the surgical wound</strong> during procedures like <strong>cesarean section, laparotomy, or episiotomy</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During uterine surgery, endometrial cells may become inoculated in the wound.</span></li><li><span style=\"font-size:14.0pt;\">Under hormonal influence, these cells undergo cyclical bleeding and inflammation, leading to <strong>painful swelling and fibrosis</strong> near the scar.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagnosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Clinical presentation</strong> is often diagnostic due to the triad:</span><ol><li><span style=\"font-size:14.0pt;\">Previous uterine surgery</span></li><li><span style=\"font-size:14.0pt;\">Painful nodule near the scar</span></li><li><span style=\"font-size:14.0pt;\">Cyclic pain associated with menses</span></li></ol></li><li><span style=\"font-size:14.0pt;\"><strong>Imaging (ultrasound or MRI)</strong> may help delineate the lesion, but <strong>definitive diagnosis</strong> is by <strong>histopathology</strong> after surgical excision.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Wide local excision</strong> of the lesion with adequate margins is the <strong>treatment of choice</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Medical therapy (e.g., OCPs, progestins, GnRH analogs) may reduce symptoms but does not eliminate the lesion, and recurrence is common after discontinuation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fine-needle aspiration cytology (FNAC) to rule out malignancy:&nbsp;</strong>Although FNAC can show endometrial cells, it is <strong>not recommended as the first step</strong>, since the lesion is clinically characteristic and FNAC may lead to <strong>seeding or inadequate diagnosis</strong>. Histopathological confirmation is obtained after excision.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Incision and drainage:&nbsp;</strong>Incorrect because the lesion is <strong>not an abscess</strong>. Incision and drainage would not relieve symptoms and could worsen scarring or spread endometrial tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trial of nonsteroidal anti-inflammatory drugs (NSAIDs):&nbsp;</strong>NSAIDs may provide <strong>temporary pain relief</strong>, but they do not treat the underlying pathology. The definitive management is <strong>surgical excision</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a woman with <strong>painful, cyclic swelling near a surgical scar following cesarean delivery</strong>, the most likely diagnosis is <strong>scar endometriosis</strong>, and the <strong>definitive treatment</strong> is <strong>wide local excision</strong> with histopathological confirmation.</span></p>",
      "correct_choice_id": 383261,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96278/Ini-Cet_Gt_30_Oct_2025_Obg_Q_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96278/Ini-Cet_Gt_30_Oct_2025_Obg_Q_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96320,
      "choices": [
        {
          "id": 383424,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-C, 4-D</span></p>"
        },
        {
          "id": 383425,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        },
        {
          "id": 383426,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-A, 4-B</span></p>"
        },
        {
          "id": 383427,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following clinical signs with their descriptions:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20182340.jpg\" width=\"1100\" height=\"341\"></span></p>",
      "unique_key": "Q7825337",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1-B, 2-A, 3-C, 4-D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20174628.jpg\" width=\"1163\" height=\"668\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bruising patterns such as <strong>Cullen, Grey Turner, Fox, and Bryant signs</strong> are classic external markers of <strong>intra-abdominal or retroperitoneal hemorrhage</strong>, often seen in <strong>acute pancreatitis</strong> or ruptured abdominal/gynecological catastrophes.</span></p>",
      "correct_choice_id": 383424,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96320/NEET_PG_30_Oct_2025_GT_Surgery_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96320/NEET_PG_30_Oct_2025_GT_Surgery_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96095,
      "choices": [
        {
          "id": 382544,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3&nbsp;</span></p>"
        },
        {
          "id": 382545,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
        },
        {
          "id": 382546,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4&nbsp;</span></p>"
        },
        {
          "id": 382547,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following muscles are supplied by superficial peroneal nerve?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Peroneus brevis</span></li><li><span style=\"font-size:14.0pt;\">Peroneus longus</span></li><li><span style=\"font-size:14.0pt;\">Peroneus tertius</span></li><li><span style=\"font-size:14.0pt;\">Extensor hallucis longus</span></li></ol>",
      "unique_key": "Q6945520",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The leg is divided into three compartments, each with its specific nerve supply.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The lateral compartment of the leg contains only two muscles: peroneus longus and peroneus brevis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both of these muscles are innervated by the superficial peroneal nerve.</span></li><li><span style=\"font-size:14.0pt;\">The superficial peroneal nerve is the nerve of the lateral compartment and supplies:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Peroneus longus</span></li><li><span style=\"font-size:14.0pt;\">Peroneus brevis</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These muscles are responsible for eversion of the foot and play important roles in maintaining balance during walking and standing.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iqJXzZc.png\" width=\"516\" height=\"724\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Peroneus tertius:</strong> This muscle belongs to the anterior compartment of the leg, not the lateral compartment. According to Grey's Anatomy 42nd edition (page 1418), peroneus tertius is supplied by the deep peroneal nerve, which is the nerve of the anterior compartment. This is a common source of confusion as the name suggests it belongs with the other peroneus muscles, but anatomically it functions with the anterior compartment muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Extensor hallucis longus:</strong> This muscle is located in the anterior compartment of the leg and is supplied by the deep peroneal nerve. It functions to extend the great toe and assist in dorsiflexion of the foot. The anterior compartment muscles include tibialis anterior, extensor digitorum longus, extensor hallucis longus, and peroneus tertius - all supplied by the deep peroneal nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The superficial peroneal nerve supplies only the two muscles of the lateral compartment of the leg: peroneus longus and peroneus brevis.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_M6OQ9oM.png\" width=\"402\" height=\"592\"></p>",
      "correct_choice_id": 382545,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96095/Anatomy_INICET_GT_30_Oct_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96095/Anatomy_INICET_GT_30_Oct_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96335,
      "choices": [
        {
          "id": 383484,
          "text": "<p><span style=\"font-size:14.0pt;\">Start azathioprine</span></p>"
        },
        {
          "id": 383485,
          "text": "<p><span style=\"font-size:14.0pt;\">Resume pyridostigmine</span></p>"
        },
        {
          "id": 383486,
          "text": "<p><span style=\"font-size:14.0pt;\">Start plasmapheresis</span></p>"
        },
        {
          "id": 383487,
          "text": "<p><span style=\"font-size:14.0pt;\">Intubate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman with myasthenia gravis presents with 2 weeks of progressive weakness - difficulty swallowing, speaking, and walking. She recently had an upper respiratory infection and stopped her medications (prednisolone, pyridostigmine) 2 months ago. She is tachypneic (RR 34/min), using accessory muscles, unable to lift her head, with bilateral ptosis, diplopia, and fatigable weakness of limbs. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4414096",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Intubate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This presentation represents a <strong>myasthenic crisis</strong> - life-threatening <strong>respiratory muscle weakness</strong> due to exacerbation of <strong>myasthenia gravis</strong>, often precipitated by <strong>infection, medication withdrawal, or stress</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key points:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Myasthenic crisis</strong> occurs in ~15–20% of MG patients.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Indications for intubation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Vital capacity <strong>&lt;15 mL/kg</strong> or</span></li><li><span style=\"font-size:14.0pt;\">Negative inspiratory pressure less than <strong>25 to 30 cm H₂O</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Immediate management:</strong></span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Airway protection and mechanical ventilation.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Rapid immunomodulation</strong> with <strong>plasmapheresis</strong> or <strong>IV immunoglobulin (IVIG)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>High-dose corticosteroids</strong> (e.g., IV methylprednisolone) to sustain long-term benefit.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hold pyridostigmine</strong> temporarily to prevent excess secretions.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Start Azathioprine:&nbsp;</strong>Used for long-term immunosuppression, not for acute crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Resume pyridostigmine:&nbsp;</strong>Contraindicated during crisis — may <strong>increase airway secretions</strong> and worsen ventilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Start plasmapheresis:&nbsp;</strong>Non-invasive ventilation is insufficient in severe crisis; <strong>intubation</strong> is the standard for respiratory failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Myasthenic crisis</strong> = acute respiratory failure due to <strong>exacerbation of MG</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immediate priorities:</strong> airway protection, mechanical ventilation, and <strong>rapid immunotherapy</strong> (plasmapheresis or IVIG).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Avoid cholinesterase inhibitors</strong> during crisis.</span></li><li><span style=\"font-size:14.0pt;\">Reintroduce maintenance therapy (e.g., pyridostigmine, azathioprine) once the crisis resolves.</span></li></ul>",
      "correct_choice_id": 383487,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96335/Medicine_INICET_GT_30_Oct_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96335/Medicine_INICET_GT_30_Oct_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96109,
      "choices": [
        {
          "id": 382600,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 382601,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 382602,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 382603,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding thyroid hormone synthesis and regulation, consider the following statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Thyroid peroxidase catalyzes both iodination and coupling reactions.</span></li><li><span style=\"font-size:14.0pt;\">Peripheral conversion of T₄ to T₃ is inhibited by propranolol and glucocorticoids.</span></li><li><span style=\"font-size:14.0pt;\">TRH acts via a cAMP-mediated pathway in thyrotrophs.</span></li><li><span style=\"font-size:14.0pt;\">Iodide deficiency increases thyroidal T₃:T₄ ratio.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is true?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2323317",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>1. Thyroid peroxidase catalyzes both iodination and coupling reactions:</strong> Correct. <strong>Thyroid peroxidase (TPO)</strong> catalyzes both <strong>iodination (organification)</strong> and <strong>coupling</strong> of iodotyrosines (MIT, DIT).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>2. Peripheral conversion of T₄ to T₃ is inhibited by propranolol and glucocorticoids:</strong> Correct. <strong>Propranolol, PTU, and glucocorticoids</strong> inhibit peripheral conversion of <strong>T₄ → T₃</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Iodide deficiency increases thyroidal T₃:T₄ ratio:</strong> Correct. In <strong>iodine deficiency</strong>, gland adapts by increasing <strong>T₃ over T₄</strong> synthesis (T₃ more potent, less iodine needed).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>TRH acts via a cAMP-mediated pathway in thyrotrophs:</strong> Incorrect. TRH acts through <strong>IP₃/DAG</strong>, not cAMP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">TPO is central to thyroid hormone synthesis, and <strong>T₃ production increases in iodine deficiency</strong> as an adaptive mechanism.</span></p>",
      "correct_choice_id": 382602,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96109/Physiology_INICET_GT_30_Oct_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96109/Physiology_INICET_GT_30_Oct_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96343,
      "choices": [
        {
          "id": 383516,
          "text": "<p><span style=\"font-size:14.0pt;\">Age of 65</span></p>"
        },
        {
          "id": 383517,
          "text": "<p><span style=\"font-size:14.0pt;\">MELD 18</span></p>"
        },
        {
          "id": 383518,
          "text": "<p><span style=\"font-size:14.0pt;\">PaO₂ &lt; 60 mmHg on room air</span></p>"
        },
        {
          "id": 383519,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of severe portal hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman with cirrhosis (MELD 18) reports dyspnea that worsens when upright and improves when supine. An echocardiogram shows bubbles in the right heart followed by appearance in the left heart after 5 heartbeats. Arterial blood gas on room air: PaO₂ 55 mm Hg. ABG shows a PaO₂ of 55 mm Hg; CT chest is normal. Which condition would increase her liver transplant priority score?&nbsp;</span></p>",
      "unique_key": "Q6344572",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) PaO₂ &lt; 60 mmHg on room air</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>Hepatopulmonary Syndrome (HPS)</strong> — a complication of cirrhosis that causes <strong>intrapulmonary vascular dilatation</strong> and <strong>arterial hypoxemia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Because her <strong>PaO₂ &lt; 60 mmHg</strong> despite only moderate liver dysfunction, she qualifies for a <strong>MELD exception</strong> to receive higher transplant priority.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Criteria for HPS MELD Exception</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jkFh1vK.png\" width=\"672\" height=\"284\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">If criteria are met → patient is granted <strong>MELD exception = Median MELD at Transplant (MMaT)</strong> (≈ <strong>MELD 22</strong>).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Common MELD Exceptions</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_g1I4iRR.png\" width=\"683\" height=\"536\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Age of 65:</strong> Age is not a prioritization factor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. MELD 18:</strong> This is the calculated score, not an exception.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Presence of severe portal hypertension:</strong> Confirms disease severity but does not affect MELD allocation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Patients with <strong>Hepatopulmonary Syndrome (PaO₂ &lt; 60 mmHg)</strong> who meet defined criteria are eligible for <strong>MELD exception points (MMaT ≈ 22)</strong>, ensuring fair transplant prioritization for conditions where the lab-based MELD score underestimates true mortality risk.</span></p>",
      "correct_choice_id": 383518,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96343/Medicine_Inicet_Gt_30_Oct_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96343/Medicine_Inicet_Gt_30_Oct_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96303,
      "choices": [
        {
          "id": 383360,
          "text": "<p><span style=\"font-size:14.0pt;\">I – e, II – f, III – a, IV – g</span></p>"
        },
        {
          "id": 383361,
          "text": "<p><span style=\"font-size:14.0pt;\">I – f, II – h, III – b, IV – g</span></p>"
        },
        {
          "id": 383362,
          "text": "<p><span style=\"font-size:14.0pt;\">I – e, II – h, III – d, IV – g</span></p>"
        },
        {
          "id": 383363,
          "text": "<p><span style=\"font-size:14.0pt;\">I – d, II – f, III – b, IV – c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following conditions with their associated pupillary findings:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20163138.jpg\" width=\"1105\" height=\"455\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the correct match?</span></p>",
      "unique_key": "Q9858673",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) I – f, II – h, III – b, IV – g</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>I – f. Pontine lesions → Pinpoint pupil:&nbsp;</strong>Pontine hemorrhage or infarct affects descending sympathetic fibers. Leads to <strong>bilateral pinpoint pupils</strong> due to <strong>unopposed parasympathetic activity</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>II – h. Topical atropine → Pharmacologic mydriasis:&nbsp;</strong>Atropine is an anticholinergic and causes fixed dilated pupils.</span></li><li><span style=\"font-size:14.0pt;\"><strong>III – b. Central retinal artery occlusion → Marcus Gunn pupil:&nbsp;</strong>Relative afferent pupillary defect (RAPD), aka Marcus Gunn pupil, is seen in severe retinal/optic nerve disease.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IV – g. Tabes dorsalis → Argyll Robertson pupil:&nbsp;</strong>Classically seen in neurosyphilis — <strong>small, irregular pupils that accommodate but don’t react to light</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Different neurological and pharmacological disorders produce specific pupillary abnormalities, such as:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Marcus Gunn pupil</strong> in CRAO,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Argyll Robertson pupil</strong> in neurosyphilis,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pharmacological mydriasis</strong> with topical atropine,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pinpoint pupils</strong> in pontine hemorrhage.</span></li></ul>",
      "correct_choice_id": 383361,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96303/Ophthalmology_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96303/Ophthalmology_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96384,
      "choices": [
        {
          "id": 383680,
          "text": "<p><span style=\"font-size:14.0pt;\">Mixed connective tissue disease</span></p>"
        },
        {
          "id": 383681,
          "text": "<p><span style=\"font-size:14.0pt;\">Polymyositis with interstitial lung disease</span></p>"
        },
        {
          "id": 383682,
          "text": "<p><span style=\"font-size:14.0pt;\">Systemic lupus erythematosus</span></p>"
        },
        {
          "id": 383683,
          "text": "<p><span style=\"font-size:14.0pt;\">Rheumatoid arthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman presents with progressive proximal muscle weakness and joint pain for the past several months. She also reports shortness of breath and a dry cough. Physical examination reveals muscle tenderness in the shoulders and thighs and crackles at the lung bases. Laboratory testing shows elevated creatine kinase (CK) and a positive antinuclear antibody (ANA). Further serologic testing reveals the presence of anti–Jo-1 antibodies. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q6722196",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Polymyositis with interstitial lung disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Anti–Jo-1 antibody</strong> is directed against <strong>histidyl-tRNA synthetase</strong> and is highly specific for <strong>Polymyositis</strong> and <strong>Dermatomyositis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is part of a group of <strong>antisynthetase antibodies</strong>, which are associated with the <strong>Antisynthetase Syndrome</strong> — a condition that combines <strong>inflammatory myopathy</strong>, <strong>arthritis</strong>, and <strong>interstitial lung disease (ILD)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Features of Polymyositis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Autoimmune inflammatory myopathy</strong> characterized by T-cell–mediated muscle fiber injury.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Symmetrical proximal muscle weakness</strong> (difficulty climbing stairs, combing hair).</span></li><li><span style=\"font-size:14.0pt;\"><strong>No skin involvement</strong> (distinguishing it from dermatomyositis).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Elevated muscle enzymes:</strong> Creatine kinase (CK), aldolase.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Muscle biopsy:</strong> Endomysial inflammation with CD8⁺ T cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Antibodies:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Anti–Jo-1 (Histidyl-tRNA synthetase)</strong> — most common.</span></li><li><span style=\"font-size:14.0pt;\">Associated with <strong>interstitial lung disease</strong> and <strong>non-erosive arthritis</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mixed connective tissue disease (MCTD):&nbsp;</strong>Characterized by overlapping features of SLE, systemic sclerosis, and polymyositis. Associated with <strong>anti–U1 RNP antibodies</strong>, not anti–Jo-1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Systemic lupus erythematosus (SLE):&nbsp;</strong>Characterized by malar rash, nephritis, and hematologic abnormalities. Associated with <strong>anti–dsDNA</strong> and <strong>anti–Sm antibodies</strong>, not anti–Jo-1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rheumatoid arthritis (RA):&nbsp;</strong>Presents with chronic symmetric small joint inflammation. Associated with <strong>anti–CCP (cyclic citrullinated peptide)</strong> and <strong>rheumatoid factor (IgM against Fc portion of IgG)</strong>, not anti–Jo-1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Anti–Jo-1 antibodies</strong> target <strong>histidyl-tRNA synthetase</strong> and are specific for <strong>Polymyositis</strong> (and sometimes <strong>Dermatomyositis</strong>). Their presence suggests <strong>Antisynthetase Syndrome</strong>, characterized by <strong>myositis, interstitial lung disease, arthritis, and Raynaud phenomenon</strong>.</span></p>",
      "correct_choice_id": 383681,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96384/Pathology_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96384/Pathology_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96091,
      "choices": [
        {
          "id": 382528,
          "text": "<p><span style=\"font-size:14.0pt;\">Iliac crest</span></p>"
        },
        {
          "id": 382529,
          "text": "<p><span style=\"font-size:14.0pt;\">Trapezius</span></p>"
        },
        {
          "id": 382530,
          "text": "<p><span style=\"font-size:14.0pt;\">Latissimus dorsi</span></p>"
        },
        {
          "id": 382531,
          "text": "<p><span style=\"font-size:14.0pt;\">External oblique</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The image shows a type of hernia. Which of the following muscles or structures does not form a boundary of the anatomical space related to this hernia?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nF3DDkc.png\" width=\"450\" height=\"457\"></span></p>",
      "unique_key": "Q6849281",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Trapezius</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>inferior lumbar triangle (Petit's triangle)</strong> is a weak anatomical area in the lower posterior abdominal wall through which <strong>lumbar hernias</strong> may occur.</span></li><li><span style=\"font-size:14.0pt;\">Its <strong>boundaries</strong> are:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Anteriorly:</strong> External oblique muscle</span></li><li><span style=\"font-size:14.0pt;\"><strong>Posteriorly:</strong> Latissimus dorsi muscle</span></li><li><span style=\"font-size:14.0pt;\"><strong>Inferiorly:</strong> Iliac crest</span></li><li><span style=\"font-size:14.0pt;\"><strong>Floor:</strong> Internal oblique muscle</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>trapezius muscle</strong> lies <strong>superomedially</strong> and <strong>is not part of this triangle</strong>.</span><br><span style=\"font-size:14.0pt;\">When intra-abdominal pressure rises (e.g., due to coughing, straining, or lifting), the hernia may protrude through this weak area.</span></li><li><span style=\"font-size:14.0pt;\">Thus, in this clinical scenario, the hernia occurs through the <strong>Petit's triangle</strong>, and <strong>trapezius</strong> does not form its boundary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QwhcZir.png\" width=\"742\" height=\"507\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Iliac crest:&nbsp;</strong>Incorrect. The <strong>iliac crest</strong> forms the <strong>inferior boundary</strong> of Petit's triangle and provides attachment for the <strong>external and internal oblique muscles</strong>, playing a structural role in the lower abdominal wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Latissimus dorsi:&nbsp;</strong>Incorrect. The <strong>latissimus dorsi</strong> forms the <strong>posterior boundary</strong> of the triangle and is a large, flat muscle involved in extension and adduction of the arm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. External oblique:&nbsp;</strong>Incorrect. The <strong>external oblique</strong> forms the <strong>anterior boundary</strong> of the triangle and is an important abdominal wall muscle contributing to trunk rotation and compression of abdominal contents.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Petit’s triangle</strong> (inferior lumbar triangle) is a potential site for <strong>lumbar hernias</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is bounded by the <strong>latissimus dorsi posteriorly</strong>, <strong>external oblique anteriorly</strong>, and <strong>iliac crest inferiorly</strong>, with the <strong>internal oblique</strong> forming its floor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>trapezius muscle</strong> is <strong>not part of this boundary</strong>.</span></li></ul>",
      "correct_choice_id": 382529,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96091/Anatomy_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96091/Anatomy_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96094,
      "choices": [
        {
          "id": 382540,
          "text": "<p><span style=\"font-size:14.0pt;\">Internal thoracic artery</span></p>"
        },
        {
          "id": 382541,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary arteries</span></p>"
        },
        {
          "id": 382542,
          "text": "<p><span style=\"font-size:14.0pt;\">Intercostal vessels</span></p>"
        },
        {
          "id": 382543,
          "text": "<p><span style=\"font-size:14.0pt;\">Left common carotid artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old boy falls from a tree and sustains a rib fracture at the midaxillary line on the right side. He develops difficulty breathing, and investigations reveal a hemothorax with lung collapse. Which of the following is the most likely source of bleeding responsible for this condition?</span></p>",
      "unique_key": "Q4871696",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Intercostal vessels</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>intercostal vessels (posterior and anterior intercostal arteries and veins)</strong> lie within the <strong>costal groove</strong> along the <strong>inferior border of each rib</strong>, arranged from <strong>superior to inferior</strong> as: <strong>Vein → Artery → Nerve (VAN)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>rib fracture at the midaxillary line</strong> often injures these <strong>intercostal vessels</strong>, leading to bleeding into the <strong>pleural cavity (hemothorax)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The blood accumulation compresses the lung, causing <strong>atelectasis</strong> and <strong>respiratory distress</strong>, as described in this case.</span></li><li><span style=\"font-size:14.0pt;\">In a <strong>3-year-old child</strong>, the ribs are relatively flexible but can still fracture under significant trauma, making the intercostal vessels vulnerable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ODEKNXu.png\" width=\"1102\" height=\"692\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Internal thoracic artery:&nbsp;</strong>Incorrect. It runs <strong>parallel to the sternum</strong>, along the <strong>anterior chest wall</strong>, and would be injured only in <strong>parasternal fractures</strong>, not in lateral (midaxillary) rib injuries.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pulmonary arteries:&nbsp; </strong>Incorrect. These vessels are located deep within the lung tissue and are <strong>not directly affected by rib fractures</strong>. Injury here would cause a <strong>massive intrapulmonary hemorrhage</strong>, not a localized hemothorax.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Left common carotid artery:&nbsp;</strong>Incorrect. This vessel is located in the <strong>neck</strong>, supplying the head and upper extremities, and is unrelated to trauma in the <strong>thoracic wall</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>rib fracture at the midaxillary line</strong> commonly injures <strong>intercostal vessels</strong>, which run along the <strong>inferior margin of the ribs within the costal groove</strong>. Damage to these vessels causes <strong>bleeding into the pleural cavity</strong>, resulting in a <strong>hemothorax</strong> and potential <strong>lung collapse (atelectasis)</strong>.</span></p>",
      "correct_choice_id": 382542,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96094/Anatomy_INICET_GT_30_Oct_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96094/Anatomy_INICET_GT_30_Oct_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96291,
      "choices": [
        {
          "id": 383312,
          "text": "<p><span style=\"font-size:14.0pt;\">Induction of labor</span></p>"
        },
        {
          "id": 383313,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue the NST for up to 40 minutes</span></p>"
        },
        {
          "id": 383314,
          "text": "<p><span style=\"font-size:14.0pt;\">Wait and watch</span></p>"
        },
        {
          "id": 383315,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency lower segment cesarean section&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An NST is performed for a pregnant woman who presents with decreased fetal movements. The tracing shows 1 acceleration in 20 minutes and no decelerations. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9131368",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Continue the NST for up to 40 minutes</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>nonstress test (NST)</strong> evaluates <strong>fetal heart rate (FHR) accelerations</strong> in response to fetal movements to assess <strong>fetal oxygenation and neurologic integrity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A healthy fetus exhibits periodic <strong>FHR accelerations</strong> due to an intact autonomic nervous system and adequate oxygenation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>NST Interpretation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Reactive NST (normal):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">At least <strong>2 accelerations</strong> of ≥15 bpm above baseline lasting ≥15 seconds within <strong>20 minutes</strong> (for gestation ≥32 weeks).</span></li><li><span style=\"font-size:14.0pt;\">Indicates adequate fetal well-being.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Nonreactive NST:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Fewer than <strong>2 accelerations</strong> in 20 minutes.</span></li><li><span style=\"font-size:14.0pt;\">This can result from <strong>fetal sleep cycle</strong>, <strong>maternal medications</strong>, or <strong>fetal hypoxia</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Since <strong>fetal sleep cycles</strong> can last up to <strong>40 minutes</strong>, the <strong>next best step</strong> after a nonreactive 20-minute NST is to <strong>continue monitoring for up to 40 minutes</strong>.</span></li><li><span style=\"font-size:14.0pt;\">If the NST remains nonreactive after 40 minutes, further evaluation should be done with a <strong>biophysical profile (BPP)</strong> or <strong>contraction stress test (CST)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Induction of labor:&nbsp;</strong>Premature intervention — indicated only if further testing (BPP or CST) confirms fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Wait and watch:&nbsp;</strong>Inappropriate because immediate further evaluation (extending NST) is required, not passive observation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Emergency lower segment cesarean section (LSCS):&nbsp;</strong>Not indicated after a single 20-minute nonreactive NST. Cesarean delivery is performed only for <strong>confirmed fetal distress</strong> or <strong>abnormal subsequent testing</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">If a <strong>nonstress test</strong> shows <strong>only one acceleration in 20 minutes</strong>, it is <strong>nonreactive</strong>. The <strong>next step</strong> is to <strong>continue the NST for up to 40 minutes</strong> to allow for fetal sleep cycles before labeling it abnormal or proceeding with further fetal assessment.</span></p>",
      "correct_choice_id": 383313,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96291/Ini-Cet_Gt_30_Oct_2025_Obg_Q_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96291/Ini-Cet_Gt_30_Oct_2025_Obg_Q_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96340,
      "choices": [
        {
          "id": 383504,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenoxybenzamine&nbsp;</span></p>"
        },
        {
          "id": 383505,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 383506,
          "text": "<p><span style=\"font-size:14.0pt;\">Prazosin&nbsp;</span></p>"
        },
        {
          "id": 383507,
          "text": "<p><span style=\"font-size:14.0pt;\">Phentolamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old farmer presents to the emergency department 2 hours after being stung by a scorpion on his right hand. He complains of severe pain at the sting site, profuse sweating, palpitations, and difficulty breathing. On examination, his BP is 180/110 mmHg, pulse is 120/min, and he has muscle fasciculations. What is the drug of choice for managing this patient?</span></p>",
      "unique_key": "Q5637009",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Prazosin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prazosin is the drug of choice (DOC) for scorpion sting. Scorpion venom causes massive release of catecholamines leading to severe hypertension, tachycardia, and sympathetic overstimulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Prazosin, being a selective α₁ blocker, effectively counteracts the α-adrenergic effects of the venom without causing severe tachycardia (unlike non-selective α blockers).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient's presentation of hypertension, tachycardia, sweating, and muscle fasciculations is classic for scorpion envenomation requiring immediate α₁ blockade.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Phenoxybenzamine:</strong> This is a non-selective, irreversible α blocker primarily used for pheochromocytoma. It would cause severe tachycardia and prolonged effects, making it unsuitable for scorpion sting management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Propranolol:</strong> A non-selective β blocker would be contraindicated as it could worsen hypertension by blocking β₂-mediated vasodilation, leaving α₁-mediated vasoconstriction unopposed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Phentolamine:</strong> Though a reversible α blocker, it's non-selective (α₁ + α₂) and would cause severe tachycardia due to α₂ blockade, making prazosin the preferred choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Prazosin is the drug of choice for scorpion sting due to its selective α₁ blocking property that effectively counters catecholamine-induced hypertension without causing severe reflex tachycardia.</span></p>",
      "correct_choice_id": 383506,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96340/Pharmacology_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96340/Pharmacology_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96132,
      "choices": [
        {
          "id": 382688,
          "text": "<p><span style=\"font-size:14.0pt;\">Case–control study comparing prior vaccination among GBS cases vs matched controls</span></p>"
        },
        {
          "id": 382689,
          "text": "<p><span style=\"font-size:14.0pt;\">RCT randomizing populations to vaccine vs placebo</span></p>"
        },
        {
          "id": 382690,
          "text": "<p><span style=\"font-size:14.0pt;\">Small case series of GBS patients describing recent vaccine exposure</span></p>"
        },
        {
          "id": 382691,
          "text": "<p><span style=\"font-size:14.0pt;\">Ecological study correlating monthly vaccine doses with GBS rates by state</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A new vaccine is suspected to cause Guillain–Barré syndrome (GBS), a rare outcome. You must choose a design that is most efficient and appropriate to quickly test the association.<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3883490",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Case–control study comparing prior vaccination among GBS cases vs matched controls</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For <strong>rare outcomes</strong>, the <strong>case–control design</strong> is the most efficient analytic approach.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Investigators <strong>ascertain all incident GBS cases</strong> within a defined catchment and select an appropriate set of <strong>controls</strong> from the same source population (matched on key factors such as age, calendar time, and geography).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Prior <strong>exposure status (recent vaccination)</strong> is then ascertained from medical records/registries and compared between cases and controls.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Why this works well here:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rarity of outcome:</strong> When the disease is uncommon, assembling a cohort large enough to accrue sufficient events is slow and expensive; case–control sampling focuses resources on <strong>all cases</strong> and a manageable number of <strong>controls</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Timeliness:</strong> Data can be pulled quickly from <strong>immunization registries</strong> and <strong>hospital records</strong>, enabling a prompt risk estimate—often as an <strong>odds ratio</strong> that approximates the relative risk when the outcome is rare.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Exposure windowing:</strong> Case–control studies can define biologically plausible <strong>risk windows</strong> (e.g., exposure within 6 weeks before symptom onset) to test temporality.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Advanced note:</strong> a <strong>self-controlled case series</strong> is another efficient vaccine-safety design, but it is not among the answer choices.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. RCT randomizing populations to vaccine vs placebo:</strong> Impractical and <strong>unethical</strong> for suspected harm: randomizing to withhold a recommended vaccine or to expose large numbers solely to detect <strong>rare adverse events</strong> would require <strong>very large sample sizes</strong> and long follow-up; moreover, RCTs are not typically the first-line tool for post-marketing safety signals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Small case series of GBS patients describing recent vaccine exposure:</strong> Descriptive only (no control group). A list of GBS cases with recent vaccination <strong>cannot estimate risk</strong> or quantify association; it is useful for hypothesis generation but <strong>cannot test causality</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ecological study</strong> <strong>correlating monthly vaccine doses with GBS rates by state:</strong> Compares <strong>group-level</strong> vaccine uptake and <strong>population</strong> GBS rates and is prone to <strong>ecological fallacy</strong> and <strong>confounding</strong> (e.g., changes in diagnostics or reporting). It does <strong>not</strong> provide valid individual-level risk estimates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When investigating a suspected association between vaccination and a rare adverse event (e.g., GBS), a case–control study is the most efficient and appropriate design—allowing rapid estimation of the association by comparing prior exposure among cases and suitable controls.</span></p>",
      "correct_choice_id": 382688,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96132/NEET_PG_30_Oct_2025_GT_PSM_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96132/NEET_PG_30_Oct_2025_GT_PSM_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96322,
      "choices": [
        {
          "id": 383432,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-C</span></p>"
        },
        {
          "id": 383433,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-A</span></p>"
        },
        {
          "id": 383434,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-C, 3-A</span></p>"
        },
        {
          "id": 383435,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following staging systems with the tumors they are commonly used for:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-29%20104132.jpg\" width=\"1143\" height=\"345\"></p>",
      "unique_key": "Q8678209",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) 1-B, 2-C, 3-A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20174718.jpg\" width=\"982\" height=\"562\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Different cancers use <strong>specific staging systems</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Masaoka</strong> → thymoma</span></li><li><span style=\"font-size:14.0pt;\"><strong>BCLC</strong> → hepatocellular carcinoma</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ann-Arbor</strong> → lymphomas</span></li></ul>",
      "correct_choice_id": 383434,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96322/NEET_PG_30_Oct_2025_GT_Surgery_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96322/NEET_PG_30_Oct_2025_GT_Surgery_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96114,
      "choices": [
        {
          "id": 382620,
          "text": "<p><span style=\"font-size:14.0pt;\">Thiamine (Vitamin B1)</span></p>"
        },
        {
          "id": 382621,
          "text": "<p><span style=\"font-size:14.0pt;\">Niacin (Vitamin B3)</span></p>"
        },
        {
          "id": 382622,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyridoxal Phosphate (Vitamin B6)&nbsp;</span></p>"
        },
        {
          "id": 382623,
          "text": "<p><span style=\"font-size:14.0pt;\">Biotin (Vitamin B7)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old boy is brought to the clinic with complaints of easy fatigability and muscle cramps after mild exercise. On examination, there is mild hepatomegaly. Laboratory studies show low blood glucose levels during fasting. A muscle biopsy reveals accumulation of glycogen with normal structure but decreased glycogen phosphorylase activity. Which of the following vitamins, when deficient, could most directly impair the function of this enzyme?&nbsp;</span></p>",
      "unique_key": "Q2021579",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pyridoxal Phosphate (Vitamin B6)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The child presents with <strong>easy fatigability</strong>, <strong>muscle cramps after mild exercise</strong>, <strong>mild hepatomegaly</strong>, and <strong>hypoglycemia during fasting</strong>, which are characteristic findings of a <strong>glycogen storage disorder</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>muscle biopsy showing normal-structured glycogen with decreased glycogen phosphorylase activity</strong> identifies this as a <strong>defect in glycogen breakdown</strong> — specifically <strong>McArdle disease (Type V)</strong> in muscle or <strong>Hers disease (Type VI)</strong> in the liver, depending on the isoenzyme affected.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Glycogen phosphorylase</strong> is the key enzyme responsible for cleaving α-1,4-glycosidic bonds in glycogen to release glucose-1-phosphate.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This enzyme <strong>requires pyridoxal phosphate (Vitamin B6)</strong> as a <strong>coenzyme</strong> for its catalytic activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A deficiency of Vitamin B6 would directly <strong>impair the function of glycogen phosphorylase</strong>, leading to decreased glycogen breakdown and resulting in <strong>exercise intolerance, fatigue, and fasting hypoglycemia</strong> due to reduced glucose availability.</span></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>Pyridoxal phosphate (Vitamin B6)</strong> is the vitamin whose deficiency would <strong>most directly impair glycogen phosphorylase function</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Thiamine (Vitamin B1):&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Thiamine acts as a cofactor for enzymes such as <strong>pyruvate dehydrogenase</strong>, <strong>α-ketoglutarate dehydrogenase</strong>, and <strong>transketolase</strong>, which are involved in <strong>energy metabolism</strong> and the <strong>pentose phosphate pathway</strong>. While important for carbohydrate metabolism, it does <strong>not directly participate</strong> in the function of glycogen phosphorylase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Niacin (Vitamin B3):&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Niacin is a precursor for <strong>NAD⁺ and NADP⁺</strong>, which are electron carriers in <strong>oxidation-reduction reactions</strong> such as glycolysis and the TCA cycle. Although niacin deficiency can affect energy production, <strong>it does not serve as a cofactor for glycogen phosphorylase</strong>, and hence does not directly impair glycogen breakdown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Biotin (Vitamin B7):&nbsp;</strong>Incorrect. Biotin acts as a cofactor for <strong>carboxylase enzymes</strong> (e.g., <strong>pyruvate carboxylase</strong>, <strong>acetyl-CoA carboxylase</strong>, <strong>propionyl-CoA carboxylase</strong>), which are involved in <strong>gluconeogenesis and fatty acid synthesis</strong>, not glycogen breakdown. Hence, its deficiency would not impair glycogen phosphorylase activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pyridoxal phosphate (Vitamin B6)</strong> is a required coenzyme for <strong>glycogen phosphorylase</strong>, the enzyme responsible for glycogen breakdown.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Deficiency of Vitamin B6 directly impairs <strong>glycogenolysis</strong>, leading to <strong>glycogen accumulation</strong>, <strong>muscle cramps</strong>, and <strong>hypoglycemia</strong>.</span></li></ul>",
      "correct_choice_id": 382622,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96114/Biochemistry_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96114/Biochemistry_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96370,
      "choices": [
        {
          "id": 383624,
          "text": "<p><span style=\"font-size:14.0pt;\">VI, XII, V</span></p>"
        },
        {
          "id": 383625,
          "text": "<p><span style=\"font-size:14.0pt;\">VII, XII, VI</span></p>"
        },
        {
          "id": 383626,
          "text": "<p><span style=\"font-size:14.0pt;\">VI, VII, VIII</span></p>"
        },
        {
          "id": 383627,
          "text": "<p><span style=\"font-size:14.0pt;\">VII, VI, XII</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old child is brought by parents with complaints of inability to smile, difficulty in closing eyes, and convergent squint since birth. On examination, the child has facial diplegia, impaired abduction of both eyes, and poor sucking reflex in infancy. From most common to least common, which cranial nerves are affected in Möbius syndrome?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7853399",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) VII, VI, XII</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Möbius syndrome</strong> is a <strong>congenital non-progressive cranial nerve palsy</strong>, primarily involving the <strong>pons</strong>, due to <strong>hypoplasia or agenesis of the abducens (VI)</strong> and <strong>facial (VII)</strong> nuclei.</span></li><li><span style=\"font-size:14.0pt;\">The most <strong>frequently affected nerve</strong> is the <strong>facial nerve (VII)</strong>, followed by <strong>abducens (VI)</strong> and occasionally the <strong>hypoglossal (XII)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This combination explains <strong>facial paralysis</strong>, <strong>bilateral medial strabismus (due to loss of abduction)</strong>, and <strong>tongue weakness</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Typical Clinical Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bilateral <strong>facial paralysis</strong> (mask-like face, absent blinking, drooling)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Medial squint</strong> due to <strong>abducens palsy</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Feeding and speech difficulty</strong> due to tongue weakness (XII)</span></li><li><span style=\"font-size:14.0pt;\">Sometimes associated limb deformities (e.g., clubfoot, syndactyly)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. VI, XII, V:</strong> Trigeminal (V) is rarely involved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. VII, XII, VI:</strong> Order incorrect (VII most common, then VI, XII).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. VI, VII, VIII:</strong> Vestibulocochlear nerve is not typically affected.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Möbius syndrome</strong> primarily affects <strong>facial (VII)</strong> and <strong>abducens (VI)</strong> nerves (pons level), sometimes <strong>hypoglossal (XII)</strong>—leading to <strong>bilateral facial paralysis and impaired eye abduction</strong>.</span></p>",
      "correct_choice_id": 383627,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96370/ENT_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96370/ENT_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96107,
      "choices": [
        {
          "id": 382592,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 382593,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 382594,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 382595,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding reflex arcs in human physiology, consider the following statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The stretch reflex is the only monosynaptic reflex in humans.</span></li><li><span style=\"font-size:14.0pt;\">Reciprocal inhibition associated with the reflex is polysynaptic.</span></li><li><span style=\"font-size:14.0pt;\">The flexor withdrawal reflex is confined to a single spinal segment.</span></li><li><span style=\"font-size:14.0pt;\">The crossed-extensor reflex involves commissural interneurons.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following combinations is correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6911832",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. The stretch reflex is the only monosynaptic reflex in humans:</strong> Correct. The <strong>stretch (myotatic) reflex</strong> (e.g., patellar reflex) is <strong>monosynaptic</strong>, involving Ia afferent → α-motor neuron.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Reciprocal inhibition associated with the reflex is polysynaptic:</strong> Correct. <strong>Reciprocal inhibition</strong> uses <strong>interneurons</strong> to inhibit antagonistic muscle activity → <strong>polysynaptic</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. The crossed-extensor reflex involves commissural interneurons:</strong> Correct. <strong>Crossed-extensor reflex</strong> involves <strong>commissural interneurons</strong> that project to the opposite side of the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. The flexor withdrawal reflex is confined to a single spinal segment:</strong> Incorrect. <strong>Flexor withdrawal</strong> reflex spreads to multiple segments through <strong>propriospinal pathways</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reflex integration in the spinal cord involves both <strong>monosynaptic</strong> and <strong>polysynaptic</strong> mechanisms, often spreading across <strong>multiple spinal levels</strong>.</span></p>",
      "correct_choice_id": 382592,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96107/Physiology_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96107/Physiology_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96097,
      "choices": [
        {
          "id": 382552,
          "text": "<p><span style=\"font-size:14.0pt;\">Medial rotation of hip</span></p>"
        },
        {
          "id": 382553,
          "text": "<p><span style=\"font-size:14.0pt;\">External rotation of hip/ Abduction of hip</span></p>"
        },
        {
          "id": 382554,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexion at knee</span></p>"
        },
        {
          "id": 382555,
          "text": "<p><span style=\"font-size:14.0pt;\">Extension at knee</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the primary action of the muscle attached to the area indicated by the arrow in the image given below?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TijJo7l.png\" width=\"448\" height=\"428\"></span></p>",
      "unique_key": "Q5180422",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) External rotation of hip/ Abduction of hip</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The arrow in the image points to the <strong>attachment site of the gluteus maximus muscle</strong> on the sacrum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The gluteus maximus is the largest and most superficial muscle of the gluteal region.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anatomical details of gluteus maximus:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Origin:</strong> Posterior gluteal line, area behind posterior gluteal line, outer lip of iliac crest (posterior 1/3rd), adjacent surfaces of sacrum and coccyx, and sacrotuberous ligament</span></li><li><span style=\"font-size:14.0pt;\"><strong>Insertion:</strong> Gluteal tuberosity of femur (1/4th) and iliotibial tract (3/4th)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nerve supply:</strong> Inferior gluteal nerve (L5, S1, S2)</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Actions of gluteus maximus:</strong></span></li></ul><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Primary action:</strong> Extension at hip joint (chief extensor) - helps in moving from sitting to standing position</span></li><li><span style=\"font-size:14.0pt;\"><strong>Secondary actions:</strong>&nbsp;</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\"><strong>External rotation of hip</strong> - due to its posterior placement and fiber direction</span></li><li><span style=\"font-size:14.0pt;\"><strong>Abduction at hip</strong> - especially the upper fibers</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adduction at hip</strong> - especially the lower fibers</span></li></ul></li></ol><ul><li><span style=\"font-size:14.0pt;\">While <strong>extension at the hip</strong> would be the most accurate primary action, it is not listed among the options.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Among the given choices, <strong>external rotation and abduction</strong> are both valid secondary actions of the gluteus maximus muscle.</span></li><li><span style=\"font-size:14.0pt;\">The upper fibers of gluteus maximus, which attach more superiorly on the sacrum and iliac crest, particularly contribute to <strong>abduction of the hip</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The muscle's position posterior to the hip joint axis makes it an effective <strong>external rotator</strong> of the femur.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EtngGa8.png\" width=\"909\" height=\"691\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Medial rotation of hip:</strong> This is incorrect. The gluteus maximus causes <strong>external rotation</strong> of the hip, not medial rotation. Its fiber direction and position posterior to the hip joint make it an external rotator.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Flexion at knee:</strong> This is incorrect. The gluteus maximus primarily acts on the hip joint. While some fibers insert into the iliotibial tract which crosses the knee, the primary action is not knee flexion. The muscle does not significantly contribute to knee flexion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Extension at knee:</strong> This is incorrect. Although some fibers of gluteus maximus insert into the iliotibial tract which crosses the lateral aspect of the knee, the muscle does not significantly contribute to knee extension. The primary knee extensors are the quadriceps muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The gluteus maximus muscle, attached to the sacrum and other posterior pelvic structures, primarily extends the hip and secondarily performs external rotation and abduction of the hip joint.</span></p>",
      "correct_choice_id": 382553,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96097/Anatomy_INICET_GT_30_Oct_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96097/Anatomy_INICET_GT_30_Oct_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96344,
      "choices": [
        {
          "id": 383520,
          "text": "<p><span style=\"font-size:14.0pt;\">Quinidine</span></p>"
        },
        {
          "id": 383521,
          "text": "<p><span style=\"font-size:14.0pt;\">Encainide</span></p>"
        },
        {
          "id": 383522,
          "text": "<p><span style=\"font-size:14.0pt;\">Verapamil</span></p>"
        },
        {
          "id": 383523,
          "text": "<p><span style=\"font-size:14.0pt;\">Lidocaine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following drugs is most likely to prolong the action potential duration (APD) and delay repolarization in cardiac myocytes, thereby predisposing to prolonged QT interval?</span></p>",
      "unique_key": "Q6683133",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Quinidine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The drug that&nbsp;<strong>prolongs action potential duration (APD)</strong>&nbsp;and&nbsp;<strong>delays repolarization</strong>, leading to a&nbsp;<strong>prolonged QT interval</strong> is a feature typical of&nbsp;<strong>Class IA antiarrhythmic drug like Quinidine.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mechanism of Action by Class (Vaughan–Williams classification):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20175756.jpg\" width=\"916\" height=\"695\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Encainide (Class IC):&nbsp;</strong>Potently blocks Na⁺ channels but <strong>does not affect K⁺ channels</strong>. It has <strong>minimal or no effect on AP duration</strong> or QT interval.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Verapamil (Class IV):&nbsp;</strong>A <strong>calcium channel blocker</strong> that primarily affects <strong>AV nodal conduction</strong>, slowing the heart rate. It has <strong>little to no effect</strong> on ventricular AP duration or QT interval.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lidocaine (Class IB):&nbsp;</strong>A <strong>weak Na⁺ channel blocker</strong> that <strong>shortens AP duration</strong> and <strong>decreases QT interval</strong>. Used mainly in <strong>ischemic ventricular arrhythmias</strong>, not supraventricular arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Quinidine’s QT prolongation can predispose to&nbsp;<strong>Torsades de Pointes</strong>&nbsp;— a potentially fatal ventricular arrhythmia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Always monitor ECG when using such drugs.</span></li></ul>",
      "correct_choice_id": 383520,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96344/Pharmacology_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96344/Pharmacology_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96306,
      "choices": [
        {
          "id": 383372,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 383373,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 383374,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 383375,
          "text": "<p><span style=\"font-size:14.0pt;\">3 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following patients is least suitable for implantation of a multifocal intraocular lens?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. A 55-year-old teacher with mild myopic astigmatism</span><br><span style=\"font-size:14.0pt;\">2. A 60-year-old with stable diabetic retinopathy</span><br><span style=\"font-size:14.0pt;\">3. A 52-year-old software engineer with corneal scars</span><br><span style=\"font-size:14.0pt;\">4. A 58-year-old without any systemic comorbidities</span></p>",
      "unique_key": "Q8447974",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2 and 3 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Multifocal intraocular lenses (IOLs)</strong> split light into multiple focal points, allowing patients to see at both near and far distances without glasses.</span></li><li><span style=\"font-size:14.0pt;\">However, they also <strong>reduce contrast sensitivity</strong> and can cause <strong>glare and halos</strong>, making them <strong>unsuitable</strong> for patients with preexisting ocular pathology that already compromises visual quality.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 2. A 60-year-old with stable diabetic retinopathy:</strong> Even when retinopathy is stable, diabetic retinal disease <strong>reduces contrast sensitivity</strong> and may worsen post-surgery with multifocal lenses. These patients are <strong>not ideal</strong> candidates due to the potential for suboptimal visual outcomes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 3. A 52-year-old software engineer with corneal scars:</strong> Corneal opacities scatter light, and the addition of a multifocal lens can <strong>exacerbate visual distortion</strong>. Patients with irregular corneal surfaces or scarring typically do <strong>poorly with multifocal IOLs</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Thus, patients <strong>2 and 3 are least suitable</strong> for multifocal lens implantation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statements 1 and 4.</strong> <strong>A 55-year-old teacher with mild myopic astigmatism and A 58-year-old without any systemic comorbidities:&nbsp;</strong>Correct. Patient 1 has <strong>mild myopic astigmatism</strong>, which can be managed with laser correction or toric multifocal IOLs. Patient 4 is otherwise healthy. Both are <strong>potentially good candidates</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Multifocal intraocular lenses are contraindicated or discouraged in patients with ocular comorbidities that reduce contrast sensitivity, such as diabetic retinopathy and corneal scars.</strong> These conditions can lead to poor visual outcomes and patient dissatisfaction.</span></p>",
      "correct_choice_id": 383373,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96306/Ophthalmology_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96306/Ophthalmology_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96098,
      "choices": [
        {
          "id": 382556,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 382557,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 382558,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 382559,
          "text": "<p><span style=\"font-size:14.0pt;\">All 4 statements</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following postmortem findings are typically associated with the poisoning caused by the fruit/seeds shown in the image?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pnp9Vdm.png\" width=\"554\" height=\"558\"></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Early onset of rigor mortis due to violent convulsions.</span></li><li><span style=\"font-size:14.0pt;\">Congestion of viscera and petechial hemorrhages in serous membranes.</span></li><li><span style=\"font-size:14.0pt;\">Fixed and dilated pupils due to muscarinic stimulation.</span></li><li><span style=\"font-size:14.0pt;\">Extravasation of blood in voluntary muscles.</span></li></ol>",
      "unique_key": "Q6390725",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows <strong>Strychnos nux-vomica</strong>, a poisonous seed containing <strong>strychnine and brucine</strong>, potent neurotoxins. Strychnine acts by <strong>blocking glycine receptors</strong> in the spinal cord, leading to uncontrolled motor neuron stimulation and violent convulsions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The postmortem findings reflect the <strong>extreme neuromuscular activity</strong> prior to death:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Statement 1. Early onset of rigor mortis due to violent convulsions</strong>: Due to intense muscle contraction before death.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 2 and 4. Congestion of viscera and petechial hemorrhages in serous membranes and Extravasation of blood in voluntary muscles:</strong> Caused by repeated convulsive episodes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pupillary constriction (not dilation)</strong> is typically cholinergic, but muscarinic stimulation is not a feature of strychnine (this rules out statement 3).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Fixed and dilated pupils due to muscarinic stimulation:&nbsp;</strong>Incorrect. Fixed and dilated pupils are not a consistent finding in strychnine poisoning. The action is central via glycine inhibition, not through muscarinic receptors like in organophosphate or muscarine poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>strychnine poisoning</strong>, the postmortem findings include <strong>early onset of rigor mortis</strong>, <strong>extravasated blood in muscles</strong>, and <strong>congested viscera</strong>, reflecting severe pre-mortem convulsions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Muscarinic features like fixed/dilated pupils are <strong>not typically seen</strong>.</span></li></ul>",
      "correct_choice_id": 382556,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96098/FMT_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96098/FMT_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96325,
      "choices": [
        {
          "id": 383444,
          "text": "<p><span style=\"font-size:14.0pt;\">It reverses both depolarizing and non-depolarizing blockade</span></p>"
        },
        {
          "id": 383445,
          "text": "<p><span style=\"font-size:14.0pt;\">It forms an inclusion complex with aminosteroid neuromuscular blockers</span></p>"
        },
        {
          "id": 383446,
          "text": "<p><span style=\"font-size:14.0pt;\">It increases acetylcholine concentration at the neuromuscular junction</span></p>"
        },
        {
          "id": 383447,
          "text": "<p><span style=\"font-size:14.0pt;\">It is contraindicated in patients with renal impairment because it causes hepatotoxicity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male undergoing laparoscopic cholecystectomy receives rocuronium for neuromuscular blockade. At the end of surgery, the anesthetist decides to reverse the block using sugammadex. Which of the following statements about sugammadex is true?</span></p>",
      "unique_key": "Q3156950",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) It forms an inclusion complex with aminosteroid neuromuscular blockers</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sugammadex is a <strong>modified γ-cyclodextrin</strong> that <strong>encapsulates aminosteroid non-depolarizing neuromuscular blockers</strong> such as <strong>rocuronium and vecuronium</strong> in a 1:1 inclusion complex.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This binding reduces the free plasma concentration of the relaxant, creating a concentration gradient that draws the drug out of the neuromuscular junction back into plasma — leading to <strong>rapid reversal</strong> of paralysis.</span></li><li><span style=\"font-size:14.0pt;\">It acts <strong>independently of acetylcholinesterase</strong> and thus avoids muscarinic side effects (e.g., bradycardia) typical of neostigmine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It reverses both depolarizing and non-depolarizing blockade:</strong> Incorrect. Sugammadex only works on <strong>aminosteroid non-depolarizing agents</strong> (rocuronium, vecuronium). It does <strong>not</strong> reverse depolarizing blockers such as <strong>succinylcholine</strong> or benzylisoquinoliniums like atracurium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It increases acetylcholine concentration at the neuromuscular junction:&nbsp;</strong>Incorrect. This is the mechanism of <strong>neostigmine (AChE inhibitor)</strong>, not sugammadex. Sugammadex acts by <strong>encapsulation and chemical inactivation</strong> of the relaxant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is contraindicated in patients with renal impairment because it causes hepatotoxicity:&nbsp;</strong>Incorrect. Sugammadex is <strong>renally excreted unchanged</strong>; caution or avoidance is due to <strong>renal accumulation</strong>, not liver toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sugammadex is a <strong>selective relaxant-binding agent</strong> that rapidly reverses <strong>rocuronium and vecuronium</strong> blockade by <strong>encapsulation</strong>, not by acetylcholinesterase inhibition.</span></li><li><span style=\"font-size:14.0pt;\">It enables <strong>faster and more complete recovery</strong> with fewer cardiovascular side effects compared to neostigmine.</span></li></ul>",
      "correct_choice_id": 383445,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96325/Anesthesia_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96325/Anesthesia_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96288,
      "choices": [
        {
          "id": 383300,
          "text": "<p><span style=\"font-size:14.0pt;\">28–30 weeks gestation</span></p>"
        },
        {
          "id": 383301,
          "text": "<p><span style=\"font-size:14.0pt;\">35–37 weeks gestation</span></p>"
        },
        {
          "id": 383302,
          "text": "<p><span style=\"font-size:14.0pt;\">38–40 weeks gestation</span></p>"
        },
        {
          "id": 383303,
          "text": "<p><span style=\"font-size:14.0pt;\">32–34 weeks gestation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">At what gestational age should Group B Streptococcus (GBS) screening be performed in pregnant women according to ACOG guidelines to prevent early-onset neonatal sepsis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6352969",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 35–37 weeks gestation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Group B Streptococcus (GBS)</strong> is a leading cause of <strong>early-onset neonatal sepsis</strong> (within the first 7 days of life).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Vertical transmission occurs from a colonized mother during labor or rupture of membranes.</span></li><li><span style=\"font-size:14.0pt;\">To prevent neonatal infection, the <strong>American College of Obstetricians and Gynecologists (ACOG)</strong> recommends <strong>universal screening</strong> for maternal GBS colonization using a <strong>rectovaginal swab</strong> between <strong>35–37 weeks gestation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This time frame provides an accurate reflection of colonization status close to delivery.</span></li><li><span style=\"font-size:14.0pt;\">Women who test <strong>positive for GBS</strong> should receive <strong>intrapartum antibiotic prophylaxis</strong> (most commonly <strong>Penicillin G</strong>) during labor to prevent transmission to the neonate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Indications for intrapartum prophylaxis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Positive GBS screening at 35–37 weeks</span></li><li><span style=\"font-size:14.0pt;\">Previous delivery of an infant with GBS disease</span></li><li><span style=\"font-size:14.0pt;\">GBS bacteriuria during current pregnancy</span></li><li><span style=\"font-size:14.0pt;\">Unknown GBS status with risk factors: preterm labor (&lt;37 weeks), intrapartum fever (≥38°C), or prolonged rupture of membranes (&gt;18 hours)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>GBS screening</strong> should be performed at <strong>35–37 weeks gestation</strong> using a <strong>rectovaginal swab</strong>. If the result is positive, <strong>intrapartum antibiotic prophylaxis</strong> should be given to prevent <strong>early-onset neonatal GBS sepsis</strong>.</span></p>",
      "correct_choice_id": 383301,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96288/Ini-Cet_Gt_30_Oct_2025_Obg_Q_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96288/Ini-Cet_Gt_30_Oct_2025_Obg_Q_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96292,
      "choices": [
        {
          "id": 383316,
          "text": "<p><span style=\"font-size:14.0pt;\">Symmetrical IUGR</span></p>"
        },
        {
          "id": 383317,
          "text": "<p><span style=\"font-size:14.0pt;\">Asymmetrical IUGR</span></p>"
        },
        {
          "id": 383318,
          "text": "<p><span style=\"font-size:14.0pt;\">Preterm AGA</span></p>"
        },
        {
          "id": 383319,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal term baby</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A term baby is born with birth weight 2 kg and length 50 cm. PI is 1.6. Head circumference is normal. Which is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q5991451",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Asymmetrical IUGR</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Low weight with preserved length and HC. Ponderal Index &lt; 2.0. Commonly due to <strong>placental insufficiency</strong> (late insult).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Symmetrical IUGR:</strong> Both weight and length are proportionally reduced; <strong>PI is normal or high</strong>, not low.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Preterm AGA:</strong> Preterm babies usually have normal or slightly high PI.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Normal term baby:</strong> PI 2.2–2.5 is normal. PI of 1.6 is low → abnormal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Ponderal Index</strong> helps distinguish <strong>asymmetrical (low PI)</strong> from <strong>symmetrical (normal/high PI)</strong> IUGR in term infants.</span></p>",
      "correct_choice_id": 383317,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96292/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96292/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96219,
      "choices": [
        {
          "id": 383028,
          "text": "<p><span style=\"font-size:14.0pt;\">A woman with poorly controlled asthma and chronic urticaria</span></p>"
        },
        {
          "id": 383029,
          "text": "<p><span style=\"font-size:14.0pt;\">A woman with a history of polycystic ovarian syndrome (PCOS) and oligomenorrhea</span></p>"
        },
        {
          "id": 383030,
          "text": "<p><span style=\"font-size:14.0pt;\">A woman who recently recovered from viral hepatitis with mild liver enzyme elevation</span></p>"
        },
        {
          "id": 383031,
          "text": "<p><span style=\"font-size:14.0pt;\">A woman with irregular menstrual cycles due to dysfunctional uterine bleeding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">You are supervising a new community health worker in a government contraceptive distribution program. She shows you the medication in the image and asks which patient groups should avoid this drug. Which of the following patients is safest for this medication?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Z7PLJBR.png\" width=\"528\" height=\"293\"></strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1%20(1)_F1jUgxo.jpg\" width=\"1200\" height=\"671\"></p>",
      "unique_key": "Q6182622",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) A woman with irregular menstrual cycles due to dysfunctional uterine bleeding</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Centchroman (also known as <strong>Saheli</strong> or <strong>Chhaya</strong>) is a <strong>non-steroidal contraceptive</strong> with <strong>Selective Estrogen Receptor Modulator (SERM)</strong> activity.</span></li><li><span style=\"font-size:14.0pt;\">It's <strong>approved in India</strong> and used in national contraceptive programs. Apart from its contraceptive effect, it is <strong>also used in the management of dysfunctional uterine bleeding</strong>, making Option D the best choice.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A woman with poorly controlled asthma and chronic urticaria</strong>: Centchroman is contraindicated in <strong>severe allergic conditions</strong>, especially if they involve hypersensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. A woman with a history of polycystic ovarian syndrome (PCOS) and oligomenorrhea (Stein-Leventhal syndrome)</strong>: It is <strong>specifically contraindicated</strong> due to hormonal imbalance and poor cycle control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. A woman who recently recovered from viral hepatitis with mild liver enzyme elevation</strong>: Centchroman should be <strong>avoided in recent or active hepatic disorders</strong> due to its hepatic metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Centchroman is a <strong>weekly, non-steroidal contraceptive</strong> safe for use in women with <strong>dysfunctional uterine bleeding</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Contraindicated</strong> in:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>PCOS</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Recent jaundice</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Severe allergic disorders</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cervical hyperplasia</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism</strong>: SERM with <strong>anti-implantation</strong> and <strong>anti-estrogenic</strong> effects on the uterus.</span></li><li><span style=\"font-size:14.0pt;\">Distributed <strong>free</strong> under India’s <strong>“Chhaya” program</strong> by the Ministry of Health.</span></li></ul>",
      "correct_choice_id": 383031,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96219/NEET_PG_30_Oct_2025_GT_PSM_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96219/NEET_PG_30_Oct_2025_GT_PSM_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96341,
      "choices": [
        {
          "id": 383508,
          "text": "<p><span style=\"font-size:14.0pt;\">Heroin</span></p>"
        },
        {
          "id": 383509,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenobarbital</span></p>"
        },
        {
          "id": 383510,
          "text": "<p><span style=\"font-size:14.0pt;\">Imipramine</span></p>"
        },
        {
          "id": 383511,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenytoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 18-year-old boy is found unresponsive at home and is brought to the emergency department. His family reports that he ingested an unknown quantity of medication in a suicide attempt. On examination, he is somnolent, with shallow respiration at a rate of 8 breaths per minute and a blood pressure of 82/46 mmHg. Blisters are noted on his upper arm, as shown in the image. Laboratory results reveal a blood pH of 7.25, PaCO2 of 68 mmHg, and HCO3- of 24 mmol/L. Which of the following medications is most likely responsible for this patient’s presentation?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20175726.jpg\" width=\"660\" height=\"496\"></strong></span></p>",
      "unique_key": "Q2816292",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Phenobarbital</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with shallow respirations, hypotension, and a large pressure blister, which are characteristic of barbiturate poisoning (e.g., phenobarbital).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Barbiturates depress the central nervous system, leading to respiratory depression, hypotension, and coma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pressure blisters develop due to prolonged immobility, which causes localized pressure and ischemia.</span></li><li><span style=\"font-size:14.0pt;\">Barbiturates also cause respiratory acidosis, as evidenced by the elevated PaCO2 and low pH in this patient’s arterial blood gas results.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hypotension occurs due to vasodilation and myocardial depression caused by barbiturates.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Heroin:</strong> Opioid overdose can cause similar symptoms of respiratory depression and hypotension but is not typically associated with the development of pressure blisters.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Imipramine:</strong> Overdose with tricyclic antidepressants like imipramine can lead to anticholinergic toxicity, seizures, and cardiac arrhythmias. Pressure blisters are not a common finding in this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Phenytoin:</strong> Phenytoin toxicity may cause neurological symptoms such as ataxia, nystagmus, and altered mental status, but it does not typically result in respiratory depression or pressure blister formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Barbiturate poisoning presents with central nervous system depression, respiratory acidosis, hypotension, and features such as pressure blisters due to prolonged immobility.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Management includes supportive care and, in severe cases, the use of activated charcoal or hemodialysis.</span></li></ul>",
      "correct_choice_id": 383509,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96341/Pharmacology_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96341/Pharmacology_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96357,
      "choices": [
        {
          "id": 383572,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-a, 3-c, 4-d</span></p>"
        },
        {
          "id": 383573,
          "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-b, 3-d, 4-c</span></p>"
        },
        {
          "id": 383574,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-b, 4-a</span></p>"
        },
        {
          "id": 383575,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-a, 4-d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following anticancer drugs with their most characteristic dose-limiting toxicities:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-28%20104816.jpg\" width=\"903\" height=\"260\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the correct matching?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6196185",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 1-b, 2-c, 3-a, 4-d</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Vincristine → Peripheral neuropathy (b):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong>&nbsp;Microtubule inhibitor (vinca alkaloid).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Toxicity:</strong>&nbsp;Causes&nbsp;<strong>sensory and motor neuropathy</strong>,&nbsp;<strong>areflexia</strong>,&nbsp;<strong>foot drop</strong>,&nbsp;<strong>constipation</strong>, and&nbsp;<strong>cranial nerve palsies</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mnemonic:</strong>&nbsp;“<strong>Vin</strong>cristine →&nbsp;<strong>Neuro</strong>toxicity;&nbsp;<strong>Vin</strong>blastine →&nbsp;<strong>Bl</strong>ood toxicity (bone marrow suppression).”</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Ifosfamide → Hemorrhagic cystitis (c):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong>&nbsp;Alkylating agent (nitrogen mustard analogue).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Toxicity:</strong>&nbsp;Acrolein metabolite&nbsp;causes&nbsp;<strong>hemorrhagic cystitis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Prevention:</strong>&nbsp;Mesna (2-mercaptoethane sulfonate)&nbsp;binds and neutralizes acrolein in urine.</span></li><li><span style=\"font-size:14.0pt;\">Also causes&nbsp;<strong>encephalopathy</strong>&nbsp;(due to chloroacetaldehyde).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Bleomycin → Flagellated dermatitis (a):&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong>&nbsp;Generates free radicals → DNA strand breaks.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Toxicities:</strong>&nbsp;Pulmonary fibrosis (dose-limiting)&nbsp;and&nbsp;<strong>flagellated hyperpigmentation</strong>&nbsp;(linear streaks on skin).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mnemonic:</strong>&nbsp;“<strong>Bleo</strong>-marks (flagellated lines) on the skin.”</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Capecitabine → Hand-foot syndrome (d):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong>&nbsp;Oral prodrug of 5-fluorouracil (5-FU).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Toxicity:</strong>&nbsp;Palmar–plantar erythrodysesthesia (hand-foot syndrome)&nbsp;– redness, pain, and peeling on palms and soles.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mnemonic:</strong>&nbsp;“Capecitabine caps your hands and feet with redness.”</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Each chemotherapeutic agent has a characteristic dose-limiting toxicity:&nbsp;</strong>vincristine (neuropathy), ifosfamide (hemorrhagic cystitis), bleomycin (flagellated dermatitis and pulmonary fibrosis), and capecitabine (hand-foot syndrome).</span></p>",
      "correct_choice_id": 383575,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96357/Pharmacology_INICET_GT_30_Oct_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96357/Pharmacology_INICET_GT_30_Oct_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96311,
      "choices": [
        {
          "id": 383392,
          "text": "<p><span style=\"font-size:14.0pt;\">Foley catheter</span></p>"
        },
        {
          "id": 383393,
          "text": "<p><span style=\"font-size:14.0pt;\">Malecot catheter</span></p>"
        },
        {
          "id": 383394,
          "text": "<p><span style=\"font-size:14.0pt;\">Jackson-Pratt drain</span></p>"
        },
        {
          "id": 383395,
          "text": "<p><span style=\"font-size:14.0pt;\">Mushroom catheter</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with a history of prostate cancer undergoes a percutaneous nephrostomy for obstructive uropathy. The interventional radiology team places the catheter shown in the image below. Which of the following best identifies the catheter in use?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20174428.jpg\" width=\"586\" height=\"491\"></strong></span></p>",
      "unique_key": "Q9042909",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Malecot catheter</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Malecot catheter</strong> is recognized by its <strong>winged, flower-petal–like tip</strong>, which provides <strong>anchorage</strong> in body cavities such as the <strong>renal pelvis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is frequently used in <strong>percutaneous nephrostomy</strong> to facilitate <strong>urinary diversion</strong> when retrograde access is not feasible or is contraindicated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The wings help it <strong>remain securely in position</strong> and prevent dislodgement.</span></li><li><span style=\"font-size:14.0pt;\">It is particularly useful in:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Nephrostomy drainage</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Suprapubic cystostomy</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Pelvic abscess drainage</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The image shows the <strong>classic flared, expanded distal tip</strong> design, confirming it as a Malecot catheter.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Foley catheter:&nbsp;</strong>Incorrect. A Foley catheter has a <strong>balloon at the tip</strong> and is used for <strong>bladder drainage via the urethra</strong>. It lacks the <strong>winged tip</strong> characteristic of a Malecot catheter.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Jackson-Pratt drain:&nbsp;</strong>Incorrect. A Jackson-Pratt (JP) drain is a <strong>closed-suction surgical drain</strong> with a bulb at the end and is typically used postoperatively for <strong>serous or blood fluid drainage</strong>, not urinary diversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mushroom catheter:&nbsp;</strong>Incorrect. The <strong>Mushroom catheter</strong>, or <strong>Pezzer catheter</strong>, also has a retention head but is shaped more like a <strong>rounded button or mushroom cap</strong>. It is <strong>not winged</strong> and is typically used for <strong>bladder drainage</strong> in suprapubic catheterization, not renal pelvis drainage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Malecot catheter features a winged tip for anchorage and is commonly used in procedures like percutaneous nephrostomy for urinary drainage from the renal pelvis.</span></p>",
      "correct_choice_id": 383393,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96311/NEET_PG_30_Oct_2025_GT_Surgery_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96311/NEET_PG_30_Oct_2025_GT_Surgery_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96099,
      "choices": [
        {
          "id": 382560,
          "text": "<p><span style=\"font-size:14.0pt;\">Rigor mortis allows joint movement with moderate resistance unless fully developed</span></p>"
        },
        {
          "id": 382561,
          "text": "<p><span style=\"font-size:14.0pt;\">Cold stiffening produces a “crackling” sensation on movement if attempted before thawing</span></p>"
        },
        {
          "id": 382562,
          "text": "<p><span style=\"font-size:14.0pt;\">Heat stiffening is pliable and allows easy joint extension</span></p>"
        },
        {
          "id": 382563,
          "text": "<p><span style=\"font-size:14.0pt;\">Rigor mortis disappears sequentially; heat and cold stiffening disappear uniformly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following are correct regarding joint manipulation during various types of postmortem stiffening, except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6968993",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Heat stiffening is pliable and allows easy joint extension</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Heat stiffening results from <strong>coagulation of muscle proteins</strong> due to exposure to high temperatures (≥65°C), such as in <strong>burns or electrocution</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This causes the body to become <strong>extremely rigid</strong>, and <strong>joint manipulation is difficult</strong>, often risking <strong>rupture of muscles</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Hence, <strong>Option C is false</strong> — heat stiffening <strong>is not pliable</strong>; in fact, it is <strong>more rigid</strong> than rigor mortis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rigor mortis allows joint movement with moderate resistance unless fully developed:</strong> True. Early rigor can be overcome with moderate force; fully developed rigor offers more resistance but doesn't lead to rupture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cold stiffening produces a “crackling” sensation on movement if attempted before thawing:</strong> True. The frozen state of the muscles and joints leads to a <strong>crepitus-like sensation</strong> if manipulated before thawing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Rigor mortis disappears sequentially; heat and cold stiffening disappear uniformly:</strong> True. Rigor mortis passes in a <strong>head-to-toe sequence</strong>, whereas <strong>heat and cold stiffening disappear suddenly</strong>, typically <strong>with putrefaction (heat)</strong> or <strong>on thawing (cold)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Heat stiffening</strong> results from <strong>thermal coagulation</strong> of muscle proteins and leads to <strong>extreme, non-pliable rigidity</strong> that <strong>cannot be reversed</strong> by ordinary manipulation — unlike rigor mortis, which develops gradually and can be overcome in early stages.</span></p>",
      "correct_choice_id": 382562,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96099/FMT_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96099/FMT_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96096,
      "choices": [
        {
          "id": 382548,
          "text": "<p><span style=\"font-size:14.0pt;\">Merocrine gland</span></p>"
        },
        {
          "id": 382549,
          "text": "<p><span style=\"font-size:14.0pt;\">Endocrine gland</span></p>"
        },
        {
          "id": 382550,
          "text": "<p><span style=\"font-size:14.0pt;\">Holocrine gland</span></p>"
        },
        {
          "id": 382551,
          "text": "<p><span style=\"font-size:14.0pt;\">Apocrine gland</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which type of gland is depicted in the histological image given below?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MS7fAlf.png\" width=\"655\" height=\"408\"></span></p>",
      "unique_key": "Q6615410",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Holocrine gland</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows <strong>sebaceous glands</strong>, which are <strong>holocrine glands</strong> associated with hair follicles.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>holocrine secretion</strong>, the <strong>entire secretory cell ruptures</strong> to release its contents — a mixture of <strong>lipids, cell debris, and sebum</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This mechanism provides lubrication and waterproofing for the skin and hair.</span></li><li><span style=\"font-size:14.0pt;\">The glandular cells undergo <strong>continuous mitosis</strong> at the base, replacing the ones lost during secretion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These glands are most numerous on the <strong>face, scalp, and upper trunk</strong>, and their activity increases during puberty under <strong>androgen stimulation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_luLg4eF.png\" width=\"832\" height=\"689\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Merocrine gland:&nbsp;</strong>Incorrect. Merocrine glands release their secretions via <strong>exocytosis</strong> without cell damage (e.g., <strong>eccrine sweat glands</strong> and <strong>pancreatic acini</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Endocrine gland:&nbsp;</strong>Incorrect. Endocrine glands are <strong>ductless</strong> and secrete hormones directly into the <strong>bloodstream</strong> (e.g., thyroid, adrenal). Sebaceous glands release onto the skin surface, not into blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Apocrine gland:&nbsp;</strong>Incorrect. Apocrine glands release secretion by <strong>pinching off part of the apical cytoplasm</strong> (e.g., mammary glands, sweat glands in the axilla).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Sebaceous glands</strong> are <strong>holocrine glands</strong> whose secretory cells disintegrate to release <strong>sebum</strong>. This distinguishes them from <strong>merocrine</strong> (exocytotic) and <strong>apocrine</strong> (apical shedding) glands.</span></p>",
      "correct_choice_id": 382550,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96096/Anatomy_INICET_GT_30_Oct_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96096/Anatomy_INICET_GT_30_Oct_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96321,
      "choices": [
        {
          "id": 383428,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 are correct</span></p>"
        },
        {
          "id": 383429,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 are correct</span></p>"
        },
        {
          "id": 383430,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 are correct</span></p>"
        },
        {
          "id": 383431,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3 and 4 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A neonatology resident is evaluating a 4-week-old male infant presenting with persistent vomiting. Consider the following statements regarding infantile hypertrophic pyloric stenosis (IHPS). Which of the statements is true?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The most common presentation is non-bilious projectile vomiting.</span></li><li><span style=\"font-size:14.0pt;\">An olive-shaped mass may be palpable in the epigastrium or right upper quadrant, and on test feeding, visible peristalsis moves from left to right across the abdomen.</span></li><li><span style=\"font-size:14.0pt;\">The condition is most commonly seen between 3 and 6 weeks of age, with females at the highest risk.</span></li><li><span style=\"font-size:14.0pt;\">The fluid for correction is DNS + KCl (0.15%) after stabilizing dehydration and electrolyte imbalance.</span></li></ol>",
      "unique_key": "Q1834794",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2 and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. The most common presentation is non-bilious projectile vomiting: </strong>Correct<strong>.</strong> IHPS typically presents with <strong>progressive, non-bilious projectile vomiting</strong> after 2–8 weeks of life (not at birth).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>An olive-shaped mass may be palpable in the epigastrium or right upper quadrant, and on test feeding, visible peristalsis moves from left to right across the abdomen: </strong>Correct<strong>.</strong> The classic finding is an <strong>olive-shaped mass</strong> in the RUQ/epigastrium, with visible <strong>left-to-right gastric peristalsis</strong> after a test feed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The fluid for correction is DNS + KCl (0.15%) after stabilizing dehydration and electrolyte imbalance: </strong>Correct<strong>.</strong> Initial management is fluid and electrolyte correction — <strong>DNS + KCl (0.15%)</strong> is appropriate before surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>The condition is most commonly seen between 3 and 6 weeks of age, with females at the highest risk: </strong>Incorrect<strong>.&nbsp;</strong>The most common age group is indeed 3–6 weeks, but <strong>first-born males</strong> (not females) are at highest risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Infantile hypertrophic pyloric stenosis</strong> presents at <strong>2–8 weeks</strong> with <strong>non-bilious projectile vomiting</strong>, palpable “olive” mass, and visible peristalsis. <strong>First-born males</strong> are most at risk.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Treatment includes initial <strong>fluid/electrolyte stabilization</strong> followed by <strong>Ramstedt pyloromyotomy</strong>.</span></li></ul>",
      "correct_choice_id": 383429,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96321/NEET_PG_30_Oct_2025_GT_Surgery_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96321/NEET_PG_30_Oct_2025_GT_Surgery_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96375,
      "choices": [
        {
          "id": 383644,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 383645,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 5</span></p>"
        },
        {
          "id": 383646,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 383647,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man presents with new-onset seizures. MRI brain with contrast reveals a ring-enhancing lesion. Which of the following conditions are most likely to present with such radiologic findings?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Brain abscess</span></li><li><span style=\"font-size:14.0pt;\">Resolving hematoma</span></li><li><span style=\"font-size:14.0pt;\">Primary CNS lymphoma</span></li><li><span style=\"font-size:14.0pt;\">Encephalopathy</span></li><li><span style=\"font-size:14.0pt;\">Infarction</span></li></ol>",
      "unique_key": "Q1752993",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1, 2 and 3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ring-enhancing lesions on CT/MRI occur when there is a central area of necrosis, liquefaction, or cystic change surrounded by a rim of active inflammation, granulation tissue, or tumor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These appear as rings of enhancement after contrast administration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Brain abscess:</strong> Classic cause. Central necrosis of infection is surrounded by granulation tissue and a capsule, producing ring enhancement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Resolving hematoma:</strong> As blood products break down, granulation tissue with leaky capillaries leads to ring enhancement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Primary CNS lymphoma:</strong> Can present as ring-enhancing lesions, especially in immunocompromised patients (e.g., HIV, transplant recipients). Enhancement may be homogeneous but can also be ring-like if central necrosis occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Encephalopathy:</strong> Usually shows diffuse or patchy non-enhancing white matter changes, not a discrete ring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Infarction:</strong> Acute/subacute infarcts enhance patchily or diffusely; frank ring enhancement is unusual and nonspecific unless there is hemorrhagic transformation or abscess formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ring-enhancing brain lesions are most classically seen in brain abscesses, resolving hematomas, and CNS lymphoma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Encephalopathy and uncomplicated infarction do not typically present with ring enhancement.</span></li></ul>",
      "correct_choice_id": 383646,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96375/RADIOLOGY_INICET_GT_5_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96375/RADIOLOGY_INICET_GT_5_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96120,
      "choices": [
        {
          "id": 382644,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyruvate kinase</span></p>"
        },
        {
          "id": 382645,
          "text": "<p><span style=\"font-size:14.0pt;\">Phosphofructokinase</span></p>"
        },
        {
          "id": 382646,
          "text": "<p><span style=\"font-size:14.0pt;\">Phosphoenolpyruvate carboxykinase</span></p>"
        },
        {
          "id": 382647,
          "text": "<p><span style=\"font-size:14.0pt;\">Phosphoglycerate kinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old man is fasting overnight. His liver begins to produce glucose via gluconeogenesis to maintain blood glucose levels. Some of the enzymes used in this pathway are also shared with glycolysis, while others are unique. Which of the following enzymes is common to both glycolysis and gluconeogenesis?&nbsp;</span></p>",
      "unique_key": "Q6153201",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Phosphoglycerate kinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This enzyme catalyzes the <strong>reversible</strong> reaction: <strong>1,3-bisphosphoglycerate&nbsp;⇌ 3-phosphoglycerate</strong>, and thus functions in <strong>both glycolysis and gluconeogenesis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pyruvate kinase:&nbsp;</strong>False.<strong>&nbsp;</strong>Catalyzes the final irreversible step in <strong>glycolysis</strong> (PEP → pyruvate).</span></p><p><br><span style=\"font-size:14.0pt;\">In gluconeogenesis, this step is bypassed by <strong>pyruvate carboxylase</strong> and <strong>PEP carboxykinase</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Phosphofructokinase:&nbsp;</strong>False.<strong>&nbsp;</strong>Catalyzes the irreversible step <strong>fructose-6-phosphate → fructose-1,6-bisphosphate</strong> in glycolysis.</span><br><span style=\"font-size:14.0pt;\">In gluconeogenesis, it is bypassed by <strong>fructose-1,6-bisphosphatase</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Phosphoenolpyruvate carboxykinase:&nbsp;</strong>False.<strong>&nbsp;</strong>Functions only in <strong>gluconeogenesis</strong> (oxaloacetate → PEP).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Phosphoglycerate kinase</strong> is one of the <strong>reversible enzymes shared by glycolysis and gluconeogenesis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It catalyzes the interconversion of <strong>1,3-bisphosphoglycerate and 3-phosphoglycerate</strong>, utilizing or generating ATP depending on the metabolic direction.</span></li></ul>",
      "correct_choice_id": 382647,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96120/Biochemistry_INICET_GT_30_Oct_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96120/Biochemistry_INICET_GT_30_Oct_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96113,
      "choices": [
        {
          "id": 382616,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-A, 4-B</span></p>"
        },
        {
          "id": 382617,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        },
        {
          "id": 382618,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-C, 4-A</span></p>"
        },
        {
          "id": 382619,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-C, 3-B, 4-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match each disease in Column I with the corresponding defective DNA repair mechanism in Column II.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column I (Disease)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Severe Combined Immunodeficiency (SCID)</span></li><li><span style=\"font-size:14.0pt;\">Xeroderma Pigmentosum</span></li><li><span style=\"font-size:14.0pt;\">Hereditary Nonpolyposis Colorectal Cancer (HNPCC)</span></li><li><span style=\"font-size:14.0pt;\">MUTYH-associated Polyposis (MAP)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column II (Defective Repair Mechanism)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Base Excision Repair</span></li><li><span style=\"font-size:14.0pt;\">Nucleotide Excision Repair</span></li><li><span style=\"font-size:14.0pt;\">Mismatch Repair</span></li><li><span style=\"font-size:14.0pt;\">Non-Homologous End Joining</span></li></ol>",
      "unique_key": "Q6963181",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1-D, 2-B, 3-C, 4-A</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-D. Severe Combined Immunodeficiency (SCID)</strong> — <strong>Defective Non-Homologous End Joining:&nbsp;</strong>SCID, particularly the form caused by <strong>defects in DNA-dependent protein kinase (DNA-PK)</strong> or <strong>Artemis</strong>, involves failure of <strong>V(D)J recombination</strong> during B and T cell receptor formation. This recombination process depends on <strong>non-homologous end joining (NHEJ)</strong> to repair double-stranded DNA breaks. Thus, a defect in NHEJ leads to <strong>lymphocyte maturation failure</strong>, resulting in <strong>combined immunodeficiency</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-B. Xeroderma Pigmentosum (XP)</strong> — <strong>Defective Nucleotide Excision Repair:&nbsp;</strong>XP is characterized by <strong>extreme UV sensitivity</strong> and <strong>predisposition to skin cancers</strong> due to mutations in genes responsible for <strong>nucleotide excision repair (NER)</strong>. NER normally removes bulky <strong>thymine dimers</strong> and <strong>pyrimidine dimers</strong> caused by UV light. Defective NER results in the accumulation of UV-induced DNA damage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-C. Hereditary Nonpolyposis Colorectal Cancer (HNPCC or Lynch Syndrome)</strong> — <strong>Defective Mismatch Repair:&nbsp;</strong>HNPCC is caused by germline mutations in <strong>DNA mismatch repair (MMR)</strong> genes such as <strong>MLH1, MSH2, MSH6, and PMS2</strong>. These genes correct <strong>base-pair mismatches</strong> and <strong>microsatellite instability</strong> that occur during DNA replication. Loss of mismatch repair leads to <strong>microsatellite instability</strong> and promotes <strong>colorectal and endometrial cancers</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4-A. MUTYH-Associated Polyposis (MAP)</strong> — <strong>Defective Base Excision Repair:&nbsp;</strong>The <strong>MUTYH gene</strong> encodes a <strong>DNA glycosylase</strong> involved in <strong>base excision repair (BER)</strong>, which removes oxidatively damaged bases such as <strong>8-oxoguanine</strong>. Mutations in MUTYH impair BER, causing accumulation of base substitution mutations and leading to <strong>multiple colorectal adenomas and cancer</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Different DNA repair mechanisms correct specific types of DNA damage:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Non-Homologous End Joining → SCID</span></li><li><span style=\"font-size:14.0pt;\">Nucleotide Excision Repair → Xeroderma Pigmentosum</span></li><li><span style=\"font-size:14.0pt;\">Mismatch Repair → HNPCC</span></li><li><span style=\"font-size:14.0pt;\">Base Excision Repair → MUTYH-Associated Polyposis</span></li></ul>",
      "correct_choice_id": 382618,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96113/Biochemistry_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96113/Biochemistry_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96279,
      "choices": [
        {
          "id": 383264,
          "text": "<p><span style=\"font-size:14.0pt;\">Levonorgestrel intrauterine device (LNG-IUD)</span></p>"
        },
        {
          "id": 383265,
          "text": "<p><span style=\"font-size:14.0pt;\">Depot medroxyprogesterone acetate (DMPA) injection</span></p>"
        },
        {
          "id": 383266,
          "text": "<p><span style=\"font-size:14.0pt;\">Etonogestrel implant (Implanon)</span></p>"
        },
        {
          "id": 383267,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaginal combined hormonal ring (NuvaRing)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old woman para 1, living 1, is currently on warfarin therapy for treatment of deep vein thrombosis (DVT). She seeks a reliable method of contraception. Which of the following contraceptive options should be avoided in her case?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9460429",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Vaginal combined hormonal ring (NuvaRing)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Women with <strong>deep vein thrombosis (DVT)</strong> or on <strong>anticoagulant therapy</strong> (such as warfarin) have a high risk of <strong>thromboembolic events</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, contraceptive methods containing <strong>estrogen</strong> are <strong>contraindicated</strong>, as estrogen increases the risk of <strong>venous thromboembolism (VTE)</strong> by promoting hepatic synthesis of clotting factors (II, VII, IX, X) and decreasing antithrombin III activity.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>NuvaRing</strong> is a <strong>combined hormonal contraceptive</strong> device that releases <strong>ethinyl estradiol</strong> (estrogen) and <strong>etonogestrel</strong> (progestin). Because of its <strong>estrogen component</strong>, it is contraindicated in:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Women with <strong>active or prior DVT or PE</strong></span></li><li><span style=\"font-size:14.0pt;\">Women on <strong>anticoagulation therapy</strong> (e.g., warfarin)</span></li><li><span style=\"font-size:14.0pt;\">Women with <strong>known thrombophilia</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Therefore, in this patient with DVT on warfarin, the <strong>NuvaRing</strong> must be <strong>avoided</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Safe alternatives include <strong>progestin-only</strong> and <strong>nonhormonal</strong> methods, which have no significant impact on coagulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Levonorgestrel intrauterine device (LNG-IUD):&nbsp;</strong>Safe and effective in women with DVT. The LNG-IUD releases <strong>local progestin</strong>, has minimal systemic absorption, and <strong>does not increase thrombosis risk</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Depot medroxyprogesterone acetate (DMPA) injection:&nbsp;</strong>A <strong>progestin-only</strong> contraceptive that <strong>does not contain estrogen</strong>. It is safe in women with DVT, although prolonged use may decrease bone mineral density.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Etonogestrel implant (Implanon):&nbsp;</strong>Also a <strong>progestin-only</strong> method with minimal thrombotic risk. It is <strong>safe</strong> for women with a history of DVT or on anticoagulants.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In women with <strong>deep vein thrombosis (DVT)</strong> or on <strong>anticoagulant therapy</strong>, <strong>estrogen-containing contraceptives</strong> (such as <strong>the vaginal ring, combined oral pills, or transdermal patches</strong>) are <strong>contraindicated</strong> due to the increased risk of <strong>venous thromboembolism</strong>. <strong>Progestin-only</strong> or <strong>nonhormonal methods</strong> are preferred.</span></p>",
      "correct_choice_id": 383267,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96279/Ini-Cet_Gt_30_Oct_2025_Obg_Q_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96279/Ini-Cet_Gt_30_Oct_2025_Obg_Q_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96308,
      "choices": [
        {
          "id": 383380,
          "text": "<p><span style=\"font-size:14.0pt;\">Immune complex deposition in dermal vessels</span></p>"
        },
        {
          "id": 383381,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytotoxic T-cell–mediated keratinocyte apoptosis</span></p>"
        },
        {
          "id": 383382,
          "text": "<p><span style=\"font-size:14.0pt;\">Autoantibody against desmoglein 3</span></p>"
        },
        {
          "id": 383383,
          "text": "<p><span style=\"font-size:14.0pt;\">Type I IgE-mediated mast cell degranulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female develops targetoid skin lesions with central necrosis after starting phenytoin therapy. She also develops erosions on lips and buccal<strong>&nbsp;</strong>mucosa, and conjunctivitis. Pseudonikolsky sign is positive. Which of the following best explains the underlying pathogenesis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1553996",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cytotoxic T-cell–mediated keratinocyte apoptosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The description fits <strong>Stevens–Johnson syndrome (SJS)</strong>, a severe mucocutaneous drug reaction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> CD8+ cytotoxic T-cells induce <strong>keratinocyte apoptosis via Fas–FasL interaction</strong> → epidermal necrosis.</span></li><li><span style=\"font-size:14.0pt;\">Common drugs: <strong>Sulfonamides, phenytoin, carbamazepine, allopurinol, NSAIDs</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Nikolsky sign positive due to epidermal detachment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Immune complex deposition in dermal vessels:</strong> Occurs in <strong>vasculitis</strong>, not in drug-induced epidermal necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Autoantibody against desmoglein 3:</strong> Seen in <strong>pemphigus vulgaris</strong>, not SJS/TEN.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Type I IgE-mediated mast cell degranulation:</strong> Causes <strong>urticaria</strong>, not <strong>necrotic epidermal detachment</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>SJS/TEN</strong> represents a <strong>type IV (cytotoxic T-cell–mediated)</strong> hypersensitivity reaction with <strong>keratinocyte apoptosis</strong> leading to <strong>epidermal necrolysis and mucosal involvement</strong>.</span></p>",
      "correct_choice_id": 383381,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96308/Dermatology_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96308/Dermatology_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96337,
      "choices": [
        {
          "id": 383492,
          "text": "<p><span style=\"font-size:14.0pt;\">Lower BP immediately to &lt;185/110 mm Hg</span></p>"
        },
        {
          "id": 383493,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduce by about 15% during the first 24 hours</span></p>"
        },
        {
          "id": 383494,
          "text": "<p><span style=\"font-size:14.0pt;\">Lower BP rapidly to &lt;140/90 within 2 hours to prevent hemorrhagic transformation</span></p>"
        },
        {
          "id": 383495,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate oral antihypertensive therapy and observe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man presents with 6 hours of right-sided weakness and slurred speech. CT brain shows an acute left MCA infarct without hemorrhage. He has no prior hypertension or diabetes. On arrival: BP 230/140 mm Hg, HR 88 bpm, and no pulmonary edema or aortic dissection. What is the most appropriate blood pressure management strategy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1836275",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Reduce by about 15% during the first 24 hours</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>acute ischemic stroke (AIS)</strong>, <strong>permissive hypertension</strong> is allowed to maintain <strong>cerebral perfusion</strong> in the ischemic penumbra.</span></li><li><span style=\"font-size:14.0pt;\">Overly rapid BP reduction may <strong>worsen cerebral ischemia</strong> by reducing perfusion pressure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Guideline-based approach:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aRqHwPm.png\" width=\"678\" height=\"309\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Since this patient <strong>is not receiving thrombolysis</strong> and has <strong>no hypertensive emergency</strong>, the correct strategy is <strong>gradual reduction (~15%) in 24 hours</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lower BP immediately to &lt;185/110 mm Hg:&nbsp;</strong>Applies only to <strong>patients eligible for thrombolysis</strong> (tPA).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lower BP rapidly to &lt;140/90 within 2 hours to prevent hemorrhagic transformation:&nbsp;</strong>Rapid reduction may <strong>reduce cerebral perfusion</strong>, worsening infarct.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Initiate oral antihypertensive therapy and observe:&nbsp;</strong>Delays controlled reduction; IV titratable agents (e.g., labetalol, nicardipine) preferred for safe, gradual lowering.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>acute ischemic stroke without thrombolysis</strong>, avoid aggressive BP lowering unless <strong>&gt;220/120 mm Hg</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Aim for <strong>~15% reduction in the first 24 hours</strong> to balance perfusion and safety.</span></li><li><span style=\"font-size:14.0pt;\">Preferred IV agents: <strong>labetalol</strong>, <strong>nicardipine</strong>, or <strong>clevidipine</strong> (titrated to effect).</span></li></ul>",
      "correct_choice_id": 383493,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96337/Medicine_Inicet_Gt_30_Oct_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96337/Medicine_Inicet_Gt_30_Oct_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96331,
      "choices": [
        {
          "id": 383468,
          "text": "<p><span style=\"font-size:14.0pt;\">Amoxicillin + metronidazole</span></p>"
        },
        {
          "id": 383469,
          "text": "<p><span style=\"font-size:14.0pt;\">Ciprofloxacin + co-trimoxazole</span></p>"
        },
        {
          "id": 383470,
          "text": "<p><span style=\"font-size:14.0pt;\">Gentamicin + cefixime</span></p>"
        },
        {
          "id": 383471,
          "text": "<p><span style=\"font-size:14.0pt;\">Vancomycin + linezolid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old man with ADPKD presents with fever, left flank pain, dysuria, and pyuria. Both kidneys are palpable and the left flank is tender. Labs show WBC 14.7 × 10⁹/L, CRP 45 mg/L, and&nbsp;Urinanalysis shows pus cells and blood. Which antibiotics should be started empirically?</span></p>",
      "unique_key": "Q3980053",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ciprofloxacin + co-trimoxazole</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>ADPKD with suspected infected renal cysts/pyelonephritis</strong>, the empiric regimen should include agents that <strong>penetrate cysts</strong> and cover <strong>Enterobacterales</strong> (e.g., E. coli, Klebsiella, Proteus).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fluoroquinolones (e.g., ciprofloxacin)</strong> and <strong>co-trimoxazole</strong> are <strong>lipid-soluble</strong> and <strong>cross cyst epithelium</strong>, achieving therapeutic intra-cyst concentrations and providing broad Gram-negative coverage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cyst aspiration</strong> for culture is the <strong>gold standard</strong> to direct therapy, but treatment should begin empirically while awaiting results.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amoxicillin + metronidazole:</strong> Inadequate Gram-negative aerobic coverage; metronidazole targets anaerobes, which are uncommon in this setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gentamicin + cefixime:</strong> Gentamicin has <strong>poor cyst penetration</strong> and nephrotoxicity risk; cefixime (oral 3rd-gen) alone is suboptimal empirically.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vancomycin + linezolid:</strong> Primarily anti-Gram-positive (including MRSA); <strong>insufficient Enterobacterales coverage</strong> and not first-line for presumed cyst/urinary Gram-negative infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>ADPKD with suspected infected cysts</strong>, choose <strong>lipid-soluble antibiotics</strong> that <strong>penetrate cysts</strong> and provide <strong>Gram-negative coverage</strong> (e.g., <strong>fluoroquinolones</strong> or <strong>co-trimoxazole</strong>).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Obtain <strong>urine and blood cultures</strong>, consider <strong>imaging</strong> (CT/US) if abscess suspected, and <strong>perform cyst aspiration</strong> when diagnosis is uncertain or response is poor.</span></li></ul>",
      "correct_choice_id": 383469,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96331/Medicine_INICET_GT_30_Oct_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96331/Medicine_INICET_GT_30_Oct_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96141,
      "choices": [
        {
          "id": 382724,
          "text": "<p><span style=\"font-size:14.0pt;\">DDT</span></p>"
        },
        {
          "id": 382725,
          "text": "<p><span style=\"font-size:14.0pt;\">Malathion</span></p>"
        },
        {
          "id": 382726,
          "text": "<p><span style=\"font-size:14.0pt;\">Deltamethrin</span></p>"
        },
        {
          "id": 382727,
          "text": "<p><span style=\"font-size:14.0pt;\">DEET</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The bed net in the image is distributed by government under vector control program. Which of the following insecticides is most likely used to treat this net?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7Fd11v5.png\" width=\"574\" height=\"387\"></strong></span></p>",
      "unique_key": "Q3389846",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Deltamethrin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>LLINs (Long-Lasting Insecticidal Nets)</strong> are <strong>pre-treated bed nets</strong> with synthetic pyrethroids.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are a <strong>cost-effective, WHO-endorsed strategy</strong> for malaria control and prevention.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Deltamethrin</strong> is the most widely used synthetic pyrethroid in LLINs.</span></li><li><span style=\"font-size:14.0pt;\">It kills mosquitoes upon contact and provides protection even after multiple washes (up to 20+ times).</span></li><li><span style=\"font-size:14.0pt;\">Effectiveness lasts for <strong>3 years or more</strong>, depending on use and washing frequency.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. DDT:</strong> An organochlorine insecticide. Though historically used in <strong>indoor residual spraying</strong>, it is <strong>not used for bed net treatment</strong> due to safety/environmental concerns.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Malathion:</strong> An organophosphate. Used in <strong>fogging/spraying</strong> for vector control (e.g., dengue, filariasis) but <strong>not suitable</strong> for treating fabric like bed nets.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. DEET:</strong> A <strong>topical repellent</strong>, not an insecticide. Applied to skin, not used for bed net impregnation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>LLINs impregnated with deltamethrin</strong> are a cornerstone of malaria control. They <strong>reduce mosquito density</strong> and <strong>interrupt transmission</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The use of safe, effective insecticides like <strong>pyrethroids</strong> ensures broad coverage and community-level protection in endemic areas.</span></li></ul>",
      "correct_choice_id": 382726,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96141/NEET_PG_30_Oct_2025_GT_PSM_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96141/NEET_PG_30_Oct_2025_GT_PSM_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96118,
      "choices": [
        {
          "id": 382636,
          "text": "<p><span style=\"font-size:14.0pt;\">Dihydrolipoyl transacetylase</span></p>"
        },
        {
          "id": 382637,
          "text": "<p><span style=\"font-size:14.0pt;\">Dihydrolipoyl dehydrogenase</span></p>"
        },
        {
          "id": 382638,
          "text": "<p><span style=\"font-size:14.0pt;\">Citrate synthase</span></p>"
        },
        {
          "id": 382639,
          "text": "<p><span style=\"font-size:14.0pt;\">α-Ketoglutarate dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Within a multienzyme mitochondrial complex that converts pyruvate into acetyl-CoA, which specific enzyme catalyzes the reoxidation of reduced lipoamide by transferring electrons first to FAD and then to NAD?&nbsp;</span></p>",
      "unique_key": "Q3338144",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Dihydrolipoyl dehydrogenase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The mitochondrial enzyme complex responsible for oxidative decarboxylation of pyruvate to acetyl-CoA operates through a series of enzymatic steps requiring multiple cofactors (TPP, lipoic acid, CoA, FAD, and NAD⁺).</span></li><li><span style=\"font-size:14.0pt;\">Within this system:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Dihydrolipoyl dehydrogenase (E3)</strong> is the enzyme that <strong>reoxidizes reduced lipoamide</strong>, restoring it to its oxidized form so the catalytic cycle can continue.</span></li><li><span style=\"font-size:14.0pt;\">During this process, <strong>electrons are transferred from lipoamide to FAD</strong>, forming <strong>FADH₂</strong>, and then from <strong>FADH₂ to NAD⁺</strong>, producing <strong>NADH + H⁺</strong>.</span><br><span style=\"font-size:14.0pt;\">This regeneration of cofactors is essential to maintain continuous conversion of pyruvate into acetyl-CoA and energy production in the mitochondria.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Dihydrolipoyl transacetylase:&nbsp;</strong>Transfers the acetyl group from lipoamide to coenzyme A to form acetyl-CoA but does not regenerate lipoamide or handle electron transfer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Citrate synthase:&nbsp;</strong>A citric acid cycle enzyme that catalyzes condensation of acetyl-CoA with oxaloacetate to form citrate, unrelated to lipoamide oxidation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. α-Ketoglutarate dehydrogenase:&nbsp;</strong>Although mechanistically similar (it also requires lipoamide, FAD, and NAD⁺), it functions in the <strong>citric acid cycle</strong>, not in the oxidative decarboxylation of pyruvate to acetyl-CoA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Dihydrolipoyl dehydrogenase</strong> reoxidizes reduced lipoamide by transferring electrons to <strong>FAD</strong> and then <strong>NAD⁺</strong>, producing <strong>NADH</strong> and regenerating the enzyme complex for continued catalytic activity.</span></p>",
      "correct_choice_id": 382637,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96118/Biochemistry_INICET_GT_30_Oct_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96118/Biochemistry_INICET_GT_30_Oct_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96089,
      "choices": [
        {
          "id": 382520,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4, and 5</span></p>"
        },
        {
          "id": 382521,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, and 5</span></p>"
        },
        {
          "id": 382522,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 4</span></p>"
        },
        {
          "id": 382523,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4, and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding the Achilles tendon, which of the following statements are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">It is formed by the tendinous union of gastrocnemius and soleus muscles.</span></li><li><span style=\"font-size:14.0pt;\">It is supplied by the superficial peroneal nerve.</span></li><li><span style=\"font-size:14.0pt;\">It inserts into the posterior surface of the calcaneus.</span></li><li><span style=\"font-size:14.0pt;\">Its primary action is plantar flexion at the ankle joint.</span></li><li><span style=\"font-size:14.0pt;\">It is the strongest tendon in the human body.</span></li></ol>",
      "unique_key": "Q6780660",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 3, 4, and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>1. It is formed by the tendinous union of gastrocnemius and soleus muscles:</strong> It is formed by the <strong>union of the gastrocnemius and soleus muscles</strong>, occasionally receiving fibers from the plantaris muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. It inserts into the posterior surface of the calcaneus:</strong> It inserts into the middle portion of the posterior surface of the calcaneus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Its primary action is plantar flexion at the ankle joint:</strong> It produces <strong>plantar flexion at the ankle joint</strong> and assists in <strong>knee flexion</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>5. It is the strongest tendon in the human body:</strong> The <strong>Achilles tendon (tendo calcaneus)</strong> is the <strong>thickest and strongest tendon</strong> in the human body.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FpeFX7n.png\" width=\"599\" height=\"508\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qoHg0X0.png\" width=\"856\" height=\"491\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. It is supplied by the superficial peroneal nerve:</strong> The Achilles tendon is <strong>not supplied by the superficial peroneal nerve</strong>; it receives innervation from the <strong>tibial nerve (S1, S2)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Achilles tendon</strong>, formed by the <strong>gastrocnemius and soleus</strong>, is the <strong>strongest tendon</strong> in the body, <strong>inserts into the posterior calcaneus</strong>, and is responsible for <strong>plantar flexion</strong> of the foot.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is supplied by the <strong>tibial nerve (S1, S2)</strong>.</span></li></ul>",
      "correct_choice_id": 382520,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96089/Anatomy_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96089/Anatomy_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96401,
      "choices": [
        {
          "id": 383748,
          "text": "<p><span style=\"font-size:14.0pt;\">Embryonal carcinoma</span></p>"
        },
        {
          "id": 383749,
          "text": "<p><span style=\"font-size:14.0pt;\">Choriocarcinoma</span></p>"
        },
        {
          "id": 383750,
          "text": "<p><span style=\"font-size:14.0pt;\">Yolk sac tumor</span></p>"
        },
        {
          "id": 383751,
          "text": "<p><span style=\"font-size:14.0pt;\">Seminoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old boy presents with a rapidly enlarging, non-tender testicular mass. Serum studies reveal a markedly elevated alpha-fetoprotein (AFP) level. Histopathologic examination of the tumor is shown below. Which of the following is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180349.jpg\" width=\"552\" height=\"416\"></span></p>",
      "unique_key": "Q7182414",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Yolk sac tumor</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Yolk sac tumor (endodermal sinus tumor) is the <strong>most common testicular tumor in children under 3- years</strong> and a <strong>malignant germ cell tumor</strong> derived from yolk sac elements.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Histopathology:</strong> The presence of <strong>Schiller-Duval bodies</strong>, which are <strong>glomerulus-like structures</strong> with a central blood vessel surrounded by tumor cells in a cystic space lined by more tumor cells, is <strong>pathognomonic</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immunohistochemistry and markers:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>AFP (alpha-fetoprotein):</strong> Elevated in serum.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cytokeratin:</strong> Positive.</span></li><li><span style=\"font-size:14.0pt;\"><strong>PLAP (Placental Alkaline Phosphatase):</strong> Typically, negative.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Gross appearance:</strong> Often mucinous, yellow-tan, and hemorrhagic.</span></li><li><span style=\"font-size:14.0pt;\">The tumor mimics <strong>primitive yolk sac</strong> and <strong>endodermal sinus structures</strong>, explaining its name.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Embryonal carcinoma:&nbsp;</strong>Occurs in young adults, composed of pleomorphic cells with indistinct borders and prominent nucleoli; lacks Schiller-Duval bodies and does <strong>not elevate AFP as consistently</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Choriocarcinoma:&nbsp;</strong>Highly malignant tumor with <strong>cytotrophoblastic and syncytiotrophoblastic cells</strong>, associated with <strong>elevated β-hCG</strong>, not AFP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Seminoma:&nbsp;</strong>Composed of <strong>uniform cells with clear cytoplasm and central nuclei</strong>, resembling “fried-egg” appearance; <strong>PLAP positive</strong>, <strong>AFP negative</strong>, and <strong>Schiller-Duval bodies absent</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Schiller-Duval bodies</strong>—glomerulus-like structures with a central vessel—are <strong>pathognomonic for Yolk Sac Tumor</strong>, which is the <strong>most common testicular neoplasm in children</strong> and shows <strong>elevated serum AFP</strong> levels.</span></p>",
      "correct_choice_id": 383750,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96401/Pathology_INICET_GT_30_Oct_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96401/Pathology_INICET_GT_30_Oct_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96342,
      "choices": [
        {
          "id": 383512,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 383513,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 383514,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 383515,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding anti-androgen therapies is/are true?&nbsp;</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Flutamide antagonizes the effects of testosterone at the hypothalamus, leading to decreased LH release.</span></li><li><span style=\"font-size:14.0pt;\">Dutasteride decreases the formation of DHT and is useful in BPH patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Flutamide monotherapy may paradoxically increase serum testosterone levels via loss of negative feedback.</span></li><li><span style=\"font-size:14.0pt;\">Bicalutamide selectively inhibits 5α-reductase in the prostate.</span></li></ol>",
      "unique_key": "Q5841049",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2 and 3 only.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Statement 2. Dutasteride decreases the formation of DHT and is useful in BPH patients:&nbsp;</strong>True. Dutasteride is a 5α-reductase inhibitor that blocks both type I and type II isoenzymes. This leads to decreased conversion of testosterone to dihydrotestosterone (DHT), a more potent androgen that plays a significant role in prostate tissue growth. It is commonly used in the management of BPH to reduce prostate size and improve urinary symptoms.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Flutamide monotherapy may paradoxically increase serum testosterone levels via loss of negative feedback:&nbsp;</strong>True. Flutamide is a nonsteroidal androgen receptor antagonist. When used as monotherapy, it blocks androgen receptors at the hypothalamus and pituitary. This inhibition removes the normal negative feedback exerted by androgens, leading to increased luteinizing hormone (LH) release, and consequently elevated testosterone levels from the testes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>False Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Flutamide antagonizes the effects of testosterone at the hypothalamus, leading to decreased LH release:&nbsp;</strong>False. Flutamide does not <strong>decrease</strong> LH release; rather, it <strong>increases</strong> LH due to blockade of androgen receptors at the hypothalamic-pituitary axis. This results in loss of negative feedback, which causes the hypothalamus to increase gonadotropin-releasing hormone (GnRH) secretion, stimulating the pituitary to release more LH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Bicalutamide selectively inhibits 5α-reductase in the prostate:&nbsp;</strong>False. Bicalutamide is a <strong>nonsteroidal androgen receptor antagonist</strong>, not a 5α-reductase inhibitor. It blocks the action of androgens at their receptor sites, particularly in the prostate, but it does <strong>not</strong> affect the enzymatic conversion of testosterone to DHT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dutasteride inhibits 5α-reductase to reduce DHT production in BPH, while flutamide monotherapy increases LH and testosterone by removing androgen negative feedback at the hypothalamus.</span></p>",
      "correct_choice_id": 383513,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96342/Pharmacology_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96342/Pharmacology_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96386,
      "choices": [
        {
          "id": 383688,
          "text": "<p><span style=\"font-size:14.0pt;\">Corynebacterium xerosis&nbsp;</span></p>"
        },
        {
          "id": 383689,
          "text": "<p><span style=\"font-size:14.0pt;\">Corynebacterium urealyticum&nbsp;</span></p>"
        },
        {
          "id": 383690,
          "text": "<p><span style=\"font-size:14.0pt;\">Corynebacterium renale&nbsp;</span></p>"
        },
        {
          "id": 383691,
          "text": "<p><span style=\"font-size:14.0pt;\">Corynebacterium pseudotuberculosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male renal transplant recipient presents with dysuria, suprapubic pain, and alkaline urine (pH 8.5) for the past 3 weeks. Cystoscopy reveals white-gray plaques adherent to the bladder mucosa. Which organism is most likely responsible for this patient's encrusted cystitis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7328291",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Corynebacterium urealyticum</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with classic features of alkaline encrusted cystitis, a rare but serious urinary tract infection characterized by alkaline urine and struvite stone formation on the bladder wall.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">C. urealyticum is a skin commensal that uniquely causes this condition, particularly in immunocompromised patients such as renal transplant recipients.</span></li><li><span style=\"font-size:14.0pt;\"><strong>The key diagnostic features include:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Strong urease production leading to urea hydrolysis and ammonia formation</span></li><li><span style=\"font-size:14.0pt;\">Resultant alkaline urine (pH &gt; 7)</span></li><li><span style=\"font-size:14.0pt;\">Formation of struvite (magnesium ammonium phosphate) crystals that encrust the bladder mucosa</span></li><li><span style=\"font-size:14.0pt;\">Slow growth requiring extended incubation (48-72 hours)</span></li><li><span style=\"font-size:14.0pt;\">Occurrence primarily in immunocompromised hosts</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The organism's potent urease activity is central to its pathogenesis, creating the alkaline environment necessary for struvite precipitation and the characteristic encrusted plaques seen on cystoscopy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Corynebacterium xerosis:</strong> This is a common skin commensal that rarely causes infections. It does not produce significant urease activity and is not associated with encrusted cystitis or alkaline urine. It may occasionally cause prosthetic device infections but not the clinical presentation described.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Corynebacterium renale:</strong> This organism primarily causes urinary tract infections in cattle and other animals, not humans. While it can produce urease, it is not a human pathogen and would not be isolated from a human transplant recipient with encrusted cystitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Corynebacterium pseudotuberculosis:</strong> This species causes caseous lymphadenitis in sheep and goats, and rarely causes lymphadenitis in humans with animal contact. It does not cause urinary tract infections or encrusted cystitis, and lacks the strong urease activity characteristic of C. urealyticum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Corynebacterium urealyticum causes alkaline encrusted cystitis through strong urease production, leading to alkaline urine and struvite stone formation on bladder mucosa, particularly in immunocompromised and renal transplant recipients.</span></p>",
      "correct_choice_id": 383689,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96386/Microbiology_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96386/Microbiology_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96400,
      "choices": [
        {
          "id": 383744,
          "text": "<p><span style=\"font-size:14.0pt;\">EGFR amplification</span></p>"
        },
        {
          "id": 383745,
          "text": "<p><span style=\"font-size:14.0pt;\">MGMT promoter methylation</span></p>"
        },
        {
          "id": 383746,
          "text": "<p><span style=\"font-size:14.0pt;\">IDH1 mutation</span></p>"
        },
        {
          "id": 383747,
          "text": "<p><span style=\"font-size:14.0pt;\">1p/19q codeletion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man presents with progressive headaches, seizures, and subtle personality changes over several months. MRI of the brain reveals a well-circumscribed, calcified mass in the frontal lobe. Histopathologic examination of the biopsy is shown in the image below. Which of the following genetic abnormalities is most characteristic of this tumor?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180334.jpg\" width=\"513\" height=\"393\"></span></p>",
      "unique_key": "Q2060150",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 1p/19q codeletion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The described findings are classic for an <strong>oligodendroglioma</strong>, a <strong>diffusely infiltrating glioma</strong> that typically arises in the <strong>cerebral hemispheres</strong>, most commonly the <strong>frontal lobe</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Histology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Round, regular nuclei with clear perinuclear halos (the “fried-egg” appearance).</span></li><li><span style=\"font-size:14.0pt;\">Delicate branching capillaries resembling a <strong>chicken-wire</strong> pattern.</span></li><li><span style=\"font-size:14.0pt;\">Frequent calcifications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Genetics:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Combined loss of chromosomal arms 1p and 19q (1p/19q codeletion) is the molecular hallmark.</span></li><li><span style=\"font-size:14.0pt;\">It predicts better prognosis and responsiveness to chemotherapy and radiation.</span></li><li><span style=\"font-size:14.0pt;\">Most cases also harbor an IDH1 mutation, but 1p/19q codeletion is the defining alteration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. EGFR amplification:&nbsp;</strong>Typical of <strong>glioblastoma multiforme (GBM)</strong>, not oligodendroglioma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. MGMT promoter methylation:&nbsp;</strong>Associated with <strong>better response to alkylating chemotherapy</strong> in <strong>glioblastoma</strong>, not diagnostic for oligodendroglioma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IDH1 mutation:&nbsp;</strong>Can be seen in both <strong>astrocytomas</strong> and <strong>oligodendrogliomas</strong>, but not specific; the defining lesion for oligodendroglioma is <strong>1p/19q codeletion</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Oligodendrogliomas</strong> are <strong>WHO Grade 2–3 gliomas</strong> of oligodendrocyte origin that show <strong>1p/19q codeletion</strong> and <strong>IDH mutation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>1p/19q codeletion</strong> is a <strong>diagnostic and prognostic marker</strong>, associated with <strong>favorable treatment response and prolonged survival</strong>.</span></li></ul>",
      "correct_choice_id": 383747,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96400/Pathology_INICET_GT_30_Oct_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96400/Pathology_INICET_GT_30_Oct_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96128,
      "choices": [
        {
          "id": 382672,
          "text": "<p><span style=\"font-size:14.0pt;\">Start first-line antitubercular therapy and repeat CBNAAT after 2 weeks</span></p>"
        },
        {
          "id": 382673,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat CBNAAT on a fresh specimen now</span></p>"
        },
        {
          "id": 382674,
          "text": "<p><span style=\"font-size:14.0pt;\">Send the same residual sample for liquid culture only</span></p>"
        },
        {
          "id": 382675,
          "text": "<p><span style=\"font-size:14.0pt;\">Classify as rifampicin-resistant TB and refer to a DR-TB center</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old woman presents with painless cervical lymphadenopathy. Fine-needle aspiration cytology (FNAC) is performed. CBNAAT (Xpert MTB/RIF) on the aspirate detects Mycobacterium tuberculosis, but the rifampicin resistance result is reported as “indeterminate.” According to the diagnostic algorithm for extra-pulmonary TB (EPTB), what is the next best step?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8167213",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Repeat CBNAAT on a fresh specimen now</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In EPTB, a CBNAAT result of <strong>“MTB detected; rif indeterminate”</strong> most often reflects <strong>low bacillary load or a technical issue</strong> that prevents reliable detection of rpoB mutations.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Programmatic algorithms direct that the <strong>first action is to repeat CBNAAT on a fresh specimen</strong> (another aspirate/biopsy from the involved node).</span></li><li><span style=\"font-size:14.0pt;\">If the repeat again reports <strong>rif indeterminate</strong>, the algorithm advises <strong>collecting a fresh sample for liquid culture (and DST) to resolve rif status</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Jumping straight to a drug-resistant pathway or starting therapy without clarifying rif status risks <strong>overtreatment</strong> or <strong>undertreatment</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Thus, repeating CBNAAT on a <strong>newly collected specimen</strong> is the appropriate immediate step.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Start first-line antitubercular therapy and repeat CBNAAT after 2 weeks:</strong> Incorrect. Empirically starting treatment <strong>before clarifying rif status</strong> can delay recognition of drug resistance. The algorithm prioritizes <strong>repeat CBNAAT now</strong> on a <strong>fresh sample</strong>, not delayed retesting after empiric therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Send the same residual sample for liquid culture only:</strong> Incorrect. Residual material may be <strong>insufficient or degraded</strong>, and culture alone delays results. Culture/DST is recommended <strong>only if the second, fresh CBNAAT remains indeterminate</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Classify as rifampicin-resistant TB and refer to DR-TB center:&nbsp;</strong>Incorrect. An <strong>indeterminate</strong> rif result is <strong>not evidence of resistance</strong>. Labeling as DR-TB without confirmation may lead to <strong>unnecessary toxic, prolonged regimens</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagnostic Algorithm for Extra-pulmonary TB (EPTB)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_92zbdiF.png\" width=\"1171\" height=\"720\"></strong></span></p>",
      "correct_choice_id": 382673,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96128/NEET_PG_30_Oct_2025_GT_PSM_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96128/NEET_PG_30_Oct_2025_GT_PSM_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96129,
      "choices": [
        {
          "id": 382676,
          "text": "<p><span style=\"font-size:14.0pt;\">Artesunate + sulfadoxine-pyrimethamine for 3 days, plus primaquine single dose on day 2</span></p>"
        },
        {
          "id": 382677,
          "text": "<p><span style=\"font-size:14.0pt;\">Artemether-lumefantrine for 3 days, plus primaquine single dose (0.75 mg/kg) on day 2</span></p>"
        },
        {
          "id": 382678,
          "text": "<p><span style=\"font-size:14.0pt;\">Chloroquine for 3 days, plus primaquine daily for 14 days</span></p>"
        },
        {
          "id": 382679,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral quinine for 7 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old boy from Manipur (North-Eastern India) presents with 2 days of fever, chills, and headache. There is no jaundice, altered sensorium, severe anemia, or respiratory distress. A rapid diagnostic test and peripheral smear are positive for Plasmodium falciparum. He is able to take oral medications and has no history of G6PD deficiency. According to the national treatment recommendations used in India, which of the following is the most appropriate regimen?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6275886",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Artemether-lumefantrine for 3 days, plus primaquine single dose (0.75 mg/kg) on day 2</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Under the NVBDCP recommendations you provided:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Uncomplicated P. falciparum malaria in the North-Eastern states</strong> (e.g., Manipur, Assam, Meghalaya, Mizoram, Nagaland, Tripura, Arunachal Pradesh) is treated with <strong>ACT-AL</strong> (artemether-lumefantrine) for <strong>3 days</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In addition, give <strong>primaquine 0.75 mg/kg as a single dose on day 2</strong> to clear gametocytes and reduce transmission.</span></li><li><span style=\"font-size:14.0pt;\">Age-wise blister packs are used for dosing; children <strong>5–8 years</strong> receive the <strong>green</strong> pack (useful for practical dispensing, though not needed to choose the regimen).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, artemether-lumefantrine for 3 days <strong>plus</strong> a <strong>single 0.75 mg/kg primaquine dose on day 2</strong> is the correct programmatic regimen for this child with uncomplicated falciparum malaria in a North-Eastern state.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Artesunate + sulfadoxine-pyrimethamine for 3 days, plus primaquine single dose on day 2:</strong> Incorrect in the <strong>North-Eastern states</strong>, where SP resistance is a concern. ACT-SP is used in <strong>other Indian states</strong> (non-NE).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chloroquine for 3 days, plus primaquine daily for 14 days:</strong> This is the regimen for <strong>P. vivax</strong> (chloroquine for 3 days + primaquine 0.25 mg/kg daily for 14 days) per the sheet; it is <strong>not</strong> appropriate for falciparum malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Oral quinine for 7 days:</strong> Quinine is reserved for <strong>1st-trimester pregnancy</strong> with uncomplicated falciparum malaria (and for some severe malaria settings). This patient is a non-pregnant child with uncomplicated disease in NE India, so <strong>ACT-AL</strong> is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Uncomplicated P. falciparum malaria in India:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>North-Eastern states:</strong> <strong>ACT-AL</strong> (artemether-lumefantrine for 3 days) <strong>+ primaquine 0.75 mg/kg single dose on day 2</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Other states:</strong> <strong>ACT-SP</strong> (artesunate + sulfadoxine-pyrimethamine) <strong>+ primaquine single dose on day 2</strong>.</span></li></ul>",
      "correct_choice_id": 382677,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96129/NEET_PG_30_Oct_2025_GT_PSM_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96129/NEET_PG_30_Oct_2025_GT_PSM_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96317,
      "choices": [
        {
          "id": 383412,
          "text": "<p><span style=\"font-size:14.0pt;\">Wound infection</span></p>"
        },
        {
          "id": 383413,
          "text": "<p><span style=\"font-size:14.0pt;\">Intra-abdominal abscess</span></p>"
        },
        {
          "id": 383414,
          "text": "<p><span style=\"font-size:14.0pt;\">Portal pyemia&nbsp;</span></p>"
        },
        {
          "id": 383415,
          "text": "<p><span style=\"font-size:14.0pt;\">Ileocolic bleed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient underwent an appendectomy for acute appendicitis. However, on the 5<sup>th</sup> day following surgery, the patient experienced spiking fever, abdominal pain and diarrhoea. Which post operative complication is likely to have occurred?</span></p>",
      "unique_key": "Q6454118",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Intra-abdominal abscess</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Approximately 8% of patients following appendicectomy will develop a <strong>postoperative intra-abdominal abscess</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Characteristically presents 5–7 days postoperatively with spiking fevers, abdominal pain, and generalized malaise, suggestive of an intraperitoneal collection, matching the clinical picture described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Wound infection</strong>: Commonly presents with localized symptoms such as erythema, tenderness, and purulent discharge at the incision site, often occurring on the 4th or 5th day postoperatively, not typically associated with spiking fever or abdominal pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Portal pyemia:&nbsp;</strong>A rare complication involving infection of the portal venous system, typically presenting with multiple liver abscesses, jaundice, and systemic illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Ileocolic bleed:</strong> Bleeding would present with syncope and tachycardia, usually within 24 hours of surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical presentation of a postoperative intra-abdominal abscess following appendectomy, includes delayed onset of spiking fever, abdominal pain, and malaise.</span></p>",
      "correct_choice_id": 383413,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96317/NEET_PG_30_Oct_2025_GT_Surgery_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96317/NEET_PG_30_Oct_2025_GT_Surgery_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96333,
      "choices": [
        {
          "id": 383476,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal tubular acidosis type 1</span></p>"
        },
        {
          "id": 383477,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal tubular acidosis type 2</span></p>"
        },
        {
          "id": 383478,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal tubular acidosis type 4</span></p>"
        },
        {
          "id": 383479,
          "text": "<p><span style=\"font-size:14.0pt;\">Diabetic ketoacidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 57-year-old woman with diabetes, nephropathy, neuropathy, hypertension, HIV, and COPD presents for follow-up in your OPD. Labs show the following - Na 134, K 5.2, Cl 110, HCO₃⁻ 17, BUN 30, Cr 1.1, Glucose 233 mg/dL. Urinalysis shows the following - pH 5.3, 2+ protein, no blood/ketones. What is the most likely cause of these abnormalities?</span></p>",
      "unique_key": "Q4867544",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Renal tubular acidosis type 4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>non–anion gap metabolic acidosis (NAGMA)</strong> with <strong>mild hyperkalemia</strong> and <strong>acidic urine (pH &lt;5.5)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The combination of <strong>diabetic nephropathy</strong> and <strong>HIV</strong> strongly suggests <strong>Type 4 RTA (hyporeninemic hypoaldosteronism)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key features of Type 4 RTA:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> Aldosterone deficiency or resistance → impaired distal tubular K⁺ and H⁺ secretion.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Electrolytes:</strong> Mild hyperkalemia, mild to moderate metabolic acidosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anion gap:</strong> Normal (Na - [Cl + HCO₃] = 134 - 127 = 7 → normal).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Urine pH:</strong> &lt;5.5 (acidic; distal H⁺ secretion intact but reduced due to low aldosterone).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Common causes:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Diabetic nephropathy</strong></span></li><li><span style=\"font-size:14.0pt;\">ACE inhibitors, ARBs, heparin, TMP-SMX, NSAIDs</span></li><li><span style=\"font-size:14.0pt;\"><strong>HIV infection</strong></span></li><li><span style=\"font-size:14.0pt;\">Chronic tubulointerstitial disease</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Renal tubular acidosis type 1 (Distal RTA):&nbsp;</strong>Defect in distal H⁺ secretion → <strong>alkaline urine (pH &gt;5.5)</strong> and <strong>hypokalemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Renal tubular acidosis type 2 (Proximal RTA):&nbsp;</strong>Impaired HCO₃⁻ reabsorption → <strong>hypokalemia</strong>, <strong>urine pH &lt;5.5 after acidosis develops</strong>, often part of <strong>Fanconi syndrome</strong> (with glycosuria, phosphaturia, aminoaciduria).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Diabetic ketoacidosis:&nbsp;</strong>Causes <strong>high anion gap metabolic acidosis</strong>, <strong>ketonuria</strong>, and <strong>much higher glucose (&gt;250 mg/dL)</strong>; <strong>not seen here</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Type 4 renal tubular acidosis (RTA)</strong>, or <strong>hyporeninemic hypoaldosteronism</strong>, is characterized by NAGMA and hyperkalemia. Common causes include diabetes, HIV, ACE inhibitors, ARBs, heparin</span></li><li><span style=\"font-size:14.0pt;\">In a diabetic or HIV patient with <strong>mild hyperkalemia, NAGMA, and acidic urine</strong>, <strong>Type 4 RTA</strong> is the most likely diagnosis.</span></li></ul>",
      "correct_choice_id": 383478,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96333/Medicine_INICET_GT_30_Oct_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96333/Medicine_INICET_GT_30_Oct_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96314,
      "choices": [
        {
          "id": 383404,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 are correct</span></p>"
        },
        {
          "id": 383405,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 are correct</span></p>"
        },
        {
          "id": 383406,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 are correct</span></p>"
        },
        {
          "id": 383407,
          "text": "<p><span style=\"font-size:14.0pt;\">All 4 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding commonly used surgical sutures, which of the following statements are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Polypropylene (Prolene) is a non-absorbable monofilament suture</span></li><li><span style=\"font-size:14.0pt;\">Polyglactin (Vicryl) is a delayed absorbable suture that completely absorbs within 180–210 days by hydrolysis.</span></li><li><span style=\"font-size:14.0pt;\">Polydioxanone (PDS) is an absorbable suture that provides prolonged wound support and is completely absorbed within 180–210 days.</span></li><li><span style=\"font-size:14.0pt;\">Delayed absorbable sutures such as Vicryl and PDS are preferred for biliary and urological anastomoses to reduce risk of foreign body stone formation.</span></li></ol>",
      "unique_key": "Q3347674",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>B) 1, 3 and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Polypropylene (Prolene) is a non-absorbable monofilament suture: </strong>Correct<strong>.&nbsp;</strong>Polypropylene (Prolene) is a monofilament non-absorbable suture, composed of isotactic crystalline stereoisomer of polypropylene. Its blue color enhances visibility, and it is highly favored for <strong>vascular anastomosis</strong> due to inertness and minimal tissue reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Polydioxanone (PDS) is an absorbable suture that provides prolonged wound support and is completely absorbed within 180–210 days: </strong>Correct<strong>.&nbsp;</strong>Polydioxanone (PDS) is a <strong>delayed absorbable suture</strong>, ideal for cases needing extended wound support. It retains tensile strength for up to 6 weeks and is completely absorbed by <strong>180–210 days</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Delayed absorbable sutures such as Vicryl and PDS are preferred for biliary and urological anastomoses to reduce risk of foreign body stone formation</strong>:<strong> </strong>Correct<strong>. </strong>Delayed absorbable sutures (Vicryl and PDS) are recommended for <strong>biliary and urological anastomoses</strong>, since permanent sutures can act as a nidus for stone formation in these regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Polyglactin (Vicryl) is a delayed absorbable suture that completely absorbs within 180–210 days by hydrolysis: </strong>Incorrect<strong>.</strong></span><br><span style=\"font-size:14.0pt;\">Polyglactin (Vicryl) is <strong>not a delayed absorbable suture</strong>; it is a <strong>synthetic absorbable suture</strong> that is fully absorbed within <strong>56–70 days</strong>, not 180–210 days. It retains ~70% tensile strength at 14 days.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Polypropylene is a permanent vascular suture; Vicryl is absorbed within 2 months, while PDS provides delayed absorption over 6 months — delayed absorbables are preferred in biliary and urological anastomoses to prevent stone formation.</span></p>",
      "correct_choice_id": 383405,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96314/NEET_PG_30_Oct_2025_GT_Surgery_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96314/NEET_PG_30_Oct_2025_GT_Surgery_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96369,
      "choices": [
        {
          "id": 383620,
          "text": "<p><span style=\"font-size:14.0pt;\">Fosfomycin</span></p>"
        },
        {
          "id": 383621,
          "text": "<p><span style=\"font-size:14.0pt;\">Fidaxomicin</span></p>"
        },
        {
          "id": 383622,
          "text": "<p><span style=\"font-size:14.0pt;\">Teicoplanin</span></p>"
        },
        {
          "id": 383623,
          "text": "<p><span style=\"font-size:14.0pt;\">Dalbavancin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with a recent history of broad-spectrum antibiotic use presents with profuse watery diarrhea, abdominal cramping, and leukocytosis. Stool assay is positive for Clostridioides difficile toxin. He is started on oral vancomycin but develops severe nausea, making oral administration intolerable. Which of the following is the most appropriate alternative that can be administered orally with minimal systemic absorption?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2479690",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Fidaxomicin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fidaxomicin</strong> is a narrow-spectrum <strong>oral macrocyclic antibiotic</strong> that is bactericidal against Clostridioides difficile.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It <strong>inhibits the sigma subunit of RNA polymerase</strong>, thereby blocking transcription.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Importantly, it has <strong>minimal systemic absorption</strong> and <strong>acts locally in the gut</strong>, making it a suitable <strong>alternative to oral vancomycin</strong> in patients who cannot tolerate it.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>equally effective</strong> as vancomycin and is associated with <strong>lower recurrence rates</strong> of C. difficile infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fosfomycin:&nbsp;</strong>This antibiotic is primarily used <strong>for uncomplicated urinary tract infections</strong>. It is <strong>absorbed systemically</strong> and <strong>excreted in urine</strong>, making it ineffective against C. difficile, which resides in the colon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Teicoplanin:&nbsp;</strong>Though related to vancomycin and sometimes used in C. difficile treatment in Europe, it <strong>requires parenteral administration</strong> in most formulations. It <strong>does not have FDA approval for C. difficile</strong> in the U.S., and it is <strong>less accessible and studied</strong> than fidaxomicin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dalbavancin:&nbsp;</strong>This is a <strong>long-acting IV glycopeptide</strong> antibiotic used primarily for <strong>MRSA skin infections</strong>. It has <strong>no role</strong> in the management of C. difficile infections because it <strong>lacks gut lumen activity</strong> due to systemic absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fidaxomicin</strong> is an effective <strong>oral alternative to vancomycin</strong> for Clostridioides difficile infection, especially in patient’s intolerant to vancomycin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is minimally absorbed and <strong>acts locally in the gut</strong>, with a <strong>low recurrence rate</strong> and <strong>favorable safety profile</strong>.</span></li></ul>",
      "correct_choice_id": 383621,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96369/Pharmacology_INICET_GT_30_Oct_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96369/Pharmacology_INICET_GT_30_Oct_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96290,
      "choices": [
        {
          "id": 383308,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogen ↓, Progesterone ↓; FSH ↓, LH ↑</span></p>"
        },
        {
          "id": 383309,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogen ↓, Progesterone ↑; FSH ↑, LH ↑</span></p>"
        },
        {
          "id": 383310,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogen ↑, Progesterone ↑; FSH,↓, LH ↓</span></p>"
        },
        {
          "id": 383311,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogen, ↓&nbsp;Progesterone ↓; FSH ↓, LH ↓</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A woman presents for a routine health checkup. She reports having a regular 28-day<strong>&nbsp;</strong>menstrual cycle. On days 21–25 of the cycle, what are the typical patterns of reproductive hormone levels?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2981508",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Estrogen ↑, Progesterone ↑; FSH,↓, LH ↓</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During a <strong>normal 28-day menstrual cycle</strong>, hormone levels fluctuate in a predictable pattern.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>luteal phase (days 15–28)</strong> follows ovulation and is dominated by <strong>progesterone</strong>, secreted from the <strong>corpus luteum</strong>, with moderate levels of <strong>estrogen</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Days 21–25</strong> correspond to the <strong>mid-luteal phase</strong>, which is the <strong>peak functional period</strong> of the corpus luteum:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Progesterone</strong>: <strong>High</strong> — prepares the endometrium for implantation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Estrogen</strong>: <strong>Moderately high</strong> — supports endometrial growth and vascularization.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FSH and LH</strong>: <strong>Suppressed</strong> due to negative feedback from high estrogen and progesterone levels.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">If <strong>fertilization does not occur</strong>, the corpus luteum regresses near day 26–28, leading to a decline in progesterone and estrogen and the onset of menstruation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20154217.jpg\" width=\"661\" height=\"761\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Estrogen ↓, Progesterone ↓; FSH ↓, LH ↑:&nbsp;</strong>Occurs <strong>after luteal regression (late luteal/menstrual phase)</strong> — not during days 21–25.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Estrogen ↓, Progesterone ↑; FSH ↑, LH ↑:&nbsp;</strong>FSH and LH are not elevated in the luteal phase — they are <strong>suppressed</strong> by negative feedback.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Estrogen↓, Progesterone ↓; FSH ↓, LH ↓:&nbsp;</strong>This pattern corresponds to the <strong>early follicular phase (days 1–5)</strong> when hormone levels are low after corpus luteum breakdown.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During the <strong>mid-luteal phase (days 21–25)</strong> of a <strong>28-day menstrual cycle</strong>, both <strong>estrogen and progesterone levels are high</strong>, while <strong>FSH and LH levels are suppressed</strong> due to negative feedback from ovarian hormones.</span></p>",
      "correct_choice_id": 383310,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96290/Ini-Cet_Gt_30_Oct_2025_Obg_Q_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96290/Ini-Cet_Gt_30_Oct_2025_Obg_Q_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96297,
      "choices": [
        {
          "id": 383336,
          "text": "<p><span style=\"font-size:14.0pt;\">Dolichocephaly&nbsp;</span></p>"
        },
        {
          "id": 383337,
          "text": "<p><span style=\"font-size:14.0pt;\">Plagiocephaly&nbsp;</span></p>"
        },
        {
          "id": 383338,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxycephaly&nbsp;</span></p>"
        },
        {
          "id": 383339,
          "text": "<p><span style=\"font-size:14.0pt;\">Trigonocephaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-month-old female infant is brought to the pediatrician with concerns about head shape. Physical examination reveals an elongated and narrow head with prominence in the anterior-posterior direction. The sagittal suture feels ridge-like on palpation. The infant has achieved age-appropriate milestones and neurological examination is normal. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20160059.jpg\" width=\"360\" height=\"445\"></strong></span></p>",
      "unique_key": "Q5649629",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Dolichocephaly</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation in this case is classic for <strong>dolichocephaly</strong>, which results from premature fusion (craniosynostosis) of the sagittal suture.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is the <strong>most common type of craniosynostosis</strong>, accounting for approximately 40-60% of cases.</span></li><li><span style=\"font-size:14.0pt;\">The key findings supporting this diagnosis are:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Elongated, narrow head</strong> with increased anterior-posterior diameter (scaphocephaly)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ridge-like sagittal suture</strong> on palpation, indicating premature fusion</span></li><li><span style=\"font-size:14.0pt;\"><strong>Normal developmental milestones</strong>, suggesting isolated craniosynostosis without associated syndromic features</span></li></ul></li><li><span style=\"font-size:14.0pt;\">When the sagittal suture fuses prematurely, the skull cannot grow in width but compensates by growing in length, resulting in the characteristic boat-shaped (scaphocephalic) deformity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The sagittal suture runs from the anterior fontanelle to the posterior fontanelle along the top midline of the skull.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20160134.jpg\" width=\"1023\" height=\"400\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Plagiocephaly:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Results from <strong>unilateral coronal suture fusion</strong>, causing asymmetric flattening of one side of the forehead</span></li><li><span style=\"font-size:14.0pt;\">Produces facial asymmetry with displacement of the orbit and ear on the affected side</span></li><li><span style=\"font-size:14.0pt;\">The head appears flattened on one side with compensatory prominence on the contralateral side</span></li><li><span style=\"font-size:14.0pt;\">Can also be positional (without suture fusion) due to preferential head positioning in infants</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oxycephaly:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Results from fusion of <strong>coronal and sphenofrontal sutures</strong></span></li><li><span style=\"font-size:14.0pt;\">Causes a <strong>tower-like skull</strong> appearance (turricephaly or \"tower head\")</span></li><li><span style=\"font-size:14.0pt;\">Often associated with shallow orbits, exophthalmos, and midface hypoplasia</span></li><li><span style=\"font-size:14.0pt;\">May be seen in syndromic craniosynostosis (Apert, Crouzon syndromes)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trigonocephaly:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Results from <strong>metopic suture fusion</strong></span></li><li><span style=\"font-size:14.0pt;\">Causes a <strong>triangular-shaped forehead</strong> with narrowing at the front</span></li><li><span style=\"font-size:14.0pt;\">Often associated with hypotelorism (abnormally close-set eyes)</span></li><li><span style=\"font-size:14.0pt;\">The metopic suture runs from the anterior fontanelle to the nasal bridge</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Craniosynostosis types are defined by which cranial suture(s) fuse prematurely:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20160245.jpg\" width=\"1087\" height=\"582\"></strong></span></p>",
      "correct_choice_id": 383336,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96297/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96297/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96296,
      "choices": [
        {
          "id": 383332,
          "text": "<p><span style=\"font-size:14.0pt;\">50,000 IU single dose on day 1&nbsp;</span></p>"
        },
        {
          "id": 383333,
          "text": "<p><span style=\"font-size:14.0pt;\">100,000 IU single dose on day 1&nbsp;</span></p>"
        },
        {
          "id": 383334,
          "text": "<p><span style=\"font-size:14.0pt;\">200,000 IU single dose on day 1&nbsp;</span></p>"
        },
        {
          "id": 383335,
          "text": "<p><span style=\"font-size:14.0pt;\">400,000 IU split into two doses over 2 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 14-month-old boy weighing 6.2 kg is brought to the malnutrition clinic with visible severe wasting, bilateral pitting edema, and skin changes. His mid-upper arm circumference (MUAC) is 10.5 cm. After initial stabilization, the healthcare team begins planning micronutrient supplementation. Which of the following vitamin A dosing regimens is correct for this child?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9576597",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 100,000 IU single dose on day 1</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For children with Severe Acute Malnutrition (SAM), vitamin A supplementation is an essential component of treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The dosing of vitamin A is age-dependent, with children older than 12 months receiving 200,000 IU as a single dose on day 1 of treatment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This child is 14 months old, so option C is correct.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 50,000 IU single dose on day 1:</strong> 50,000 IU is the appropriate dose for infants under 6 months of age with SAM. This dose would be insufficient for a 14-month-old and would not provide adequate supplementation to address vitamin A deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 200,000 IU single dose on day 1:</strong> If the child is more than 1 year and less than 8 kg then instead of giving 2 lakh IU, we give one lakh IU of vitamin A</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 400,000 IU split into two doses over 2 days:</strong> 400,000 IU is excessive and potentially toxic. There is no recommendation to split vitamin A doses in SAM treatment protocols, and this total dose exceeds the recommended amount for any pediatric age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Comprehensive Micronutrient Supplementation in SAM:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20155900.jpg\" width=\"1148\" height=\"725\"></strong></span></p>",
      "correct_choice_id": 383333,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96296/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96296/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96084,
      "choices": [
        {
          "id": 382500,
          "text": "<p><span style=\"font-size:14.0pt;\">Patellar Tendon Rupture&nbsp;</span></p>"
        },
        {
          "id": 382501,
          "text": "<p><span style=\"font-size:14.0pt;\">Medial Collateral Ligament (MCL) Sprain&nbsp;</span></p>"
        },
        {
          "id": 382502,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior Cruciate Ligament (ACL) Tear&nbsp;</span></p>"
        },
        {
          "id": 382503,
          "text": "<p><span style=\"font-size:14.0pt;\">Meniscus Injury</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old female college basketball player presents to the OPD immediately after injuring her knee during a game. She reports landing awkwardly after a jump shot and feeling a sharp pop followed by immediate, excruciating pain. Within minutes, her knee began to swell rapidly. Testing the ligamentous stability reveals a soft or absent endpoint during the Lachman test. An initial X-ray shows no fracture. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9449989",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Anterior Cruciate Ligament (ACL) Tear</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rationale:</strong> The patient's presentation is highly specific for an acute, high-grade ACL tear:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> Non-contact deceleration, pivoting, or awkward landing.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Symptoms:</strong> Audible <strong>\"</strong>pop,\" followed by the cardinal sign of immediate, massive swelling (acute hemarthrosis), and the subjective feeling of instability (\"giving way\").</span></li><li><span style=\"font-size:14.0pt;\"><strong>Physical Exam:</strong> The Lachman test is the most sensitive physical exam test for an acute ACL tear. A soft or absent endpoint indicates significant anterior translation of the tibia, confirming the tear.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Patellar Tendon Rupture:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A patellar tendon rupture would cause an inability to actively extend the knee against gravity, leading to a visible gap above or below the kneecap (patella alta or infera).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While it involves pain and a pop, the primary deficit is a loss of the extensor<strong>&nbsp;</strong>mechanism, which is not the main finding described here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Medial Collateral Ligament (MCL) Sprain:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">MCL sprains are typically caused by a valgus stress (a blow to the outside of the knee).</span></li><li><span style=\"font-size:14.0pt;\">While they cause swelling, they usually do not result in the rapid, massive hemarthrosis or profound instability associated with an ACL tear.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Instability is tested by stressing the knee into valgus at 30∘ of flexion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Meniscus Injury:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A meniscus tear also involves a pop and swelling, but the swelling is often delayed (not immediate hemarthrosis).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The most characteristic symptom is mechanical catching or locking of the joint.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While meniscus tears often coexist with ACL tears, the rapid swelling and profound instability are the dominant features pointing to the ligamentous injury.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The classic clinical triad of an acute Anterior Cruciate Ligament (ACL) tear: non-contact pivoting/landing mechanism, a pop sensation followed by immediate, massive swelling (hemarthrosis), and knee instability.</span></p>",
      "correct_choice_id": 382502,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96084/Orthopedic_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96084/Orthopedic_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96398,
      "choices": [
        {
          "id": 383736,
          "text": "<p><span style=\"font-size:14.0pt;\">CD117 (c-KIT)</span></p>"
        },
        {
          "id": 383737,
          "text": "<p><span style=\"font-size:14.0pt;\">Napsin A</span></p>"
        },
        {
          "id": 383738,
          "text": "<p><span style=\"font-size:14.0pt;\">Chromogranin A</span></p>"
        },
        {
          "id": 383739,
          "text": "<p><span style=\"font-size:14.0pt;\">Calretinin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man presents with cough and shortness of breath. He has been working in a shipyard factory for 30 years. A chest X-ray shows a pleural-based mass in the right lung apex. A biopsy from the lesion on electron microscopy is shown below. Which of the following tumor markers is most likely to be positive in this tumor?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180303.jpg\" width=\"484\" height=\"360\"></span></p>",
      "unique_key": "Q4627970",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Calretinin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The description of <strong>long, slender microvilli</strong> seen on <strong>electron microscopy</strong> is <strong>pathognomonic for malignant mesothelioma</strong>, a tumor of the <strong>pleural mesothelial cells</strong> strongly linked to <strong>asbestos exposure</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Diagnostic Features of Mesothelioma:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Histology:</strong> Epithelioid or sarcomatoid pattern.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Electron Microscopy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Profuse, long, slender, and sometimes branching microvilli</strong> on apical and lateral surfaces.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Numerous desmosomes</strong> and <strong>tonofilaments</strong> may be present.</span></li><li><span style=\"font-size:14.0pt;\">Helps distinguish mesothelioma from adenocarcinoma, which has <strong>short, stubby microvilli</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Immunohistochemistry (IHC):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Positive:</strong> Calretinin, CK5/6, WT-1, D2-40 (podoplanin).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Negative:</strong> TTF-1, CEA, Napsin A (seen in adenocarcinoma).</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> Asbestos fibers deposit in pleural tissue → chronic inflammation → DNA damage and tumor formation → malignant mesothelioma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. CD117 (c-KIT):&nbsp;</strong>Marker expressed in<strong> gastrointestinal stromal tumors (GISTs) and seminomas,&nbsp;</strong>unrelated to pleural neoplasms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Napsin A:&nbsp;</strong>Marker of <strong>lung adenocarcinoma</strong>, not mesothelioma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Chromogranin A:&nbsp;</strong>Marker of <strong>neuroendocrine tumors</strong> (e.g., carcinoid tumor, small cell carcinoma), not mesothelial origin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Malignant mesothelioma</strong>, caused by <strong>asbestos exposure</strong>, typically expresses <strong>Calretinin, CK5/6, and WT-1 positivity</strong>, with <strong>long, slender microvilli</strong> on electron microscopy.</span></li><li><span style=\"font-size:14.0pt;\">These features distinguish it from <strong>adenocarcinoma of the lung</strong>, which expresses <strong>TTF-1 and Napsin A</strong>.</span></li></ul>",
      "correct_choice_id": 383739,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96398/Pathology_INICET_GT_30_Oct_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96398/Pathology_INICET_GT_30_Oct_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96269,
      "choices": [
        {
          "id": 383224,
          "text": "<p><span style=\"font-size:14.0pt;\">Endocervical curettage</span></p>"
        },
        {
          "id": 383225,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervical punch biopsy from the abnormal acetowhite areas</span></p>"
        },
        {
          "id": 383226,
          "text": "<p><span style=\"font-size:14.0pt;\">Cold knife conization from the abnormal acetowhite areas</span></p>"
        },
        {
          "id": 383227,
          "text": "<p><span style=\"font-size:14.0pt;\">Loop electrosurgical excision procedure (LEEP) from the abnormal acetowhite areas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old postmenopausal woman presents with postcoital bleeding for the past month. On pelvic examination, the cervix appears grossly normal. A Pap smear reveals high-grade squamous intraepithelial lesion (HSIL). Colposcopy demonstrates dense acetowhite areas with abnormal vascular patterns. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6748911",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cervical punch biopsy from the abnormal acetowhite areas</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>Pap smear</strong> showing <strong>high-grade squamous intraepithelial lesion (HSIL)</strong> indicates a strong suspicion for <strong>cervical intraepithelial neoplasia (CIN 2/3)</strong> or even <strong>microinvasive carcinoma</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The next diagnostic step depends on the <strong>colposcopic findings</strong>.</span></li><li><span style=\"font-size:14.0pt;\">When <strong>colposcopy</strong> reveals <strong>dense acetowhite lesions with abnormal vascularity</strong>, the most appropriate next step is a <strong>targeted cervical punch biopsy</strong> from these abnormal acetowhite areas to obtain <strong>tissue for histopathological examination</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This confirms the diagnosis and helps guide further management (e.g., excisional procedures if CIN 2/3 is confirmed).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key principle:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pap smear = Screening test</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Biopsy = Diagnostic confirmation</strong></span><br><span style=\"font-size:14.0pt;\">Only after biopsy confirms a high-grade lesion should excisional therapy (LEEP or conization) be considered.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Endocervical curettage:&nbsp;</strong>Used when the <strong>transformation zone is not fully visualized</strong> or to evaluate the <strong>endocervical canal</strong> for hidden lesions. It is <strong>not the first-line step</strong> when abnormal acetowhite areas are clearly seen and accessible for biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cold knife conization for the abnormal acetowhite areas:&nbsp;</strong>Indicated when <strong>colposcopy is unsatisfactory</strong>, or <strong>invasive carcinoma</strong> is suspected. In this case, colposcopy is satisfactory, so a <strong>biopsy</strong> (not conization) is the correct next step.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Loop electrosurgical excision procedure (LEEP) from the abnormal acetowhite areas:&nbsp;</strong>LEEP is a <strong>diagnostic and therapeutic excision</strong> method but is <strong>performed only after biopsy confirms CIN 2/3</strong>. Performing LEEP without histologic confirmation may result in <strong>unnecessary excision</strong> or <strong>missed invasive disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a woman with <strong>HSIL on Pap smear</strong> and <strong>visible abnormal acetowhite areas on colposcopy</strong>, the <strong>next best step</strong> is a <strong>targeted cervical punch biopsy</strong> from those acetowhite areas to obtain histologic confirmation before proceeding to excisional therapy.</span></p>",
      "correct_choice_id": 383225,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96269/Ini-Cet_Gt_30_Oct_2025_Obg_Q_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96269/Ini-Cet_Gt_30_Oct_2025_Obg_Q_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96387,
      "choices": [
        {
          "id": 383692,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyclin A → Cyclin E → Cyclin D → Cyclin B</span></p>"
        },
        {
          "id": 383693,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyclin B → Cyclin A → Cyclin D → Cyclin E</span></p>"
        },
        {
          "id": 383694,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyclin D → Cyclin E → Cyclin A → Cyclin B</span></p>"
        },
        {
          "id": 383695,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyclin E → Cyclin D → Cyclin B → Cyclin A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During cell cycle progression, specific cyclins activate corresponding cyclin-dependent kinases (CDKs) in a defined order to ensure proper phase transitions. Which of the following represents the correct sequential activation of cyclins during the normal cell cycle?&nbsp;</span></p>",
      "unique_key": "Q8547269",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cyclin D → Cyclin E → Cyclin A → Cyclin B</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cyclins act <strong>intermittently</strong> in coordination with <strong>cyclin-dependent kinases (CDKs)</strong> to regulate different phases of the <strong>cell cycle</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Each cyclin activates a specific CDK that controls a checkpoint or transition.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Normal sequence of cyclin activation: Cyclin D → Cyclin E → Cyclin A → Cyclin B</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180107.jpg\" width=\"981\" height=\"504\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical relevance:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cyclin D1 overexpression</strong> due to <strong>t(11;14)</strong> translocation causes <strong>Mantle Cell Lymphoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">CDK4/6 inhibitors (e.g., <strong>Palbociclib</strong>) are used in <strong>ER⁺ breast cancer</strong> to halt tumor cell cycle progression at G₁.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cyclin activation occurs in a specific order — <strong>D → E → A → B</strong> — ensuring orderly progression through <strong>G₁ → S → G₂ → M</strong> phases.</span></li><li><span style=\"font-size:14.0pt;\">Overexpression or mutation in these cyclins, particularly <strong>Cyclin D1</strong>, can lead to <strong>uncontrolled cell proliferation</strong> and malignancy (e.g., <strong>Mantle Cell Lymphoma</strong>).</span></li></ul>",
      "correct_choice_id": 383694,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96387/Pathology_INICET_GT_30_Oct_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96387/Pathology_INICET_GT_30_Oct_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96350,
      "choices": [
        {
          "id": 383544,
          "text": "<p><span style=\"font-size:14.0pt;\">Idiopathic hypercalciuria with recurrent renal stones</span></p>"
        },
        {
          "id": 383545,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypercalcemia</span></p>"
        },
        {
          "id": 383546,
          "text": "<p><span style=\"font-size:14.0pt;\">Congestive heart failure (CHF)</span></p>"
        },
        {
          "id": 383547,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old man with newly diagnosed hypertension is being considered for thiazide diuretic therapy. Which of the following associated conditions is least likely to benefit from this class of drugs?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4592833",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hypercalcemia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thiazide diuretics, such as hydrochlorothiazide and chlorthalidone, are commonly used to treat <strong>hypertension</strong> and <strong>congestive heart failure</strong> and to reduce <strong>urinary calcium excretion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They <strong>lower blood pressure</strong> by reducing plasma volume initially and decreasing peripheral vascular resistance with chronic use.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>CHF</strong>, they are effective adjuncts to loop diuretics in managing <strong>volume overload</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Thiazides also <strong>increase calcium reabsorption in the distal convoluted tubule</strong>, which <strong>reduces urinary calcium</strong> and thereby <strong>prevents calcium-based kidney stones</strong>, especially in cases of <strong>idiopathic hypercalciuria</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, this <strong>same mechanism</strong> can lead to or <strong>worsen hypercalcemia</strong>, especially in predisposed individuals such as those with primary hyperparathyroidism or other causes of elevated serum calcium.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since thiazides <strong>decrease urinary calcium excretion</strong>, they are <strong>contraindicated or used with caution</strong> in patients with <strong>hypercalcemia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Idiopathic hypercalciuria with recurrent renal stones: </strong>Correct indication. Thiazides reduce urinary calcium excretion, making them helpful in <strong>preventing calcium stone formation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Congestive heart failure (CHF):&nbsp;</strong>Thiazides are effective <strong>diuretics for mild fluid overload</strong> and serve as adjuncts to loop diuretics in <strong>volume management</strong> in CHF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hypertension:&nbsp;</strong>Thiazides are <strong>first-line agents</strong> for managing uncomplicated hypertension and are particularly effective in <strong>older adults and African American patients</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thiazide diuretics reduce urinary calcium excretion, which benefits conditions like idiopathic hypercalciuria but may worsen hypercalcemia.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, they are contraindicated or used cautiously in patients with elevated serum calcium.</span></li></ul>",
      "correct_choice_id": 383545,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96350/Pharmacology_INICET_GT_30_Oct_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96350/Pharmacology_INICET_GT_30_Oct_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96287,
      "choices": [
        {
          "id": 383296,
          "text": "<p><span style=\"font-size:14.0pt;\">Letrozole ovulation induction</span></p>"
        },
        {
          "id": 383297,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic chromopertubation</span></p>"
        },
        {
          "id": 383298,
          "text": "<p><span style=\"font-size:14.0pt;\">Intrauterine insemination (IUI)</span></p>"
        },
        {
          "id": 383299,
          "text": "<p><span style=\"font-size:14.0pt;\">In vitro fertilization (IVF)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman with a history of primary infertility undergoes a hysterosalpingography (HSG) which reveals bilateral tubal blockage. She has regular menstrual cycles and no history of pelvic surgery or infections. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6100458",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Laparoscopic chromopertubation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a woman with <strong>primary infertility</strong> and <strong>bilateral tubal block on HSG</strong>, the next step is to <strong>confirm the diagnosis with laparoscopy and chromopertubation</strong>, rather than proceeding directly to assisted reproductive techniques (ART).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Rationale:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hysterosalpingography (HSG)</strong> is a screening test that may show <strong>false-positive tubal blockage</strong>, especially due to <strong>tubal spasm or mucus plugs</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, before labeling the tubes as permanently blocked, <strong>laparoscopic chromopertubation</strong> is performed to directly visualize the tubes and assess <strong>tubal patency</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Methylene blue dye</strong> is injected through the cervix, and its passage through the fimbrial ends confirms <strong>patency</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Laparoscopy also allows the surgeon to identify and treat <strong>pelvic adhesions, endometriosis, or tubal pathology</strong> in the same sitting, which are common causes of infertility.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, <strong>laparoscopy with chromopertubation</strong> is the <strong>next best diagnostic and therapeutic step</strong> following an abnormal HSG report.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Letrozole ovulation induction:&nbsp;</strong>Used for <strong>anovulatory infertility</strong>, especially in <strong>polycystic ovarian syndrome (PCOS)</strong>. Since this patient’s problem lies with <strong>tubal blockage</strong>, ovulation induction will not help in conception.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Intrauterine insemination (IUI):&nbsp;</strong>Requires <strong>at least one patent fallopian tube</strong> for sperm transport and fertilization. In bilateral tubal blockage, IUI is <strong>ineffective</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. In vitro fertilization (IVF):&nbsp;</strong>IVF bypasses the fallopian tubes and is indicated in <strong>confirmed bilateral tubal occlusion</strong>. However, since HSG may be falsely positive, <strong>laparoscopic confirmation</strong> is necessary before starting IVF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In women with <strong>bilateral tubal blockage on HSG</strong>, the <strong>next best step</strong> is <strong>laparoscopic chromopertubation</strong> to confirm true tubal occlusion and evaluate for pelvic pathology before proceeding to advanced fertility treatments such as <strong>IVF</strong>.</span></p>",
      "correct_choice_id": 383297,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96287/Ini-Cet_Gt_30_Oct_2025_Obg_Q_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96287/Ini-Cet_Gt_30_Oct_2025_Obg_Q_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96371,
      "choices": [
        {
          "id": 383628,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased thresholds</span></p>"
        },
        {
          "id": 383629,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased amplitude</span></p>"
        },
        {
          "id": 383630,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased latency</span></p>"
        },
        {
          "id": 383631,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased amplitude</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An elderly man undergoes vestibular evoked myogenic potential (VEMP) testing as part of a balance disorder evaluation. Which of the following findings is most commonly observed on VEMP in older adults?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8534107",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Decreased amplitude</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>VEMP</strong> is a <strong>neurophysiological test</strong> that assesses the integrity of the <strong>saccule</strong> and <strong>inferior vestibular nerve pathway</strong> (via sound-evoked muscle potentials recorded from the sternocleidomastoid).</span></li><li><span style=\"font-size:14.0pt;\">With aging, there is <strong>degeneration of otolith organs (saccule/utricle)</strong> and <strong>reduced vestibular hair cell sensitivity</strong>, leading to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Reduced amplitude</strong> of VEMP responses</span></li><li><span style=\"font-size:14.0pt;\"><strong>Increased thresholds</strong> (need louder stimulus)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Prolonged latency</strong> (delayed conduction)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Among these, the <strong>most consistent and common finding</strong> is a <strong>decrease in amplitude</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This reflects <strong>diminished vestibular receptor function</strong> in the elderly.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Decreased threshold:</strong> Thresholds are <strong>elevated</strong>, not reduced.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreased latency:</strong> Opposite occurs; latency is often prolonged.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased amplitude:</strong> Not seen; amplitude reduces with age.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>most common VEMP finding in the elderly</strong> is <strong>decreased response amplitude</strong>, due to <strong>age-related vestibular receptor degeneration</strong>.</span></p>",
      "correct_choice_id": 383629,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96371/ENT_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96371/ENT_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96092,
      "choices": [
        {
          "id": 382532,
          "text": "<p><span style=\"font-size:14.0pt;\">Facial nerve &amp; Nerve to mylohyoid</span></p>"
        },
        {
          "id": 382533,
          "text": "<p><span style=\"font-size:14.0pt;\">Facial nerve &amp; Glossopharyngeal nerve</span></p>"
        },
        {
          "id": 382534,
          "text": "<p><span style=\"font-size:14.0pt;\">Facial nerve &amp; Hypoglossus nerve</span></p>"
        },
        {
          "id": 382535,
          "text": "<p><span style=\"font-size:14.0pt;\">Facial nerve &amp; Vagus nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the given image, muscles A and B are labelled. Which of the following nerves supply muscles A and B, respectively?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KFy6aWi.png\" width=\"657\" height=\"501\"></span></p>",
      "unique_key": "Q4900593",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Facial nerve &amp; Nerve to mylohyoid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The cadaveric image shows the <strong>digastric muscle</strong>, which is a unique \"hybrid muscle\" of the neck with dual innervation:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Muscle A (Anterior belly of digastric)</strong>: This muscle is derived from the <strong>first pharyngeal arch</strong> and is supplied by the <strong>mandibular nerve (V3)</strong>, specifically through the <strong>nerve to mylohyoid</strong> branch. The nerve to mylohyoid runs along the mylohyoid muscle and sends a branch to innervate the anterior belly of the digastric.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Muscle B (Posterior belly of digastric)</strong>: This muscle is derived from the <strong>second pharyngeal arch</strong> and is supplied by the <strong>facial nerve (CN VII)</strong>, specifically through the <strong>digastric branch</strong> of the facial nerve that arises near the stylomastoid foramen.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The digastric muscle is classified as a hybrid muscle because its two bellies have different embryological origins and nerve supplies:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">First arch → Mandibular nerve (V3) → Nerve to mylohyoid → Anterior belly</span></li><li><span style=\"font-size:14.0pt;\">Second arch → Facial nerve (CN VII) → Posterior belly</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Facial nerve &amp; Glossopharyngeal nerve:&nbsp;</strong>Incorrect. While the facial nerve correctly supplies the posterior belly, the glossopharyngeal nerve (CN IX) does not supply the digastric muscle. The glossopharyngeal nerve supplies the stylopharyngeus muscle (third pharyngeal arch derivative) and provides sensory innervation to the posterior third of the tongue and pharynx.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Facial nerve &amp; Hypoglossus nerve</strong>: Incorrect. The hypoglossal nerve (CN XII) supplies all intrinsic and most extrinsic muscles of the tongue (except palatoglossus), not the digastric muscle. While the hypoglossal nerve does run in close proximity to the digastric muscle in the submandibular region, it does not innervate it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Facial nerve &amp; Vagus nerve:&nbsp;</strong>&nbsp;Incorrect. The vagus nerve (CN X) does not supply the digastric muscle. The vagus nerve supplies muscles of the palate (except tensor veli palatini), pharynx (except stylopharyngeus), and larynx (all intrinsic muscles except cricothyroid via recurrent laryngeal nerve). The vagus is the nerve of the fourth pharyngeal arch.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>digastric muscle</strong> is a hybrid muscle with dual innervation: the <strong>anterior belly</strong> is supplied by the <strong>nerve to mylohyoid</strong> (branch of mandibular nerve, V3) as it is a first pharyngeal arch derivative, while the <strong>posterior belly</strong> is supplied by the <strong>facial nerve (CN VII)</strong> as it is a second pharyngeal arch derivative.</span></p>",
      "correct_choice_id": 382532,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96092/Anatomy_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96092/Anatomy_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96289,
      "choices": [
        {
          "id": 383304,
          "text": "<p><span style=\"font-size:14.0pt;\">Rubin → McRobert’s → Gaskin → Zavanelli</span></p>"
        },
        {
          "id": 383305,
          "text": "<p><span style=\"font-size:14.0pt;\">McRobert’s → Rubin → Gaskin → Zavanelli&nbsp;</span></p>"
        },
        {
          "id": 383306,
          "text": "<p><span style=\"font-size:14.0pt;\">Gaskin → McRobert’s → Rubin → Zavanelli</span></p>"
        },
        {
          "id": 383307,
          "text": "<p><span style=\"font-size:14.0pt;\">McRobert’s → Gaskin → Rubin → Zavanelli</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 33-year-old woman with gestational diabetes mellitus (GDM) is in active labor. After the fetal head delivers, the shoulders fail to deliver and become impacted behind the maternal symphysis pubis. Which of the following represents the correct sequence of maneuvers to manage this complication?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2653424",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) McRobert’s → Rubin → Gaskin → Zavanelli</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The described scenario is a classic case of <strong>shoulder dystocia</strong>, a <strong>true obstetric emergency</strong> that occurs when the <strong>anterior fetal shoulder becomes impacted behind the maternal pubic symphysis</strong> after delivery of the fetal head.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Risk factors:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Maternal diabetes (GDM)</strong> → large fetal shoulders (macrosomia)</span></li><li><span style=\"font-size:14.0pt;\">Prolonged labor or instrumental delivery</span></li><li><span style=\"font-size:14.0pt;\">Obesity or excessive maternal weight gain</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management involves a stepwise approach</strong>, starting from least to most invasive maneuvers:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. McRobert’s Maneuver (First step)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Action:</strong> Flex maternal thighs sharply onto the abdomen.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> Rotates the symphysis pubis cephalad and flattens the lumbar lordosis, increasing the anteroposterior diameter of the pelvis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Effectiveness:</strong> Resolves &gt;40% of shoulder dystocia cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Rubin Maneuver (Second step)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Action:</strong> Insert a hand into the vagina and apply pressure on the <strong>posterior aspect of the anterior shoulder</strong> to adduct it toward the fetal chest.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> Reduces the bisacromial diameter (shoulder width) to help the shoulder slip under the pubic symphysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Gaskin Maneuver (Third step)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Action:</strong> Have the mother <strong>move to an all-fours (hands-and-knees)</strong> position.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> Changes pelvic dimensions and allows the posterior shoulder to dislodge more easily.</span></li><li><span style=\"font-size:14.0pt;\">Often used when McRobert’s and Rubin maneuvers fail.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Zavanelli Maneuver (Last resort)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Action:</strong> <strong>Cephalic replacement of the fetal head into the vagina</strong>, followed by <strong>cesarean section</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong> Used only when all other maneuvers fail; it carries high maternal and fetal risk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>shoulder dystocia</strong>, management should proceed stepwise as follows:</span><br><span style=\"font-size:14.0pt;\"><strong>McRobert’s maneuver → Rubin maneuver → Gaskin maneuver → Zavanelli maneuver. </strong>This sequence progresses from the least invasive to the most invasive interventions, aiming to relieve shoulder impaction and prevent fetal hypoxia or brachial plexus injury.</span></p>",
      "correct_choice_id": 383305,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96289/Ini-Cet_Gt_30_Oct_2025_Obg_Q_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96289/Ini-Cet_Gt_30_Oct_2025_Obg_Q_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96326,
      "choices": [
        {
          "id": 383448,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 383449,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 383450,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 383451,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What are the indications to treat hypertension as per the current recommendations?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">ABPM ≥130/80 mmHg over 24 hours</span></li><li><span style=\"font-size:14.0pt;\">Daytime ABPM ≥135/85 mmHg</span></li><li><span style=\"font-size:14.0pt;\">Night-time ABPM ≥120/70 mmHg</span></li><li><span style=\"font-size:14.0pt;\">Office BP ≥140/90 mmHg</span></li></ol>",
      "unique_key": "Q6311804",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>diagnostic thresholds for hypertension</strong> differ based on the method of measurement:</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_sOI0Q22.png\" width=\"606\" height=\"250\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">These thresholds align with <strong>ESC/ESH guidelines</strong>, which emphasize the importance of out-of-office BP monitoring to identify <strong>white coat hypertension</strong> and <strong>masked hypertension</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Treatment initiation thresholds (based on office BP):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">BP&nbsp;≥ 140/90 mmHg</span></li><li><span style=\"font-size:14.0pt;\">BP ≥ 130/80 mmHg + CVD, CKD, DM, or high CV risk (based on risk models)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Equivalent Office BP thresholds:</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vgEC4hM.png\" width=\"685\" height=\"178\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hypertension diagnosis depends on <strong>measurement setting</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Office ≥140/90 mmHg</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>24-hour ABPM ≥130/80 mmHg</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Daytime ≥135/85 mmHg</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Night-time ≥120/70 mmHg</strong></span><br><span style=\"font-size:14.0pt;\">Out-of-office monitoring improves diagnostic accuracy and risk stratification.</span></li></ul>",
      "correct_choice_id": 383448,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96326/Medicine_Inicet_Gt_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96326/Medicine_Inicet_Gt_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96351,
      "choices": [
        {
          "id": 383548,
          "text": "<p><span style=\"font-size:14.0pt;\">PAS&nbsp;</span></p>"
        },
        {
          "id": 383549,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyrazinamide</span></p>"
        },
        {
          "id": 383550,
          "text": "<p><span style=\"font-size:14.0pt;\">Bedaquiline</span></p>"
        },
        {
          "id": 383551,
          "text": "<p><span style=\"font-size:14.0pt;\">Capreomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following anti-tubercular drugs exerts its therapeutic action by interfering with Mycobacterium tuberculosis folate metabolism, unlike the others that act via unrelated mechanisms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9129568",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) PAS&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PAS is a structural analogue of <strong>para-aminobenzoic acid (PABA)</strong> and acts as a <strong>competitive inhibitor of folate synthesis</strong> in Mycobacterium tuberculosis.</span></li><li><span style=\"font-size:14.0pt;\">It targets the same pathway as sulfonamides but is specifically active against mycobacteria.</span></li><li><span style=\"font-size:14.0pt;\">This disruption inhibits the formation of <strong>dihydrofolic acid</strong>, leading to impaired <strong>nucleic acid synthesis</strong> and <strong>cell replication</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pyrazinamide:&nbsp;</strong>Targets <strong>mycobacterial cell membrane function</strong> and <strong>energy metabolism</strong>, especially in acidic environments. It does <strong>not</strong> affect folate pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bedaquiline:&nbsp;</strong>A <strong>diarylquinoline</strong> drug that selectively inhibits <strong>mycobacterial ATP synthase</strong>, leading to energy depletion. It is independent of folate metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Capreomycin:&nbsp;</strong>An aminoglycoside-like agent that <strong>inhibits protein synthesis</strong> by binding to <strong>ribosomal subunits</strong>. It has no effect on folate metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>PAS is the only anti-TB drug that inhibits folate metabolism</strong>, mimicking PABA.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Understanding drug mechanisms is crucial for rational use in multi-drug-resistant TB regimens.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note: Mechanism of action of anti-tubercular drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20175905.jpg\" width=\"1063\" height=\"680\"></strong></span></p>",
      "correct_choice_id": 383548,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96351/Pharmacology_INICET_GT_30_Oct_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96351/Pharmacology_INICET_GT_30_Oct_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96402,
      "choices": [
        {
          "id": 383752,
          "text": "<p><span style=\"font-size:14.0pt;\">Detection of Negri bodies on H&amp;E stain</span></p>"
        },
        {
          "id": 383753,
          "text": "<p><span style=\"font-size:14.0pt;\">DFA test on corneal impressions</span></p>"
        },
        {
          "id": 383754,
          "text": "<p><span style=\"font-size:14.0pt;\">RT-PCR on nape of neck biopsy</span></p>"
        },
        {
          "id": 383755,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum antibody testing using IFA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old man presents with low-grade fever, malaise, and tingling around a recent dog bite wound sustained two weeks ago. He has not received post-exposure prophylaxis. Neurological examination is normal. The physician suspects early rabies infection and wants to confirm the diagnosis using the most sensitive test available at this stage. Which of the following is the most appropriate diagnostic test for confirming rabies in this patient during the early phase of infection?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4429183",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) RT-PCR on nape of neck biopsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In living patients, especially during the <strong>early stages</strong> of rabies infection, <strong>RT-PCR (Reverse Transcription-Polymerase Chain Reaction)</strong> is the <strong>most sensitive and specific</strong> method for detecting <strong>rabies viral RNA</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>nape of the neck biopsy</strong> contains hair follicles with <strong>rich innervation</strong>, making it an ideal site for detecting rabies RNA before CNS symptoms fully develop.</span></li><li><span style=\"font-size:14.0pt;\">RT-PCR can detect <strong>even low levels of viral RNA</strong>, offering early and reliable diagnosis <strong>before antibodies develop</strong> or inclusion bodies (e.g., Negri) appear.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Detection of Negri bodies on H&amp;E stain:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Negri bodies</strong> are eosinophilic intracytoplasmic inclusions found in neurons (especially hippocampus and Purkinje cells).</span></li><li><span style=\"font-size:14.0pt;\">They are <strong>pathognomonic</strong> but only visible <strong>post-mortem</strong> or <strong>late in the disease</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Additionally, <strong>up to 20% of rabies cases may lack Negri bodies</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incorrect: Not useful early and not reliable in living patients.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. DFA test on corneal impressions:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Direct Fluorescent Antibody (DFA)</strong> is a rapid test that detects rabies <strong>nucleoprotein antigen</strong>, typically in <strong>corneal impression smears</strong> or <strong>nape biopsies</strong>.</span></li><li><span style=\"font-size:14.0pt;\">While it is useful, <strong>corneal smears have lower sensitivity (~30%)</strong>, especially early in infection.</span></li><li><span style=\"font-size:14.0pt;\">DFA on <strong>nape biopsy</strong> is preferred over corneal smear but still inferior to <strong>RT-PCR</strong>.</span></li><li><span style=\"font-size:14.0pt;\">&nbsp;<strong>Incorrect: DFA is less sensitive than RT-PCR and corneal site is suboptimal.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serum antibody testing using IFA:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Antibodies in serum appear late</strong> and are often detectable <strong>after vaccination or in the late stage of infection</strong>.</span></li><li><span style=\"font-size:14.0pt;\">CSF antibody is more specific, but even then, it’s not a preferred <strong>early diagnostic method</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incorrect: Antibody-based tests are not sensitive early and may give false reassurance.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>RT-PCR on a nape of the neck biopsy</strong> is the most sensitive and specific diagnostic method for <strong>early rabies detection</strong> in living patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It detects viral RNA before antibody response or histopathological changes (e.g., Negri bodies) occur.</span></li></ul>",
      "correct_choice_id": 383754,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96402/Microbiology_INICET_GT_30_Oct_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96402/Microbiology_INICET_GT_30_Oct_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96380,
      "choices": [
        {
          "id": 383664,
          "text": "<p><span style=\"font-size:14.0pt;\">Echocardiography</span></p>"
        },
        {
          "id": 383665,
          "text": "<p><span style=\"font-size:14.0pt;\">Cardiac MRI</span></p>"
        },
        {
          "id": 383666,
          "text": "<p><span style=\"font-size:14.0pt;\">MUGA scan</span></p>"
        },
        {
          "id": 383667,
          "text": "<p><span style=\"font-size:14.0pt;\">CT angiography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old woman with breast cancer is starting anthracycline chemotherapy. Which imaging modality is most accurate and reproducible for serial monitoring of her left ventricular ejection fraction (LVEF)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1186351",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Echocardiography</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Transthoracic echocardiography (TTE) is the first-line and most commonly used imaging modality for serial monitoring of LVEF in patients undergoing cardiotoxic chemotherapy (e.g., anthracyclines).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is non-invasive, radiation-free, widely available, and provides not only information about LVEF but also about diastolic function, wall motion abnormalities, and valvular structure.</span></li><li><span style=\"font-size:14.0pt;\">Modern advancements like 3D echocardiography and global longitudinal strain (GLS) analysis have significantly improved the reproducibility and sensitivity of echocardiography for detecting early subclinical myocardial dysfunction, making it preferable over MUGA scans in current practice.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cardiac MRI:</strong> While highly accurate for LVEF and myocardial characterization, CMR is expensive, less accessible, and time-consuming. It is typically reserved for inconclusive echocardiograms or more complex cardiomyopathies—not for routine monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. MUGA scan:</strong> Previously favored for high reproducibility of LVEF, especially in oncology, but it involves radiation exposure and limited structural detail. Its use has declined in favor of echocardiography enhanced with strain imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CT angiography:</strong> Primarily used for coronary artery assessment, not routinely for LVEF monitoring. It involves radiation and contrast, making it unsuitable for serial follow-up.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Echocardiography, especially with 3D imaging and global longitudinal strain (GLS), is the preferred modality for serial LVEF monitoring during anthracycline chemotherapy due to its non-invasive nature, accessibility, and comprehensive cardiac assessment&nbsp;capabilities.</span></p>",
      "correct_choice_id": 383664,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96380/RADIOLOGY_INICET_GT_5_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96380/RADIOLOGY_INICET_GT_5_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96377,
      "choices": [
        {
          "id": 383652,
          "text": "<p><span style=\"font-size:14.0pt;\">Breast carcinoma</span></p>"
        },
        {
          "id": 383653,
          "text": "<p><span style=\"font-size:14.0pt;\">Melanoma</span></p>"
        },
        {
          "id": 383654,
          "text": "<p><span style=\"font-size:14.0pt;\">Thyroid carcinoma&nbsp;</span></p>"
        },
        {
          "id": 383655,
          "text": "<p><span style=\"font-size:14.0pt;\">Lung carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following malignancies is most strongly associated with radiation exposure during infancy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7445218",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Thyroid carcinoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Radiation exposure during childhood/infancy</strong>, especially involving the <strong>head and neck</strong>, is strongly associated with the development of <strong>thyroid carcinoma</strong>, particularly <strong>papillary thyroid carcinoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The thyroid is highly sensitive to ionizing radiation during early life because of its high mitotic activity and concentration of iodine uptake.</span></li><li><span style=\"font-size:14.0pt;\">Historical cases (irradiation for thymic enlargement, acne, tonsillar hypertrophy, or lymphomas in infants) showed markedly increased incidence of thyroid cancers decades later.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Breast carcinoma:</strong> Radiation is indeed a risk factor for breast cancer, but primarily in <strong>adolescents and young women</strong> exposed to chest radiation (e.g., mantle radiation for Hodgkin lymphoma). It is not the primary cancer linked to infant radiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Melanoma:</strong> Ultraviolet radiation, not therapeutic ionizing radiation in infancy, is the major risk factor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lung carcinoma:</strong> Risk is mostly associated with smoking, environmental toxins (radon, asbestos), and high-dose radiation exposures in adults (e.g., atomic bomb survivors), not infancy radiation to the neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ionizing radiation exposure in infancy, particularly to the head and neck, is most strongly associated with an increased risk of thyroid carcinoma (especially papillary type).</span></p>",
      "correct_choice_id": 383654,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96377/RADIOLOGY_INICET_GT_5_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96377/RADIOLOGY_INICET_GT_5_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96121,
      "choices": [
        {
          "id": 382648,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct isoniazid toxicity causing niacin depletion</span></p>"
        },
        {
          "id": 382649,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B6 deficiency leading to impaired tryptophan-to-niacin conversion</span></p>"
        },
        {
          "id": 382650,
          "text": "<p><span style=\"font-size:14.0pt;\">Malabsorption of niacin due to isoniazid-induced enteropathy</span></p>"
        },
        {
          "id": 382651,
          "text": "<p><span style=\"font-size:14.0pt;\">Competitive inhibition of niacin by isoniazid metabolites</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman being treated for tuberculosis with isoniazid presents with a 6-week history of photosensitive dermatitis on her face and hands, diarrhea, and confusion. She also complains of peripheral numbness and tingling. Physical examination reveals a symmetrical rash on sun-exposed areas and decreased sensation in her distal extremities. Which of the following best explains her pellagra-like symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1013415",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Vitamin B6 deficiency leading to impaired tryptophan-to-niacin conversion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>pellagra-like symptoms</strong> (dermatitis, diarrhea, dementia) caused by <strong>secondary niacin (B3) deficiency</strong> due to vitamin B6 deficiency from isoniazid therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Mechanism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vitamin B6 (pyridoxine) is a cofactor for enzymes involved in converting <strong>tryptophan to niacin (B3)</strong></span></li><li><span style=\"font-size:14.0pt;\">Isoniazid depletes vitamin B6 stores and interferes with B6 metabolism</span></li><li><span style=\"font-size:14.0pt;\">Without adequate B6, the body cannot synthesize niacin from dietary tryptophan</span></li><li><span style=\"font-size:14.0pt;\">This leads to functional niacin deficiency → pellagra symptoms</span></li><li><span style=\"font-size:14.0pt;\">The peripheral neuropathy is a direct effect of B6 deficiency itself</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Direct isoniazid toxicity causing niacin depletion:&nbsp;</strong>Incorrect. Isoniazid toxicity does not directly deplete niacin. The drug’s adverse effects stem primarily from <strong>interference with vitamin B6 metabolism</strong> and <strong>hepatic injury</strong>, not from direct niacin depletion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Malabsorption of niacin due to isoniazid-induced enteropathy:&nbsp;</strong>Incorrect. Isoniazid does not cause intestinal mucosal damage or malabsorption. Niacin levels fall due to <strong>impaired synthesis</strong>, not poor absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Competitive inhibition of niacin by isoniazid metabolites:&nbsp;</strong>Incorrect. Isoniazid does not compete with niacin for receptor or enzyme sites. Its effect is through <strong>enzyme cofactor (pyridoxal phosphate)</strong> depletion, not substrate competition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Isoniazid therapy</strong> can cause <strong>vitamin B6 deficiency</strong> by forming a complex with pyridoxal phosphate.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This impairs the <strong>conversion of tryptophan to niacin</strong>, leading to <strong>secondary pellagra</strong> (dermatitis, diarrhea, dementia) and <strong>peripheral neuropathy</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Co-administration of pyridoxine (vitamin B6)</strong> prevents these adverse effects.</span></li></ul>",
      "correct_choice_id": 382649,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96121/Biochemistry_INICET_GT_30_Oct_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96121/Biochemistry_INICET_GT_30_Oct_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96332,
      "choices": [
        {
          "id": 383472,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 5</span></p>"
        },
        {
          "id": 383473,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4, 5</span></p>"
        },
        {
          "id": 383474,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3</span></p>"
        },
        {
          "id": 383475,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old woman with ESRD on haemodialysis develops painful leg ulcers over 1 month as shown below. She is currently taking amlodipine, calcium supplements, alfacalcidol, erythropoietin. Labs show Ca 10.8 mg/dL, Phosphate 9.3 mg/dL and iPTH ~1150 pg/mL. Which of the following would be inappropriate for her condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6Nq1Qjq.png\" width=\"366\" height=\"311\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Sodium thiosulfate</span></p><p><span style=\"font-size:14.0pt;\">2. Paracalcitol</span></p><p><span style=\"font-size:14.0pt;\">3. Warfarin</span></p><p><span style=\"font-size:14.0pt;\">4. Cinacalcet</span></p><p><span style=\"font-size:14.0pt;\">5. Hyperbaric oxygen therapy</span></p>",
      "unique_key": "Q8156634",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 2, 3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presentation is consistent with <strong>calcific uraemic arteriolopathy (calciphylaxis)</strong> in a haemodialysis patient with hypercalcaemia, severe hyperphosphataemia, and very high PTH.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2. Paricalcitol:</strong> Is an active vitamin D analogue that can <strong>raise calcium–phosphate burden</strong> and worsen calcification; avoid in calciphylaxis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. Warfarin:</strong> Inhibits matrix Gla protein, a natural inhibitor of vascular calcification, and is a <strong>recognized risk factor</strong> for calciphylaxis; avoid/stop if possible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Appropriate therapies include:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Sodium thiosulfate:</strong> IV post-dialysis to aid dissolution of calcium deposits and relieve pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Cinacalcet:</strong> To lower PTH and Ca×P product; medical alternative to parathyroidectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Hyperbaric oxygen therapy:</strong> As an adjunct to promote wound healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Management of <strong>calciphylaxis</strong>: remove drivers (stop calcium salts/active vitamin D, avoid warfarin, use low-calcium dialysate, control phosphate), treat lesions (meticulous wound care; consider <strong>hyperbaric oxygen</strong>), and use <strong>sodium thiosulfate</strong> plus <strong>PTH-lowering therapy</strong> (e.g., <strong>cinacalcet</strong> or parathyroidectomy if refractory).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Avoid <strong>paricalcitol</strong> and <strong>warfarin</strong>.</span></li></ul>",
      "correct_choice_id": 383474,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96332/Medicine_INICET_GT_30_Oct_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96332/Medicine_INICET_GT_30_Oct_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96286,
      "choices": [
        {
          "id": 383292,
          "text": "<p><span style=\"font-size:14.0pt;\">Ampullary portion – because it is the widest and most tortuous segment</span></p>"
        },
        {
          "id": 383293,
          "text": "<p><span style=\"font-size:14.0pt;\">Isthmic portion – because it is narrow and has thick muscular walls</span></p>"
        },
        {
          "id": 383294,
          "text": "<p><span style=\"font-size:14.0pt;\">Fimbrial portion – because it lies closest to the ovary and is easily accessible</span></p>"
        },
        {
          "id": 383295,
          "text": "<p><span style=\"font-size:14.0pt;\">Infundibular portion – because it contains the largest number of fimbriae for easy identification</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following represents the most common site chosen for tubal ligation and the reason for selecting it?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6777100",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Isthmic portion – because it is narrow and has thick muscular walls</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>isthmic portion of the fallopian tube</strong> is the <strong>most common site</strong> for performing <strong>tubal ligation (female sterilization)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Anatomical rationale:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>isthmus</strong> is the <strong>narrowest</strong> part of the fallopian tube and has <strong>thick circular muscle fibers</strong>, which make it ideal for safe and effective ligation.</span></li><li><span style=\"font-size:14.0pt;\">Ligation at this point ensures <strong>permanent tubal occlusion</strong> with minimal chance of recanalization.</span></li><li><span style=\"font-size:14.0pt;\">It is located close to the <strong>uterine cornu</strong>, allowing easy surgical access during <strong>minilaparotomy or laparoscopy</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Common methods used:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pomeroy’s method:</strong> Loop of isthmic tube is tied and segment excised.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Modified Pomeroy’s or Parkland’s method:</strong> Used for higher efficacy and lower failure rates.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical relevance:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ligation at the isthmic portion provides the best balance between <strong>surgical accessibility</strong>, <strong>low failure rate</strong>, and <strong>preservation of blood supply</strong> to adjacent segments.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ampullary portion – because it is the widest and most tortuous segment:&nbsp;</strong>The ampulla is the usual site of <strong>fertilization</strong>, but ligation here increases the risk of <strong>failure and ectopic pregnancy</strong> due to its wider lumen and delicate wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fimbrial portion – because it lies closest to the ovary and is easily accessible:&nbsp;</strong>Used in <strong>fimbriectomy (Madlener method)</strong> but less preferred due to <strong>higher recanalization rates</strong> and difficulty in identifying the exact segment intraoperatively.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Infundibular portion – because it contains the largest number of fimbriae for easy identification:&nbsp;</strong>The infundibulum is fragile and close to the ovary, making it <strong>unsuitable for ligation</strong> because of the risk of damage to ovarian blood supply.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>isthmic portion of the fallopian tube</strong> is the <strong>preferred site for tubal ligation</strong> because it is <strong>narrow, muscular, and easily accessible</strong>, ensuring a <strong>low failure rate</strong> and effective permanent sterilization.</span></p>",
      "correct_choice_id": 383293,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96286/Ini-Cet_Gt_30_Oct_2025_Obg_Q_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96286/Ini-Cet_Gt_30_Oct_2025_Obg_Q_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96102,
      "choices": [
        {
          "id": 382572,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 382573,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        },
        {
          "id": 382574,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 382575,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following situations qualify as medico-legally acceptable privileged communication?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">A bus driver with epilepsy refusing to inform his employer.</span></li><li><span style=\"font-size:14.0pt;\">A syphilitic patient about to get married.</span></li><li><span style=\"font-size:14.0pt;\">A case of suspected child sexual abuse.</span></li><li><span style=\"font-size:14.0pt;\">An impotent man preparing to marry, without any health risk to others.</span></li></ol>",
      "unique_key": "Q2523660",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2 and 3 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Privileged communication is an <strong>exception to medical confidentiality</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It allows a physician to disclose patient information <strong>without consent</strong> when necessary to <strong>protect the health or safety of the individual or the public</strong>, or as required by law.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>A bus driver with epilepsy refusing to inform his employer:</strong> Is correct. A bus driver with epilepsy poses a <strong>risk to public safety</strong>, and the doctor has a duty to report such a condition if the patient refuses to do so.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>A syphilitic patient about to get married:</strong> Is correct. A syphilitic patient marrying can transmit a <strong>sexually transmitted infection</strong>, justifying privileged communication.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>A case of suspected child sexual abuse:</strong> Is correct. <strong>Child sexual abuse must be mandatorily reported</strong> as per the Protection of Children from Sexual Offences (POCSO) Act, 2012.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. An impotent man preparing to marry, without any health risk to others:</strong> Incorrect. Impotence is <strong>not</strong> a public health threat, and hence, does <strong>not</strong> justify privileged communication.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Privileged communication</strong> permits physicians to disclose patient information <strong>without consent</strong> in situations involving <strong>public health threats</strong>, <strong>legal obligations</strong>, or when <strong>required to protect vulnerable individuals (e.g., children, elderly, disabled)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Impotence, however, is not considered a reportable or dangerous condition and does <strong>not qualify</strong> under privileged communication.</span></li></ul>",
      "correct_choice_id": 382572,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96102/FMT_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96102/FMT_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96122,
      "choices": [
        {
          "id": 382652,
          "text": "<p><span style=\"font-size:14.0pt;\">Epworth Sleepiness Scale</span></p>"
        },
        {
          "id": 382653,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiple Sleep Latency Test (MSLT)</span></p>"
        },
        {
          "id": 382654,
          "text": "<p><span style=\"font-size:14.0pt;\">EEG with photic stimulation</span></p>"
        },
        {
          "id": 382655,
          "text": "<p><span style=\"font-size:14.0pt;\">Overnight pulse oximetry</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old college student reports excessive daytime sleepiness, episodes of sudden muscle weakness triggered by laughter, and occasional hallucinations while falling asleep. His nocturnal polysomnography is unremarkable. Which of the following is the most appropriate diagnostic test to confirm narcolepsy?&nbsp;</span></p>",
      "unique_key": "Q5954591",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Multiple Sleep Latency Test (MSLT)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 22-year-old student presents with <strong>classic symptoms of narcolepsy</strong>, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Excessive daytime sleepiness</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Cataplexy</strong> (sudden loss of muscle tone triggered by laughter)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypnagogic hallucinations</strong> (hallucinations while falling asleep)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">While <strong>nocturnal polysomnography (PSG)</strong> may appear unremarkable, the <strong>Multiple Sleep Latency Test (MSLT)</strong> is the <strong>diagnostic test</strong> for narcolepsy. MSLT measures the speed at which a person falls asleep in a quiet environment during the day and checks for <strong>sleep-onset REM periods (SOREMPs)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Narcolepsy is diagnosed when the mean sleep latency is &lt;8 minutes and ≥2 SOREMPs are observed.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Epworth Sleepiness Scale</strong>: This is a <strong>screening tool</strong>, not a diagnostic test. It measures the <strong>subjective severity of daytime sleepiness</strong>, but cannot confirm narcolepsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. EEG with photic stimulation</strong>: This is used primarily in the diagnosis of <strong>epilepsy</strong>, particularly <strong>photosensitive seizures</strong>, and has no role in narcolepsy diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Overnight pulse oximetry</strong>: This is used to screen for <strong>sleep-related breathing disorders</strong> such as <strong>obstructive sleep apnea (OSA)</strong>, not for narcolepsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Multiple Sleep Latency Test (MSLT)</strong> is the diagnostic test for <strong>narcolepsy</strong>, especially after an unremarkable overnight PSG.</span></li><li><span style=\"font-size:14.0pt;\">It evaluates <strong>daytime sleep latency</strong> and the presence of <strong>REM-onset sleep episodes</strong>, helping to confirm the diagnosis in patients with <strong>daytime sleepiness, cataplexy, and sleep-related hallucinations.</strong></span></li></ul>",
      "correct_choice_id": 382653,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96122/Psychiatry_INICET_GT_30_Oct_Question_1_mer20mM.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96122/Psychiatry_INICET_GT_30_Oct_Question_1_mer20mM.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96339,
      "choices": [
        {
          "id": 383500,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer for ERCP</span></p>"
        },
        {
          "id": 383501,
          "text": "<p><span style=\"font-size:14.0pt;\">Check anti-sp100 and anti-gp210 antibody titers&nbsp;</span></p>"
        },
        {
          "id": 383502,
          "text": "<p><span style=\"font-size:14.0pt;\">Trial of prednisone to see whether alkaline phosphatase improves</span></p>"
        },
        {
          "id": 383503,
          "text": "<p><span style=\"font-size:14.0pt;\">Check serum bile acids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old woman presents with 8 months of fatigue and pruritus. Labs show ALP 409 U/L (normal 40-120), bilirubin 1.8 mg/dL, AMA negative, ANA 1:80 (positive), ASMA negative, IgG 900 mg/dL (normal). MRCP is normal. What is the next best step before considering liver biopsy?</span></p>",
      "unique_key": "Q9009020",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Check anti-sp100 and anti-gp210 antibody titers&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Primary biliary cholangitis (PBC) can be diagnosed when <strong>2 of 3</strong> are present:</span></li></ul><ol><li><span style=\"font-size:14.0pt;\"><strong>Chronic cholestasis</strong> (elevated ALP),</span></li><li><span style=\"font-size:14.0pt;\"><strong>PBC-specific autoantibodies</strong> (typically AMA; in AMA-negative cases, <strong>anti-sp100</strong> and <strong>anti-gp210</strong>),</span></li><li><span style=\"font-size:14.0pt;\"><strong>Compatible histology</strong> (nonsuppurative destructive cholangitis).</span></li></ol><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has cholestatic labs (markedly elevated ALP) with <strong>AMA-negative</strong> serology and normal MRCP.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Testing for <strong>anti-sp100 and anti-gp210</strong> (highly specific for PBC) can establish <strong>AMA-negative PBC</strong> without biopsy; if positive, the scheduled biopsy can be canceled.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Refer for ERCP:</strong> Not indicated with a <strong>normal MRCP</strong> and no obstructive features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Trial of prednisone to see whether alkaline phosphatase improves:</strong> Empiric steroids are <strong>not appropriate</strong> for suspected isolated PBC (normal AST/ALT and IgG argue against AIH).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Check serum bile acids:</strong> Not useful for <strong>diagnosis</strong> of PBC; they are more relevant for cholestasis severity/symptom assessment (e.g., pruritus, pregnancy-related cholestasis).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In suspected <strong>AMA-negative PBC</strong> with cholestatic liver tests and normal cholangiography, check <strong>PBC-specific antibodies (anti-sp100, anti-gp210)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A diagnosis of PBC can be made <strong>without biopsy</strong> when cholestasis and PBC-specific autoantibodies are present.</span></li></ul>",
      "correct_choice_id": 383501,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96339/Medicine_Inicet_Gt_30_Oct_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96339/Medicine_Inicet_Gt_30_Oct_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96345,
      "choices": [
        {
          "id": 383524,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal temperature</span></p>"
        },
        {
          "id": 383525,
          "text": "<p><span style=\"font-size:14.0pt;\">Stable hematocrit at baseline level</span></p>"
        },
        {
          "id": 383526,
          "text": "<p><span style=\"font-size:14.0pt;\">Platelet count &gt; 50,000/mm³</span></p>"
        },
        {
          "id": 383527,
          "text": "<p><span style=\"font-size:14.0pt;\">Convalescent rash or itching on extremities</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old man hospitalized with dengue with warning signs and is not recovering. Which of the following is not a sign of recovery of dengue patients?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4487489",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Platelet count &gt; 50,000/mm³</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to the <strong>National Vector Borne Disease Control Programme (NVBDCP, 2023)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Signs of Recovery</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Stable pulse, blood pressure, and respiratory rate</span></li><li><span style=\"font-size:14.0pt;\">Normal temperature</span></li><li><span style=\"font-size:14.0pt;\">No external or internal bleeding</span></li><li><span style=\"font-size:14.0pt;\">Return of appetite</span></li><li><span style=\"font-size:14.0pt;\">No vomiting or abdominal pain</span></li><li><span style=\"font-size:14.0pt;\">Good urinary output</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stable hematocrit at baseline level</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Convalescent confluent petechial rash or itching</strong>, especially on extremities</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Criteria for Discharge</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Afebrile ≥ 24 hours without antipyretics</span></li><li><span style=\"font-size:14.0pt;\">Presence of above <strong>signs of recovery</strong></span></li><li><span style=\"font-size:14.0pt;\">≥ 2–3 days after recovery from shock (if present)</span></li><li><span style=\"font-size:14.0pt;\">No respiratory distress from effusion/ascites</span></li><li><span style=\"font-size:14.0pt;\"><strong>Platelet count &gt; 50,000/mm³</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Hence, <strong>platelet count &gt; 50,000/mm³</strong> is not a sign of recovery but a <strong>criterion for discharge</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Platelet rise usually <strong>lags behind clinical recovery</strong> and stabilization of hematocrit.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Normal temperature:</strong> Defervescence is an early and reliable sign of recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Stable hematocrit at baseline level:</strong> Indicates resolution of plasma leakage and clinical stability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Convalescent rash/itching on extremities:</strong> Typical of the recovery phase due to immune reactivation and skin re-perfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In dengue, <strong>clinical recovery precedes hematologic normalization</strong>.</span><br><span style=\"font-size:14.0pt;\">According to <strong>NVBDCP 2023</strong>, <strong>stable vitals, appetite return, good urine output, stable hematocrit, and convalescent rash</strong> define recovery, whereas <strong>platelet &gt; 50,000/mm³</strong> marks <strong>readiness for discharge</strong>, not recovery.</span></p>",
      "correct_choice_id": 383526,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96345/Medicine_Inicet_Gt_30_Oct_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96345/Medicine_Inicet_Gt_30_Oct_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96358,
      "choices": [
        {
          "id": 383576,
          "text": "<p><span style=\"font-size:14.0pt;\">Everolimus</span></p>"
        },
        {
          "id": 383577,
          "text": "<p><span style=\"font-size:14.0pt;\">Erlotinib</span></p>"
        },
        {
          "id": 383578,
          "text": "<p><span style=\"font-size:14.0pt;\">Idelalisib</span></p>"
        },
        {
          "id": 383579,
          "text": "<p><span style=\"font-size:14.0pt;\">Olaparib</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old patient is diagnosed with advanced pancreatic neuroendocrine tumor (PNET). The oncologist chooses a targeted therapy that inhibits the mTOR pathway to reduce tumor proliferation and angiogenesis. Which of the following agents fits this profile?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1406013",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Everolimus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Everolimus</strong> is a small molecule inhibitor of <strong>mTOR (mechanistic target of rapamycin)</strong> and is <strong>approved for use in advanced pancreatic neuroendocrine tumors (PNETs)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">By inhibiting mTOR, it interferes with cell growth, proliferation, and angiogenesis in tumor cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is also approved for renal cell carcinoma and other indications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Erlotinib</strong>: An EGFR tyrosine kinase inhibitor used mainly in <strong>non-small cell lung cancer</strong> and <strong>pancreatic adenocarcinoma</strong> (with gemcitabine), <strong>not neuroendocrine tumors</strong>. It does <strong>not target mTOR</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Idelalisib</strong>: A <strong>PI3Kδ inhibitor</strong> approved for <strong>chronic lymphocytic leukemia (CLL)</strong> and <strong>follicular lymphoma</strong>, not indicated in PNETs or as an mTOR inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Olaparib</strong>: A <strong>PARP inhibitor</strong> used in <strong>BRCA-mutated ovarian and breast cancers</strong>. It targets DNA repair mechanisms and is <strong>not related to mTOR inhibition</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Everolimus</strong> is a key mTOR inhibitor used in the management of <strong>advanced pancreatic neuroendocrine tumors</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its mechanism targets a pathway central to cell growth and angiogenesis, making it an effective agent in selected cancers with dysregulated mTOR signaling.</span></li></ul>",
      "correct_choice_id": 383576,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96358/Pharmacology_INICET_GT_30_Oct_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96358/Pharmacology_INICET_GT_30_Oct_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96362,
      "choices": [
        {
          "id": 383592,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 1 is true; statement 2 is true</span></p>"
        },
        {
          "id": 383593,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 1 is true; statement 2 is false</span></p>"
        },
        {
          "id": 383594,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 1 is false; statement 2 is true</span></p>"
        },
        {
          "id": 383595,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 1 is false; statement 2 is false</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Trimetazidine exerts its anti‑ischemic effect primarily via metabolic modulation in cardiomyocytes. Which of the following statements about its mechanism is true, and which is incorrect?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">It inhibits mitochondrial long‑chain 3‑ketoacyl‑CoA thiolase, thereby reducing fatty acid β-oxidation and shifting energy utilization toward glucose.</span></li><li><span style=\"font-size:14.0pt;\">It causes significant coronary vasodilation and reduces myocardial oxygen demand via hemodynamic effects.</span></li></ol>",
      "unique_key": "Q1409679",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Statement 1 is true; statement 2 is false</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. It inhibits mitochondrial long‑chain 3‑ketoacyl‑CoA thiolase, thereby reducing fatty acid β-oxidation and shifting energy utilization toward glucose: </strong>True. Trimetazidine <strong>inhibits the mitochondrial enzyme 3‑ketoacyl‑CoA thiolase (LC-3-KAT)</strong>, an essential component of β-oxidation of fatty acids. By inhibiting this pathway, the myocardium switches to <strong>glucose oxidation</strong>, which requires <strong>less oxygen per ATP molecule</strong> — a major advantage in ischemic tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>It causes significant coronary vasodilation and reduces myocardial oxygen demand via hemodynamic effects:&nbsp;</strong>False. Unlike nitrates or beta-blockers, <strong>trimetazidine does not exert any significant hemodynamic effect</strong>. It does <strong>not alter heart rate, blood pressure, or coronary vasomotor tone</strong>. Its benefit is <strong>purely metabolic</strong>, making it suitable in patients intolerant to hemodynamic agents.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Trimetazidine</strong> is a <strong>metabolic modulator</strong>, not a vasodilator.</span></li><li><span style=\"font-size:14.0pt;\">It improves myocardial ischemia by <strong>enhancing glucose oxidation</strong> and <strong>reducing fatty acid metabolism</strong>, <strong>without affecting blood pressure or heart rate</strong> — making it ideal for <strong>stable angina</strong> patients who cannot tolerate standard antianginal drugs.</span></li></ul>",
      "correct_choice_id": 383593,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96362/Pharmacology_INICET_GT_30_Oct_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96362/Pharmacology_INICET_GT_30_Oct_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96115,
      "choices": [
        {
          "id": 382624,
          "text": "<p><span style=\"font-size:14.0pt;\">Glycogen breakdown</span></p>"
        },
        {
          "id": 382625,
          "text": "<p><span style=\"font-size:14.0pt;\">Ketogenesis</span></p>"
        },
        {
          "id": 382626,
          "text": "<p><span style=\"font-size:14.0pt;\">Glycogen storage&nbsp;</span></p>"
        },
        {
          "id": 382627,
          "text": "<p><span style=\"font-size:14.0pt;\">Gluconeogenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old man has been fasting for the past 24 hours as part of a religious ritual. He reports feeling slightly weak but alert. His blood glucose is 65 mg/dL, and serum ketone levels are mildly elevated. Hormonal studies reveal a low insulin-to-glucagon ratio. Which of the following metabolic processes is least likely to occur under these hormonal conditions?&nbsp;</span></p>",
      "unique_key": "Q6457014",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Glycogen storage</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This 25-year-old man has been <strong>fasting for 24 hours</strong>, which means his body is in a <strong>post-absorptive (fasting) state</strong>.</span></li><li><span style=\"font-size:14.0pt;\">During fasting, <strong>insulin levels fall</strong>, and <strong>glucagon levels rise</strong>, resulting in a <strong>low insulin-to-glucagon ratio</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This hormonal pattern promotes <strong>catabolic</strong> processes that generate glucose and energy substrates to maintain blood glucose levels and support essential organ function (especially the brain).</span></li><li><span style=\"font-size:14.0pt;\">The man’s <strong>blood glucose level of 65 mg/dL</strong> (slightly low but not dangerously hypoglycemic) and <strong>mildly elevated serum ketones</strong> confirm a normal adaptive response to fasting.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The low insulin-to-glucagon ratio activates enzymes involved in <strong>glycogenolysis (glycogen breakdown)</strong>, <strong>gluconeogenesis (glucose synthesis from non-carbohydrate sources)</strong>, and <strong>ketogenesis (production of ketone bodies from fatty acids)</strong> to provide energy.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, <strong>glycogen storage</strong> is an <strong>anabolic process</strong> that occurs in the <strong>fed state</strong>, when insulin levels are high and glucose is abundant. Under the current fasting, low-insulin, high-glucagon conditions, <strong>glycogen synthesis (storage)</strong> is suppressed, as the body prioritizes <strong>energy release</strong>, not storage.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the metabolic process <strong>least likely to occur</strong> under these hormonal conditions is <strong>glycogen storage</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Glycogen breakdown:&nbsp;</strong>True (Likely to occur).<strong>&nbsp;</strong>In fasting, <strong>glycogenolysis</strong> is stimulated by the low insulin-to-glucagon ratio. Glucagon activates <strong>glycogen phosphorylase</strong>, which breaks down glycogen into glucose-1-phosphate, eventually yielding glucose for release into the bloodstream to maintain normal blood sugar levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ketogenesis:&nbsp;</strong>True (Likely to occur).<strong>&nbsp;</strong>As fasting continues and hepatic glycogen stores become depleted, <strong>fatty acid oxidation</strong> increases, producing <strong>acetyl-CoA</strong>, which is converted into <strong>ketone bodies (acetoacetate, β-hydroxybutyrate)</strong> in the liver. The elevated serum ketones in this patient confirm that <strong>ketogenesis</strong> is active.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Gluconeogenesis:&nbsp;</strong>True (Likely to occur).<strong>&nbsp;</strong>When fasting exceeds several hours and glycogen stores begin to decline, the liver activates <strong>gluconeogenesis</strong>, producing glucose from substrates such as <strong>lactate, glycerol, and alanine</strong>. This ensures that blood glucose remains stable, especially for glucose-dependent tissues such as the brain and red blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During fasting, a <strong>low insulin-to-glucagon ratio</strong> stimulates <strong>glycogenolysis, gluconeogenesis, and ketogenesis</strong>, while <strong>glycogen storage</strong> is inhibited — making <strong>glycogen storage</strong> the <strong>least likely process</strong> to occur.</span></p>",
      "correct_choice_id": 382626,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96115/Biochemistry_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96115/Biochemistry_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96354,
      "choices": [
        {
          "id": 383560,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 383561,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 383562,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
        },
        {
          "id": 383563,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following pairs of antibody and manifestation in SLE is correctly matched?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DlRsLBk.png\" width=\"563\" height=\"208\"></strong></span></p>",
      "unique_key": "Q7327326",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 1, 2, 3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Based on the standard <strong>SLE autoantibody associations</strong> (as in Harrison’s 22e / ACR-EULAR), the correct pairings are:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hzpGHu3.png\" width=\"681\" height=\"474\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, the correctly matched antibodies are <strong>1, 2, and 3</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Anti-Ro (SSA)</strong> → Subacute cutaneous lupus, neonatal lupus, heart block</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-dsDNA</strong> → Nephritis and disease activity marker</span></li><li><span style=\"font-size:14.0pt;\"><strong>Antiphospholipid antibodies</strong> → Thrombotic CNS events and pregnancy loss</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anti-RNP</strong> → High interferon signature and MCTD overlap</span></li></ul>",
      "correct_choice_id": 383563,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96354/Medicine_INICET_GT_30_Oct_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96354/Medicine_INICET_GT_30_Oct_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96328,
      "choices": [
        {
          "id": 383456,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
        },
        {
          "id": 383457,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3</span></p>"
        },
        {
          "id": 383458,
          "text": "<p><span style=\"font-size:14.0pt;\">4 only</span></p>"
        },
        {
          "id": 383459,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which pair of syndromic or metabolic cardiomyopathy and its management is correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Sarcoidosis – Selective transthyretin stabilizer and polyneuropathy treatment</span></li><li><span style=\"font-size:14.0pt;\">Danon disease – Enzyme replacement therapy</span></li><li><span style=\"font-size:14.0pt;\">ATTR cardiac amyloidosis – Steroids and immunosuppressants</span></li><li><span style=\"font-size:14.0pt;\">Anderson–Fabry disease – Enzyme replacement therapy</span></li></ol>",
      "unique_key": "Q8716965",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Anderson–Fabry disease – Enzyme replacement therapy</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Anderson–Fabry disease</strong> is an <strong>X-linked lysosomal storage disorder</strong> caused by deficiency of <strong>α-galactosidase A</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Leads to <strong>accumulation of globotriaosylceramide (Gb3)</strong> in lysosomes, causing <strong>cardiac, renal, and neurological</strong> manifestations.</span></li><li><span style=\"font-size:14.0pt;\">Treated with <strong>enzyme replacement therapy (ERT)</strong> using <strong>agalsidase-α or agalsidase-β</strong>, which replaces the deficient enzyme and slows disease progression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Sarcoidosis –– Selective transthyretin stabilizer and polyneuropathy treatment:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cardiac sarcoidosis</strong> is treated with <strong>corticosteroids</strong> and, if needed, <strong>steroid-sparing immunosuppressants</strong> (e.g., methotrexate, azathioprine).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Selective transthyretin stabilizers</strong> (e.g., tafamidis) are used for <strong>ATTR amyloidosis</strong>, not sarcoidosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Danon disease – Enzyme replacement therapy:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Danon disease</strong> is an <strong>X-linked lysosomal storage disorder</strong> caused by <strong>LAMP2 deficiency</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No specific enzyme replacement therapy</strong> currently exists.</span></li><li><span style=\"font-size:14.0pt;\">Management is supportive—heart failure therapy, ICD, or heart transplantation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Enzyme replacement therapy</strong> applies to <strong>Anderson–Fabry</strong> or <strong>Pompe disease</strong>, not Danon.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. ATTR cardiac amyloidosis – Steroids and immunosuppressants:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>ATTR (transthyretin) amyloidosis</strong> is treated with <strong>selective transthyretin stabilizers</strong> (e.g., tafamidis, diflunisal) and <strong>neuropathy-directed therapy</strong> (e.g., patisiran, inotersen).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Steroids and immunosuppressants</strong> are <strong>not effective</strong> in ATTR amyloidosis; they are used in sarcoidosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XIP1mKE.png\" width=\"682\" height=\"373\"></strong></span></p>",
      "correct_choice_id": 383458,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96328/Medicine_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96328/Medicine_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96304,
      "choices": [
        {
          "id": 383364,
          "text": "<p><span style=\"font-size:14.0pt;\">Loss of pupillary light reflex</span></p>"
        },
        {
          "id": 383365,
          "text": "<p><span style=\"font-size:14.0pt;\">Response of vessels to 2.5% phenylephrine</span></p>"
        },
        {
          "id": 383366,
          "text": "<p><span style=\"font-size:14.0pt;\">Fluorescein staining of cornea</span></p>"
        },
        {
          "id": 383367,
          "text": "<p><span style=\"font-size:14.0pt;\">Tonometry revealing increased intraocular pressure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following examination findings best helps differentiate episcleritis from scleritis in an outpatient setting?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7779132",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Response of vessels to 2.5% phenylephrine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>episcleritis</strong>, the inflamed <strong>episcleral vessels blanch</strong> with topical <strong>2.5% phenylephrine</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>scleritis</strong>, the inflamed <strong>deep scleral vessels do not blanch</strong>, because the inflammation is deeper and less accessible to the vasoconstrictive effect of phenylephrine.</span></li><li><span style=\"font-size:14.0pt;\">This test is a <strong>commonly used clinical maneuver</strong> to distinguish between the two in real-life outpatient ophthalmologic practice.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Loss of pupillary light reflex:&nbsp;</strong>This would suggest more severe intraocular pathology like <strong>optic nerve involvement</strong>, <strong>retinal detachment</strong>, or <strong>acute glaucoma</strong>, not typically seen in either <strong>episcleritis or scleritis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fluorescein staining of cornea:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Useful for <strong>corneal abrasions, ulcers, keratitis</strong>, etc.</span></li><li><span style=\"font-size:14.0pt;\">Not relevant for differentiating <strong>episcleral vs. scleral</strong> inflammation (which is deeper).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tonometry revealing increased intraocular pressure:&nbsp;</strong>Elevated IOP is associated with <strong>glaucoma</strong> or <strong>uveitis with angle involvement</strong>, not diagnostic for episcleritis or scleritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Episcleritis</strong>: Mild, self-limiting inflammation, vessels blanch with 2.5% phenylephrine.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Scleritis</strong>: Deep, severe pain, no blanching with phenylephrine, may impair vision.</span></li><li><span style=\"font-size:14.0pt;\">Phenylephrine response is the <strong>most reliable outpatient clinical test</strong> to differentiate between the two.</span></li></ul>",
      "correct_choice_id": 383365,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96304/Ophthalmology_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96304/Ophthalmology_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96385,
      "choices": [
        {
          "id": 383684,
          "text": "<p><span style=\"font-size:14.0pt;\">Mycolic acid</span></p>"
        },
        {
          "id": 383685,
          "text": "<p><span style=\"font-size:14.0pt;\">Arabinogalactan</span></p>"
        },
        {
          "id": 383686,
          "text": "<p><span style=\"font-size:14.0pt;\">Lipoarabinomannan (LAM)</span></p>"
        },
        {
          "id": 383687,
          "text": "<p><span style=\"font-size:14.0pt;\">Peptidoglycan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man presents with a persistent cough, weight loss, and night sweats for the past month. Chest radiograph reveals cavitary lesions in the upper lobe of the right lung. The schematic image below represents the cell envelope structure of the causative organism. Which of the following components depicted in the image is the primary urinary antigen detected in this patient?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_OPzCNGv.png\" width=\"822\" height=\"630\"></strong></span></p>",
      "unique_key": "Q4740618",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Lipoarabinomannan (LAM)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lipoarabinomannan (LAM) is a lipopolysaccharide specific to the <strong>Mycobacterium tuberculosis</strong> cell wall.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>released into body fluids during active infection</strong> and <strong>can be detected in urine</strong>, especially in immunocompromised patients (e.g., HIV).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The image shows LAM as an extended branched structure (pink) linked to the mycobacterial cell wall.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Detection of urinary LAM is a <strong>non-invasive diagnostic marker</strong> for active tuberculosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mycolic acid:&nbsp;</strong>These are long-chain fatty acids responsible for the <strong>acid-fast nature</strong> of the organism, but not excreted in urine or used for antigen detection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Arabinogalactan:&nbsp;</strong>This polysaccharide links peptidoglycan to mycolic acids but remains bound within the bacterial cell wall; not excreted or antigenically detected in clinical tests.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Peptidoglycan:&nbsp;</strong>Present in almost all bacteria; not specific, and its fragments are <strong>not typically used in TB diagnostics</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Urinary detection of Lipoarabinomannan (LAM), a unique mycobacterial lipoglycan, is used for rapid diagnosis of Mycobacterium tuberculosis, especially in immunocompromised patients.</span></p>",
      "correct_choice_id": 383686,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96385/Microbiology_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96385/Microbiology_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96108,
      "choices": [
        {
          "id": 382596,
          "text": "<p><span style=\"font-size:14.0pt;\">1–c, 2–b, 3–d, 4–a</span></p>"
        },
        {
          "id": 382597,
          "text": "<p><span style=\"font-size:14.0pt;\">1–a, 2–c, 3–b, 4–d</span></p>"
        },
        {
          "id": 382598,
          "text": "<p><span style=\"font-size:14.0pt;\">1–c, 2–d, 3–b, 4–a</span></p>"
        },
        {
          "id": 382599,
          "text": "<p><span style=\"font-size:14.0pt;\">1–d, 2–a, 3–c, 4–b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following choose the correct match:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1lBZ2Yh.png\" width=\"987\" height=\"214\"></p>",
      "unique_key": "Q2239059",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1–c, 2–b, 3–d, 4–a</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1–c. Cerebral circulation:</strong> Controlled mainly by <strong>local CO₂ and H⁺ levels</strong> → vasodilation when ↑CO₂ or ↓pH.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2–b. Coronary circulation:</strong> <strong>Metabolic control (adenosine)</strong> dominates, increasing blood flow with cardiac work.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3–d. Skeletal muscle:</strong> Resting tone under <strong>sympathetic vasoconstriction</strong> (α₁). During exercise, local metabolites override this.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4–a. Renal circulation:</strong> Controlled by <strong>myogenic and tubuloglomerular feedback</strong> mechanisms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Each vascular bed has a <strong>dominant autoregulatory mechanism</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Brain:</strong> CO₂ and H⁺ levels</span></li><li><span style=\"font-size:14.0pt;\"><strong>Heart:</strong> Adenosine-mediated metabolic control</span></li><li><span style=\"font-size:14.0pt;\"><strong>Muscle:</strong> Metabolic vasodilation</span></li><li><span style=\"font-size:14.0pt;\"><strong>Kidney:</strong> Myogenic response</span></li></ul>",
      "correct_choice_id": 382596,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96108/Physiology_INICET_GT_30_Oct_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96108/Physiology_INICET_GT_30_Oct_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96087,
      "choices": [
        {
          "id": 382512,
          "text": "<p><span style=\"font-size:14.0pt;\">Swan-Neck Deformity&nbsp;</span></p>"
        },
        {
          "id": 382513,
          "text": "<p><span style=\"font-size:14.0pt;\">Mallet Finger&nbsp;</span></p>"
        },
        {
          "id": 382514,
          "text": "<p><span style=\"font-size:14.0pt;\">Boutonnière Deformity&nbsp;</span></p>"
        },
        {
          "id": 382515,
          "text": "<p><span style=\"font-size:14.0pt;\">Ulnar Drift</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman with a 15-year history of rheumatoid arthritis presents with chronic stiffness and deformity in her hands. She reports that she is unable to completely straighten the middle joint of her fingers. She often has trouble performing activities requiring fine motor control, like buttoning a shirt. An X-ray confirms chronic erosive changes consistent with RA. Which of the following is the most likely diagnosis for this specific finger deformity?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qRuznEz.png\" width=\"533\" height=\"324\"></strong></span></p>",
      "unique_key": "Q6199361",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Boutonnière Deformity</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The definition of Boutonnière (French for \"buttonhole\") deformity is the specific posturing described: Flexion of the PIP joint combined with hyperextension of the DIP joint.</span></li><li><span style=\"font-size:14.0pt;\">This deformity results from disruption (rupture or severe stretching) of the central slip of the extensor tendon at the PIP joint.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Without the central slip, the lateral bands of the extensor mechanism slide downward (palmarward) and become flexors of the PIP joint, causing the PIP flexion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The tension then increases on the terminal tendon, causing compensatory DIP hyperextension.</span></li><li><span style=\"font-size:14.0pt;\">The patient's history of chronic RA (a common cause), inability to straighten the middle joint (PIP flexion), and the specific posture fit the Boutonnière deformity perfectly.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Swan-Neck Deformity:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Swan-neck deformity is the exact opposite posturing: Hyperextension of the PIP joint and flexion of the DIP joint.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is also common in RA but is defined by this contrasting position.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cdt1e8V.png\" width=\"579\" height=\"391\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mallet Finger:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mallet finger involves an isolated injury or rupture of the terminal extensor tendon at the DIP joint.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This leads to an isolated, uncontrolled flexion of the DIP joint only, with the PIP joint remaining straight or neutral.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does not involve the PIP joint flexion characteristic of the Boutonnière deformity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_GPB4CFz.png\" width=\"689\" height=\"462\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ulnar Drift:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ulnar drift is a common overall hand deformity in RA characterized by the fingers deviating toward the ulnar (little finger) side at the metacarpophalangeal (MCP) joints.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While present in the patient, it describes the hand-level deviation, not the specific PIP/DIP joint posturing of a single finger.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iabKi0u.png\" width=\"739\" height=\"432\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Boutonnière (or Buttonhole) Deformity is a characteristic finger deformity resulting from damage to the central slip of the extensor tendon at the Proximal Interphalangeal (PIP) joint.</span></p>",
      "correct_choice_id": 382514,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96087/Orthopedic_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96087/Orthopedic_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96275,
      "choices": [
        {
          "id": 383248,
          "text": "<p><span style=\"font-size:14.0pt;\">Serial ultrasound monitoring</span></p>"
        },
        {
          "id": 383249,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate chemotherapy</span></p>"
        },
        {
          "id": 383250,
          "text": "<p><span style=\"font-size:14.0pt;\">CT scan of the abdomen and pelvis followed by staging laparotomy</span></p>"
        },
        {
          "id": 383251,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat CA-125 level in 2 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 61-year-old postmenopausal woman presents with progressive abdominal distension and early satiety. Pelvic ultrasound shows a 10 cm complex adnexal mass with thick septations and ascites. Her CA-125 level is 580 U/mL. What is the most appropriate next step in management?</span></p>",
      "unique_key": "Q8719384",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) CT scan of the abdomen and pelvis followed by staging laparotomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a <strong>postmenopausal woman</strong> presenting with a <strong>large complex adnexal mass</strong>, <strong>ascites</strong>, and <strong>markedly elevated CA-125</strong>, the primary concern is <strong>epithelial ovarian carcinoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The appropriate <strong>next step</strong> is to obtain a <strong>CT scan of the abdomen and pelvis</strong> to assess the <strong>extent of disease</strong>, possible <strong>metastases</strong>, and <strong>operability</strong>, followed by a <strong>staging laparotomy</strong> (not laparoscopy) for both <strong>diagnosis and definitive surgical management</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Staging laparotomy includes:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Total abdominal hysterectomy with bilateral salpingo-oophorectomy (TAH-BSO)</span></li><li><span style=\"font-size:14.0pt;\">Omentectomy</span></li><li><span style=\"font-size:14.0pt;\">Peritoneal washings and multiple peritoneal biopsies</span></li><li><span style=\"font-size:14.0pt;\">Lymph node sampling</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This approach allows for <strong>accurate staging</strong> and <strong>optimal cytoreduction</strong>, which are critical for prognosis and guiding postoperative chemotherapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Serial ultrasound monitoring:&nbsp;</strong>Appropriate for <strong>premenopausal women</strong> with <strong>simple cysts &lt;5 cm</strong> and normal CA-125 levels. In a postmenopausal woman with a large complex mass and elevated CA-125, this would delay diagnosis and treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Immediate chemotherapy:&nbsp;</strong>Chemotherapy should <strong>never precede histologic confirmation</strong> unless the patient is <strong>medically unfit for surgery</strong> or has <strong>inoperable disease</strong> confirmed by imaging and biopsy. First-line management is <strong>surgical staging and cytoreduction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Repeat CA-125 level in 2 weeks:&nbsp;</strong>Repeating CA-125 is useful for <strong>monitoring known disease</strong>, not for initial diagnosis. The markedly elevated CA-125 with imaging findings already warrants immediate further evaluation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a <strong>postmenopausal woman</strong> with a <strong>complex adnexal mass, ascites, and elevated CA-125</strong>, the <strong>most appropriate next step</strong> is a <strong>CT scan of the abdomen and pelvis</strong> to evaluate disease extent, followed by <strong>staging laparotomy</strong> for diagnosis, staging, and surgical management of <strong>suspected ovarian carcinoma</strong>.</span></p>",
      "correct_choice_id": 383250,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96275/Ini-Cet_Gt_30_Oct_2025_Obg_Q_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96275/Ini-Cet_Gt_30_Oct_2025_Obg_Q_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96133,
      "choices": [
        {
          "id": 382692,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 382693,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 382694,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 382695,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following statements about vaccination in HIV or immunosuppressed individuals are incorrect, except?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">In asymptomatic HIV, there are no vaccine contraindications listed.</span></li><li><span style=\"font-size:14.0pt;\">In symptomatic HIV, all live vaccines are absolutely contraindicated.</span></li><li><span style=\"font-size:14.0pt;\">In symptomatic HIV, MMR and varicella (and zoster) may be given if required.</span></li><li><span style=\"font-size:14.0pt;\">In corticosteroid-induced immunosuppression, all live vaccines are contraindicated.</span></li></ol>",
      "unique_key": "Q9510649",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. In asymptomatic HIV, there are no vaccine contraindications listed:</strong> Correct. In the provided program list, asymptomatic HIV has <strong>no specific vaccine contraindications</strong> noted; routine immunization generally proceeds as indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. In symptomatic HIV, MMR and varicella (and zoster) may be given if required: </strong>Correct. Although live vaccines are usually avoided in symptomatic HIV, the list <strong>explicitly allows MMR, varicella, and zoster</strong> when required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. In corticosteroid-induced immunosuppression, all live vaccines are contraindicated:</strong> Correct. <strong>All live vaccines</strong> are contraindicated during significant immunosuppression (e.g., high-dose systemic corticosteroids).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. In symptomatic HIV, MMR and varicella (and zoster) may be given if required:</strong> Incorrect. “All live vaccines are absolutely contraindicated in symptomatic HIV” is <strong>too strict</strong> because <strong>MMR, varicella, and zoster</strong> are permitted exceptions in the provided guidance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Asymptomatic HIV:</strong> no listed vaccine contraindications.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Symptomatic HIV:</strong> live vaccines generally avoided <strong>except</strong> <strong>MMR, varicella, and zoster</strong> may be given if required.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Any significant immunosuppression (e.g., high-dose steroids):</strong> <strong>avoid all live vaccines</strong>.</span></li></ul>",
      "correct_choice_id": 382693,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96133/NEET_PG_30_Oct_2025_GT_PSM_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96133/NEET_PG_30_Oct_2025_GT_PSM_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96329,
      "choices": [
        {
          "id": 383460,
          "text": "<p><span style=\"font-size:14.0pt;\">Dengue fever</span></p>"
        },
        {
          "id": 383461,
          "text": "<p><span style=\"font-size:14.0pt;\">Chikungunya fever</span></p>"
        },
        {
          "id": 383462,
          "text": "<p><span style=\"font-size:14.0pt;\">Zika virus infection</span></p>"
        },
        {
          "id": 383463,
          "text": "<p><span style=\"font-size:14.0pt;\">Falciparum malaria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman has 4 days of high fever (40°C), arthralgia, and a diffuse pink macular rash on the trunk. Exam shows synovitis of proximal small joints in both hands and tenderness over both MTPs. Vitals are stable (HR 95, BP 108/80, SpO₂ 97%). CBC is normal. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q3021551",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Chikungunya fever</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s presentation of <strong>acute high-grade fever</strong>, <strong>maculopapular rash</strong>, and <strong>severe polyarthralgia with synovitis</strong> strongly suggests <strong>Chikungunya fever</strong>, an <strong>RNA virus (Togaviridae, Alphavirus)</strong> transmitted by the <strong>Aedes mosquito</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key diagnostic clues:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>High fever</strong> and <strong>polyarthritis/polyarthralgia</strong> (especially small joints of hands and feet)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Maculopapular or pinkish rash</strong> on trunk and limbs</span></li><li><span style=\"font-size:14.0pt;\"><strong>Normal platelet and WBC counts</strong> (distinguishes from dengue)</span></li><li><span style=\"font-size:14.0pt;\">Usually <strong>self-limited</strong> but joint pain can persist for months in some cases</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Dengue fever:&nbsp;</strong>Often presents with <strong>thrombocytopenia</strong>, <strong>leukopenia</strong>, <strong>severe myalgia (“breakbone fever”)</strong>, and sometimes <strong>hemorrhagic manifestations</strong> — not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Zika virus infection:&nbsp;</strong>Typically causes <strong>mild fever</strong>, <strong>conjunctivitis</strong>, and <strong>maculopapular rash</strong> with <strong>less severe arthralgia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Falciparum malaria:&nbsp;</strong>Characterized by <strong>high fever with chills</strong>, <strong>anemia</strong>, and <strong>splenomegaly</strong>, none of which are seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Chikungunya fever</strong> is a <strong>mosquito-borne viral infection</strong> characterized by:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4qpCGCC.png\" width=\"563\" height=\"288\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key distinction:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Severe <strong>arthralgia with normal platelet count</strong> → <strong>Chikungunya</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Thrombocytopenia and hemorrhagic signs</strong> → <strong>Dengue</strong></span></li></ul>",
      "correct_choice_id": 383461,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96329/Medicine_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96329/Medicine_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96086,
      "choices": [
        {
          "id": 382508,
          "text": "<p><span style=\"font-size:14.0pt;\">Lumbar Radiculopathy</span></p>"
        },
        {
          "id": 382509,
          "text": "<p><span style=\"font-size:14.0pt;\">Spinal Stenosis&nbsp;</span></p>"
        },
        {
          "id": 382510,
          "text": "<p><span style=\"font-size:14.0pt;\">Transverse Myelitis&nbsp;</span></p>"
        },
        {
          "id": 382511,
          "text": "<p><span style=\"font-size:14.0pt;\">Cauda Equina Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old male with a known history of severe lumbar disc herniation presents to the OPD with a 24-hour history of severe low back pain radiating down both legs, bilateral leg weakness, and numbness in his inner thighs and buttocks. He reports difficulty initiating urination and an inability to feel the sensation of a full bladder. Physical examination reveals decreased anal sphincter tone and absent ankle jerks bilaterally. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8186184",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Cauda Equina Syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">CES represents a massive compression of the cauda equina nerve roots (L2-S5) below the termination of the spinal cord. The classic presentation—which is fully met by the patient—involves:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Saddle Anesthesia:</strong> Numbness and paresthesia affecting the perineum, buttocks, and inner thighs, corresponding to the S2-S5 nerve roots.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bowel and Bladder Dysfunction:</strong> Urinary retention (difficulty initiating urination and inability to sense a full bladder) is the most sensitive sign, often accompanied by decreased anal sphincter tone. This is critical for S2-S4 function.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bilateral Lower Extremity Deficits:</strong> Multi-level weakness and sensory changes, evidenced here by bilateral leg weakness and absent ankle jerks (S1 root).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The patient's history of a severe lumbar disc herniation is the most common cause of acute CES. This condition requires emergency surgical decompression to prevent permanent neurological damage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lumbar Radiculopathy:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lumbar radiculopathy is compression of a single nerve root (e.g., L5 or S1), typically caused by a smaller, unilateral disc herniation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The symptoms are characterized by pain, numbness, and weakness in the distribution of that single root, and are nearly always unilateral.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Radiculopathy does not cause bilateral neurological deficits or bladder/bowel dysfunction, making it an incorrect diagnosis for this severe, bilateral presentation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Spinal Stenosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Spinal stenosis is a chronic narrowing of the spinal canal, most common in older adults, leading to neurogenic claudication (leg pain/weakness brought on by standing or walking and relieved by sitting or bending forward).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While severe stenosis can occasionally precipitate CES, the typical presentation is chronic and positional, not the acute, severe onset of catastrophic deficits involving bladder function seen here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Transverse Myelitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Transverse myelitis is an inflammatory disorder of the spinal cord itself.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pathology involving the spinal cord (above L1/L2) causes upper motor neuron (UMN) signs below the level of the lesion, which include spasticity, hyperreflexia, and a positive Babinski sign.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since CES affects the nerve roots (lower motor neurons) below the cord, it causes flaccidity and absent reflexes (lower motor neuron signs), as evidenced by the absent ankle jerks.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the pattern of deficits is inconsistent with a spinal cord lesion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recognize Cauda Equina Syndrome (CES) as an acute neurosurgical emergency by identifying its characteristic clinical triad—saddle anesthesia, bowel/bladder dysfunction, and bilateral, multi-level lower extremity motor/sensory deficits—and differentiating it from more common, less urgent spinal pathologies.</span></p>",
      "correct_choice_id": 382511,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96086/Orthopedic_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96086/Orthopedic_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96138,
      "choices": [
        {
          "id": 382712,
          "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-d, 3-a, 4-b</span></p>"
        },
        {
          "id": 382713,
          "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-b, 3-c, 4-d</span></p>"
        },
        {
          "id": 382714,
          "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-a, 3-b, 4-d</span></p>"
        },
        {
          "id": 382715,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-b, 4-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following diagnostic/public health tests with their purpose:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20165133.jpg\" width=\"1078\" height=\"237\"></p>",
      "unique_key": "Q9410330",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1-c, 2-a, 3-b, 4-d</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-c. Shake Test → Freeze damage to aluminium-adjuvanted vaccines:&nbsp;</strong>Used to check if vaccines like DPT, TT, Hep B, PCV13 have been damaged by freezing.</span></li><li><span style=\"font-size:14.0pt;\"><strong>2-a. Schick Test → Susceptibility to diphtheria:&nbsp;</strong>An intradermal skin test to detect immunity against diphtheria toxin.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-b. Habel Test → Potency of rabies vaccine</strong>: An in vivo test historically used to assess rabies vaccine potency.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4-d. Tine Test → Screening for tuberculosis: </strong>An outdated, multipuncture skin test for TB exposure, less reliable than Mantoux.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Shake test</strong>: Cold chain quality check for freeze-sensitive vaccines.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Schick test</strong>: Diphtheria susceptibility.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Habel test</strong>: Rabies vaccine potency.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tine test, Heaf test, Mantoux test:</strong> TB screening.</span></li></ul>",
      "correct_choice_id": 382714,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96138/NEET_PG_30_Oct_2025_GT_PSM_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96138/NEET_PG_30_Oct_2025_GT_PSM_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96319,
      "choices": [
        {
          "id": 383420,
          "text": "<p><span style=\"font-size:14.0pt;\">Myocutaneous flap</span></p>"
        },
        {
          "id": 383421,
          "text": "<p><span style=\"font-size:14.0pt;\">Osseomyocutaneous flap</span></p>"
        },
        {
          "id": 383422,
          "text": "<p><span style=\"font-size:14.0pt;\">Subcutaneous flap</span></p>"
        },
        {
          "id": 383423,
          "text": "<p><span style=\"font-size:14.0pt;\">Fasciocutaneous flap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with oral carcinoma requires free tissue transfer for reconstruction after resection. This type of flap is best classified as which of the following?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-29%20103732.jpg\" width=\"685\" height=\"472\"></p>",
      "unique_key": "Q2552240",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Fasciocutaneous flap</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>radial forearm free flap (FRAFF)</strong> is a <strong>fasciocutaneous flap</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is based on fasciocutaneous perforators arising from the <strong>radial artery</strong>, with the greatest density of perforators between 12–20 cm from its origin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This flap provides a thin, pliable, and reliable tissue for reconstruction, making it especially useful in <strong>oral cavity and head-neck reconstruction</strong> where contour and mobility are important.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Myocutaneous flap:&nbsp;</strong>Incorrect. These include flaps like latissimus dorsi or transverse rectus abdominis (TRAM), where both muscle and overlying skin are transferred together. FRAFF does not include muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Osseomyocutaneous flap:&nbsp;</strong>Incorrect. These involve bone along with muscle and skin, such as <strong>fibula osteocutaneous flap</strong> or iliac crest flaps. The radial forearm flap can sometimes include a small segment of radius bone, but the <strong>standard FRAFF is fasciocutaneous only</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Subcutaneous flap:&nbsp;</strong>Incorrect. Pure subcutaneous flaps are rare and consist only of fat and overlying skin. FRAFF has a fascial component and is classified under fasciocutaneous flaps.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The free radial artery forearm flap is a fasciocutaneous flap based on radial artery perforators, widely used in head and neck reconstructive surgery for its thin, pliable, and reliable tissue.</span></p>",
      "correct_choice_id": 383423,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96319/NEET_PG_30_Oct_2025_GT_Surgery_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96319/NEET_PG_30_Oct_2025_GT_Surgery_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96090,
      "choices": [
        {
          "id": 382524,
          "text": "<p><span style=\"font-size:14.0pt;\">A lesion at point C results in paralytic agitans, while a lesion at point F leads to disturbance in the Papez circuit.</span></p>"
        },
        {
          "id": 382525,
          "text": "<p><span style=\"font-size:14.0pt;\">Point B is considered the fifth lobe of the brain, and point F is part of the sixth (limbic) lobe.</span></p>"
        },
        {
          "id": 382526,
          "text": "<p><span style=\"font-size:14.0pt;\">Point A is not part of the basal nuclei, while point F is not part of the limbic system.</span></p>"
        },
        {
          "id": 382527,
          "text": "<p><span style=\"font-size:14.0pt;\">Point D represents the largest commissural fiber, and point E acts as an afferent to the mammillary body.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following statements regarding the labelled brain sections are correct, except:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FB3NGgU.png\" width=\"555\" height=\"335\"></span></p>",
      "unique_key": "Q7335062",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Point</strong> <strong>A is not part of the basal nuclei, while point F is not part of the limbic system.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Point A (Claustrum)</strong> is <strong>not part of the basal nuclei</strong>, but <strong>F (Hippocampus)</strong> <strong>is</strong> part of the <strong>limbic system</strong>, making the statement incorrect.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point</strong> <strong>C (Substantia Nigra)</strong> → Lesion here causes <strong>parkinsonism (paralytic agitans)</strong> due to dopaminergic neuron loss.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point</strong> <strong>F (Hippocampus)</strong> → Involved in the <strong>Papez circuit</strong>, crucial for <strong>memory and emotion</strong>, part of the <strong>limbic lobe</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point</strong> <strong>B (Insula)</strong> → Considered the <strong>fifth lobe</strong> of the brain.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point</strong> <strong>D (Corpus Callosum)</strong> → The <strong>largest commissural fiber</strong>, connecting both cerebral hemispheres.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point</strong> <strong>E (Fornix)</strong> → Carries <strong>afferent fibers from the hippocampus to the mammillary bodies</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Tyz8cGt.png\" width=\"727\" height=\"575\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Sd83CBG.png\" width=\"718\" height=\"479\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hippocampus</strong> forms an essential component of the <strong>limbic system</strong> and the <strong>Papez circuit</strong>, while the <strong>corpus callosum</strong> is the <strong>largest commissural fiber</strong> connecting the cerebral hemispheres.</span></p>",
      "correct_choice_id": 382526,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96090/Anatomy_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96090/Anatomy_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96361,
      "choices": [
        {
          "id": 383588,
          "text": "<p><span style=\"font-size:14.0pt;\">Pustular psoriasis</span></p>"
        },
        {
          "id": 383589,
          "text": "<p><span style=\"font-size:14.0pt;\">Staphylococcal infection</span></p>"
        },
        {
          "id": 383590,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute generalized exanthematous pustulosis</span></p>"
        },
        {
          "id": 383591,
          "text": "<p><span style=\"font-size:14.0pt;\">Subcorneal pustulosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient was treated with steroids for psoriasis. On stopping the treatment, he developed fever, malaise, and pustular lesions as shown in the image below. What is the most probable diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KO3QmyW.png\" width=\"625\" height=\"396\"></strong></span></p>",
      "unique_key": "Q9993991",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Pustular psoriasis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pustular psoriasis</strong> is an <strong>acute, severe, and potentially life-threatening variant</strong> of psoriasis characterized by <strong>widespread sterile pustules on an erythematous base</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is often <strong>precipitated by sudden withdrawal of systemic corticosteroids or coal tar therapy</strong> in a patient with chronic plaque psoriasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical features include:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fever, malaise, leukocytosis</strong> (systemic toxicity)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sterile pustules</strong> that may coalesce to form “lakes of pus”</span></li><li><span style=\"font-size:14.0pt;\">Histology shows <strong>spongiform pustules of Kogoj</strong> (collections of neutrophils in epidermis)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Staphylococcal infection:&nbsp;</strong>Causes pustules filled with <strong>infected pus</strong> (positive culture) and <strong>systemic sepsis</strong>; not seen following steroid withdrawal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acute generalized exanthematous pustulosis (AGEP):&nbsp;</strong>A <strong>drug reaction</strong> (commonly to beta-lactams or macrolides) with <strong>pinpoint pustules</strong> and <strong>rapid desquamation</strong>, resolving within days after drug withdrawal; not related to psoriasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Subcorneal pustulosis (Sneddon–Wilkinson disease):&nbsp;</strong>A <strong>chronic relapsing sterile pustular dermatosis</strong> seen in <strong>middle-aged women</strong>, limited to <strong>flexural areas</strong>, and not associated with systemic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Withdrawal of systemic corticosteroids</strong> in a psoriatic patient can precipitate <strong>generalized pustular psoriasis (von Zumbusch type)</strong> — a dermatologic emergency characterized by <strong>fever, malaise, and widespread sterile pustules</strong> on erythematous skin.</span></p>",
      "correct_choice_id": 383588,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96361/Dermatology_INICET_GT_30_Oct_Question__3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96361/Dermatology_INICET_GT_30_Oct_Question__3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96083,
      "choices": [
        {
          "id": 382496,
          "text": "<p><span style=\"font-size:14.0pt;\">Diffuse Idiopathic Skeletal Hyperostosis&nbsp;</span></p>"
        },
        {
          "id": 382497,
          "text": "<p><span style=\"font-size:14.0pt;\">Ankylosing Spondylitis&nbsp;</span></p>"
        },
        {
          "id": 382498,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteoarthritis</span></p>"
        },
        {
          "id": 382499,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteomyelitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman presents with a 6-month history of low back stiffness and pain that is worst in the morning and improves significantly with exercise. She also reports alternating buttock pain. Her physical exam is notable for restricted range of motion in the lumbar spine. Which of the following is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_lt5whw0.png\" width=\"453\" height=\"451\"></span></p>",
      "unique_key": "Q2796521",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ankylosing Spondylitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's presentation perfectly aligns with the diagnostic profile of AS:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Patient Profile:</strong> Young man (30-year-old).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pain Pattern (Inflammatory):</strong> Back pain that is worst in the morning and improves significantly with exercise. This is the hallmark of inflammatory back pain.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical Signs:</strong> Restricted range of motion and alternating buttock pain (referred pain from the sacroiliac joints).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Radiographic Signs:</strong> Bilateral sacroiliitis (erosions and fusion in the SI joints) is the earliest and most essential radiographic feature. Thin, vertical syndesmophytes represent the classic spine ossification pattern.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The presence of sacroiliitis combined with inflammatory back pain in a young man makes AS the definitive diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Diffuse Idiopathic Skeletal Hyperostosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rationale:</strong> DISH is a major differential for spinal ossification but is easily distinguished by key factors:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Patient Profile:</strong> Typically affects older individuals (≥50 years), often associated with obesity and diabetes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pain Pattern (Mechanical/Non-inflammatory):</strong> Back pain is usually mild stiffness, often not significantly improved by exercise.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Radiographic Contrast:</strong> DISH is characterized by thick, \"flowing\" ossification (like melted candle wax) that bridges vertebrae, but crucially, the sacroiliac joints are preserved (no erosions or fusion), and the disc spaces are generally maintained.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The patient's age and, most importantly, the presence of sacroiliitis strongly rule out classic DISH.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Osteoarthritis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rationale:</strong> Osteoarthritis (OA) is a degenerative joint disease:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Patient Profile:</strong> Usually affects older individuals.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pain Pattern (Mechanical):</strong> Pain is typically worse with activity and relieved<strong>&nbsp;</strong>by rest (the opposite of this patient's symptoms).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Radiographic Contrast:</strong> While OA causes osteophytes (bony spurs), it does not cause the severe, bilateral erosive and fusing changes seen in the sacroiliac joints (sacroiliitis) or the specific thin, vertical syndesmophytes of AS.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The inflammatory nature of the pain and the specific radiographic signs of sacroiliitis excludes OA.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Osteomyelitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Rationale:</strong> Osteomyelitis is a bone infection:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Pain Pattern:</strong> Causes severe, localized, acute pain that is often unremitting and may be accompanied by systemic signs like fever and malaise.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Radiographic Contrast:</strong> X-rays would show signs of acute bony destruction and disc space narrowing at the site of infection, typically involving only one or two segments, not the bilateral, chronic inflammatory changes seen across the entire sacroiliac joint and spine.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The chronic, 6-month history and the specific widespread, bilateral inflammatory pattern rule out acute bacterial bone infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The classic inflammatory features (clinical and radiographic) that differentiate Ankylosing Spondylitis (AS) from other chronic spine conditions, particularly the distinction between inflammatory and mechanical back pain patterns, and the specific radiographic signs of sacroiliitis and syndesmophytes.</span></p>",
      "correct_choice_id": 382497,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96083/Orthopedic_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96083/Orthopedic_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96265,
      "choices": [
        {
          "id": 383208,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypergonadotropic hypogonadism with gynecomastia</span></p>"
        },
        {
          "id": 383209,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypogonadotropic hypogonadism with anosmia</span></p>"
        },
        {
          "id": 383210,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypergonadotropic hypogonadism with short stature</span></p>"
        },
        {
          "id": 383211,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypogonadotropic hypogonadism with normal olfaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following conditions best describes Kallmann syndrome?&nbsp;</span></p>",
      "unique_key": "Q5310908",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hypogonadotropic hypogonadism with anosmia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Kallmann syndrome</strong> is a <strong>congenital form of hypogonadotropic hypogonadism</strong> caused by defective migration of <strong>gonadotropin-releasing hormone (GnRH) neurons</strong> and <strong>olfactory neurons</strong> from the olfactory placode to the hypothalamus during embryonic development.</span></li><li><span style=\"font-size:14.0pt;\">As a result:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>GnRH secretion is decreased</strong>, leading to low <strong>LH</strong> and <strong>FSH</strong> levels.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Testosterone (or estrogen)</strong> levels are also reduced.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>olfactory bulbs</strong> fail to develop, resulting in <strong>anosmia (loss of smell)</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical features include:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Delayed or absent puberty</span></li><li><span style=\"font-size:14.0pt;\">Micropenis, cryptorchidism in males</span></li><li><span style=\"font-size:14.0pt;\">Amenorrhea in females</span></li><li><span style=\"font-size:14.0pt;\">Loss of smell (anosmia or hyposmia)</span></li><li><span style=\"font-size:14.0pt;\">Occasionally midline defects (e.g., cleft lip/palate)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Genetics:</strong> Most commonly <strong>X-linked recessive (KAL1 gene)</strong>, though autosomal variants exist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Treatment:</strong> Pulsatile <strong>GnRH therapy</strong> or <strong>exogenous gonadotropins</strong> to induce puberty and restore fertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hypergonadotropic hypogonadism with gynecomastia:&nbsp;</strong>Seen in <strong>Klinefelter syndrome (47,XXY)</strong> due to primary testicular failure, resulting in high LH and FSH, not seen in Kallmann syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hypergonadotropic hypogonadism with short stature:&nbsp;</strong>Occurs in <strong>Turner syndrome (45, X)</strong>, affecting females with streak ovaries and elevated gonadotropins, not males.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hypogonadotropic hypogonadism with normal olfaction:&nbsp;</strong>Can result from hypothalamic or pituitary disorders but <strong>without olfactory deficits</strong>, distinguishing it from Kallmann syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Kallmann syndrome</strong> is characterized by <strong>hypogonadotropic hypogonadism with anosmia</strong> due to <strong>failed migration of GnRH and olfactory neurons</strong>, resulting in delayed puberty and infertility.</span></p>",
      "correct_choice_id": 383209,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96265/Ini-Cet_Gt_30_Oct_2025_Obg_Q_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96265/Ini-Cet_Gt_30_Oct_2025_Obg_Q_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96373,
      "choices": [
        {
          "id": 383636,
          "text": "<p><span style=\"font-size:14.0pt;\">Well-defined lytic lesion</span></p>"
        },
        {
          "id": 383637,
          "text": "<p><span style=\"font-size:14.0pt;\">Narrow zone of transition</span></p>"
        },
        {
          "id": 383638,
          "text": "<p><span style=\"font-size:14.0pt;\">No surrounding sclerotic rim</span></p>"
        },
        {
          "id": 383639,
          "text": "<p><span style=\"font-size:14.0pt;\">Associated exophytic soft-tissue component</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old patient presents with chronic knee pain. An X-ray shows a lytic lesion, and a non-contrast CT (NCCT) was performed for better evaluation. The scan demonstrates a well-circumscribed, nonaggressive lesion without cortical breach or periosteal reaction. Which of the following features would not be expected in this type of lesion?</span></p>",
      "unique_key": "Q7960396",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>D) Associated exophytic soft-tissue component</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Nonaggressive bone lesions</strong> (e.g., unicameral bone cyst, enchondroma) typically demonstrate:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Well-defined lytic appearance</strong> → margins are smooth.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Narrow zone of transition</strong> → indicates slow-growing/benign process.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sclerotic rim may or may not be present</strong> → but absence of sclerosis does not imply aggressiveness if other benign features are present.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Aggressive lesions</strong> (osteosarcoma, Ewing sarcoma, metastasis) usually demonstrate:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Wide zone of transition.</span></li><li><span style=\"font-size:14.0pt;\">Cortical destruction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Exophytic soft-tissue component</strong> due to breach of periosteum and extraosseous extension.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Hence, <strong>exophytic soft-tissue component</strong> is <strong>not compatible</strong> with a nonaggressive lesion, making it the correct “except” choice.</span></li><li><span style=\"font-size:14.0pt;\">Indicates aggressiveness → not seen in nonaggressive lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Well-defined lytic lesion:&nbsp;</strong>Classic for benign/nonaggressive pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Narrow zone of transition:</strong> Hallmark of benign lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. No surrounding sclerotic rim:&nbsp;</strong>Benign lesions may lack sclerosis (not all have a rim).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In bone imaging, <strong>zone of transition</strong> is the most reliable indicator of aggressiveness:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Narrow zone</strong> → benign.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Wide zone/poorly defined</strong> → malignant/aggressive. Presence of a <strong>soft-tissue component</strong> strongly suggests an <strong>aggressive lesion</strong>.</span></li></ul>",
      "correct_choice_id": 383639,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96373/RADIOLOGY_INICET_GT_5_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96373/RADIOLOGY_INICET_GT_5_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96389,
      "choices": [
        {
          "id": 383700,
          "text": "<p><span style=\"font-size:14.0pt;\">1–B, 2–D, 3–C, 4–A</span></p>"
        },
        {
          "id": 383701,
          "text": "<p><span style=\"font-size:14.0pt;\">1–C, 2–A, 3–B, 4–D</span></p>"
        },
        {
          "id": 383702,
          "text": "<p><span style=\"font-size:14.0pt;\">1–B, 2–C, 3–A, 4–D</span></p>"
        },
        {
          "id": 383703,
          "text": "<p><span style=\"font-size:14.0pt;\">1–A, 2–C, 3–B, 4–D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following genes with their associated conditions:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180134.jpg\" width=\"1000\" height=\"384\"></span></p>",
      "unique_key": "Q6706558",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1–B, 2–C, 3–A, 4–D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180203.jpg\" width=\"981\" height=\"702\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>SMAD 2/4 → TGF-β regulation</strong> → Juvenile polyposis</span></li><li><span style=\"font-size:14.0pt;\"><strong>VHL gene → chromosome 3p25 deletion</strong> → Renal cell carcinoma, pheochromocytoma, hemangioblastoma</span></li><li><span style=\"font-size:14.0pt;\"><strong>SDHB gene → mitochondrial dysfunction</strong> → Paraganglioma, pheochromocytoma</span></li><li><span style=\"font-size:14.0pt;\"><strong>STK11 gene → kinase tumor suppressor</strong> → Peutz–Jeghers syndrome</span></li></ul>",
      "correct_choice_id": 383702,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96389/Pathology_INICET_GT_30_Oct_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96389/Pathology_INICET_GT_30_Oct_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96123,
      "choices": [
        {
          "id": 382656,
          "text": "<p><span style=\"font-size:14.0pt;\">Somatic symptom disorder</span></p>"
        },
        {
          "id": 382657,
          "text": "<p><span style=\"font-size:14.0pt;\">Factitious disorder</span></p>"
        },
        {
          "id": 382658,
          "text": "<p><span style=\"font-size:14.0pt;\">Malingering</span></p>"
        },
        {
          "id": 382659,
          "text": "<p><span style=\"font-size:14.0pt;\">Illness anxiety disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old nurse frequently presents to the emergency department with unexplained hypoglycemic episodes. Lab results show low blood glucose with high insulin levels but suppressed C-peptide. She refuses psychiatric referral and changes hospitals often. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6519260",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Factitious disorder</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture shows <strong>intentional production of symptoms (hypoglycemia via insulin injection)</strong> in the absence of external rewards (e.g., financial gain, avoiding responsibilities), suggesting <strong>Factitious Disorder</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Key lab finding is <strong>high insulin with low C-peptide</strong>, pointing to <strong>exogenous insulin administration</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Her behavior of <strong>hospital hopping and refusal of psychiatric referral</strong> further supports a diagnosis rooted in a <strong>desire to assume the sick role</strong>, which is typical of <strong>factitious disorder</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Somatic symptom disorder</strong>: This involves <strong>unintentional symptoms</strong> that are <strong>medically unexplained</strong>, often accompanied by anxiety about health. Here, the hypoglycemia is <strong>intentionally induced</strong>, which rules this out.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Malingering</strong>: Also involves <strong>intentional symptom production</strong>, but <strong>with clear external rewards</strong> (e.g., avoiding work, gaining drugs, financial compensation). In this case, there’s <strong>no external incentive</strong>, making malingering unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Illness anxiety disorder</strong>: Characterized by <strong>preoccupation with having or acquiring a serious illness</strong> despite <strong>normal medical evaluation</strong>. There’s <strong>no fabrication or induction of symptoms</strong> in illness anxiety disorder, unlike in factitious disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Factitious disorder (Munchausen syndrome) is characterized by the willful production of false symptoms (physical or psychological) or exaggeration of actual symptoms to get medical attention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pseudologia fantastica</strong> is the term used for the ‘false stories’ that these patients make to get medical attention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Often, signs of previous interventions, such as scars from previous surgeries, are present.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient may have a <strong>gridiron abdomen</strong> (mass of scars on the abdomen).</span></li><li><span style=\"font-size:14.0pt;\">The term ‘<strong>professional patients</strong>’ has been used for these patients, and the illness has been called ‘hospital addiction’ or ‘poly surgical addiction’. Patients try to assume a sick role (i.e., they want to be treated as if they are very sick and want extra attention from doctors and medical staff).</span></li></ul>",
      "correct_choice_id": 382657,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96123/Psychiatry_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96123/Psychiatry_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96365,
      "choices": [
        {
          "id": 383604,
          "text": "<p><span style=\"font-size:14.0pt;\">Endolymphatic hydrops</span></p>"
        },
        {
          "id": 383605,
          "text": "<p><span style=\"font-size:14.0pt;\">Noise-induced trauma</span></p>"
        },
        {
          "id": 383606,
          "text": "<p><span style=\"font-size:14.0pt;\">Presbycusis</span></p>"
        },
        {
          "id": 383607,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man presents with gradual, progressive hearing loss, especially for high-pitched sounds and conversations in noisy environments. Audiometry shows bilateral, symmetric, down-sloping sensorineural hearing loss (SNHL) involving higher frequencies. Which of the following is the most likely cause?&nbsp;</span></p>",
      "unique_key": "Q8902732",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Presbycusis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Presbycusis</strong> is <strong>age-related bilateral symmetric high-frequency SNHL</strong>, caused by degenerative changes in the cochlea — particularly <strong>loss of hair cells</strong> at the <strong>basal turn</strong> (which encodes high frequencies).</span></li><li><span style=\"font-size:14.0pt;\">The <strong>audiogram</strong> typically shows a <strong>bilateral down-sloping curve</strong> — the hallmark of presbycusis.</span></li><li><span style=\"font-size:14.0pt;\">It begins insidiously, leading to <strong>difficulty in hearing high-pitched sounds</strong>, <strong>understanding speech in noisy places</strong>, and <strong>impaired speech discrimination</strong>.</span></li><li><span style=\"font-size:14.0pt;\">No associated vertigo or tinnitus (unlike Ménière’s disease).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Endolymphatic hydrops (Ménière’s disease):</strong> Causes <strong>fluctuating low-frequency SNHL</strong>, not high-frequency; usually unilateral and associated with <strong>vertigo + tinnitus</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Noise-induced trauma:</strong> Produces a <strong>notch-type audiogram at 4000 Hz (Boilermaker’s notch)</strong>, typically asymmetrical and occupationally related.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">A <strong>bilateral, symmetric, down-sloping high-frequency SNHL</strong> is characteristic of <strong>presbycusis</strong>, the most common cause of hearing loss in the elderly due to cochlear hair cell degeneration at the basal turn.</span></p>",
      "correct_choice_id": 383606,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96365/ENT_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96365/ENT_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96364,
      "choices": [
        {
          "id": 383600,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 383601,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 only</span></p>"
        },
        {
          "id": 383602,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 383603,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding adrenaline dosing is correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">1:10,000 is preferred IV during cardiac arrest&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">1:200,000 adrenaline with local anesthetic reduces systemic adverse effects and prolongs duration of action of local anaesthetics</span></li><li><span style=\"font-size:14.0pt;\">1:1,000 can be safely used IV in adult anaphylactic shock</span></li><li><span style=\"font-size:14.0pt;\">1:100 adrenaline is used for inhalational therapy in severe asthma attacks</span></li></ol>",
      "unique_key": "Q8078710",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>1:10,000 is preferred IV during cardiac arrest:&nbsp;</strong>1:10,000 (0.1 mg/mL) is the correct IV formulation for <strong>cardiac arrest</strong>, allowing controlled systemic administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. 1:200,000 adrenaline with local anesthetic reduces systemic adverse effects and prolongs duration of action of local anaesthetics:&nbsp;</strong>1:200,000 adrenaline&nbsp;is commonly mixed with <strong>lidocaine</strong> or other anesthetics to reduce bleeding and prolong effect, especially in dental and minor procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>1:100 adrenaline is used for inhalational therapy in severe asthma attacks:&nbsp;</strong>1:100 adrenaline (10 mg/mL)&nbsp;may be <strong>diluted for nebulization</strong> in <strong>life-threatening asthma</strong> or croup, especially in pediatrics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>1:1,000 can be safely used IV in adult anaphylactic shock:&nbsp;</strong>Incorrect.<strong> 1:1,000 adrenaline (1 mg/mL)</strong> is <strong>NOT given IV</strong> — it is used <strong>intramuscularly or subcutaneously</strong> for <strong>anaphylaxis</strong>. IV use of this concentration can lead to fatal arrhythmias and hypertensive crises.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adrenaline formulations must be matched precisely with the <strong>route and indication:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>1:1,000</strong> → IM/SC (Anaphylaxis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>1:10,000</strong> → IV (Cardiac arrest)</span></li><li><span style=\"font-size:14.0pt;\"><strong>1:200,000</strong> → With LA (minor surgery)</span></li><li><span style=\"font-size:14.0pt;\"><strong>1:100</strong> → Nebulized (rare/emergency bronchospasm cases)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Improper dosing can lead to severe cardiovascular complications.&nbsp;</span></li></ul>",
      "correct_choice_id": 383600,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96364/Pharmacology_INICET_GT_30_Oct_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96364/Pharmacology_INICET_GT_30_Oct_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96390,
      "choices": [
        {
          "id": 383704,
          "text": "<p><span style=\"font-size:14.0pt;\">Bartonella quintana</span></p>"
        },
        {
          "id": 383705,
          "text": "<p><span style=\"font-size:14.0pt;\">Bartonella bacilliformis</span></p>"
        },
        {
          "id": 383706,
          "text": "<p><span style=\"font-size:14.0pt;\">Bartonella henselae</span></p>"
        },
        {
          "id": 383707,
          "text": "<p><span style=\"font-size:14.0pt;\">Bartonella elizabethae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man with advanced HIV (CD4 count &lt;50 cells/µL) presents with multiple red, vascular, nodular skin lesions on his trunk and face. The lesions are friable and bleed on touch. A biopsy reveals vascular proliferation with neutrophilic infiltrate and bacilli that are silver-stain positive. He also reports close contact with cats. What is the most likely causative organism?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5827200",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Bartonella henselae</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Bacillary angiomatosis</strong> is a vascular proliferative disease caused by <strong>Bartonella spp.</strong>, typically affecting <strong>immunocompromised patients</strong>, especially those with <strong>AIDS</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bartonella henselae</strong> is the <strong>most common cause</strong>, and is transmitted by <strong>cat scratches, bites</strong>, or flea exposure.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bartonella quintana</strong> can also cause bacillary angiomatosis but is <strong>less common</strong>, and associated with <strong>trench fever</strong> and <strong>lice</strong> exposure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bartonella quintana:</strong> Less common cause of bacillary angiomatosis; transmitted via <strong>body lice</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bartonella bacilliformis:</strong> Causes <strong>Carrion’s disease</strong> (Oroya fever and verruga peruana); seen in <strong>South America</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bartonella elizabethae:&nbsp;</strong>&nbsp;Rare; associated with <strong>culture-negative endocarditis</strong>, not bacillary angiomatosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Bartonella henselae</strong> is the <strong>most frequent cause</strong> of bacillary angiomatosis in AIDS patients, presenting with angiomatous skin lesions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis is confirmed with <strong>Warthin-Starry staining</strong> or PCR.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Macrolides</strong> are the treatment of choice.</span></li></ul>",
      "correct_choice_id": 383706,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96390/Microbiology_INICET_GT_30_Oct_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96390/Microbiology_INICET_GT_30_Oct_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96376,
      "choices": [
        {
          "id": 383648,
          "text": "<p><span style=\"font-size:14.0pt;\">Selectins</span></p>"
        },
        {
          "id": 383649,
          "text": "<p><span style=\"font-size:14.0pt;\">Integrins (CD18)</span></p>"
        },
        {
          "id": 383650,
          "text": "<p><span style=\"font-size:14.0pt;\">ICAM-1 (CD54)</span></p>"
        },
        {
          "id": 383651,
          "text": "<p><span style=\"font-size:14.0pt;\">PECAM-1 (CD31)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old boy presents with recurrent bacterial skin infections and poor wound healing with history of delayed separation of the umbilical cord. Despite infection, no pus is seen, and a wound swab shows absence of neutrophils at the site. Laboratory findings reveal marked neutrophilia. Which of the following molecular defects best explains this child’s condition?</span></p>",
      "unique_key": "Q3956275",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Integrins (CD18)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This child’s presentation is characteristic of <strong>Leukocyte Adhesion Deficiency type 1 (LAD-1)</strong>, a rare congenital immunodeficiency caused by <strong>defective β2 integrins (CD18 subunit)</strong> on leukocytes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Normal process of leukocyte adhesion and migration:</strong></span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Margination and rolling:</strong> Mediated by <strong>selectins</strong> (E-selectin, P-selectin).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adhesion (firm attachment):</strong> Mediated by <strong>integrins</strong> on leukocytes binding to <strong>ICAM (CD54, CD102)</strong> and <strong>VCAM (CD106)</strong> on endothelial cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Transmigration (diapedesis):</strong> Mediated by <strong>PECAM-1 (CD31)</strong>.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>In LAD-1:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Mutation in <strong>CD18</strong> → defective <strong>integrin function</strong> → failure of <strong>firm adhesion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Neutrophils cannot migrate out of circulation to infection sites, leading to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Recurrent bacterial infections without pus formation</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Delayed umbilical cord separation (&gt;30 days)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Leukocytosis and neutrophilia</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Selectins:&nbsp;</strong>Mediate <strong>rolling phase</strong> of leukocyte extravasation, not firm adhesion. Defect in selectins would impair initial rolling, not adhesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. ICAM-1 (CD54):&nbsp;</strong>Endothelial adhesion molecule that interacts with integrins. The defect in LAD is on <strong>leukocytes (CD18 integrins)</strong>, not on the endothelial ICAM.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. PECAM-1 (CD31):&nbsp;</strong>Involved in <strong>transmigration</strong> (movement through endothelium). Defect would impair diapedesis, not adhesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Firm adhesion of leukocytes</strong> to endothelium during inflammation is mediated by <strong>integrins (CD18)</strong> binding to <strong>ICAM and VCAM</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency of CD18 causes <strong>Leukocyte Adhesion Deficiency type 1 (LAD-1)</strong>, presenting with <strong>delayed umbilical cord separation, recurrent bacterial infections, and absence of pus formation.</strong></span></li></ul>",
      "correct_choice_id": 383649,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96376/Pathology_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96376/Pathology_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96267,
      "choices": [
        {
          "id": 383216,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 are correct</span></p>"
        },
        {
          "id": 383217,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 are correct</span></p>"
        },
        {
          "id": 383218,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 are correct</span></p>"
        },
        {
          "id": 383219,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 4 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Based on the Rotterdam criteria for diagnosing polycystic ovary syndrome (PCOS), evaluate the following statements:</span></p><ol><li><span style=\"font-size:14.0pt;\">Hyperandrogenism can be clinical (hirsutism, acne) or biochemical (elevated testosterone).</span></li><li><span style=\"font-size:14.0pt;\">Oligo- or anovulation is defined as fewer than 9 cycles per year or cycles lasting more than 35 days.</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis requires all three criteria to be present simultaneously.</span></li><li><span style=\"font-size:14.0pt;\">Polycystic ovaries are defined as ≥12 antral follicles in one ovary or ovarian volume &gt;10 cm³.</span></li></ol><p><span style=\"font-size:14.0pt;\">Which of the following options is correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6593693",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2 and 4 are correct</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Rotterdam criteria</strong> (2003) state that <strong>PCOS</strong> is diagnosed when <strong>any two of the following three</strong> features are present (after excluding other endocrine causes):</span><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:14.0pt;\"><strong>Hyperandrogenism</strong> – may be <strong>clinical</strong> (hirsutism, acne, androgenic alopecia) or <strong>biochemical</strong> (elevated serum testosterone or DHEAS).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Oligo- or anovulation</strong> – characterized by <strong>&lt;9 menstrual cycles per year</strong> or cycles lasting <strong>&gt;35 days</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Polycystic ovaries on ultrasound</strong> – <strong>≥12 antral follicles</strong> in one ovary <strong>and/or</strong> ovarian volume <strong>&gt;10 cm³</strong>.</span></li></ol></li></ul><p><span style=\"font-size:14.0pt;\">Only <strong>two out of three criteria</strong> are required for diagnosis. Therefore, statement <strong>3</strong> (“all three criteria required”) is <strong>incorrect</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Polycystic ovary syndrome (PCOS) is diagnosed when any two of the following three are present:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Hyperandrogenism (clinical or biochemical)</span></li><li><span style=\"font-size:14.0pt;\">Oligo-/anovulation (&lt;9 cycles/year or &gt;35-day cycles)</span></li><li><span style=\"font-size:14.0pt;\">Polycystic ovaries (≥12 follicles or ovarian volume &gt;10 cm³)</span></li></ul></li></ul>",
      "correct_choice_id": 383217,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96267/Ini-Cet_Gt_30_Oct_2025_Obg_Q_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96267/Ini-Cet_Gt_30_Oct_2025_Obg_Q_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96301,
      "choices": [
        {
          "id": 383352,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 2/6&nbsp;</span></p>"
        },
        {
          "id": 383353,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 3/6&nbsp;</span></p>"
        },
        {
          "id": 383354,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 4/6&nbsp;</span></p>"
        },
        {
          "id": 383355,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 5/6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During examination of a 6-year-old child with a history of poor weight gain and recurrent respiratory infections, you note a harsh systolic murmur at the left lower sternal border associated with a palpable thrill. The child's height and weight are below the 5th percentile for age. Chest X-ray findings are shown below. Echocardiography is pending. What grade of murmur is this most likely to be?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20162214.jpg\" width=\"538\" height=\"450\"></span></p>",
      "unique_key": "Q1070861",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)</strong> <strong>Grade 4/6&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This murmur has characteristics of Grade 4/6, which is defined as a <strong>loud murmur with an associated palpable thrill</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of a palpable thrill is the key diagnostic feature that distinguishes a Grade 4 murmur from lower grades.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the VSD (Ventricular Septal Defect) produces a harsh systolic murmur at the left sternal border, which is typical of this condition.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The poor weight gain indicates a hemodynamically significant VSD with increased pulmonary blood flow, which is consistent with a Grade 4 murmur.</span></li><li><span style=\"font-size:14.0pt;\"><strong>TIPTOE\"</strong> - From softest to loudest:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>T</strong>iny whisper (Grade 1) - Barely audible, need perfect conditions</span></li><li><span style=\"font-size:14.0pt;\"><strong>I</strong>dentifiable easily (Grade 2) - Quiet but clearly audible</span></li><li><span style=\"font-size:14.0pt;\"><strong>P</strong>rominent sound (Grade 3) - Moderately loud, no thrill</span></li><li><span style=\"font-size:14.0pt;\"><strong>T</strong>hrill appears (Grade 4) - Loud with palpable thrill</span></li><li><span style=\"font-size:14.0pt;\"><strong>O</strong>ff chest partially (Grade 5) - Very loud, stethoscope partially lifted</span></li><li><span style=\"font-size:14.0pt;\"><strong>E</strong>ven without stethoscope (Grade 6) - Can be heard without stethoscope</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other</strong> <strong>Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Grade 2/6:</strong> This describes a soft but easily audible murmur without thrill. Grade 2 murmurs are not associated with a palpable thrill, and they are typically not harsh in quality. A Grade 2 murmur would be unlikely to correlate with the significant clinical findings (poor weight gain) described in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Grade 3/6:</strong> While this is a moderately loud murmur, Grade 3 murmurs do not have an associated thrill. They are defined as loud murmurs that are easily heard but without a palpable thrill. Since this patient has a palpable thrill, the murmur must be at least Grade 4.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Grade 5/6:</strong> A Grade 5 murmur is very loud and can be heard with the stethoscope partly off the chest wall. While Grade 5 murmurs also have a thrill, they represent a more severe finding than described in this clinical scenario. Grade 5 murmurs are often associated with more severe symptoms and clinical deterioration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Levine grading system</strong> for cardiac murmurs is based on intensity, with Grades 1-6.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of a <strong>palpable thrill</strong> is the defining characteristic of a Grade 4/6 murmur or higher.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In pediatric patients with VSD, the grade of the murmur often correlates with the size of the defect and its hemodynamic significance.</span></li></ul>",
      "correct_choice_id": 383354,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96301/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96301/Ini-Cet_Gt_30_Oct_2025_Pediatrics_Q_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96366,
      "choices": [
        {
          "id": 383608,
          "text": "<p><span style=\"font-size:14.0pt;\">Nicardipine&nbsp;</span></p>"
        },
        {
          "id": 383609,
          "text": "<p><span style=\"font-size:14.0pt;\">Sodium nitroprusside&nbsp;</span></p>"
        },
        {
          "id": 383610,
          "text": "<p><span style=\"font-size:14.0pt;\">Fenoldopam&nbsp;</span></p>"
        },
        {
          "id": 383611,
          "text": "<p><span style=\"font-size:14.0pt;\">Labetalol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old man with a BP of 230/125 mmHg and rising creatinine is started on IV antihypertensive therapy. Within hours, his urine output improves, and BP begins to normalize. The drug acts via peripheral arterial dilation and increases renal perfusion. Which of the following drugs can produce these effects?</span></p>",
      "unique_key": "Q3589629",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Fenoldopam</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with a <strong>hypertensive emergency</strong> (severely elevated BP with evidence of target-organ damage, in this case rising creatinine).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The improvement in <strong>urine output</strong> after antihypertensive treatment suggests <strong>enhanced renal perfusion</strong>, which helps distinguish the mechanism of action.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fenoldopam</strong> is a <strong>selective dopamine-1 receptor agonist</strong> that causes <strong>arteriolar vasodilation</strong>, especially in <strong>renal, mesenteric, coronary, and peripheral arteries</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>It:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Increases renal blood flow and glomerular filtration rate (GFR)</span></li><li><span style=\"font-size:14.0pt;\">Promotes <strong>natriuresis and diuresis</strong></span></li><li><span style=\"font-size:14.0pt;\">Is particularly useful in <strong>hypertensive emergencies with renal impairment</strong></span></li><li><span style=\"font-size:14.0pt;\">Is given <strong>intravenously</strong> with a <strong>short half-life</strong>, allowing tight BP control</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These properties match the clinical improvement observed in this patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nicardipine:</strong> IV calcium channel blocker (DHP type) → arterial vasodilator. Used in hypertensive emergencies, but&nbsp;<strong>does not improve renal perfusion</strong>&nbsp;specifically.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Sodium nitroprusside:</strong> Releases NO → arterial + venous vasodilator. Rapidly lowers BP but&nbsp;<strong>can decrease renal perfusion</strong>&nbsp;and causes&nbsp;<strong>cyanide toxicity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Labetalol:</strong> α₁ and β-blocker. Effective IV drug for hypertensive emergencies, but&nbsp;<strong>no renal vasodilatory effect</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fenoldopam is a selective dopamine-1 receptor agonist used in hypertensive emergencies.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It lowers blood pressure while increasing renal perfusion and is particularly beneficial in patients with acute kidney injury.</span></li></ul>",
      "correct_choice_id": 383610,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96366/Pharmacology_INICET_GT_30_Oct_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96366/Pharmacology_INICET_GT_30_Oct_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96281,
      "choices": [
        {
          "id": 383272,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage IV</span></p>"
        },
        {
          "id": 383273,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage I</span></p>"
        },
        {
          "id": 383274,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage III</span></p>"
        },
        {
          "id": 383275,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage II</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old woman presents with a sensation of vaginal heaviness and difficulty walking. On pelvic examination, Valsalva maneuver demonstrates descent of the vaginal wall and uterus, confirming pelvic organ prolapse and finding is shown below. Based on this finding, which stage of prolapse best describes her condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20150919.jpg\" width=\"262\" height=\"365\"></span></p>",
      "unique_key": "Q4588103",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Stage II</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pelvic organ prolapse (POP) occurs when the <strong>pelvic floor muscles and connective tissues weaken</strong>, allowing the uterus or vaginal walls to descend.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis is <strong>confirmed on physical examination</strong>, often by performing a <strong>Valsalva maneuver</strong> or asking the patient to <strong>bear down</strong>, which accentuates the descent.</span></li><li><span style=\"font-size:14.0pt;\">In the image the leading edge of the bulge is observed to be approximately even with the plane of the hymen or within 1 cm distal to it.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>Pelvic Organ Prolapse Quantification (POP-Q) system</strong> classifies prolapse based on the relationship between the <strong>leading edge of the prolapsed organ</strong> and the <strong>hymenal plane</strong>:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20151032.jpg\" width=\"1144\" height=\"402\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Since the <strong>leading edge of the prolapse</strong> is <strong>at or within 1 cm of the hymen</strong>, the correct diagnosis is <strong>Stage II prolapse</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stage IV:&nbsp;</strong>Represents <strong>complete eversion of the vagina</strong> or <strong>total uterine procidentia</strong>, where the entire vaginal wall and uterus lie outside the introitus—more severe than the described finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Stage I:&nbsp;</strong>Occurs when the prolapse remains more than 1 cm <strong>above</strong> the hymen and is often not visible externally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Stage III:&nbsp;</strong>Defined as descent of the leading edge <strong>&gt;1 cm below</strong> the hymen but not complete eversion—more advanced than this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pelvic organ prolapse</strong> is assessed during a <strong>pelvic examination with a Valsalva maneuver</strong>. When the <strong>leading edge of the prolapse</strong> is <strong>at or within 1 cm of the hymen</strong>, it is classified as <strong>Stage II prolapse</strong> according to the <strong>POP-Q system</strong>.</span></p>",
      "correct_choice_id": 383275,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96281/Ini-Cet_Gt_30_Oct_2025_Obg_Q_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96281/Ini-Cet_Gt_30_Oct_2025_Obg_Q_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96393,
      "choices": [
        {
          "id": 383716,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 2, 4 and 5 are correct</span></p>"
        },
        {
          "id": 383717,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2, 3 and 4 are correct</span></p>"
        },
        {
          "id": 383718,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 3 and 5 are correct</span></p>"
        },
        {
          "id": 383719,
          "text": "<p><span style=\"font-size:14.0pt;\">All five statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the diagnostic criteria for multiple myeloma are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The presence of ≥10% clonal plasma cells in bone marrow or a biopsy-proven plasmacytoma is essential for diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">Hypercalcemia, defined as serum calcium &gt;11.5 mg/dL, is a myeloma-defining event.</span></li><li><span style=\"font-size:14.0pt;\">Renal impairment is considered when serum creatinine exceeds 1 mg/dL or GFR falls below 60 mL/min.</span></li><li><span style=\"font-size:14.0pt;\">Anemia with hemoglobin &lt;10 g/dL or ≥2 g/dL below normal is a criterion for end-organ damage.</span></li><li><span style=\"font-size:14.0pt;\">One or more osteolytic bone lesions detected on radiographic imaging confirms bone involvement.</span></li></ol>",
      "unique_key": "Q1360684",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only 1, 2, 4 and 5 are correct</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Diagnosis of <strong>Multiple Myeloma (MM)</strong> requires <strong>≥10% clonal plasma cells</strong> in the bone marrow <strong>or</strong> a <strong>biopsy-proven plasmacytoma</strong>, <strong>AND</strong></span></li><li><span style=\"font-size:14.0pt;\">Evidence of <strong>myeloma-defining events</strong>, summarized by the mnemonic <strong>CRAB</strong>:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20180249.jpg\" width=\"1100\" height=\"476\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Renal impairment is considered when serum creatinine exceeds 1 mg/dL or GFR falls below 60 mL/min:</strong> Incorrect because renal impairment in MM requires <strong>creatinine &gt;2 mg/dL</strong>, not 1 mg/dL, and <strong>GFR &lt;40 mL/min</strong>, not 60 mL/min.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The diagnosis of <strong>multiple myeloma</strong> requires evidence of <strong>clonal plasma cell proliferation (≥10%)</strong> along with <strong>one or more myeloma-defining events (CRAB — hyperCalcemia, Renal dysfunction, Anemia, Bone lesions)</strong> indicating <strong>end-organ damage</strong>.</span></p>",
      "correct_choice_id": 383716,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96393/Pathology_INICET_GT_30_Oct_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96393/Pathology_INICET_GT_30_Oct_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96142,
      "choices": [
        {
          "id": 382728,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 382729,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 382730,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 382731,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding the importance and limitations of the Dependency Ratio, which statements are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">A higher DR indicates increased strain on the working population.</span></li><li><span style=\"font-size:14.0pt;\">DR includes economic status (employed/unemployed) of the population in its calculation.</span></li><li><span style=\"font-size:14.0pt;\">DR is considered a crude index because it does not differentiate between earners and non-earners.</span></li><li><span style=\"font-size:14.0pt;\">An increasing old age DR implies greater pressure on pension systems and health services.</span></li></ol>",
      "unique_key": "Q3215179",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. A higher DR indicates increased strain on the working population:&nbsp;</strong>Correct. A high dependency ratio means fewer people in the working-age group (15–64 years) are supporting more dependents (children and elderly), increasing economic pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. DR is considered a crude index because it does not differentiate between earners and non-earners:</strong> Correct. As it does not consider whether a person is economically active, it's considered <strong>crude</strong>. For example, a 30-year-old unemployed person is not counted as dependent by DR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>4. An increasing old age DR implies greater pressure on pension systems and health services:</strong> Correct. An increase in <strong>old-age DR</strong> reflects more elderly people requiring <strong>pension, health care, and long-term support</strong>, which burdens public health and social welfare systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect</strong> <strong>Statement</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>2. DR includes economic status (employed/unemployed) of the population in its calculation:</strong> Incorrect.<strong> DR is a crude measure</strong>. It does <strong>not</strong> account for actual employment or income status — it’s based purely on <strong>age structure</strong>, not on whether individuals are working or not.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Understand that the <strong>Dependency Ratio</strong> is a <strong>demographic tool</strong> measuring the <strong>age-based economic burden</strong> on the productive population.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While useful for macro-planning, it <strong>doesn’t reflect actual employment</strong>, making it a <strong>crude but critical measure</strong> in population studies.</span></li></ul>",
      "correct_choice_id": 382729,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96142/NEET_PG_30_Oct_2025_GT_PSM_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96142/NEET_PG_30_Oct_2025_GT_PSM_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96368,
      "choices": [
        {
          "id": 383616,
          "text": "<p><span style=\"font-size:14.0pt;\">It should be treated with surgical removal of mucin and polyps</span></p>"
        },
        {
          "id": 383617,
          "text": "<p><span style=\"font-size:14.0pt;\">Fungal stains and cultures are not necessary</span></p>"
        },
        {
          "id": 383618,
          "text": "<p><span style=\"font-size:14.0pt;\">Postoperative oral corticosteroids are not as important</span></p>"
        },
        {
          "id": 383619,
          "text": "<p><span style=\"font-size:14.0pt;\">Topical antifungal medications reduce postoperative recurrence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding allergic fungal rhinosinusitis (AFRS) is most accurate?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7929767",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) It should be treated with surgical removal of mucin and polyps</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Allergic Fungal Rhinosinusitis (AFRS)</strong> is a <strong>non-invasive</strong> fungal sinusitis seen in <strong>atopic individuals</strong> with <strong>nasal polyposis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The key management step is <strong>endoscopic surgical clearance</strong> of <strong>thick allergic mucin and polyps</strong>, restoring sinus ventilation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Systemic corticosteroids</strong> postoperatively are essential to reduce inflammation and recurrence.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fungal cultures/stains</strong> confirm the diagnosis (they are necessary for diagnosis, not optional).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Topical or systemic antifungals</strong> have <strong>no proven benefit</strong> in AFRS, as the fungi are not tissue-invasive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fungal stains and cultures not necessary:</strong> Incorrect — histologic confirmation with fungal elements (Aspergillus, Alternaria, etc.) is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Postoperative oral corticosteroids are not as important:</strong> False — they are the mainstay to reduce recurrence and mucosal inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Topical antifungal medications reduce postoperative recurrence:</strong> Ineffective; AFRS is an <strong>immunologic</strong> rather than infective process.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>AFRS</strong> is treated primarily by <strong>functional endoscopic sinus surgery (FESS)</strong> with <strong>meticulous removal of mucin and polyps</strong>, followed by <strong>systemic corticosteroids</strong> to prevent recurrence.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Antifungal drugs have <strong>no established role</strong>.</span></li></ul>",
      "correct_choice_id": 383616,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96368/ENT_INICET_GT_30_Oct_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96368/ENT_INICET_GT_30_Oct_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96409,
      "choices": [
        {
          "id": 383780,
          "text": "<p><span style=\"font-size:14.0pt;\">For intubation in an anticipated difficult airway</span></p>"
        },
        {
          "id": 383781,
          "text": "<p><span style=\"font-size:14.0pt;\">Guide placement of double lumen tube</span></p>"
        },
        {
          "id": 383782,
          "text": "<p><span style=\"font-size:14.0pt;\">Suction of blood from the airways</span></p>"
        },
        {
          "id": 383783,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the use of the equipment shown below in the picture?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VMF8bAR.png\" width=\"310\" height=\"381\"></strong></span></p>",
      "unique_key": "Q2156062",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) All of the Above</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Since the <strong>bronchoscope</strong> can be <strong>used for all the above-mentioned purposes</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A</strong>. <strong>For Intubation in an Anticipated Difficult Airway</strong>: A <strong>flexible fiberoptic bronchoscope</strong> is often used to <strong>navigate</strong> and <strong>visualize the airway</strong> in cases where <strong>difficult intubation</strong> is <strong>anticipated</strong>, such as with <strong>abnormal airway anatomy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>. <strong>Guide Placement of Double Lumen Tube</strong>: In <strong>thoracic surgery</strong> requiring <strong>lung isolation</strong>, a <strong>double-lumen endotracheal tube</strong> is used, and a <strong>fiberoptic bronchoscope</strong> is often <strong>employed</strong> to <strong>confirm proper placement</strong> and <strong>position of the tube</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Suction of Blood from the Airways</strong>: While primarily used for <strong>visualization</strong>, a bronchoscope can also <strong>assist</strong> in the <strong>suctioning of blood</strong> or <strong>secretions</strong> from the <strong>airway</strong> when necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A flexible fiberoptic bronchoscope</strong> and <strong>understand its multifunctional use</strong> in airway management, including <strong>aiding difficult intubations, guiding the placement of double-lumen tubes,&nbsp;</strong>and<strong> clearing the airways of obstructions</strong> such as blood or secretions.</span></p>",
      "correct_choice_id": 383783,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96409/Anesthesia_INICET_GT_30_Oct_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96409/Anesthesia_INICET_GT_30_Oct_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96307,
      "choices": [
        {
          "id": 383376,
          "text": "<p><span style=\"font-size:14.0pt;\">Epidermolysis bullosa</span></p>"
        },
        {
          "id": 383377,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic bullous disorder of childhood</span></p>"
        },
        {
          "id": 383378,
          "text": "<p><span style=\"font-size:14.0pt;\">Congenital syphilis</span></p>"
        },
        {
          "id": 383379,
          "text": "<p><span style=\"font-size:14.0pt;\">Neonatal pemphigus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A male baby, born to a non-consanguineous couple, develops blisters over areas of friction soon after birth. There is a history of a previous child having similar complaints and dying at 2 weeks of age. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q7446419",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Epidermolysis bullosa</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Epidermolysis bullosa (EB)</strong> is an <strong>inherited mechanobullous disorder</strong> characterized by <strong>blister formation after minor trauma</strong> due to structural protein defects in the skin.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>onset in the neonatal period</strong>, <strong>blisters at friction sites</strong>, and <strong>history of sibling death</strong> indicate a <strong>severe autosomal recessive variant</strong>, most likely <strong>Junctional EB (Herlitz type)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It presents with widespread erosions, mucosal involvement, and carries a <strong>poor prognosis</strong>, often fatal within weeks to months of birth.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chronic bullous disorder of childhood:&nbsp;</strong>Occurs after <strong>6 months of age</strong>; due to <strong>IgA deposition</strong> along the basement membrane (“string of pearls” appearance). Not congenital and not lethal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Congenital syphilis:&nbsp;</strong>Presents with <strong>snuffles, rhagades, hepatosplenomegaly</strong>, and mucocutaneous fissures. No friction-induced blistering.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Neonatal pemphigus:&nbsp;</strong>Due to <strong>transplacental passage of maternal antibodies (anti-desmoglein 3)</strong> from a mother with pemphigus vulgaris. It is <strong>self-limiting</strong> and resolves as maternal IgG levels fall.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Epidermolysis bullosa</strong> is an <strong>inherited blistering disorder</strong> presenting at birth with <strong>friction-induced bullae</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>history of similar neonatal deaths</strong> points to <strong>junctional EB (Herlitz type)</strong> — the <strong>severe, often fatal autosomal recessive form</strong> caused by <strong>laminin-332 mutation</strong>.</span></li></ul>",
      "correct_choice_id": 383376,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96307/Dermatology_Inicet_Gt_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96307/Dermatology_Inicet_Gt_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96323,
      "choices": [
        {
          "id": 383436,
          "text": "<p><span style=\"font-size:14.0pt;\">Open suction</span></p>"
        },
        {
          "id": 383437,
          "text": "<p><span style=\"font-size:14.0pt;\">Closed suction</span></p>"
        },
        {
          "id": 383438,
          "text": "<p><span style=\"font-size:14.0pt;\">Closed continuous</span></p>"
        },
        {
          "id": 383439,
          "text": "<p><span style=\"font-size:14.0pt;\">Semi-closed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The device shown in the image is used for postoperative wound drainage. Identify the type of drain:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20175657.jpg\" width=\"338\" height=\"319\"></span></p>",
      "unique_key": "Q3449235",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Closed suction</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Closed suction drain</strong> (example: Jackson-Pratt drain, Romovac) consists of a <strong>drainage tube connected to a compressible reservoir bulb</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When the bulb is compressed, it creates <strong>negative pressure</strong>, allowing continuous suction of fluid/blood into a <strong>closed system</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This reduces infection risk compared to open drains and is commonly used after surgeries like mastectomy, thyroidectomy, and abdominal procedures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Open suction:&nbsp;</strong>These are open systems like Penrose drains, which drain fluid directly onto a gauze pad or stoma bag. They do not use suction, and infection risk is higher.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Closed continuous:&nbsp;</strong>This is not a standard classification; \"closed suction\" already refers to continuous suction in a sealed system.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Semi-closed:&nbsp;</strong>This is not a recognized drain type. It is often a distractor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Closed suction drains</strong> (e.g., Jackson-Pratt, Romovac) use negative pressure to drain fluid into a sealed system, minimizing infection risk compared to open drains.</span></p>",
      "correct_choice_id": 383437,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96323/NEET_PG_30_Oct_2025_GT_Surgery_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96323/NEET_PG_30_Oct_2025_GT_Surgery_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96126,
      "choices": [
        {
          "id": 382664,
          "text": "<p><span style=\"font-size:14.0pt;\">Start testosterone replacement therapy</span></p>"
        },
        {
          "id": 382665,
          "text": "<p><span style=\"font-size:14.0pt;\">Begin cognitive behavioral therapy and sex therapy</span></p>"
        },
        {
          "id": 382666,
          "text": "<p><span style=\"font-size:14.0pt;\">Prescribe long-term benzodiazepines</span></p>"
        },
        {
          "id": 382667,
          "text": "<p><span style=\"font-size:14.0pt;\">Schedule penile prosthesis implantation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A thirty-five-year-old man presents with recent-onset erectile difficulties. He reports good early morning erections but experiences failure during intercourse, especially with performance anxiety. Physical examination and hormone profile are normal. What is the most appropriate next step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1426721",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Begin cognitive behavioral therapy and sex therapy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presence of <strong>normal early morning erections</strong> and <strong>normal hormone levels</strong> with erectile difficulties in performance settings indicates a <strong>psychogenic cause</strong>, particularly <strong>performance anxiety</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In such cases, the most appropriate management is <strong>psychotherapy</strong>, especially <strong>Cognitive Behavioral Therapy (CBT)</strong> and <strong>sex therapy</strong>, which target maladaptive thoughts and performance-related anxiety.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Start testosterone replacement therapy</strong>: Testosterone therapy is indicated only in <strong>hypogonadism</strong> with <strong>low serum testosterone</strong>. Since the patient’s hormone profile is <strong>normal</strong>, this is unnecessary and may cause harm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Prescribe long-term benzodiazepines</strong>: Benzodiazepines may temporarily reduce anxiety but are <strong>not first-line treatments</strong> for performance anxiety due to risk of <strong>dependence, sedation, and sexual side effects</strong>. They are not recommended for erectile dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Schedule penile prosthesis implantation</strong>: This is a <strong>last-resort intervention</strong> for <strong>severe, treatment-resistant organic erectile dysfunction</strong>. It is invasive and not indicated in a <strong>young patient with psychogenic ED</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Psychogenic erectile dysfunction</strong> is suggested by <strong>normal morning erections, normal hormone profile, and performance-related failures</strong>. In such cases, <strong>cognitive behavioral therapy and sex therapy</strong> are first-line treatments.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Identifying the psychological basis helps avoid unnecessary hormonal or invasive treatments.</span></li></ul>",
      "correct_choice_id": 382665,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96126/Psychiatry_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96126/Psychiatry_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96381,
      "choices": [
        {
          "id": 383668,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 383669,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 383670,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 4 only</span></p>"
        },
        {
          "id": 383671,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements correctly describe the characteristics of oxidizing agents used in medical sterilization?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Peracetic acid is non-corrosive and safe for all metals.</span></li><li><span style=\"font-size:14.0pt;\">Vaporized hydrogen peroxide can be used in presence of organic matter.</span></li><li><span style=\"font-size:14.0pt;\">Plasma sterilization is ideal for heat-sensitive instruments due to its low temperature.</span></li><li><span style=\"font-size:14.0pt;\">H₂O₂ functions by releasing peroxynitrite radicals which directly lyse bacterial membranes.</span></li></ol>",
      "unique_key": "Q2922892",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 2 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Vaporized hydrogen peroxide can be used in the presence of organic matter:&nbsp;</strong>Correct. One of the <strong>advantages of H₂O₂</strong> as a sterilizing agent is its <strong>effectiveness even in the presence of organic material</strong>, unlike some other disinfectants that get inactivated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Plasma sterilization is ideal for heat-sensitive instruments due to its low temperature:&nbsp;</strong>Correct. Plasma sterilization uses <strong>low temperatures (37–44°C)</strong>, making it highly suitable for <strong>heat-labile instruments</strong>, such as <strong>ophthalmic</strong>, <strong>endoscopic</strong>, and <strong>plastic tools</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Peracetic acid is non-corrosive and safe for all metals:&nbsp;</strong>Incorrect. <strong>Peracetic acid</strong> is effective as a sterilant but is known to <strong>corrode metals</strong> like <strong>steel, iron, copper, brass, and bronze</strong>. It must be used cautiously with metal instruments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. H₂O₂ functions by releasing peroxynitrite radicals which directly lyse bacterial membranes:&nbsp;</strong>Incorrect. The <strong>active moiety</strong> of hydrogen peroxide in sterilization is the <strong>hydroxyl radical (•OH)</strong>, not <strong>peroxynitrite (ONOO⁻)</strong>. These radicals cause damage to DNA, proteins, and membrane lipids, leading to microbial death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Vaporized hydrogen peroxide (H₂O₂)</strong> and <strong>plasma sterilization</strong> are preferred methods for sterilizing <strong>heat-sensitive equipment</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>H₂O₂</strong> acts by releasing <strong>hydroxyl radicals</strong>, not peroxynitrite.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Peracetic acid</strong>, although effective, can be <strong>corrosive to certain metals</strong> and is not universally safe.</span></li></ul>",
      "correct_choice_id": 383668,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96381/Microbiology_INICET_GT_30_Oct_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96381/Microbiology_INICET_GT_30_Oct_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96139,
      "choices": [
        {
          "id": 382716,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 3 only</span></p>"
        },
        {
          "id": 382717,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 4 only</span></p>"
        },
        {
          "id": 382718,
          "text": "<p><span style=\"font-size:14.0pt;\">1 only</span></p>"
        },
        {
          "id": 382719,
          "text": "<p><span style=\"font-size:14.0pt;\">4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following provisions are true under the Mental Healthcare Act (MHCA), 2017, except:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Psychiatrists are legally liable if adverse outcomes occur while following an advance directive.</span></li><li><span style=\"font-size:14.0pt;\">Attempt to suicide is presumed to be due to severe stress and is not punishable under IPC.</span></li><li><span style=\"font-size:14.0pt;\">Supported admission can last a maximum of 30 days.</span></li><li><span style=\"font-size:14.0pt;\">Electroconvulsive therapy (ECT) is banned for minors.</span></li></ol>",
      "unique_key": "Q8854099",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Psychiatrists are legally liable if adverse outcomes occur while following an advance directive:&nbsp;</strong>False. Psychiatrists are <strong>not legally liable</strong> if adverse outcomes occur while following an advance directive in good faith.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Attempt to suicide is presumed to be due to severe stress and is not punishable under IPC:&nbsp;</strong>True<strong>.&nbsp;</strong>&nbsp;MHCA 2017 decriminalizes suicide; anyone attempting suicide is presumed under severe stress, hence not punishable.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Supported admission can last a maximum of 30 days:&nbsp;</strong>True. Supported admission is permitted for up to <strong>30 days</strong> initially.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Electroconvulsive therapy (ECT) is banned for minors:&nbsp;</strong>True. ECT is <strong>banned for minors</strong> and <strong>direct ECT without anesthesia is prohibited</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>MENTAL HEALTHCARE ACT, 2017 (MHCA 2017):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Deals with rights of patients with mental illness and treatment delivery. Important clauses-</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A. Capacity to make mental healthcare and treatment decision</strong>- Every person, including patients with mental illness, are assumed to have it if they can-</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Can understand the information provided to them</span></li><li><span style=\"font-size:14.0pt;\">Understand the consequences of their decisions</span></li><li><span style=\"font-size:14.0pt;\">Can communicate their decision</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B. Advance directive</strong>- Every person (not a minor) can make an advance directive in which he can mention-</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">How they wish to be treated/not treated for a mental illness</span></li><li><span style=\"font-size:14.0pt;\">Applicable only if a person loses the capacity to take mental healthcare or treatment decisions</span></li><li><span style=\"font-size:14.0pt;\">Duty of psychiatrist (or medical officer) to give treatment according to the advance directive</span></li><li><span style=\"font-size:14.0pt;\">Doctor is not liable in case of unforeseen consequences while following the advance directive</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C. Nominated representative (NR)-</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Every person can appoint a nominated representative</span></li><li><span style=\"font-size:14.0pt;\">In case of loss of capacity to make mental healthcare and treatment decision, NR would help in taking decisions about treatment</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D. Admission</strong>- MHCA 2017 allows two types of admissions</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Independent admissions- When the patient himself wants to get admitted</span></li><li><span style=\"font-size:14.0pt;\">Supported admission (for a maximum of 30 days)- A person who has lost the capacity to make mental healthcare or treatment decisions and requires significant support from a nominated representative can be admitted under a “supported admission”</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>E. Ban on direct ECT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>F. Ban on ECT for minors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>G. Ban on psychosurgery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>H. Decriminalisation of suicide attempt</strong> - Any person who attempts suicide shall be presumed to be under severe stress and should not be tried or punished</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>I. Restraints and seclusions</strong> - A patient can be physically restrained only-</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">If it is the only way to prevent harm to self or others</span></li><li><span style=\"font-size:14.0pt;\">If authorised by a psychiatrist in charge</span></li></ul>",
      "correct_choice_id": 382718,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96139/NEET_PG_30_Oct_2025_GT_PSM_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96139/NEET_PG_30_Oct_2025_GT_PSM_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96137,
      "choices": [
        {
          "id": 382708,
          "text": "<p><span style=\"font-size:14.0pt;\">There is correlation between the two variables and the Pearson coefficient equals +1</span></p>"
        },
        {
          "id": 382709,
          "text": "<p><span style=\"font-size:14.0pt;\">There is correlation between the two variables and the Pearson coefficient equals –1</span></p>"
        },
        {
          "id": 382710,
          "text": "<p><span style=\"font-size:14.0pt;\">There is no linear correlation between the two variables</span></p>"
        },
        {
          "id": 382711,
          "text": "<p><span style=\"font-size:14.0pt;\">There is no association between the two variables</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A quality-improvement team examines the relationship between number of units processed per batch (X) and total quantity produced (Y). Which interpretation is most appropriate with respect to Pearson correlation?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_i4GvFk3.png\" width=\"648\" height=\"368\"></strong></span></p>",
      "unique_key": "Q7533800",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) There is no linear correlation between the two variables</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pearson’s r</strong> quantifies the <strong>strength of a linear relationship</strong> (−1 to +1).</span><br><span style=\"font-size:14.0pt;\">The plotted data demonstrate a <strong>non-linear</strong> association (Y increases with X, then decreases—an inverted U).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In such settings, the <strong>overall slope averaged across the range is near zero</strong>, so Pearson’s r will be <strong>close to 0</strong>, even though the variables are clearly related.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the correct interpretation is <strong>“no linear correlation.”</strong>&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A better analysis would use a <strong>quadratic term, spline/LOESS smoother, or piecewise model</strong> to capture curvature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. There is correlation between the two variables and the Pearson coefficient equals +1:&nbsp;</strong>Would require <strong>all points to lie on a single upward straight line</strong> with no scatter, which is not what the plot shows.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. There is correlation between the two variables and the Pearson coefficient equals –1:&nbsp;</strong>Would require a <strong>straight downward line</strong>; also not present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. There is no association between the two variables:</strong> Incorrect. The plot shows a <strong>clear association</strong>, just <strong>not linear</strong>. Saying “no association” confuses no linear correlation (r ≈ 0) with <strong>independence</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pearson correlation measures linear association only.</strong></span></li><li><span style=\"font-size:14.0pt;\">A correlation near zero <strong>does not exclude</strong> a strong <strong>non-linear</strong> relationship.</span></li><li><span style=\"font-size:14.0pt;\">Always inspect the scatterplot and, when curvature is present, use <strong>non-linear modeling</strong> (e.g., polynomial or spline).</span></li></ul>",
      "correct_choice_id": 382710,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96137/NEET_PG_30_Oct_2025_GT_PSM_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96137/NEET_PG_30_Oct_2025_GT_PSM_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96334,
      "choices": [
        {
          "id": 383480,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 383481,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 383482,
          "text": "<p><span style=\"font-size:14.0pt;\">3 only</span></p>"
        },
        {
          "id": 383483,
          "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following regarding CADASIL is incorrect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">MRI is frequently normal</span></li><li><span style=\"font-size:14.0pt;\">It is caused by a mutation in the NOTCH2 gene</span></li><li><span style=\"font-size:14.0pt;\">Definitive diagnosis can be made via nerve biopsy</span></li><li><span style=\"font-size:14.0pt;\">It is inherited in an autosomal recessive fashion</span></li></ol>",
      "unique_key": "Q7409673",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>CADASIL</strong> (<strong>Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy</strong>) is a <strong>hereditary small-vessel disease</strong> of the brain caused by a <strong>NOTCH3 gene mutation</strong> on <strong>chromosome 19</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Correct facts about CADASIL:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_n4RO5ir.png\" width=\"682\" height=\"414\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. MRI is frequently normal:&nbsp;</strong>Incorrect. MRI <strong>almost always shows abnormalities</strong>, even in asymptomatic carriers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Mutation in NOTCH2 gene:&nbsp;</strong>Incorrect. Mutation occurs in <strong>NOTCH3</strong>, not NOTCH2.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Definitive diagnosis via nerve biopsy:&nbsp;</strong>Incorrect. Diagnosis is made by <strong>skin biopsy</strong>, not nerve biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Autosomal recessive inheritance:&nbsp;</strong>Incorrect. CADASIL is <strong>autosomal dominant</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>CADASIL</strong> is an <strong>autosomal dominant small-vessel arteriopathy</strong> caused by <strong>NOTCH3 mutations</strong>.</span></li><li><span style=\"font-size:14.0pt;\">MRI shows <strong>leukoencephalopathy</strong> (especially in <strong>anterior temporal lobes</strong> and <strong>external capsule</strong>).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Skin biopsy</strong> confirms diagnosis (GOM deposits, NOTCH3 positivity).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nerve biopsy is not used</strong>, and <strong>MRI is not normal</strong>.</span></li></ul>",
      "correct_choice_id": 383480,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96334/Medicine_INICET_GT_30_Oct_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96334/Medicine_INICET_GT_30_Oct_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96127,
      "choices": [
        {
          "id": 382668,
          "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-b, 3-a, 4-d</span></p>"
        },
        {
          "id": 382669,
          "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
        },
        {
          "id": 382670,
          "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-d, 3-c, 4-b</span></p>"
        },
        {
          "id": 382671,
          "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following observance days with their correct dates:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-27%20133335.jpg\" width=\"983\" height=\"256\"></span></p>",
      "unique_key": "Q2173412",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1-c, 2-b, 3-a, 4-d</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>1-c. World Sight Day → 9th October:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">World Sight Day is observed on the second Thursday of October; in 2025 that falls on 9 Oct.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">2025 theme/campaign: #LoveYourEyes, with a focus on “putting people at the heart of eye health.”</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>2-b. UN Day → 24th October:</strong> UN Day marks the <strong>anniversary of the UN Charter entering into force (24 Oct 1945)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3-a. Universal Immunization Day → 10th November:&nbsp;</strong>In India, Universal/World Immunization Day is observed <strong>annually on 10 November</strong> to spotlight vaccination and the UIP/Mission Indradhanush.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4-d. World Mental Health Day → 10th October: 2025 theme (WFMH):</strong> <strong>“Access to Services – Mental Health in Catastrophes and Emergencies.”</strong> (Announced by the World Federation for Mental Health; also reflected by global mental-health partners.)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Important Days of Public Health Importance in Oct and Nov:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">1st October - International Day for Older Persons</span></li><li><span style=\"font-size:14.0pt;\">1st October - National Voluntary Blood Donation Day</span></li><li><span style=\"font-size:14.0pt;\">2nd Wednesday of October (Now 13 October) - World Disaster Reduction Day</span></li><li><span style=\"font-size:14.0pt;\">9th October - World Sight Day</span></li><li><span style=\"font-size:14.0pt;\">10th October - World Mental Health Day</span></li><li><span style=\"font-size:14.0pt;\">16th October - World Anesthesia Day</span></li><li><span style=\"font-size:14.0pt;\">24th October - UN Day</span></li><li><span style=\"font-size:14.0pt;\">10th November - Universal Immunization Day</span></li><li><span style=\"font-size:14.0pt;\">14th November - World Diabetes Day</span></li><li><span style=\"font-size:14.0pt;\">17th November - National Epilepsy Day</span></li><li><span style=\"font-size:14.0pt;\">25th November - International Day for Elimination of Violence against Women</span></li></ul>",
      "correct_choice_id": 382668,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96127/NEET_PG_30_Oct_2025_GT_PSM_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96127/NEET_PG_30_Oct_2025_GT_PSM_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96268,
      "choices": [
        {
          "id": 383220,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine procidentia with pressure ulceration</span></p>"
        },
        {
          "id": 383221,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterovaginal prolapse with decubitus ulcer</span></p>"
        },
        {
          "id": 383222,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete pelvic organ prolapse with mucosal erosion</span></p>"
        },
        {
          "id": 383223,
          "text": "<p><span style=\"font-size:14.0pt;\">Advanced uterine descent with vaginal wall ulcer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old postmenopausal woman reports a vaginal bulge that she has noticed for several months. She was initially able to push it back inside, but over the past few days, it has become painful and irreducible. On examination, a large mass is seen as shown in the image below. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-10-29%20101030.jpg\" width=\"631\" height=\"542\"></p>",
      "unique_key": "Q2004665",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Uterovaginal prolapse with decubitus ulcer</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Uterovaginal prolapse with decubitus ulcer</strong> is a common complication of long-standing pelvic organ prolapse, particularly in <strong>postmenopausal women</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Due to <strong>loss of estrogen</strong>, pelvic floor muscles and ligaments weaken, leading to uterine descent through the vagina.</span></li><li><span style=\"font-size:14.0pt;\">The exposed vaginal mucosa is prone to <strong>chronic pressure, friction, and infection</strong>, resulting in <strong>ulceration</strong>—called a <strong>decubitus ulcer</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key features in this patient:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Postmenopausal age</span></li><li><span style=\"font-size:14.0pt;\">Irreducible uterovaginal prolapse</span></li><li><span style=\"font-size:14.0pt;\">Reddish, ulcerated area (pressure necrosis) on the protruding surface</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These findings confirm the diagnosis of <strong>uterovaginal prolapse with decubitus ulcer</strong>.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Initial treatment:</strong> Local care with antiseptics or estrogen cream to promote healing of the ulcer.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Definitive treatment:</strong> Once healed, <strong>surgical repair</strong> such as vaginal hysterectomy with pelvic floor repair or <strong>Le Fort colpocleisis</strong> (if the patient no longer desires sexual function).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Uterine procidentia with pressure ulceration:&nbsp;</strong>Although similar in presentation, \"uterine procidentia\" refers to <strong>complete uterine prolapse</strong>, where the uterus lies entirely outside the vaginal introitus. It is often used interchangeably but “uterovaginal prolapse with decubitus ulcer” is the more accurate clinical diagnosis here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complete pelvic organ prolapse with mucosal erosion:&nbsp;</strong>This term describes generalized pelvic organ descent (including bladder or rectum) with mucosal changes, but the <strong>specific ulceration due to pressure</strong> defines it as a <strong>decubitus ulcer</strong> rather than simple mucosal erosion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Advanced uterine descent with vaginal wall ulcer:&nbsp;</strong>While advanced uterine descent can cause ulceration, this is a <strong>nonspecific term</strong>. The precise diagnosis, per gynecologic terminology, is <strong>uterovaginal prolapse with decubitus ulcer</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Uterovaginal prolapse with decubitus ulcer</strong> occurs when prolonged prolapse causes <strong>pressure necrosis and ulceration</strong> of the exposed vaginal mucosa.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a hallmark complication of <strong>long-standing, irreducible uterine prolapse</strong> in postmenopausal women.</span></li></ul>",
      "correct_choice_id": 383221,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96268/Ini-Cet_Gt_30_Oct_2025_Obg_Q_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96268/Ini-Cet_Gt_30_Oct_2025_Obg_Q_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96382,
      "choices": [
        {
          "id": 383672,
          "text": "<p><span style=\"font-size:14.0pt;\">Hashimoto’s Thyroiditis</span></p>"
        },
        {
          "id": 383673,
          "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune Lymphoproliferative Syndrome (ALPS)</span></p>"
        },
        {
          "id": 383674,
          "text": "<p><span style=\"font-size:14.0pt;\">Goodpasture’s Syndrome</span></p>"
        },
        {
          "id": 383675,
          "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A mutation in the AIRE gene results in defective negative selection of autoreactive T cells in the thymus. This defect leads to failure of central tolerance and development of which of the following disorders?&nbsp;</span></p>",
      "unique_key": "Q5433630",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Autoimmune Polyendocrinopathy - Candidiasis-Ectodermal Dystrophy (APECED)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>AIRE (Autoimmune Regulator)</strong> gene is essential for <strong>central tolerance</strong> during T-cell development in the thymus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Normal function:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">AIRE promotes the expression of <strong>self-antigens</strong> in <strong>thymic medullary epithelial cells</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This allows developing T cells to be exposed to a wide variety of self-antigens.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Autoreactive T cells</strong> that bind too strongly to self-antigens undergo <strong>negative selection (apoptosis)</strong> — preventing autoimmunity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Defect:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mutation in the <strong>AIRE gene</strong> → failure to eliminate self-reactive T cells → multiple autoimmune disorders.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical features of APECED:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Autoimmune adrenal insufficiency</span></li><li><span style=\"font-size:14.0pt;\">Hypoparathyroidism</span></li><li><span style=\"font-size:14.0pt;\">Chronic mucocutaneous candidiasis&nbsp;(Also called <strong>Autoimmune Polyendocrinopathy Syndrome Type I</strong>)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hashimoto’s Thyroiditis:&nbsp;</strong>An <strong>organ-specific autoimmune disease</strong> due to <strong>autoantibodies against thyroid antigens (TPO, thyroglobulin)</strong>, not caused by AIRE gene mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Autoimmune Lymphoproliferative Syndrome (ALPS):&nbsp;</strong>Caused by a defect in <strong>FAS gene (CD95)</strong>, leading to failure of apoptosis of self-reactive lymphocytes in the periphery, not a defect in AIRE.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Goodpasture’s Syndrome:&nbsp;</strong>Due to <strong>autoantibodies against type IV collagen</strong> in basement membranes of lungs and kidneys — not related to T-cell negative selection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>AIRE gene</strong> regulates the expression of self-antigens in <strong>thymic medullary epithelial cells</strong>, promoting <strong>negative selection of autoreactive T cells</strong>. Defects in AIRE lead to <strong>Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)</strong>.</span></p>",
      "correct_choice_id": 383675,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96382/Pathology_INICET_GT_30_Oct_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96382/Pathology_INICET_GT_30_Oct_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96116,
      "choices": [
        {
          "id": 382628,
          "text": "<p><span style=\"font-size:14.0pt;\">Arachidonic acid, Linoleic acid, Gamma-linolenic acid</span></p>"
        },
        {
          "id": 382629,
          "text": "<p><span style=\"font-size:14.0pt;\">Palmitic acid, Stearic acid, Oleic acid</span></p>"
        },
        {
          "id": 382630,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervonic acid, Alpha-linolenic acid, Timnodonic acid&nbsp;</span></p>"
        },
        {
          "id": 382631,
          "text": "<p><span style=\"font-size:14.0pt;\">Linoleic acid, Arachidonic acid, Palmitic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following groups consists of omega 3 fatty acids that play essential roles in neural, retinal, and cardiovascular health?&nbsp;</span></p>",
      "unique_key": "Q4414170",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cervonic acid, Alpha-linolenic acid, Timnodonic acid</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Omega-3 fatty acids</strong> are a class of <strong>polyunsaturated fatty acids (PUFAs)</strong> characterized by the position of their first double bond at the <strong>third carbon from the methyl (ω) end</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are essential for maintaining <strong>cell membrane integrity, neuronal development, visual function, and anti-inflammatory responses</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The key omega-3 fatty acids include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Alpha-linolenic acid (ALA)</strong> – 18:3 (ω-3), a plant-derived essential fatty acid.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Timnodonic acid (Eicosapentaenoic acid, EPA)</strong> – 20:5 (ω-3), abundant in fish oil.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cervonic acid (Docosahexaenoic acid, DHA)</strong> – 22:6 (ω-3), vital for brain and retinal tissue.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These fatty acids contribute to the synthesis of <strong>anti-inflammatory eicosanoids</strong> and <strong>protective membrane phospholipids</strong> in neural and cardiac cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Arachidonic acid, Linoleic acid, Gamma-linolenic acid:&nbsp;</strong>These are <strong>omega-6 fatty acids</strong>, precursors to <strong>pro-inflammatory prostaglandins and leukotrienes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Palmitic acid, Stearic acid, Oleic acid:&nbsp;</strong>Palmitic and stearic acids are <strong>saturated</strong>, while oleic acid is <strong>monounsaturated (ω-9)</strong>—none are ω-3 PUFAs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Linoleic acid, Arachidonic acid, Palmitic acid:&nbsp;</strong>Linoleic and arachidonic acids are <strong>omega-6</strong>, and palmitic acid is <strong>saturated</strong>, not omega-3.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cervonic acid (DHA), Timnodonic acid (EPA), and Alpha-linolenic acid (ALA)</strong> are the principal <strong>omega-3 fatty acids</strong>, with the first double bond located at the <strong>third carbon from the methyl end</strong>, providing <strong>anti-inflammatory, neuroprotective, and cardioprotective</strong> effects.</span></p>",
      "correct_choice_id": 382630,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96116/Biochemistry_INICET_GT_30_Oct_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96116/Biochemistry_INICET_GT_30_Oct_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}